0001558370-21-014427.txt : 20211104 0001558370-21-014427.hdr.sgml : 20211104 20211104061751 ACCESSION NUMBER: 0001558370-21-014427 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211104 DATE AS OF CHANGE: 20211104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 22nd Century Group, Inc. CENTRAL INDEX KEY: 0001347858 STANDARD INDUSTRIAL CLASSIFICATION: CIGARETTES [2111] IRS NUMBER: 980468420 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36338 FILM NUMBER: 211377836 BUSINESS ADDRESS: STREET 1: 8560 MAIN STREET STREET 2: SUITE 4 CITY: WILLIAMSVILLE STATE: NY ZIP: 14221 BUSINESS PHONE: (716) 270-1523 MAIL ADDRESS: STREET 1: 8560 MAIN STREET STREET 2: SUITE 4 CITY: WILLIAMSVILLE STATE: NY ZIP: 14221 FORMER COMPANY: FORMER CONFORMED NAME: Touchstone Mining LTD DATE OF NAME CHANGE: 20051222 10-Q 1 xxii-20210930x10q.htm 10-Q
P5YP5Y0001347858--12-312021Q3falseP10Y162735483139061690P42MP14MP3YP1YP5YP2YP1YP9MP2Yhttp://fasb.org/us-gaap/2021-01-31#MeasurementInputPriceVolatilityMemberhttp://fasb.org/us-gaap/2021-01-31#MeasurementInputPriceVolatilityMemberP40Y0.0357140001347858xxii:KeygeneMemberxxii:SponsoredResearchAgreementMember2021-04-302021-04-300001347858xxii:TwentySecondCenturyLtdMember2021-01-012021-09-300001347858xxii:BotanicalGeneticsMember2021-01-012021-09-300001347858xxii:NorthCarolinaStateUniversityMemberxxii:LicenseAgreementMember2021-01-012021-09-300001347858xxii:ManufacturingFacilityAndWarehouseInNorthCarolinaMemberus-gaap:SubsequentEventMember2021-10-182021-10-180001347858xxii:ResearchAndDevelopmentLaboratoryInRockvilleMdMember2021-07-282021-07-280001347858xxii:InvestmentInPanaceaLifeSciencesInc.Memberus-gaap:WarrantMember2019-12-030001347858us-gaap:WarrantMember2021-01-012021-09-300001347858us-gaap:WarrantMember2020-01-012020-12-310001347858xxii:ExactusMember2021-06-302021-06-300001347858xxii:NorthCarolinaStateUniversityMemberxxii:LicenseAgreementMember2020-01-012020-06-300001347858xxii:CannametrixMemberxxii:SponsoredResearchAgreementMember2021-03-012021-03-010001347858xxii:KeygeneMemberxxii:SponsoredResearchAgreementMember2021-01-012021-09-300001347858xxii:InvestmentInPanaceaLifeSciencesInc.Memberus-gaap:WarrantMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2019-12-030001347858xxii:InvestmentInPanaceaLifeSciencesInc.Memberus-gaap:WarrantMemberus-gaap:MeasurementInputPriceVolatilityMember2019-12-030001347858xxii:InvestmentInPanaceaLifeSciencesInc.Memberus-gaap:WarrantMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2019-12-030001347858us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001347858us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300001347858us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300001347858us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001347858us-gaap:CommonStockMember2021-07-012021-09-300001347858us-gaap:CommonStockMember2020-07-012020-09-3000013478582021-06-072021-06-070001347858us-gaap:CommonStockMember2021-04-012021-06-300001347858xxii:ExactusMemberus-gaap:SubsequentEventMember2021-10-282021-10-280001347858us-gaap:RetainedEarningsMember2021-09-300001347858us-gaap:AdditionalPaidInCapitalMember2021-09-300001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300001347858us-gaap:RetainedEarningsMember2021-06-300001347858us-gaap:AdditionalPaidInCapitalMember2021-06-300001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001347858us-gaap:RetainedEarningsMember2021-03-310001347858us-gaap:AdditionalPaidInCapitalMember2021-03-310001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001347858us-gaap:RetainedEarningsMember2020-12-310001347858us-gaap:AdditionalPaidInCapitalMember2020-12-310001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001347858us-gaap:RetainedEarningsMember2020-09-300001347858us-gaap:AdditionalPaidInCapitalMember2020-09-300001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-300001347858us-gaap:RetainedEarningsMember2020-06-300001347858us-gaap:AdditionalPaidInCapitalMember2020-06-300001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001347858us-gaap:RetainedEarningsMember2020-03-310001347858us-gaap:AdditionalPaidInCapitalMember2020-03-310001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-3100013478582020-03-310001347858us-gaap:RetainedEarningsMember2019-12-310001347858us-gaap:AdditionalPaidInCapitalMember2019-12-310001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001347858us-gaap:CommonStockMember2021-09-300001347858us-gaap:CommonStockMember2021-06-300001347858us-gaap:CommonStockMember2021-03-310001347858us-gaap:CommonStockMember2020-12-310001347858us-gaap:CommonStockMember2020-09-300001347858us-gaap:CommonStockMember2020-06-300001347858us-gaap:CommonStockMember2020-03-310001347858us-gaap:CommonStockMember2019-12-3100013478582021-06-0700013478582021-03-310001347858us-gaap:ShareBasedPaymentArrangementNonemployeeMember2021-01-012021-09-300001347858us-gaap:ShareBasedPaymentArrangementEmployeeMember2021-01-012021-09-300001347858us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-07-012021-09-300001347858us-gaap:ResearchAndDevelopmentExpenseMember2021-07-012021-09-300001347858us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-09-300001347858us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-09-300001347858us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-07-012020-09-300001347858us-gaap:ResearchAndDevelopmentExpenseMember2020-07-012020-09-300001347858us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-09-300001347858us-gaap:TransferredOverTimeMember2021-07-012021-09-300001347858us-gaap:TransferredAtPointInTimeMember2021-07-012021-09-300001347858us-gaap:TransferredOverTimeMember2021-01-012021-09-300001347858us-gaap:TransferredAtPointInTimeMember2021-01-012021-09-300001347858us-gaap:TransferredOverTimeMember2020-07-012020-09-300001347858us-gaap:TransferredAtPointInTimeMember2020-07-012020-09-300001347858us-gaap:TransferredOverTimeMember2020-01-012020-09-300001347858us-gaap:TransferredAtPointInTimeMember2020-01-012020-09-300001347858xxii:ProductsOtherThanModifiedRiskTobaccoProductsMember2021-07-012021-09-300001347858xxii:ModifiedRiskTobaccoProductMember2021-07-012021-09-300001347858xxii:ProductsOtherThanModifiedRiskTobaccoProductsMember2021-01-012021-09-300001347858xxii:ModifiedRiskTobaccoProductMember2021-01-012021-09-300001347858xxii:ProductsOtherThanModifiedRiskTobaccoProductsMember2020-07-012020-09-300001347858xxii:ModifiedRiskTobaccoProductMember2020-07-012020-09-300001347858xxii:ProductsOtherThanModifiedRiskTobaccoProductsMember2020-01-012020-09-300001347858xxii:ModifiedRiskTobaccoProductMember2020-01-012020-09-300001347858srt:MinimumMemberus-gaap:EquipmentMember2021-01-012021-09-300001347858srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2021-01-012021-09-300001347858srt:MaximumMemberus-gaap:EquipmentMember2021-01-012021-09-300001347858srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2021-01-012021-09-300001347858us-gaap:OtherMachineryAndEquipmentMember2021-01-012021-09-300001347858us-gaap:FurnitureAndFixturesMember2021-01-012021-09-300001347858us-gaap:OtherMachineryAndEquipmentMember2021-09-300001347858us-gaap:LandMember2021-09-300001347858us-gaap:FurnitureAndFixturesMember2021-09-300001347858us-gaap:EquipmentMember2021-09-300001347858us-gaap:ConstructionInProgressMember2021-09-300001347858us-gaap:BuildingAndBuildingImprovementsMember2021-09-300001347858us-gaap:OtherMachineryAndEquipmentMember2020-12-310001347858us-gaap:FurnitureAndFixturesMember2020-12-310001347858us-gaap:EquipmentMember2020-12-310001347858us-gaap:BuildingAndBuildingImprovementsMember2020-12-3100013478582020-05-122020-05-1200013478582019-01-012019-12-310001347858xxii:InvestmentInPanaceaLifeSciencesInc.Member2019-12-032019-12-030001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300001347858xxii:UniversityOfKentuckyMemberxxii:LicenseAgreementMember2018-10-220001347858xxii:NorthCarolinaStateUniversityMemberxxii:LicenseAgreementMember2018-06-220001347858xxii:InvestmentInPanaceaLifeSciencesInc.Member2021-06-302021-06-300001347858us-gaap:RetainedEarningsMember2021-07-012021-09-300001347858us-gaap:RetainedEarningsMember2021-04-012021-06-300001347858us-gaap:RetainedEarningsMember2021-01-012021-03-310001347858us-gaap:CommonStockMember2021-01-012021-03-310001347858us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-3100013478582021-01-012021-03-310001347858us-gaap:RetainedEarningsMember2020-07-012020-09-300001347858us-gaap:RetainedEarningsMember2020-04-012020-06-300001347858us-gaap:RetainedEarningsMember2020-01-012020-03-310001347858us-gaap:CommonStockMember2020-01-012020-03-310001347858us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001347858us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-3100013478582020-01-012020-03-310001347858us-gaap:MoneyMarketFundsMember2021-09-3000013478582020-01-1500013478582019-11-190001347858xxii:AuroraCannabisIncMemberus-gaap:WarrantMember2021-09-300001347858xxii:ExactusMember2021-06-300001347858xxii:InvestmentInPanaceaLifeSciencesInc.Memberus-gaap:WarrantMember2020-12-310001347858xxii:InvestmentInPanaceaLifeSciencesInc.Memberus-gaap:PreferredStockMember2020-12-310001347858xxii:AuroraCannabisIncMemberus-gaap:WarrantMember2020-12-310001347858xxii:ResearchAndDevelopmentLaboratoryInRockvilleMdMember2021-07-280001347858xxii:ManufacturingFacilityAndWarehouseInNorthCarolinaMemberus-gaap:SubsequentEventMember2021-10-180001347858xxii:ExactusMemberus-gaap:SubsequentEventMember2021-10-280001347858xxii:ExactusMember2021-09-300001347858us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-09-300001347858us-gaap:CostOfSalesMember2020-01-012020-09-300001347858us-gaap:LicensingAgreementsMember2021-09-300001347858us-gaap:ContractualRightsMember2021-09-300001347858us-gaap:LicensingAgreementsMember2020-12-310001347858us-gaap:ContractualRightsMember2020-12-310001347858xxii:UniversityOfKentuckyMemberxxii:LicenseAgreementMember2018-10-222018-10-220001347858xxii:NorthCarolinaStateUniversityMemberxxii:LicenseAgreementMember2018-06-222018-06-220001347858us-gaap:LicensingAgreementsMember2021-09-300001347858us-gaap:IntellectualPropertyMember2021-09-300001347858us-gaap:LicensingAgreementsMember2020-12-310001347858us-gaap:IntellectualPropertyMember2020-12-310001347858xxii:InvestmentInPanaceaLifeSciencesInc.Memberus-gaap:WarrantMember2020-04-012020-06-300001347858us-gaap:WarrantMember2021-09-300001347858us-gaap:WarrantMember2020-12-3100013478582021-04-012021-06-3000013478582020-04-012020-06-3000013478582021-06-3000013478582020-06-300001347858xxii:MinimumAnnualRoyalty2Memberxxii:LicenseAgreementMember2021-09-300001347858xxii:MinimumAnnualRoyalty1Memberxxii:LicenseAgreementMember2021-09-300001347858xxii:KeygeneMemberxxii:SponsoredResearchAgreementMember2021-09-300001347858xxii:CannametrixMemberxxii:SponsoredResearchAgreementMember2021-09-300001347858xxii:AnnualRoyaltyMemberxxii:LicenseAgreementMember2021-09-300001347858xxii:SublicenseAgreementWithAnandiaLaboratoriesInc.Member2021-09-300001347858xxii:GrowingAgreementMember2021-09-300001347858xxii:ConsultingAgreementMember2021-09-300001347858xxii:InvestmentInPanaceaLifeSciencesInc.Member2019-12-0300013478582020-09-3000013478582019-12-310001347858us-gaap:CorporateBondSecuritiesMember2021-09-300001347858us-gaap:PreferredStockMember2020-12-310001347858us-gaap:NotesReceivableMember2020-12-310001347858us-gaap:CorporateBondSecuritiesMember2020-12-310001347858us-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:WarrantMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:WarrantMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:CommonStockMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:CommonStockMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:CommonStockMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:CommonStockMemberus-gaap:FairValueMeasurementsRecurringMember2021-09-300001347858us-gaap:WarrantMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:WarrantMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:WarrantMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:WarrantMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:NotesReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001347858xxii:InvestmentInPanaceaLifeSciencesInc.Member2021-06-300001347858us-gaap:RestrictedStockUnitsRSUMember2021-07-012021-09-300001347858us-gaap:OptionMember2021-07-012021-09-300001347858us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-09-300001347858us-gaap:OptionMember2021-01-012021-09-300001347858us-gaap:WarrantMember2020-07-012020-09-300001347858us-gaap:RestrictedStockUnitsRSUMember2020-07-012020-09-300001347858us-gaap:OptionMember2020-07-012020-09-300001347858us-gaap:WarrantMember2020-01-012020-09-300001347858us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-09-300001347858us-gaap:OptionMember2020-01-012020-09-3000013478582021-07-012021-09-3000013478582020-07-012020-09-3000013478582020-01-012020-09-300001347858us-gaap:BorrowingsMember2021-07-012021-09-300001347858us-gaap:BorrowingsMember2021-01-012021-09-300001347858us-gaap:BorrowingsMember2020-07-012020-09-300001347858us-gaap:BorrowingsMember2020-01-012020-09-3000013478582021-09-3000013478582020-12-3100013478582021-11-0300013478582021-01-012021-09-30xbrli:sharesiso4217:USDutr:acreiso4217:USDxbrli:sharesxbrli:purexxii:itemutr:sqftxxii:subsidiary

UNITED STATES

SECURITIES AND EXCHANGE

COMMISSION WASHINGTON, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2021

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From ________ to ________

Commission File Number: 001-36338

22nd Century Group, Inc.

(Exact name of registrant as specified in its charter)

Nevada

    

98-0468420

(State or other jurisdiction

(IRS Employer

of incorporation)

Identification No.)

500 Seneca Street, Suite 507, Buffalo, New York 14204

(Address of principal executive offices)

(716) 270-1523

(Registrant’s telephone number, including area code)

Securities registered under Section 12(b) of the Act:

Title of each class

    

Ticker symbol

    

Name of Exchange on Which Registered

Common Stock, $0.00001 par value

 

XXII 

 

NASDAQ Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes    No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes    No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes   No  

As of November 3, 2021, there were 162,748,483 shares of common stock issued and outstanding.

22nd CENTURY GROUP, INC.

INDEX

 

 

Page

Number

PART I.

FINANCIAL INFORMATION

 

 

 

 

Item 1.

Financial Statements

 

 

 

 

Consolidated Balance Sheets as of September 30, 2021 (unaudited) and December 31, 2020

3

 

 

Consolidated Statements of Operations and Comprehensive Loss for the Three and Nine Months Ended September 30, 2021 and 2020 (unaudited)

4

 

 

Consolidated Statements of Changes in Shareholders’ Equity for the Three and Nine Months ended September 30, 2021 and 2020 (unaudited)

5

 

 

Consolidated Statements of Cash Flows for the Nine Months ended September 30, 2021 and 2020 (unaudited)

6

 

 

Notes to Consolidated Financial Statements (unaudited)

7

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

24

 

 

 

Item 4.

Controls and Procedures

36

 

 

 

PART II.

OTHER INFORMATION

37

 

 

 

Item 1.

Legal Proceedings

37

 

 

 

Item 1A.

Risk Factors

37

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

37

 

 

 

Item 3.

Default Upon Senior Securities

37

 

 

 

Item 4.

Mine Safety Disclosures

37

 

 

 

Item 5.

Other Information

37

 

 

 

Item 6.

Exhibits

38

 

 

 

SIGNATURES

39

2

22nd CENTURY GROUP, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

($ in thousands, except per-share data)

September 30, 

December 31, 

    

2021

    

2020

ASSETS

 

  

 

  

Current assets:

 

  

 

  

Cash and cash equivalents

$

1,629

$

1,029

Short-term investment securities

 

53,532

 

21,313

Accounts receivable, net

 

1,179

 

2,159

Inventory, net

 

2,703

 

2,034

Prepaid expenses and other assets

 

3,131

 

1,806

Total current assets

 

62,174

 

28,341

Property, plant and equipment, net

 

4,754

 

2,483

Operating leases right-of-use assets, net

 

478

 

247

Intangible assets, net

 

8,036

 

8,211

Investments

 

7,300

 

6,536

Other assets

3,713

5,876

Total assets

$

86,455

$

51,694

 

  

 

  

LIABILITIES AND SHAREHOLDERS' EQUITY

 

  

 

  

Current liabilities:

 

  

 

  

Notes payable

$

1,782

$

539

Operating lease obligations

 

74

 

247

Accounts payable

 

1,443

 

1,116

Accrued expenses

 

3,440

 

4,830

Accrued severance

 

223

 

339

Deferred income

 

 

272

Total current liabilities

 

6,962

 

7,343

Long-term liabilities:

 

  

 

  

Operating lease obligations

 

407

 

Severance obligations

72

241

Total liabilities

7,441

7,584

Commitments and contingencies (Note 11)

 

 

Shareholders' equity

 

  

 

  

10,000,000 preferred shares, $.00001 par value

 

  

 

  

300,000,000 common shares, $.00001 par value

 

  

 

  

Capital stock issued and outstanding:

 

  

 

  

162,735,483 common shares (139,061,690 at December 31, 2020)

 

 

Common stock value

2

1

Capital in excess of par value

 

243,087

 

189,439

Accumulated other comprehensive (loss) income

 

(27)

 

74

Accumulated deficit

 

(164,048)

 

(145,404)

Total shareholders' equity

 

79,014

 

44,110

Total liabilities and shareholders’ equity

$

86,455

$

51,694

See accompanying notes to consolidated financial statements.

3

22nd CENTURY GROUP, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

($ in thousands, except per-share data)

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2021

    

2020

    

2021

    

2020

Revenue:

  

 

  

Sale of products, net

$

7,811

$

7,310

$

22,988

$

20,803

Cost of goods sold (exclusive of depreciation shown separately below):

 

  

 

  

 

 

Products

 

7,362

 

6,948

 

21,306

 

19,953

Gross profit (loss)

 

449

 

362

 

1,682

 

850

Operating expenses:

 

  

 

  

 

 

Research and development

 

854

 

906

 

2,287

 

2,676

Research and development - MRTP

2

4

16

158

Sales, general and administrative

 

6,821

 

3,169

 

17,827

 

9,809

Impairment of intangible assets

 

 

 

146

Depreciation

 

173

 

160

 

461

 

473

Amortization

 

168

 

163

 

471

 

524

Total operating expenses

 

8,018

 

4,402

 

21,062

 

13,786

Operating loss

 

(7,569)

 

(4,040)

 

(19,380)

 

(12,936)

Other income (expense):

 

  

 

  

 

 

Unrealized gain (loss) on investments

 

(1,900)

 

(429)

 

(2,040)

 

(562)

Impairment of Panacea investment

(1,062)

Gain on Panacea investment conversion

2,548

Gain on the sale of property, plant and equipment

 

 

1

 

 

1

Interest income, net

 

52

 

270

 

272

 

1,344

Interest expense

 

(23)

 

(23)

 

(44)

 

(54)

Total other income (expense)

 

(1,871)

 

(181)

 

736

 

(333)

Loss before income taxes

 

(9,440)

(4,221)

 

(18,644)

(13,269)

Income taxes

 

 

 

38

Net loss

$

(9,440)

$

(4,221)

$

(18,644)

$

(13,307)

Other comprehensive income (loss):

 

  

 

  

 

 

Unrealized gain (loss) on short-term investment securities

 

(28)

 

87

 

(101)

 

132

Other comprehensive income (loss)

(28)

87

(101)

132

Comprehensive loss

$

(9,468)

$

(4,134)

$

(18,745)

$

(13,175)

Net loss per common share - basic and diluted

$

(0.06)

$

(0.03)

$

(0.12)

$

(0.10)

Weighted average common shares outstanding - basic and diluted (in thousands)

 

162,721

 

138,857

 

153,998

 

138,774

See accompanying notes to consolidated financial statements.

4

22nd CENTURY GROUP, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(Unaudited)

($ in thousands)

Three and Nine Months Ended September 30, 2021

Accumulated

Common

Par Value

Capital in

Other

Total

Shares

of Common

Excess of

Comprehensive

Accumulated

Shareholders’

    

Outstanding

    

Shares

    

Par Value

    

Income (Loss)

    

Deficit

    

Equity

Balance at December 31, 2020

 

139,061,690

$

1

 

$

189,439

 

$

74

 

$

(145,404)

$

44,110

Stock issued in connection with RSU vesting

 

1,196,258

 

 

 

 

 

Stock issued in connection with option exercises

846,342

1,153

1,153

Stock issued in connection with warrant exercises

11,293,211

1

11,781

11,782

Equity-based compensation

 

 

 

507

 

 

 

507

Unrealized gain (loss) on short-term investment securities

 

 

 

 

(32)

 

 

(32)

Net loss

 

 

 

 

 

(5,030)

 

(5,030)

Balance at March 31, 2021

152,397,501

$

2

$

202,880

$

42

$

(150,434)

$

52,490

Stock issued in connection with RSU vesting, net of shares withheld for taxes

200,103

(469)

(469)

Stock issued in connection with option exercises

87,879

106

106

Stock issued in connection with capital raise

10,000,000

38,206

38,206

Equity-based compensation

1,245

1,245

Unrealized gain (loss) on short-term investment securities

(41)

(41)

Net loss

(4,174)

(4,174)

Balance at June 30, 2021

 

162,685,483

$

2

$

241,968

$

1

$

(154,608)

$

87,363

Stock issued in connection with RSU vesting

50,000

Equity-based compensation

1,119

1,119

Unrealized gain (loss) on short-term investment securities

(28)

(28)

Net loss

(9,440)

(9,440)

Balance at September 30, 2021

 

162,735,483

$

2

$

243,087

$

(27)

$

(164,048)

$

79,014

Three and Nine Months Ended September 30, 2020

Accumulated

Common

Par Value

Capital in

Other

Total

Shares

of Common

Excess of

Comprehensive

Accumulated

Shareholders’

    

Outstanding

    

Shares

    

Par Value

    

Income (Loss)

    

Deficit

    

Equity

Balance at December 31, 2019

 

138,362,809

$

1

$

187,735

$

7

$

(125,693)

$

62,050

Stock issued in connection with RSU vesting

491,384

Equity-based compensation

 

 

 

480

 

 

 

480

Unrealized gain (loss) on short-term investment securities

(196)

(196)

Reclassification of losses (gains) to net loss

3

3

Net loss

(4,029)

(4,029)

Balance at March 31, 2020

138,854,193

$

1

$

188,215

$

(186)

$

(129,722)

$

58,308

Equity-based compensation

 

376

376

Unrealized gain (loss) on short-term investment securities

241

241

Reclassification of losses (gains) to net loss

(3)

(3)

Net loss

(5,057)

(5,057)

Balance at June 30, 2020

138,854,193

$

1

$

188,591

$

52

$

(134,779)

$

53,865

Stock issued in connection with RSU vesting

5,000

Equity-based compensation

306

306

Unrealized gain (loss) on short-term investment securities

87

87

Net loss

(4,221)

(4,221)

Balance at September 30, 2020

 

138,859,193

$

1

$

188,897

$

139

$

(139,000)

$

50,037

See accompanying notes to consolidated financial statements.

5

22nd CENTURY GROUP, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

($ in thousands)

Nine Months Ended

September 30, 

    

2021

    

2020

Cash flows from operating activities:

 

  

 

  

Net loss

$

(18,644)

$

(13,307)

Adjustments to reconcile net loss to cash used in operating activities:

 

  

 

  

Impairment of intangible assets

146

Impairment of Panacea investment

1,062

Amortization and depreciation

 

745

 

810

Amortization of license fees

 

187

 

187

Amortization of ROU Asset

 

214

 

232

Unrealized (gain) loss on investment

 

2,040

 

562

Gain on the sale of machinery and equipment

 

 

(1)

Gain on Panacea investment conversion

 

(2,548)

Accretion of non-cash interest expense (income)

13

(222)

Equity-based employee compensation expense

 

2,871

 

1,162

Inventory write-off

219

(Increase) decrease in assets:

 

  

 

  

Accounts receivable

 

980

 

(692)

Inventory

 

(669)

 

(264)

Prepaid expenses and other assets

 

(1,494)

 

(1,754)

Increase (decrease) in liabilities:

 

 

  

Operating lease obligations

 

(212)

 

(228)

Accounts payable

 

289

 

(924)

Accrued expenses

 

(1,422)

 

481

Accrued severance

(285)

(88)

Deferred income

 

(272)

 

(5)

Net cash provided by (used in) operating activities

 

(18,207)

 

(12,624)

Cash flows from investing activities:

 

  

 

Acquisition of patents, trademarks, and licenses

 

(239)

 

(342)

Acquisition of property, plant and equipment

 

(470)

 

(33)

Sales and maturities of short-term investment securities

 

52,203

 

28,960

Purchase of short-term investment securities

 

(84,701)

 

(15,830)

Net cash provided by (used in) investing activities

 

(33,207)

 

12,755

Cash flows from financing activities:

 

  

 

Payment on note payable

(1,417)

(1,269)

Proceeds from note payable issuance

2,653

2,195

Net proceeds from option exercise

1,259

Net proceeds from warrant exercise

11,782

Net proceeds from issuance of common stock

38,206

Taxes paid related to net share settlement of RSUs

(469)

Proceeds from SBA loan

1,183

Repayment of SBA loan

(1,183)

Net cash provided by (used in) financing activities

 

52,014

 

926

Net increase (decrease) in cash and cash equivalents

 

600

 

1,057

Cash and cash equivalents - beginning of period

 

1,029

 

485

Cash and cash equivalents - end of period

$

1,629

$

1,542

Supplemental disclosures of cash flow information:

 

  

 

  

Net cash paid for:

 

  

 

  

Cash paid during the period for interest

$

26

$

19

Non-cash transactions:

 

  

 

  

Patent and trademark additions included in accounts payable

$

35

$

19

Property, plant and equipment additions included in accounts payable

$

4

$

9

Property, plant and equipment additions included in accrued expenses

$

10

$

Right-of-use assets and corresponding operating lease obligations

$

497

$

198

Patent and trademark additions included in accrued expenses

$

22

$

46

Panacea investment conversion

$

12,485

$

See accompanying notes to consolidated financial statements.

6

22nd CENTURY GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2021

(Unaudited)

Amounts in thousands, except for share and per-share data

NOTE 1. - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation - The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring accruals considered necessary for a fair and non-misleading presentation of the financial statements have been included.

Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements.

These interim consolidated financial statements should be read in conjunction with the December 31, 2020 audited consolidated financial statements and the notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on March 11, 2021.

Principles of Consolidation - The accompanying consolidated financial statements include the accounts of (i) 22nd Century Group, Inc. (“22nd Century Group”); (ii) its four wholly-owned subsidiaries, 22nd Century Limited, LLC (“22nd Century Ltd”), NASCO Products, LLC (“NASCO”), Botanical Genetics, LLC (“Botanical Genetics”), and 22nd Century Group Canada, Inc. (“22nd Century Group Canada”); (iii) two wholly-owned subsidiaries of 22nd Century Ltd, Goodrich Tobacco Company, LLC (“Goodrich Tobacco”) and Heracles Pharmaceuticals, LLC (“Heracles Pharma”); and (iv) one wholly-owned subsidiary of Botanical Genetics, 22nd Century Holdings, LLC (“22nd Century Holdings”). This group of subsidiaries is referred to as collectively with 22nd Century Group as the “Company”. All intercompany accounts and transactions have been eliminated.

Nature of Business – 22nd Century Group is a leading agricultural biotechnology and intellectual property company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. 22nd Century Ltd performs research and development related to the level of nicotine and other nicotinic alkaloids in tobacco plants and Botanical Genetics performs research and development related to hemp/cannabis plants. Goodrich Tobacco and Heracles Pharma are business units for the Company’s potential modified risk tobacco products. NASCO is a federally licensed tobacco products manufacturer, a subsequent participating member under the tobacco Master Settlement Agreement (“MSA”) between the tobacco industry and the settling states under the MSA and operates the Company’s tobacco products manufacturing business in North Carolina. 22nd Century Holdings and 22nd Century Group Canada are two newly formed subsidiaries where 22nd Century Holdings will own and operate the newly acquired Needle Rock Farm assets and 22nd Century Group Canada will allow for future international business opportunities in Canada.

Reclassifications Certain prior period amounts have been reclassified to conform to the current period’s classification. None of these reclassifications had a material impact on our consolidated financial statements.

COVID-19 Pandemic – The COVID-19 pandemic has adversely impacted the U.S. economy and supply chains and created volatility in U.S. financial markets. The COVID-19 pandemic has had a minimal impact on the Company’s operations in 2020 and thus far in 2021, but there is a risk that state and federal authorities’ responses to the COVID-19 pandemic or another pandemic may disrupt our business in the future.

During April 2021, the Company relocated its corporate headquarters into downtown Buffalo, NY. The new office, as well as all of our facilities, continue to operate in compliance with New York and North Carolina guidance (as applicable) related to the prevention of COVID-19 transmission and employee safety. We also continue to allow remote work arrangements by our employees where job duties permit.

7

Our executive leadership team and staff are monitoring this evolving situation and its impacts on our business. We will continue to monitor the local, state, and federal guidance regarding our business practices.

Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

Intangible Assets – Intangible assets are recorded at cost and consist primarily of (1) expenditures incurred with third-parties related to the processing of patent claims and trademarks with government authorities, as well as costs to acquire patent rights from third-parties, (2) license fees paid for third-party intellectual property, (3) costs to become a signatory under the tobacco MSA, and (4) license fees paid to acquire a predicate cigarette brand. The amounts capitalized relate to intellectual property that the Company owns or to which it has rights to use.

The Company’s capitalized intellectual property costs are amortized using the straight-line method over the remaining statutory life of the patent assets in each of the Company’s patent families, which have estimated expiration dates ranging from 2026 to 2041. Periodic maintenance or renewal fees are expensed as incurred. Annual minimum license fees are charged to expense. License fees paid for third-party intellectual property are amortized on a straight-line basis over the last to expire patents, which have expected expiration dates ranging from 2028 through 2036. The Company believes that costs associated with becoming a signatory to the MSA and costs related to the acquisition of a predicate cigarette brand have an indefinite life. As such, no amortization is taken. At each reporting period, the Company evaluates whether events and circumstances continue to support the indefinite-lived classification.

Impairment of Long-Lived Assets – The Company reviews the carrying value of its amortizing long-lived assets whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be recoverable. On at least an annual basis, the Company assesses whether events or changes in circumstances indicate that the carrying amount may not be recoverable. If any such indicators are present, the Company will test for recoverability in accordance with ASC 360-Property, plant, and equipment or ASC 350- Intangibles, Goodwill, and Other.

Intangible assets subject to amortization are reviewed for strategic importance and commercialization opportunity prior to expiration. If it is determined that the asset no longer supports the Company’s strategic objectives and/or will not be commercially viable prior to expiration, the asset is impaired. In addition, the Company will assess the expected future undiscounted cash flows for its intellectual property based on consideration of future market and economic conditions, competition, federal and state regulations, and licensing opportunities. If the carrying value of such assets are not recoverable, the carrying value will be reduced to fair value.

Indefinite-lived intangible asset carrying values are reviewed at least annually or more frequently if events or changes in circumstances indicate that it is more likely than not that an impairment exists. The Company first performs a qualitative assessment and considers its current strategic objectives, future market and economic conditions, competition, and federal and state regulations to determine if an impairment is more likely than not. If it is determined that an impairment is more likely than not, a quantitative assessment is performed to compare the asset carrying value to fair value.

Fair Value of Financial Instruments - The Company’s financial instruments include cash and cash equivalents, short-term investment securities, accounts receivable, investments, a convertible note receivable, a promissory note receivable, accounts payable, accrued expenses, and notes payable. The carrying values of these financial instruments approximate fair value. The Company carries cash equivalents, short-term investment securities, certain investments, and certain other assets at fair value which is described further in Note 6.

Investments  The Company’s equity securities are recorded at fair value with changes in fair value included within the statement of operations. Equity securities without a readily determinable market value are carried at cost less impairment, adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer. The Company considers certain debt instruments as available-for-sale securities, and accordingly, all unrealized gains and losses incurred on the short-term investment securities (the adjustment to fair value) are recorded in other comprehensive income or loss on the Company’s Consolidated Statements of Operations and Comprehensive Loss.

8

Right-of-use assets (“ROU”) and Lease Obligations – The Company reviews any lease arrangements in accordance with ASU 2016-02, Subtopic ASC 842, Leases. Any lease having a lease term greater than twelve months will be recognized on the Consolidated Balance Sheets as a ROU asset with an associated lease obligation—all other leases are considered short-term in nature and will be expensed as payments are made over the lease term. The ROU assets and lease obligations are recognized as of the commencement date at the net present value of the fixed minimum lease payments for the lease term. The lease term is determined based on the contractual conditions, including whether renewal options are reasonably certain to be exercised. The discount rate used is the interest rate implicit in the lease, if available, or the Company’s incremental borrowing rate which is determined using a base line rate plus an applicable spread.

Stock Based Compensation – The Company’s Omnibus Incentive Plan allows for various types of equity-based incentive awards. Stock based compensation expense is based on awards that are expected to vest over the requisite service periods and are based on the fair value of the award measured on the grant date. Vesting requirements vary for directors, officers, and employees. In general, time-based awards fully vest after one year for directors and vest in equal annual installments over a three-year period for officers and employees. Performance-based awards vest upon achievement of certain milestones. Forfeitures are accounted for when they occur.

Income Taxes - For interim income tax reporting, due to a full valuation allowance on net deferred tax assets, no income tax expense or benefit is recorded unless it is an unusual or infrequently occurring item. The tax effects of unusual or infrequently occurring items, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, are reported in the interim period in which they occur.

Recent Accounting Pronouncement(s) – In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments.” The standard replaces the incurred loss model with the current expected credit loss (CECL) model to estimate credit losses for financial assets measured at amortized cost and certain off-balance sheet credit exposures. The CECL model requires companies to estimate credit losses expected over the life of the financial assets based on historical experience, current conditions and reasonable and supportable forecasts. The provisions of the ASU are effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years—excluding small reporting companies (SRCs), based on a determination date as of November 15, 2019, which have an effective date beginning after December 15, 2022 and interim periods within those fiscal years. The Company is evaluating the expected impacts of the ASU.

We consider the applicability and impact of all ASUs. If the ASU is not listed above, it was determined that the ASU was either not applicable or would have an immaterial impact on our financial statements and related disclosures.

NOTE 2. - INVENTORY

Inventories are valued at the lower of historical cost or net realizable value. Cost is determined using an average cost method for tobacco leaf inventory, hemp/cannabis inventory, and raw materials inventory. Standard cost is primarily used for finished goods inventory. Inventories are evaluated to determine whether any amounts are not recoverable based on slow moving or obsolete condition and are written off or reserved as appropriate. During the nine months ended September 30, 2020, the Company wrote off inventory totaling $219 on the Company’s Consolidated Statement of Operations and Comprehensive Loss ($58 included within research and development expenses and $161 included within cost of goods sold).

9

Inventories at September 30, 2021 and December 31, 2020 consisted of the following:

    

September 30, 

    

December 31, 

    

2021

    

2020

Inventory - tobacco leaf

$

876

$

821

Inventory - hemp/cannabis

132

Inventory - finished goods

 

Cigarettes and filtered cigars

 

331

 

171

Inventory - raw materials

 

 

Cigarette and filtered cigar components

1,464

1,142

Less: inventory reserve

 

(100)

 

(100)

$

2,703

$

2,034

NOTE 3. – PROPERTY, PLANT, AND EQUIPMENT, NET

Property, plant, and equipment, net at September 30, 2021 and December 31, 2020 consisted of the following:

September 30, 

December 31, 

    

Useful Life

    

2021

    

2020

Land

$

1,665

$

Building and leasehold improvements

7 to 40 years

309

123

Manufacturing equipment

3 to 10 years

5,539

4,893

Office furniture, fixtures and equipment

5 years

 

129

 

20

Laboratory equipment

5 years

 

198

 

117

Construction in progress

42

 

 

Less: accumulated depreciation

  

 

(3,128)

 

(2,670)

Property, plant and equipment, net

  

$

4,754

$

2,483

Depreciation expense was $173 and $461 for the three and nine months ended September 30, 2021 ($160 and $473 for the three and nine months ended September 30, 2020).

NOTE 4. - RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES

The Company leases a manufacturing facility and warehouse in North Carolina, and a corporate headquarters in Buffalo, New York.

The following table summarizes the Company’s discount rate and remaining lease terms:

Weighted average remaining lease term in years

6.3

Weighted average discount rate

 

3.7

%

10

Future minimum lease payments as of September 30, 2021 are as follows:

2021

$

33

2022

 

76

2023

78

2024

 

80

2025

82

Thereafter

192

Total lease payments

 

541

Less: imputed interest

 

(60)

Total

$

481

On July 28, 2021, the Company signed a lease agreement for a new research and development (“R&D”) laboratory in Rockville, MD. The new laboratory space has over four thousand square feet and will support the Company’s continued growth and R&D partnerships. The lease has an initial monthly base rent of $12 (escalating 2.5% annually after the first year), a term of 51 months, and an expected commencement date of early fourth quarter of this year. The lease also calls for abatement of 100% of the base rent for the first five months following the lease commencement date. The Company will recognize the respective right-of-use asset and lease liability for the lease upon lease commencement, which is anticipated during the fourth quarter of 2021.

On October 18, 2021, the Company signed a lease extension for its manufacturing facility and warehouse in North Carolina. The lease has a commencement date upon expiration of the current lease term, which is November 1, 2021. The lease has a monthly base rent of $17 and an initial term of twenty-four months—with one twenty-four month renewal option at the Company’s discretion. The Company will recognize the respective right-of-use asset and lease liability during the fourth quarter of 2021.

NOTE 5. – INVESTMENTS & OTHER ASSETS

The total carrying value of the Company’s investments and other assets at September 30, 2021 and December 31, 2020 consisted of the following:

September 30, 

December 31, 

2021

2020

Aurora stock warrants

    

$

18

    

$

239

Panacea preferred stock

5,173

Panacea stock warrant

1,124

Exactus common stock

7,282

Total Investments

$

7,300

$

6,536

Convertible note receivable

$

$

5,876

Promissory note receivable

$

3,713

$

Investment in Panacea Life Sciences, Inc.

Initial Investment:

On December 3, 2019, the Company entered into a securities purchase agreement with Panacea Life Sciences, Inc. (“Panacea”) for consideration valued at $13,297 ($12,000 cash and $1,297 of the Company’s shares of common stock valued at $1 per share) in exchange for a 15.8% ownership interest. The Company’s investment consisted of three instruments: shares of Series B preferred stock (“preferred stock”); a convertible note receivable with a $7,000 face value; and a warrant (“stock warrant”) to purchase additional shares of Series B preferred stock, to obtain 51% ownership of Panacea, at an exercise price of $2.344 per share. The convertible note receivable had a term of five years, interest of 10% per annum, and could be converted to shares of Series B preferred stock at the Company’s discretion. The embedded conversion option was not considered a derivative instrument for accounting purposes. The preferred stock carried an annual 10% cumulative dividend, compounded annually, and had an implicit put option after

11

the fifth anniversary date so long that the stock warrants had not been exercised. The put option was not considered a derivative instrument for accounting purposes. The stock warrant was exercisable at any time after the fifth anniversary date and would be accelerated if Panacea achieved certain sales targets for two consecutive years. The Series B preferred stock also included first priority equity preferences in the event of a liquidation, sale, or transfer of Panacea assets. These rights entitled the Company to the original Series B issuance price of $7,000 plus any unpaid accrued dividends.

To allocate the cost of the stock warrant, the Company calculated a fair value based on the following assumptions: volatility of 70%, discount of 25% for lack of marketability, and a risk-free rate of 2%. The value of the stock warrant was allocated to the preferred stock and the convertible note receivable, equally, at a discount to the acquisition price. The discount on the preferred stock was determined to be for lack of control and the discount on the convertible note receivable was determined to be for issuing the note at a below market interest rate for similar instruments.

The convertible note receivable and the preferred stock investment were considered available for sale debt securities with a private company that was not traded in active markets. Since observable price quotations were not available at acquisition, fair value was estimated based on cost less an appropriate discount upon acquisition. The discount of each instrument is accreted into interest income over the respective term as shown within the Company’s Consolidated Statements of Operations and Comprehensive Loss. See Note 6 for additional information on these fair value measurements. The stock warrant was recorded at its cost basis in accordance with the practicability exception under ASU 2016-01.

Impairment of Panacea Investment:

As a result of increased competition and other macroeconomic factors, the Company recognized an impairment of $1,062 on the Panacea stock warrant during the second quarter of 2020. The impairment is recorded within the Consolidated Statements of Operations and Comprehensive Loss as “Impairment of Panacea Investment.” During the fourth quarter of 2020, the Company entered into a non-binding agreement with Panacea to potentially restructure the investment and business relationship—including the transfer of an agricultural facility and other assets. As of December 31, 2020, the Company adjusted certain assets to represent the fair value outlined in the non-binding agreement.

Conversion of Panacea Investment:

On June 30, 2021, the Company entered into a Promissory Note Exchange Agreement with Panacea and a Securities Exchange Agreement with Panacea, Exactus, Inc. (“Exactus”) (OTCQB:EXDI) and certain other Panacea shareholders. Pursuant to the Securities Exchange Agreement, Exactus fully acquired Panacea. These transactions effected the (i) conversion of all of the Company’s Series B Preferred Stock in Panacea into 91,016,026 shares of common stock in Exactus valued at $9,102 as of June 30, 2021 and (ii) the conversion of the Company’s existing debt in Panacea by converting the outstanding $7,000 principal balance convertible note receivable and all accrued but unpaid interest thereon for fee simple ownership of Needle Rock Farms (224 acres in Delta County, Colorado) and equipment valued at $2,248, $500 in Panacea’s Series B Preferred Stock (which was subsequently converted to Exactus common stock under the Securities Exchange Agreement), and a new $4,300 promissory note (the “Promissory note receivable”) with a maturity date of June 30, 2026 and a 0% interest rate. The Promissory note receivable is with a related party of Panacea and is fully secured by a first priority lien on Panacea’s headquarters located in Golden, Colorado. All other rights and obligations of the Company in Panacea and Panacea’s affiliate, Quintel-MC Incorporated, were terminated by this transaction—including all warrant rights and obligations for future investment. The conversion was recorded as a non-monetary transaction, based on the fair value of the assets received, and resulted in a gain of $2,548 which is included within the Consolidated Statements of Operations and Comprehensive Loss as “Gain on Panacea investment conversion.”

The Promissory note receivable was valued at $3,684 ($4,300 face value less $616 discount) and is included within the Consolidated Balance Sheets as “Other Assets.” The Company intends to hold the Promissory note receivable to maturity and the associated discount will be amortized into interest income over the term of the note. The ownership of Needle Rock Farms and related equipment is included within “Property, plant, and equipment, net” on the Consolidated Balance Sheets. The common shares of Exactus, Inc. are considered equity securities in accordance with ASC 321 and are recorded at fair value—changes in fair value will be included within the statement of operations. See Note 6 for additional information on the fair value measurements.

On October 28, 2021, Exactus announced the completion of a 1 for 28 reverse stock split as well as an entity name change to Panacea Life Sciences Holdings, Inc (OTCQB: PLSH). Panacea Life Sciences Holdings, Inc. has been assigned a temporary stock

12

symbol of “EXDID” which will formally change to “PLSH” after twenty business days. As a result of the reverse stock split, our 91,016,026 shares were adjusted to 3,250,573 shares.

Investment in Aurora Cannabis, Inc.

The Company has an investment in Aurora Cannabis Inc. (“Aurora”) stock warrants that are considered equity securities under ASC 321 – Investments – Equity Securities and a derivative instrument under ASC 815 – Derivatives and Hedging. The stock warrants are not designated as a hedging instrument, and in accordance with ASC 815, the Company’s investment in stock warrants are recorded at fair value with changes in fair value recorded to unrealized gain/loss as shown within the Company’s Consolidated Statements of Operations and Comprehensive Loss. See Note 6 for additional information on the fair value measurements.

NOTE 6. – FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS

FASB ASC 820 - “Fair Value Measurements and Disclosures” establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:

Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities;
Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument; and
Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value.

A financial asset’s or a financial liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

The following table presents information about our assets and liabilities measured at fair value as of September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:

Fair Value

September 30, 2021

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

 

  

 

  

 

  

 

  

Short-term investment securities:

 

  

 

  

 

  

 

  

Money market funds

$

18,481

$

$

$

18,481

Corporate bonds

 

 

35,051

 

 

35,051

Total short-term investment securities

$

18,481

$

35,051

$

$

53,532

Investment - Aurora stock warrants

$

$

$

18

$

18

Investment - Exactus common shares

$

7,282

$

$

$

7,282

13

Fair Value

December 31, 2020

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

 

  

 

  

 

  

 

  

Short-term investment securities:

 

  

 

  

 

  

 

  

Money market funds

$

8,636

$

$

$

8,636

Corporate bonds

 

 

12,677

 

 

12,677

Total short-term investment securities

$

8,636

$

12,677

$

$

21,313

Investment - Aurora stock warrants

$

$

$

239

$

239

Investment - Panacea preferred stock

$

$

$

5,173

$

5,173

Convertible note receivable

$

$

$

5,876

$

5,876

Money market mutual funds are valued at their daily closing price as reported by the fund. Money market mutual funds held by the Company are open-end mutual funds that are registered with the SEC that generally transact at a stable $1.00 Net Asset Value (“NAV”) representing its estimated fair value. On a daily basis the fund’s NAV is determined by the fund based on the amortized cost of the funds underlying investments.

Corporate bonds are valued using pricing models maximizing the use of observable inputs for similar securities.

The investment in the Aurora (“ACB”) stock warrants is measured at fair value using the Black-Scholes pricing model and is classified within Level 3 of the valuation hierarchy. The unobservable input is an estimated volatility factor of 94% and 137% as of September 30, 2021 and December 31, 2020, respectively. Therefore, changes in market volatility will impact the fair value measurement of our ACB investment.

A 20% increase or decrease in the volatility factor used as of September 30, 2021 would have the impact of increasing or decreasing the fair value measurement of the stock warrants by approximately $22. A 20% increase or decrease in the volatility factor used at December 31, 2020 would have the impact of increasing or decreasing the fair value measurement of the stock warrants by approximately $115.

The investment in Exactus common shares is considered an equity security with a readily determinable fair value. The fair value is determined using the quotable market price as of the last trading day of the fiscal quarter.

The Panacea convertible note receivable and the preferred stock investment were considered available-for-sale debt securities with a private company not traded in active markets. Since observable price quotations were not available, fair value was estimated based on cost less an appropriate discount upon acquisition.

The following table sets forth a summary of the changes in fair value of the Company’s Level 3 investments for the nine months ended September 30, 2021:

Fair Value at December 31, 2020

$

11,288

Unrealized gain (loss) on ACB stock warrants

(220)

Accretion of interest on Panacea preferred stock

142

Panacea investment conversion

(11,192)

Fair Value at September 30, 2021

$

18

14

The following tables set forth a summary of the Company’s available-for-sale debt securities from amortized cost basis to fair value as of September 30, 2021 and December 31, 2020:

Available for Sale Debt Securities

September 30, 2021

Amortized

Gross

Gross

Cost

Unrealized

Unrealized

Fair

    

Basis

    

Gains

    

Losses

    

Value

Corporate bonds

$

35,078

$

7

$

(34)

$

35,051

Available for Sale Debt Securities

December 31, 2020

Amortized

Gross

Gross

Cost

Unrealized 

Unrealized 

Fair

    

Basis

    

Gains

    

Losses

    

Value

Corporate bonds

$

12,603

$

74

$

$

12,677

Convertible note receivable

 

5,876

 

 

 

5,876

Investment - Panacea preferred stock

 

5,173

 

 

 

5,173

$

23,652

$

74

$

$

23,726

The following table sets forth a summary of the Company’s available-for-sale securities at amortized cost basis and fair value by contractual maturity as of September 30, 2021 and December 31, 2020:

Available for Sale Debt Securities

September 30, 2021

December 31, 2020

Amortized

Amortized

    

Cost Basis

    

Fair Value

    

Cost Basis

    

Fair Value

Due in one year or less

$

3,581

$

3,585

$

11,692

$

11,753

Due after one year through five years

 

31,497

 

31,466

 

11,960

 

11,973

$

35,078

$

35,051

$

23,652

$

23,726

NOTE 7. - INTANGIBLE ASSETS 

Total intangible assets at September 30, 2021 and December 31, 2020 consisted of the following:

September 30, 

December 31, 

    

2021

    

2020

Intangible assets, net

 

  

 

  

Patent and trademark costs

$

5,951

$

5,667

Less: accumulated amortization

 

(3,207)

 

(2,936)

Patent and trademark costs, net

 

2,744

 

2,731

License fees

 

3,876

 

3,876

Less: accumulated amortization

 

(1,136)

 

(948)

License fees, net

 

2,740

 

2,928

MSA signatory costs

 

2,202

 

2,202

  

License fee for predicate cigarette brand

 

350

 

350

$

8,036

$

8,211

Amortization expense relating to the above intangible assets for the three and nine months ended September 30, 2021 amounted to $168 and $471 ($163 and $524 for the three and nine months ended September 30, 2020). Impairment expense for the three and nine months ended September 30, 2020 amounted to $0 and $146 (cost of approximately $448 less accumulated amortization of approximately $302), respectively, and related to patent intellectual property that would be expired prior to expected commercialization.

15

NOTE 8. – NOTES PAYABLE

License Fees

On June 22, 2018, the Company entered into the Second Amendment to the License Agreement (the “Second Amendment”) with North Carolina State University (“NCSU”) that amended an original License Agreement between the Company and NCSU, dated December 8, 2015, and the First Amendment, dated February 14, 2018, to the original License Agreement. Under the terms of the Second Amendment, the Company was obligated to pay NCSU milestone payments totaling $1,200, which originally amounted to a present value of $1,175. As of June 30, 2020, the Company paid the final milestone payment of $300. The cost of the of acquired license amounted to $1,175 and is included in Intangible assets, net on the Company’s Consolidated Balance Sheets, and is amortized on a straight-line basis over the last-to-expire patent, which is expected to be in 2036.

On October 22, 2018, the Company entered into a License Agreement with the University of Kentucky. Under the terms of the License Agreement, the Company is obligated to pay the University of Kentucky milestone payments totaling $1,200, of which $300 was payable upon execution, and $300 will be payable annually over three years on the anniversary of the execution of the License Agreement. The Company has recorded the present value of the obligations under the License Agreement as a note payable that originally amounted to $1,151. The cost of the of acquired licenses amounted to $1,151 and is included in Intangible assets, net on the Company’s Consolidated Balance Sheets and will be amortized on a straight-line basis over the last-to-expire patent, which is expected to be in 2033.

D&O Insurance

During the second quarter of 2021, the Company renewed its Director and Officer (“D&O”) insurance for a one-year policy premium totaling $3,315. The Company paid $662 as a premium down payment and financed the remaining $2,653 of policy premiums over nine months at a 3.49% annual percentage rate.

During the second quarter of 2020, the Company renewed its D&O insurance for a one-year policy premium totaling $2,744. The Company paid $549 as a premium down payment and financed the remaining $2,195 of policy premiums over nine months at a 3.19% annual percentage rate.

CARES Act Paycheck Protection Program Loan

On May 1, 2020, the Company received an U.S. Small Business Administration Loan (“SBA Loan”) from Bank of America, N.A. related to the COVID-19 pandemic in the amount of $1.2 million. On May 12, 2020, the Company repaid the SBA loan in full.

The table below outlines our notes payable balances as of September 30, 2021 and December 31, 2020:

September 30, 

December 31, 

    

2021

    

2020

License Fees

$

299

$

293

D&O Insurance

 

1,483

 

246

Total current notes payable

$

1,782

$

539

Accretion of non-cash interest expense amounted to $2 and $6 for the three and nine months ended September 30, 2021 and $4 and $17 for the three and nine months ended September 30, 2020.

NOTE 9. – SEVERANCE LIABILITY

During the second quarter of 2020, the Company recorded severance benefits related to a resignation of $306. The benefits were provided over a twelve-month period.

During 2019, the Company recorded severance benefits of $881. Consistent with certain contractual obligations, $771 of the related benefit will be provided over a period of forty-two months.

16

The current and long-term accrued severance balance remaining as of September 30, 2021 was $223 and $72, respectively. The current and long-term accrued severance balance remaining as of December 31, 2020 was $339 and $241, respectively.

NOTE 10. – CAPITAL RAISE AND WARRANT EXERCISE

On June 7, 2021, the Company entered into a placement agent agreement (the “Placement Agent Agreement”) with Cowen and Company, LLC (the “Placement Agent”) relating to the Company’s registered direct offering (the “Offering”) to a select investor (the “Investor”). In addition, on June 7, 2021, the Company and the Investor entered into a securities purchase agreement relating to the issuance and sale of shares of common stock pursuant to which the Investor purchased 10,000,000 shares of common stock at $4.00 per share. The net proceeds to the Company from the Offering, after deducting Placement Agent fees and offering expenses, was $38,206.

During the first quarter of 2021, the Company’s warrant holders exercised all 11,293,211 outstanding warrants for cash in exchange for common stock. In connection with these exercises, the Company received net proceeds of $11,782. No warrants remain outstanding as of September 30, 2021. The following table summarizes the Company’s outstanding warrant activity since December 31, 2020:

Number of

Warrants

Warrants outstanding at December 31, 2020

 

11,293,211

Warrants exercised in Q1 2021

(11,293,211)

Warrants outstanding at September 30, 2021

 

NOTE 11. - COMMITMENTS AND CONTINGENCIES

License agreements and sponsored research – The Company has entered into various license, sponsored research, collaboration, and other agreements (the “Agreements”) with various counter parties in connection with the Company’s plant biotechnology business relating to tobacco and hemp/cannabis. The schedule below summarizes the Company’s commitments, both financial and other, associated with each Agreement. Costs incurred under the Agreements are generally recorded as research and development expenses on the Company’s Consolidated Statements of Operations and Comprehensive Loss.

Future Commitments

Commitment

 

Counter Party

 

Product Relationship

 

Commitment Type

 

2021

 

2022

 

2023

 

2024

 

2025 & After

 

Total

    

Research Agreement

KeyGene

Hemp / Cannabis

Contract fee

$

115

$

1,150

$

1,200

$

1,227

$

2,893

$

6,585

(1)

License Agreement

NCSU

Tobacco

Annual royalty fee

68

225

293

(2), (3)

License Agreement

NCSU

Tobacco

Minimum annual royalty

7

50

50

50

600

757

(3)

License Agreement

NCSU

Tobacco

Minimum annual royalty

14

50

50

50

500

664

(3)

Sublicense Agreement

Anandia Laboratories, Inc.

Hemp / Cannabis

Annual license fee

10

10

10

10

110

150

(4)

Research Agreement

Cannametrix

Hemp / Cannabis

Contract fee

51

50

101

(5)

Growing Agreement

Various

Various

Contract fee

127

38

165

(6)

Consulting Agreement

Various

Various

Contract fee

119

286

405

(7)

$

511

$

1,859

$

1,310

$

1,337

$

4,103

$

9,120

(1)Exclusive agreement with the Company with respect to the Cannabis Sativa L. plant (the "Field"). The initial term of the agreement was five years with an option for an additional two years. On April 30, 2021, the Company and KeyGene entered into a First Amended and Restated Framework Collaborative Research Agreement which extended the agreement term, from first-quarter 2024 to first-quarter 2027, and preserves the Company’s option for an additional 2-year extension, now through first quarter of 2029.

The Company will exclusively own all results and all intellectual property relating to the results of the collaboration with KeyGene (the "Results”). The Company will pay royalties in varying amounts to KeyGene relating to the Company's commercialization in the Field of certain Results. The Company has also granted KeyGene a license to commercialize the Results outside of the Field and KeyGene will pay royalties in varying amounts to the Company relating to KeyGene's commercialization of the Results outside of the Field.

17

(2)The license agreement also requires a milestone payment of $150 upon FDA approval or clearance of a product that uses the NCSU licensed technology. The annual royalty fee is credited against running royalties on sales of licensed products.
(3)The Company is also responsible for reimbursing NSCU for actual third-party patent costs incurred, including capitalized patent costs and patent maintenance costs. These costs vary from year to year and the Company has certain rights to direct the activities that result in these costs.
(4)The Company is also responsible for the payment of certain costs, including, capitalized patent costs and patent maintenance costs, a running royalty on future net sales of products made from the sublicensed intellectual property, and a sharing of future sublicensing consideration received from sublicensing to third parties in all countries except for Canada. Anandia retains all patent rights, and is responsible for all patent maintenance, in Canada.
(5)On March 1, 2021, the Company entered into a 14-month research agreement with Cannametrix for hemp/cannabis product development, formulation, and validation.
(6)Various R&D growing and consulting agreements for hemp / cannabis and tobacco.
(7)General corporate consulting agreements.

Modified Risk Tobacco Product Application (“MRTP Application”) – In connection with the Company’s MRTP Application for its Very Low Nicotine Content (“VLNC”) cigarettes with the FDA, the Company has entered in various contracts with third-party service providers to fulfill various requirements of the MRTP Application. Such contracts include services for clinical trials, perception studies, legal guidance, product testing, and consulting expertise. During the three and nine months ended September 30, 2021, the Company incurred expenses relating to these contracts in the approximate amount of $2 and $16, respectively, and $4 and $158 for the three and nine months ended September 30, 2020, respectively. The Company will continue to incur consulting and legal expenses as the MRTP Application continues through the FDA review process. The Company cannot currently quantify the additional expenses that the Company will incur in the FDA review process because it will involve various factors that are within the discretion and control of the FDA.

Litigation - In accordance with applicable accounting guidance, the Company establishes an accrued liability for litigation and regulatory matters when those matters present loss contingencies that are both probable and estimable. In such cases, there may be an exposure to loss in excess of any amounts accrued. When a loss contingency is not both probable and estimable, the Company does not establish an accrued liability. As a litigation or regulatory matter develops, the Company, in conjunction with any outside counsel handling the matter, evaluates on an ongoing basis whether such matter presents a loss contingency that is probable and estimable. If, at the time of evaluation, the loss contingency related to a litigation or regulatory matter is not both probable and estimable, the matter will continue to be monitored for further developments that would make such loss contingency both probable and estimable. When a loss contingency related to a litigation or regulatory matter is deemed to be both probable and estimable, the Company will establish an accrued liability with respect to such loss contingency and record a corresponding amount of related expenses. The Company will then continue to monitor the matter for further developments that could affect the amount of any such accrued liability. 

Class Action

On January 21, 2019, Matthew Jackson Bull, a resident of Denver, Colorado, filed a Complaint against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, and the Company’s then Chief Financial Officer, John T. Brodfuehrer, in the United States District Court for the Eastern District of New York entitled: Matthew Bull, Individually and on behalf of all others similarly situated, v. 22nd Century Group, Inc., Henry Sicignano III, and John T. Brodfuehrer, Case No. 1:19 cv 00409.

On January 29, 2019, Ian M. Fitch, a resident of Essex County Massachusetts, filed a Complaint against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, and the Company’s then Chief Financial Officer, John T. Brodfuehrer, in the United States District Court for the Eastern District of New York entitled: Ian Fitch, Individually and on behalf of all others similarly situated, v. 22nd Century Group, Inc., Henry Sicignano III, and John T. Brodfuehrer, Case No. 2:19 cv 00553.

On May 28, 2019, the plaintiff in the Fitch case voluntarily dismissed that action. On August 1, 2019, the Court in the Bull case issued an order designating Joseph Noto, Garden State Tire Corp, and Stephens Johnson as lead plaintiffs.

18

On September 16, 2019, pursuant to a joint motion by the parties, the Court in the Bull case transferred the class action to federal district court in the Western District of New York, where it remains pending as Case No. 1:19-cv-01285.

Plaintiffs in the Bull case filed an Amended Complaint on November 19, 2019 that alleges three counts: Count I sues the Company and Messrs. Sicignano and Brodfuehrer and alleges that the Company's quarterly and annual reports, SEC filings, press releases and other public statements and documents contained false statements in violation of Section 10(b) of the Securities Exchange Act and Rule 10b-5; Count II sues Messrs. Sicignano and Brodfuehrer pursuant to Section 10(b) of the Securities Exchange Act and Rule 10b5(a) and (c); and Count III sues Messrs. Sicignano and Brodfuehrer for the allegedly false statements pursuant to Section 20(a) of the Securities Exchange Act. The Amended Complaint seeks to certify a class, and unspecified compensatory and punitive damages, and attorney's fees and costs.

On January 29, 2020, the Company and Messrs. Sicignano and Brodfuehrer filed a Motion to Dismiss the Amended Complaint. On July 31, 2020, the Court heard oral arguments on the motion to dismiss. On January 14, 2021, the Court granted motion, dismissing all claims with prejudice. The Plaintiffs filed a notice of appeal on February 12, 2021 to the Second Circuit Court of Appeals. The Second Circuit has granted an expedited briefing schedule and Plaintiff’s/Appellant’s was filed on April 12, 2021 and the Company’s was filed on May 17, 2021. The Second Circuit heard oral arguments on September 2, 2021 and the matter remains pending with the Second Circuit.

We believe that the claims are frivolous, meritless and that the Company and Messrs. Sicignano and Brodfuehrer have substantial legal and factual defenses to the claims. We intend to vigorously defend the Company and Messrs. Sicignano and Brodfuehrer against such claims.

Shareholder Derivative Cases

On February 6, 2019, Melvyn Klein, a resident of Nassau County New York, filed a shareholder derivative claim against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, the Company’s Chief Financial Officer, John T. Brodfuehrer, and each member of the Company’s Board of Directors in the United States District Court for the Eastern District of New York entitled: Melvyn Klein, derivatively on behalf of 22nd Century Group v. Henry Sicignano, III, Richard M. Sanders, Joseph Alexander Dunn, Nora B. Sullivan, James W. Cornell, John T. Brodfuehrer and 22nd Century Group, Inc., Case No. 1:19 cv 00748. Mr. Klein brings this action derivatively alleging that (i) the director defendants supposedly breached their fiduciary duties for allegedly allowing the Company to make false statements; (ii) the director defendants supposedly wasted corporate assets to defend this lawsuit and the other related lawsuits; (iii) the defendants allegedly violated Section 10(b) of the Securities Exchange Act and Rule 10b 5 promulgated thereunder for allegedly approving or allowing false statements regarding the Company to be made; and (iv) the director defendants allegedly violated Section 14(a) of the Securities Exchange Act and Rule 14a 9 promulgated thereunder for allegedly approving or allowing false statements regarding the Company to be made in the Company’s proxy statement.

On February 11, 2019, Stephen Mathew filed a shareholder derivative claim against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, the Company’s Chief Financial Officer, John T. Brodfuehrer, and each member of the Company’s Board of Directors in the Supreme Court of the State of New York, County of Erie, entitled: Stephen Mathew, derivatively on behalf of 22nd Century Group, Inc. v. Henry Sicignano, III, John T. Brodfuehrer, Richard M. Sanders, Joseph Alexander Dunn, James W. Cornell, Nora B. Sullivan and 22nd Century Group, Inc., Index No. 801786/2019. Mr. Mathew brings this action derivatively generally alleging the same allegations as in the Klein case. The Complaint seeks declaratory relief, unspecified monetary damages, corrective corporate governance actions, and attorney’s fees and costs. On August 15, 2019, the Court consolidated the Mathew and Klein actions pursuant to a stipulation by the parties (Western District of New York, Case No. 1-19-cv-0513). We believe that the claims are frivolous, meritless and that the Company and the individual defendants have substantial legal and factual defenses to the claims. We intend to vigorously defend the Company and the individual defendants against such claims.

On June 10, 2019, Judy Rowley filed a shareholder derivative claim against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, the Company’s Chief Financial Officer, John T. Brodfuehrer, and each member of the Company’s Board of Directors in the Supreme Court of the State of New York, County of Erie, entitled: Judy Rowley, derivatively on behalf of 22nd Century Group, Inc. v. Henry Sicignano, III, Richard M. Sanders, Joseph Alexander Dunn, Nora B. Sullivan, James W. Cornell, John T. Brodfuehrer, and 22nd Century Group, Inc., Index No. 807214/2019. Ms. Rowley brings this action derivatively alleging that the director defendants supposedly breached their fiduciary duties by allegedly allowing the Company to make false statements. The Complaint seeks declaratory relief, unspecified monetary damages, corrective corporate governance actions, and

19

attorney’s fees and costs. We believe that the claims are frivolous, meritless and that the Company and the individual defendants have substantial legal and factual defenses to the claims. We intend to vigorously defend the Company and the individual defendants against such claims. On September 13, 2019, the Court ordered the litigation stayed pursuant to a joint stipulation by the parties.

On January 15, 2020, Kevin Broccuto filed a shareholder derivative claim against the Company, the Company's then Chief Executive Officer, Henry Sicignano III, the Company's Chief Financial Officer, John T. Brodfuehrer, and certain members of the Company's prior Board of Directors in the District Court of the State of Nevada, County of Clark, entitled: Kevin Broccuto, derivatively on behalf of 22nd Century Group, Inc. v. James W. Cornell, Richard M. Sanders, Nora B. Sullivan, Henry Sicignano, III, and John T. Brodfuehrer, Case No. A-20-808599. Mr. Broccuto brings this action derivatively alleging three counts: Count I alleges that the defendants breached their fiduciary duties; Count II alleges they committed corporate waste; and Count III that they were unjustly enriched, by allegedly allowing the Company to make false statements.

On February 11, 2020, Jerry Wayne filed a shareholder derivative claim against the Company, the Company's then Chief Executive Officer, Henry Sicignano III, the Company's Chief Financial Officer, John T. Brodfuehrer, and certain members of the Company's prior Board of Directors in the District Court of the State of Nevada, County of Clark, entitled: Jerry Wayne, derivatively on behalf of 22nd Century Group, Inc. v. James W. Cornell, Richard M. Sanders, Nora B. Sullivan, Henry Sicignano, III, and John T. Brodfuehrer, Case No. A-20-808599. Mr. Wayne brings this action derivatively alleging generally the same allegations as the Brocutto case. The Complaint seeks unspecified monetary damages, corrective corporate governance actions, disgorgement of alleged profits and imposition of constructive trusts, and attorney's fees and costs. The Complaint also seeks to declare as unenforceable the Company's Bylaw requiring derivative lawsuits to be filed in Erie County, New York, where the Company is headquartered.

On March 25, 2020, the Court ordered the Brocutto and Wayne cases consolidated and stayed pursuant to a joint stipulation from the parties. We believe that the claims are frivolous, meritless and that the Company and the individual defendants have substantial legal and factual defenses to the claims. We intend to vigorously defend the Company and the individual defendants against such claims.

NOTE 12 – EQUITY- BASED COMPENSATION

On May 20, 2021, the stockholders of 22nd Century Group, Inc. (the “Company”) approved the 22nd Century Group, Inc. 2021 Omnibus Incentive Plan (the “Plan”). The Plan allows for the granting of equity awards to eligible individuals over the life of the Plan, including the issuance of up to 5,000,000 shares of the Company’s common stock and any remaining shares under the Company’s 2014 Omnibus Incentive Plan pursuant to awards under the Plan. The Plan has a term of ten years and is administered by the Compensation Committee of the Company’s Board of Directors to determine the various types of incentive awards that may be granted to recipients under the Plan and the number of shares of common stock to underlie each such award under the Plan. As of September 30, 2021, the Company had available 7,449,946 shares remaining for future awards under the Plan.

20

Restricted Stock Units (“RSUs”). We typically grant RSUs to employees and non-employee directors. The following table summarizes the changes in unvested RSUs from December 31, 2020 through September 30, 2021.

Unvested RSUs

Weighted

Average

Number of

Grant-date

    

Shares

    

Fair Value

in thousands

$ per share

Unvested at December 31, 2020

 

2,938

$

0.85

Granted

 

1,995

$

3.20

Vested

(1,234)

$

0.85

Forfeited

(216)

$

0.67

Unvested at March 31, 2021

3,483

$

2.21

Granted

15

$

4.60

Vested

(288)

$

0.86

Forfeited

(25)

$

1.04

Unvested at June 30, 2021

3,185

$

2.35

Granted

190

$

3.71

Vested

(50)

$

0.80

Forfeited

(10)

$

1.90

Unvested at September 30, 2021

3,315

$

2.45

The fair value of RSUs that vested during the nine months ended September 30, 2021 was approximately $5,057 based on the stock price at the time of vesting.

Stock Options. Our outstanding stock options were valued using the Black-Scholes option-pricing model on the date of the award. A summary of all stock option activity since December 31, 2020 is as follows:

Weighted

Weighted

Average

Average

Remaining

Aggregate

Number of

Exercise

Contractual

Intrinsic

    

Options

    

Price

    

Term

    

Value

in thousands

$ per share

Outstanding at December 31, 2020

6,581

$

1.50

Granted

235

$

3.10

Exercised

(846)

$

1.36

Expired

(6)

$

2.76

Outstanding at March 31, 2021

5,964

$

1.59

4.3

years

$

7,480

Exercised

(88)

$

1.21

Forfeited

(100)

$

0.80

Outstanding at June 30, 2021

 

5,776

$

1.60

 

4.1

years

 

$

13,265

Expired

(40)

$

2.58

Forfeited

(500)

$

1.04

Outstanding at September 30, 2021

5,236

$

1.65

3.8

years

$

6,885

Exercisable at September 30, 2021

 

4,900

$

1.56

 

3.7

years

 

$

6,848

The intrinsic value of a stock option is the amount by which the current market value or the market value upon exercise of the underlying stock exceeds the exercise price of the option.

21

The weighted average of fair value assumptions used in the Black-Scholes option-pricing model for such grants were as follows:

    

2021

Risk-free interest rate (1)

 

0.54

%

Expected dividend yield (2)

 

%

Expected volatility (3)

 

87.92

%

Expected term of stock options (4)

 

4.09

years

(1)The risk-free interest rate is based on the period matching the expected term of the stock options based on the U.S. Treasury yield curve in effect on the grant date.
(2)The expected dividend yield is assumed as zero. The Company has never paid cash dividends nor does it anticipate paying dividends in the foreseeable future.
(3)The expected volatility is based on historical volatility of the Company’s stock.
(4)The expected term represents the period of time that options granted are expected to be outstanding based on vesting date and contractual term.

Compensation Expense. The Company recognized the following compensation costs, net of actual forfeitures, related to RSUs and stock options:

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2021

    

2020

    

2021

    

2020

Sales, general, and administrative

$

1,073

$

278

$

2,750

$

1,051

Research and Development

 

46

 

28

 

121

 

111

Total RSUs and stock option compensation

$

1,119

$

306

$

2,871

$

1,162

As of September 30, 2021, unrecognized compensation expense amounted to $5,931 which is expected to be recognized over a weighted average period of approximately 1.1 years. In addition, there is approximately $517 of unrecognized compensation expense that requires the achievement of certain milestones which are not yet probable.

NOTE 13. – REVENUE RECOGNITION

The Company recognizes revenue when it satisfies a performance obligation by transferring control of the product to a customer. The Company’s customer contracts consist of obligations to manufacture the customer’s branded filtered cigars and cigarettes. For certain contracts, the performance obligation is satisfied over time as the Company determines, due to contract restrictions, it does not have an alternative use of the product and it has an enforceable right to payment as the product is manufactured. The Company recognizes revenue under those contracts at the unit price stated in the contract based on the units manufactured. Revenue from the sale of the Company’s products is recognized net of cash discounts, sales returns and allowances. There was no allowance for discounts or returns and allowances at September 30, 2021 and December 31, 2020.

Contract Assets and Liabilities

Unbilled receivables (contract assets) represent revenues recognized for performance obligations that have been satisfied but have not been billed. These receivables are included as Accounts receivable, net on the Consolidated Balance Sheets. Customer payment terms vary depending on the terms of each customer contract, but payment is generally due prior to product shipment or within extended credit terms up to twenty-one (21) days after shipment. Deferred Revenue (contract liabilities) relate to down payments received from customers in advance of satisfying a performance obligation. This deferred revenue is included as Deferred income on the Consolidated Balance Sheets.

22

Total contract assets and contract liabilities are as follows:

September 30, 

December 31, 

    

2021

    

2020

Unbilled receivables

 

$

494

 

$

349

Deferred Revenue

(272)

Net contract assets

$

494

$

77

Disaggregation of Revenue

The Company’s net sales revenue is derived from customers located primarily in the United States of America and is disaggregated by the timing of revenue recognition—net sales transferred over time and net sales transferred at a point in time. All revenue is related to contract manufacturing.

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2021

    

2020

    

2021

    

2020

Net sales-over time

$

5,344

$

4,339

$

16,461

$

12,769

Net sales-point in time

 

2,467

 

2,971

 

6,527

 

8,034

Total Revenue

$

7,811

$

7,310

$

22,988

$

20,803

NOTE 14. – EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2021 and 2020, respectively. Outstanding warrants, options, and RSUs were excluded from the calculation of diluted EPS as the effect was antidilutive.

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2021

    

2020

    

2021

    

2020

(in thousands, except for per-share data)

Net loss

$

(9,440)

$

(4,221)

$

(18,644)

$

(13,307)

Weighted average common shares outstanding - basic and diluted

 

162,721

138,857

153,998

138,774

Net loss per common share - basic and diluted

$

(0.06)

$

(0.03)

$

(0.12)

$

(0.10)

Anti-dilutive shares are as follows:

Warrants

11,293

11,293

Options

5,236

7,259

5,236

7,259

Restricted stock units

3,315

2,878

3,315

2,878

8,551

21,430

8,551

21,430

23

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with, our audited consolidated financial statements, the accompanying notes and the MD&A included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as well as our consolidated financial statements and the accompanying notes included in Item 1 of this Form 10-Q. Note references are to the notes to consolidated financial statements included in Item 1 of this Form 10-Q.

For purposes of this MD&A, references to the “Company,” “we,” “us” or “our” refer to the operations of 22nd Century Group, Inc. and its direct and indirect subsidiaries for the periods described herein.

Forward Looking Statements

Except for historical information, all of the statements, expectations, and assumptions contained in this section are forward-looking statements. Forward-looking statements typically contain terms such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and similar expressions. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in “Risk Factors” in our Annual Report on Form 10-K filed on March 11, 2021. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events, or otherwise, except as otherwise required by law. All information provided in this quarterly report is as of the date hereof, and we assume no obligation to and do not intend to update these forward-looking statements, except as required by law.

Corporate Business Overview

22nd Century Group, Inc. (Nasdaq: XXII) is a leading agricultural biotechnology and intellectual property company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. We utilize modern plant breeding technologies, gene-editing, and molecular breeding to create new, proprietary tobacco, hemp/cannabis and hop plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits. With dozens of patents allowing us to control nicotine biosynthesis in the tobacco plant, we have developed our proprietary reduced nicotine content (RNC) tobacco plants and cigarettes which have become the cornerstone of the FDA’s Comprehensive Plan to address the widespread death and disease caused by smoking. We have also begun to leverage its plant science expertise and existing partnerships to create and commercialize new, proprietary hemp/cannabis and hop plants to optimize genetics and create valuable new intellectual property.

24

Tobacco Franchise Overview

In tobacco, we have developed unique and proprietary bright and burley Very Low Nicotine Content (“VLNC”) tobaccos that grow with at least 95% less nicotine than tobacco used in conventional cigarettes. In the year 2011, we developed our SPECTRUM® variable nicotine research cigarettes in collaboration with independent researchers, officials from the FDA, the National Institute on Drug Abuse (“NIDA”), which is part of the National Institutes of Health (“NIH”), the National Cancer Institute (“NCI”), and the Centers for Disease Control and Prevention (“CDC”). Since 2011, we have provided more than 31.6 million variable nicotine research cigarettes for use in numerous independent clinical studies funded in large part by agencies of the United States federal government. These independent clinical studies are estimated to have been performed at a cost of more than $125 million. The results of these independent clinical studies have been published in peer-reviewed publications (including the New England Journal of Medicine, the Journal of the American Medical Association, and many others). The results of these studies indicate that our VLNC tobaccos have been associated with reductions in smoking, nicotine exposure and nicotine dependence with little to no evidence of compensatory smoking and without serious adverse events. Lists of published and on-going clinical studies using our variable nicotine research cigarettes shown on our website at https://www.xxiicentury.com/vln-clinical-studies/published-clinical-studies-on-very-low-nicotine-content-vlnc-cigarettes and https://www.xxiicentury.com/vln-clinical-studies/on-going-clinical-studies-on-very-low-nicotine-content-vlnc-cigarettes. We do not incorporate third party studies or the information on our website into this Quarterly Report on Form 10-Q.

We believe that our proprietary reduced nicotine content cigarettes, VLN®, have a large global market opportunity. According to a 2018 report by the Foundation for a Smoke Free World, the global tobacco market was worth $817 billion and of that, $714 billion, or approximately 90% of the global tobacco market is comprised of combustible cigarettes. According to the CDC, there are more than 1 billion global and 34 million U.S. adult smokers. CDC statistics go on to state that more than two-thirds of adult smokers want to quit, yet less than ten percent of them are able to quit successfully. We believe that smokers are actively seeking alternatives to addictive combustible cigarettes. Based on our consumer perception studies, 60% of adult smokers indicate a likelihood to use VLN®.

Our VLN® cigarettes contain 95% less nicotine than conventional cigarettes and are a familiar combustible product format that replicates the conventional cigarette experience, including the sensory and experiential elements of taste, scent, smell, and “hand-to-mouth” behavior. VLN® contains 0.5 milligrams of nicotine per gram of tobacco, an amount cited by the FDA, based on clinical studies, to be “minimally or non-addictive”. Smoking VLN® cigarettes creates a dissociation between the act of smoking and the impact of nicotine which helps adult smokers reduce the harm caused by smoking.

Since 2011, our reduced nicotine content cigarettes have been used in more than 50 independent scientific clinical studies by universities and institutions. The studies, using our reduced nicotine content tobacco cigarettes, show that smokers who use our products: (i) reduce their nicotine exposure and dependence, (ii) smoke fewer cigarettes per day, (iii) increase their number of smoke-free days, and (iv) double their quit attempts – all with minimal or no evidence of nicotine withdrawal or compensatory smoking.

In December 2019, the FDA granted a Premarket Tobacco Application (“PMTA”) authorization for our reduced nicotine content cigarettes, giving us the ability to sell the product. In order to market our reduced nicotine content cigarettes under the brand name VLN®, with pack and advertising claims stating that the product contains 95% less nicotine than conventional tobacco cigarettes, as well as related claims regarding nicotine exposure, we are pursuing a Modified Risk Tobacco Product (“MRTP”) authorization from the FDA.

As a part of the MRTP application process, on February 14, 2020, we presented our application for our reduced nicotine content cigarettes, VLN® to the FDA’s Tobacco Products Scientific Advisory Committee (“TPSAC”). The FDA’s deadline for the submission of public comments on our MRTP application has now passed. The public comment period is now closed, and we believe that we are in the final stages of the review and decision-making process.

Our research cigarettes, SPECTRUM®, continue to fuel numerous independent, scientific studies to validate the enormous public health benefit identified by the FDA and others of implementing a national standard requiring all cigarettes to contain “minimally or non-addictive” levels of nicotine. In December 2020, the FDA in coordination with the National Institute on Drug Abuse (NIDA) and others, submitted an order to us for 3.6 million variable nicotine research cigarettes. On April 26, 2021, we announced the fulfillment of the order bringing the total number of research cigarettes provided for public health research to more than 31.6 million cigarettes.

25

MRTP is only the beginning of our global journey for the tobacco franchise. We believe it will serve as a catalyst for U.S. and international sales of the VLN® brand, including non-genetically modified (“non-GMO”) versions of VLN® 2.0 currently in development. We believe that our next generation non-GMO plant research is the key to commercializing our reduced nicotine content tobacco and technology in international markets. Non-GMO products are critical for success in international markets where non-GMO products are preferred, or genetically modified (“GMO”) products are banned. We continue to make progress in our non-GMO tobacco research. In partnership with North Carolina State University, we have completed successful research field trials that have validated new non-GMO methodologies for reducing nicotine in tobacco plants and have consistently achieved reductions in nicotine levels by as much as 99%. During the fourth quarter of 2020, we announced that we were granted a new U.S. patent, No. 10,669,552, entitled “Up-regulation of auxin response factor NbTF7”, related to the reduction of nicotine in the tobacco plant. The new technology provides us with a rapid pathway to introduce very low nicotine traits into virtually any variety of tobacco, including bright, burley, and oriental tobacco varieties. We have successfully applied our non-GMO technology to bright and burley varieties of tobacco and have developed a VLN® 2.0 prototype cigarette. We are also using our non-GMO technology to introduce reduced nicotine traits into oriental varieties of tobacco.

Hemp/Cannabis Franchise Overview

In hemp/cannabis, we are developing proprietary hemp/cannabis varieties with increased levels of certain cannabinoids and other desirable agronomic traits with the goal of generating new and valuable intellectual property and plant lines. Our activities in the United States involve only work with legal hemp in full compliance with U.S. federal and state laws. The hemp and the marijuana plants are both part of the same cannabis genus, except that hemp does not have more than 0.3% dry weight content of delta-9-tetrahydrocannabinol (“THC”). While the 2018 Farm Bill legalized hemp and cannabinoids extracted from hemp in the U.S., such extracts remain subject to state laws and regulation by other U.S. federal agencies such as the FDA, U.S. Drug Enforcement Administration (“DEA”), and the U.S. Department of Agriculture (“USDA”). The same plant, with a higher THC content is marijuana, which is legal under certain state laws but not yet legal under U.S. federal law. The similarities between these plants can cause confusion. To reflect this difference in law, sometimes we refer to legal hemp and the legal hemp industry as hemp/cannabis to distinguish this as being separate and apart from marijuana/cannabis which is not legal under U.S. federal law. Our activities with legal hemp have sometimes been incorrectly perceived as us being involved in federally illegal marijuana/cannabis. This is not the case. In the United States, we work only with legal hemp in full compliance with federal and state laws, and outside the U.S., we operate in full compliance with the laws of each country in which we operate.

Our goal is to provide leading companies in the life science, consumer product, and pharmaceutical end-use markets with new, disruptive, and highly differentiated plant lines or ingredients (flower, extracts, distillates, isolates, etc.) derived from hemp/cannabis plants. Most existing hemp/cannabis plant lines do not exhibit the stable genetics, predictable yield, and specific composition of cannabinoids required to fully unlock the value of the hemp/cannabis industry. Our plant genetics and innovative upstream cannabinoid value chain provide for rapid development and optimization of plant products and scale-up as the industry evolves toward mass production.

Hops Franchise Overview

We are leveraging our experience with tobacco and hemp/cannabis to accelerate the development of proprietary specialty hop varieties with valuable competitive advantages to increase yields and distinctive aroma, flavor, nutraceuticals, medicinal properties, and disease/pest resistance.

We believe that our innovative upstream alkaloid plant value chain is critical to unlocking new disruptive hop plant varieties and IP at large-scale. We are leveraging research findings from the closely related hemp/cannabis plant and our strategic partnerships to support the development of our new technologies based on molecular breeding, flowering time, and double haploid breeding to accelerate the stabilization or creation of hop varieties. Industry reliance on high-risk traditional breeding techniques makes hops ripe for disruption with our new accelerated molecular breeding technologies and gene-editing tools.

Hops is a large global addressable market with well-established hops providers and consumer brands. We are actively engaged in discussions with multiple hops grower and consumer product partners to develop specific desired traits in leading hop strains that are already well-accepted by the brewing industry. We believe hops presents a faster route to commercialization than tobacco and hemp/cannabis due to lower regulatory barriers.

26

Additional information about our business and operations is contained in our Annual Report on Form 10-K for the year ended December 31, 2020.

Notable Accomplishments and Recent Announcements

Tobacco Franchise:

Securing MRTP designation for VLN® remains our number one priority. On October 14, 2021, we attended a meeting with senior FDA staff regarding our MRTP application. Our U.S. pilot program and manufacturing capabilities are in place to launch VLN® in the U.S. within 90 days of receiving MRTP designation.
We continued our international launch process for VLN®. We are focusing on several of the leading markets in Asia and a test market in Europe. We believe these markets have a strong affinity for new, modified risk tobacco products and will likely require minimal interaction with regulators to launch VLN®. Sales to local partners in one or more markets are expected to begin in the first quarter of 2022. We also plan to establish an overseas branch in New Zealand.
Our growth in tobacco contract manufacturing volumes and disciplined operations continued in the third quarter and confirms readiness of our operations ahead of VLN® launching:
oIn July 2021, we secured a new agreement with a tobacco industry partner that specializes in exporting cigarettes to countries outside the United States.
oIn October 2021, we secured an additional new contract manufacturing customer.
oWe completed the expansion of our in-house nicotine content testing capabilities, which allows for rapid, in-house analysis of our tobacco. This initiative improves the production cost per VLN® sample, while significantly reducing the lead time to uncover key data. Internal testing of our current crop of VLN® leaf commenced in August, using the newly installed testing equipment.
Our 2021 VLN® tobacco growing program in the U.S. is driven by our latest sales projections. The new crop and our existing inventory of VLN® tobacco are earmarked for the launch and sales of VLN® cigarettes.
We signed a partnership agreement to grow and harvest VLN® in the southern hemisphere providing us with year-round growing capabilities.
We continue to leverage our non-GMO technology to rapidly introduce reduced nicotine traits into virtually any variety of tobacco expands business prospects.
In April 2021, we submitted our formal response to the New Zealand Ministry of Health’s Smokefree Aotearoa 2025 Action Plan. This follows the release of a new proposal by the New Zealand Ministry of Health Manatū Hauora that calls for reducing the amount of nicotine allowed in smoked tobacco products to “minimal levels”.

Hemp/Cannabis Franchise:

The Company and KeyGene reached a collaborative agreement with the National Institute of Science and Technology (NIST) to establish the first-ever quality and measurement standards for cannabinoids, terpenes, and other compounds across the hemp/cannabis industry. Through the Company’s collaboration with KeyGene, the two partners will provide diverse lines of cannabis plants containing varying levels of cannabinoid profiles and compounds. Utilizing these samples, NIST will look to establish quality standards for the entire hemp/cannabis industry, distinguishing higher quality products from the saturated marketplace.

27

We added strategic partnerships with additional alkaloid plant producer-breeders, including Extractas Bioscience, Sawatch Agriculture, and Folium Botanical for next-generation commercial hemp/cannabis plant breeding and commercial scale-up. The partnerships facilitate year-round growing capabilities at locations in both the southern and northern hemispheres.
We are in the process of applying for a USDA Organic Certification for our hemp farm, Needle Rock Farms.

Hops Franchise:

We announced entry into the global specialty hops market, our third and newest plant franchise, on August 30, 2021.
We are actively engaged in discussions with multiple hops growers and consumer product partners to develop specific desired traits in leading hops strains.
We are securing hop plant germplasm for use in breeding, and it is advancing valuable IP on those plants.
We are advancing our hop genome sequencing efforts through our partnership with KeyGene, which has been accelerated by our knowledge of genome sequencing in hemp/cannabis, which is closely related to the hop plant.
We are in the process of establishing a new subsidiary in the Netherlands, 22nd Century Group Europe B.V.

Corporate Business:

The Company began trading on Nasdaq Capital Markets on August 16, 2021. Uplisting to the Nasdaq aligns the Company with other high-achieving, innovative, and growth-oriented global science and technology companies.
The Company appointed accomplished life sciences and biotechnology executive Anthony Johnson to its Board of Directors.

Third Quarter 2021 Financial Highlights:

Net sales for the third quarter of 2021 were $7.8 million, an increase of 6.9% from $7.3 million in the prior year period. Net sales for the nine months ended September 30, 2021 were a record $23.0 million, an increase of 10.5% from $20.8 million in the prior year period.
Gross profit for the third quarter of 2021 improved by $87 thousand, or 24% to $449 thousand compared to the prior year period – a seventh consecutive quarter of year-over-year improvement in gross profit.
Net loss in the third quarter of 2021 was $(9.4) million, an increase of $5.1 million compared to the prior year period primarily due to an increase in non-cash charges off-set by benefits to other income and expenses, representing a net loss per share of $(0.06). This compares to the third quarter of 2020 net loss of $(4.2) million, or $(0.03) per share.
We ended the quarter with a cash position of $55.2 million as of September 30, 2021, which we believe provides sufficient runway to execute on our strategic objectives for the foreseeable future.

28

Results of Operations

Quarter and Year-to-Date September 30, 2021 compared to Quarter and Year-to-Date September 30, 2020.

All amounts in thousands, except for share and per share data.

Revenue - Sale of products, net

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Sale of products, net

$

7,811

$

7,310

$

22,988

$

20,803

Dollar Change from Prior Year

$

501

 

  

$

2,185

The increase in sales revenue for the three months ended September 30, 2021, compared to the three months ended September 30, 2020, was due to an increase in sales of contract manufactured filtered cigars offset by a decrease in sales of cigarettes. Filtered cigar sales increased by approximately $1,126 and cigarette sales decreased by $625.

The increase in sales revenue for the nine months ended September 30, 2021, was the result of increased sales of contract manufactured filtered cigars of $3,008, primarily driven by increased volume, and fulfillment of our SPECTRUM® cigarette order of $680 which did not occur in the prior period. This was partially offset by decreased sales of contract manufactured cigarettes of $1,503 which was primarily due to lower volume of orders received.

Cost of goods sold - Products / Gross profit (loss)

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Cost of goods sold

$

7,362

$

6,948

$

21,306

$

19,953

Percent of Product Sales

 

94.3

%  

 

95.0

%

92.7

%  

95.9

%  

Dollar Change from Prior Year

$

414

 

  

$

1,353

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Gross profit

$

449

$

362

$

1,682

$

850

Percent of Product Sales

 

5.7

%  

5.0

%

7.3

%  

4.1

%  

Dollar Change from Prior Year

$

87

 

  

$

832

The increase in gross profit for the three months ended September 30, 2021, compared to the three months ended September 30, 2020, was driven by improved contract manufactured filtered cigar sales mix due to new customer contracts and price increases taken on contract manufactured cigarettes.

The increase in gross profit for the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, was primarily driven by improved contract manufactured filtered cigar sales mix due to new customer contracts, cigarette price increases during the second quarter of 2021, and fulfillment of our SPECTRUM® cigarette order.

29

Research and development (“R&D”) expense

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Research and Development

$

854

$

906

$

2,287

$

2,676

Percent of Product Sales

 

10.9

%  

 

12.4

%

9.9

%

12.9

%

Dollar Change from Prior Year

 

$

(52)

 

  

$

(389)

The decrease in R&D expense for the three months ended September 30, 2021, compared to the three months ended September 30, 2020, was primarily due to tobacco leaf inventory impairment in the prior year period of $58, which did not reoccur in the current year period, and lower personnel expense of $38. This was partially offset by higher license and contract costs of $48.

Lower R&D expense for the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, was driven by a decrease in R&D personnel expense of $210, lower facilities expense of $102, a decrease in R&D contract costs of $51, a decrease in consulting and professional services of $50, and a 2020 tobacco leaf inventory impairment of $58, which did not reoccur in the current year period. This decrease was partially offset by increased patent expenses of $139 for the nine months ended September 30, 2021, compared to the prior year period. We continue to prioritize our R&D activities to achieve our strategic and investment priorities.

Research and development expense - MRTP

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Research and Development - MRTP

$

2

$

4

$

16

$

158

Percent of Product Sales

 

0.0

%  

 

0.0

%

0.1

%

0.8

%

Dollar Change from Prior Year

 

$

(2)

 

  

$

(142)

MRTP expenses for three and nine months ended September 30, 2021 declined as we submitted our MRTP application to the FDA during 2019. MRTP-related expenses for 2021 are primarily related to continued consulting services related to our application while 2020 expenses are primarily related to our February 14, 2020 Tobacco Products Scientific Advisory Committee (TPSAC) hearing.

Sales, general and administrative expense

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Sales, general and administrative

$

6,821

$

3,169

$

17,827

$

9,809

Percent of Product Sales

 

87.3

%  

 

43.4

%

77.6

%

47.2

%

Dollar Change from Prior Year

$

3,652

 

  

$

8,018

The increase in SG&A expense during the three months ended September 30, 2021, as compared to the respective prior year period, was driven by increased investor relations and consulting expenses of $2,399, increased equity compensation expense of $795, increased personnel expenses of $244, increased legal fees of $187, and increased insurance expenses of $155. This was partially offset by lower sales and marketing expenses of $129 compared to the respective prior year period.

The increase in SG&A expense during the nine months ended September 30, 2021, as compared to the respective prior year period, was driven by increased investor relations and consulting expenses of $4,131, increased equity compensation expense of $1,700, increased insurance expenses of $1,034, increased personnel expenses of $941 due to the hiring of the new management team including the Chief Executive Officer and Chief Financial Officer in the second quarter of 2020, and increased board of director fees of $249. These increases in SG&A expense were partially offset by lower legal fees of $54 compared to the respective prior year period.

30

We have deployed this incremental SG&A spending to continue our corporate investment as we move quickly to market readiness in both tobacco and hemp/cannabis. We will continue to incur incremental SG&A spending as growth and investment opportunities present themselves.

Impairment expense

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Impairment of intangible assets

$

$

$

$

146

Percent of Product Sales

 

%

 

%

%

0.7

%

Dollar Change from Prior Year

 

$

 

  

$

(146)

The decrease in impairment expense for the nine months ended September 30, 2021, was due to a one-time impairment charge of $146, in the prior year period, which was required for certain patent and trademark costs.

Depreciation expense

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Depreciation

$

173

$

160

$

461

$

473

Percent of Product Sales

 

2.2

%  

 

2.2

%

2.0

%

2.3

%

Dollar Change from Prior Year

$

13

 

  

$

(12)

The increase in depreciation expense for the three months ended September 30, 2021, as compared to the prior year period, was primarily due to new assets acquired from the conversion of our Panacea investment, as described within Note 5 to our financial statements included herein.

The decrease in depreciation expense for the nine months ended September 30, 2021, as compared to the respective prior year period, was due to a lower property, plant, and equipment depreciable base primarily due to impairments taken for the former Williamsville corporate office during the fourth quarter of 2020.

Amortization expense

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Amortization

$

168

$

163

$

471

$

524

Percent of Product Sales

 

2.2

%  

 

2.2

%

2.1

%

2.5

%

Dollar Change from Prior Year

 

$

5

 

  

$

(53)

Amortization expense was consistent with prior year for the three months ended September 30, 2021, as compared to the three months ended September 30, 2020. The decrease in amortization expense during the nine months ended September 30, 2021, as compared to the respective prior year period, was due to a lower intangible asset depreciable base primarily due to impairments taken during 2020.

Impairment of Panacea investment

Quarter-to-Date

Year-to-Date

September 30

September 30

September 30

September 30

    

2021

    

2020

2021

    

2020

Impairment of Panacea Investment

$

$

$

$

(1,062)

Percent of Product Sales

 

%

%

%

(5.1)

%

Dollar Change from Prior Year

 

$

$

1,062

31

For the nine months ended September 30, 2020, we incurred impairment charges on our investment in Panacea. Refer to Note 5 to our consolidated financial statements for additional information regarding our investment in Panacea.

Gain on Panacea investment conversion

On June 30, 2021, the Company entered into a Promissory Note Exchange Agreement with Panacea and a Securities Exchange Agreement with Panacea, Exactus, Inc. (“Exactus”) (OTCQB:EXDI) and certain other Panacea shareholders. Pursuant to the Securities Exchange Agreement, Exactus fully acquired Panacea. These transactions effect the (i) conversion of all of the Company’s existing Series B Preferred Stock in Panacea into 91,016,026 shares of common stock in Exactus valued at $9,102 as of June 30, 2021 and (ii) the conversion of the Company’s existing debt in Panacea by converting the outstanding $7,000 principal balance convertible note receivable and all accrued but unpaid interest thereon for fee simple ownership of Needle Rock Farms (224 acres in Delta County, Colorado) and equipment valued at $2,248, $500 in Panacea’s Series B Preferred Stock (which was subsequently converted to Exactus common stock under the Securities Exchange Agreement), and a new $4,300 promissory note (the “Promissory note receivable”) with a maturity date of June 30, 2026 and a 0% interest rate. The Promissory note receivable is with a related party of Panacea and is fully secured by a first priority lien on Panacea’s headquarters located in Golden, Colorado.

The conversion was recorded as a non-monetary transaction, based on the fair value of the assets received, and resulted in a gain of $2,548 which is included within the Consolidated Statements of Operations. Our shares of Exactus common stock were valued based on a closing share price of $.10 per share as published on June 30, 2021. Our investment is described further within Note 5 to our financial statements included herein.

Unrealized gain (loss) on investment

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Unrealized gain (loss) on investments

$

(1,900)

$

(429)

$

(2,040)

$

(562)

Percent of Product Sales

 

(24.3)

%

 

(5.9)

%

(8.9)

%

(2.7)

%

Dollar Change from Prior Year

 

$

(1,471)

 

  

$

(1,478)

Unrealized gain (loss) on investment includes fair value adjustments for our investment in Aurora Cannabis, Inc (“Aurora”) stock warrants and our investment in Exactus common stock. Both investments are considered equity securities and are adjusted to fair value at each reporting period as discussed within Note 6 to our consolidated financial statements included herein.

The warrants to purchase 81,164 shares of Aurora common stock were valued at $18 as of September 30, 2021, using the Black-Scholes pricing model, which amounted to an unrealized loss of $80 for the three months ended September 30, 2021 and an unrealized loss of $220 for the nine months ended September 30, 2021.

Our shares of Exactus common stock were valued based on the closing share price as of September 30, 2021. As of September 30, 2021, the shares were valued at $7,281 which amounted to an unrealized loss of $1,820. Our investment in Exactus is considered an investment in a small microcap stock which can be subject to large market volatility resulting in fluctuations to our net loss and loss per share—due to unrealized gains or losses that will be recognized within the Consolidated Statements of Operations. Our investment is described further within Note 5 to our financial statements included herein.

32

Gain on the sale of property, plant and equipment

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Gain on the sale of property, plant and equipment

$

$

1

$

$

1

Percent of Product Sales

 

%  

 

%

%

%

Dollar Change from Prior Year

$

(1)

 

  

$

(1)

We recognized a small gain on equipment sold during the three and nine months ended September 30, 2020. No similar sales occurred in 2021.

Interest income, net

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Interest Income, net

$

52

$

270

$

272

$

1,344

Percent of Product Sales

 

0.7

%  

 

3.7

%

1.2

%

6.5

%

Dollar Change from Prior Year

$

(218)

 

  

$

(1,072)

Interest income, net (interest income less investment fees) is comprised of cash interest income and non-cash interest accretion. Cash interest income is primarily derived from interest earned on our short-term investment securities and non-cash interest income is primarily related to accretion of short-term investment securities purchased at a discount or premium and accretion of certain other assets recorded at a discount.

Cash interest income for the three months ended September 30, 2021 increased $1, as compared to the respective prior year period, and non-cash interest accretion decreased $219 primarily due to our Panacea investment conversion further described within Note 5 to our financial statements included herein.

Cash interest income for the nine months ended September 30, 2021 decreased $285, as compared to the respective prior year period, primarily due to lower bond interest yields on our short-term investment securities. Non-cash interest accretion for the nine months ended September 30, 2021 decreased $787, as compared to the respective prior year period, primarily due to our Panacea investment conversion which is further described within Note 5 to our financial statements included herein.

Interest expense

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

 

2021

    

2020

Interest Expense

$

(23)

$

(23)

$

(44)

$

(54)

Percent of Product Sales

 

(0.3)

%

(0.3)

%

(0.2)

%

(0.3)

%

Dollar Change from Prior Year

 

$

 

  

$

10

Interest expense decreased for the nine months ended September 30, 2021, as compared to the nine months ended September 30, 2020, primarily due to the interest accretion on a note payable to NCSU which was fully paid off during the second quarter of 2020.

33

Net loss

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Net Loss

$

(9,440)

$

(4,221)

$

(18,644)

$

(13,307)

Percent of Product Sales

 

(120.9)

%

(57.7)

%

(81.1)

%

(64.0)

%

Dollar Change from Prior Year

 

$

(5,219)

 

  

$

(5,337)

The increase in net loss for the three months ended September 30, 2021, as compared to the same prior year period, was primarily the result of increased operating expenses of $3,529, an increase in unrealized loss on investments of $1,471, primarily relating to our Aurora stock warrants and Exactus common stock investments, and lower interest income of $218.

The increase in net loss for the nine months ended September 30, 2021, as compared to the same period during the prior year, was primarily the result of increased operating expenses of $7,276, an increase in unrealized loss on investments of $1,478, primarily relating to our Aurora stock warrants and Exactus common stock investments, and lower interest income in the amount of $1,072. This was partially offset by an increase in gross profit of $832, a gain on our Panacea investment conversion of $2,548, and a 2020 impairment of $1,062 which did not repeat in 2021.

Other Comprehensive Income (Loss)

Quarter-to-Date

 

Year-to-Date

September 30

September 30

 

September 30

September 30

    

2021

    

2020

    

2021

    

2020

Other Comprehensive Income (Loss)

$

(28)

$

87

$

(101)

$

132

Percent of Product Sales

 

(0.4)

%

 

1.2

%

(0.4)

%

0.6

%

Dollar Change from Prior Year

 

$

(115)

 

  

$

(233)

We maintain an account for short-term investment securities that are classified as available-for-sale securities and consist of money market funds and corporate bonds with maturities greater than three months at the time of acquisition. Unrealized gains and losses on short-term investment securities (the adjustment to fair value) are recorded as other comprehensive income or loss.

We recorded an unrealized loss on short-term investment securities in the amount of $28 resulting in other comprehensive loss of $28 for the three months ended September 30, 2021, as compared to an unrealized gain of $87 for the prior year respective period. For the nine months ended September 30, 2021, we recorded an unrealized loss on short-term investment securities in the amount of $101 resulting in other comprehensive loss of $101, as compared to an unrealized gain of $132 for the prior year respective period.

Liquidity and Capital Resources

Year-to-Date

September 30

September 30

    

2021

    

2020

Net cash provided by (used in) operating activities

$

(18,207)

$

(12,624)

Net cash provided by (used in) investing activities

 

(33,207)

 

12,755

Net cash provided by (used in) financing activities

 

52,014

 

926

Net increase (decrease) in cash and cash equivalents

 

600

 

1,057

Cash and cash equivalents - beginning of period

 

1,029

 

485

Cash and cash equivalents - end of period

$

1,629

 

$

1,542

Short-term investment securities

$

53,532

 

$

25,276

Working Capital

As of September 30, 2021, we had working capital of approximately $55,212 compared to working capital of approximately $20,998 at December 31, 2020 an increase of $34,214. This increase in working capital was primarily due to a $32,819 increase in

34

cash, cash equivalents and short-term investment securities resulting from (i) net proceeds of $11,782 from the cash exercises of all outstanding warrants during the first quarter of 2021; and (ii) net proceeds of $38,206 from a capital raise in June 2021 described below, offset primarily by cash and cash equivalents consumed in the operating activities of the Company.

On June 7, 2021, we entered into a placement agent agreement (the “Placement Agent Agreement”) with Cowen and Company, LLC (the “Placement Agent”) relating to a registered direct offering (the “Offering”) to a select investor (the “Investor”). Pursuant to the Placement Agent Agreement, we agreed to pay the Placement Agent a cash fee of 3.0% of the gross proceeds from the Offering. The Placement Agent Agreement requires us to indemnify the Placement Agent and certain of its affiliates against certain customary liabilities. In addition, on June 7, 2021, we and the Investor entered into a securities purchase agreement (the “Securities Purchase Agreement”) relating to the issuance and sale of shares of common stock. The Investor purchased $40,000 of shares, consisting of an aggregate of 10,000,000 shares of common stock at $4.00 per share, resulting in net proceeds of $38,206. The common stock was offered and sold pursuant to our Form S-3 shelf registration statement.

Net cash used in operating activities

The increase of cash used in operations in the amount of $5,583 was due to an increase in the cash portion of the net loss in the amount of $5,972 and a decrease in cash used for working capital components related to operations in the amount of $389 for the nine months ended September 30, 2021 as compared to the nine months ended September 30, 2020.

Net cash provided by investing activities

The increase in cash used in investing activities of $45,962 was primarily the result of a net increase in the net cash used for our short-term investments in the amount of $45,628 and an increase in the cash used for acquisition of property, plant and equipment and the acquisition of patents, trademarks and licenses in the amount of $334 for the nine months ended September 30, 2021, as compared to the nine months ended September 30, 2020. The increase in cash used in our short-term investments was primarily due to increased funds for investment, from the warrant exercises and capital raise described above, while the increased cash used for acquisition of machinery and equipment and the acquisition of patents, trademarks and licenses was primarily due to new office furnishings and additional intellectual property costs.

Net cash provided by financing activities

During the nine months ended September 30, 2021, cash provided by financing activities increased by $51,088 resulting from (i) the net proceeds of $11,782 resulting from the cash exercises of all outstanding warrants during the first quarter of 2021; (ii) net proceeds of $38,206 resulting from a capital raise in June 2021; (iii) increased net proceeds from note payable issuances and payments of $310; and (iv) net proceeds from stock option exercises of $1,259. This increase was partially offset by cash paid for taxes related to settlement of restricted stock units of $469.

Cash demands on operations

Our principal sources of liquidity are our cash and cash equivalents, short-term investment securities, and cash generated from our contract manufacturing business. As of September 30, 2021, we had approximately $55,161 of cash and cash equivalents and short-term investments which is an increase of $32,819 from December 31, 2020. This increase was primarily due to the cash exercise of our outstanding warrants in the first quarter of 2021 and a capital raise in the second quarter of 2021. Our short-term investment securities, along with sustained contract manufacturing sales, provide sufficient resources for estimated contractual commitments, described further in Note 11 to our consolidated financial statements included herein, and normal cash requirements for operations well beyond the next twelve months. In addition to the commitments described in Note 11 to our consolidated financial statements included herein, we have secured contracts with select tobacco farmers to assist with the 2021 growing of our VLNC tobacco. These contracts will increase the quantity of our current leaf inventory which will help support expected demand of VLN®, if MTRP authorization is granted by the FDA. The cost of such growing efforts is dependent on the final agricultural yields and leaf quality, but we expect the cost to range between $1.5 million and $1.9 million. We also believe that we have appropriate liquidity to successfully manufacture and distribute our VLN® cigarette within 90 days of MRTP authorization by the FDA, if granted in 2021, and appropriate liquidity for continued R&D investment in all of our plant franchises.

35

We also have an effective S-3 shelf registration statement on file with the U.S. Securities and Exchange Commission (SEC), which provides us flexibility and optionality to raise additional capital as needed. However, there can be no assurance that capital will be available to us on acceptable terms or at all.

Critical Accounting Policies and Estimates

There have been no material changes to the information set forth in our Annual Report on Form 10-K for the year ended December 31, 2020.

Inflation

Inflation did not have a material effect on our operating results for the nine months ended September 30, 2021 and 2020, respectively.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements as defined by Item 303(a)(4) of Regulation S-K.

Item 4. Controls and Procedures

(a)

Evaluation of Disclosure Controls and Procedures:

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in its Securities Exchange Act of 1934 (“Exchange Act”) reports are recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including the Company’s chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our chief executive officer and chief financial officer, after evaluating the effectiveness of the Company’s “disclosure controls and procedures” (as defined in the Exchange Act Rules 13a-15(e) or 15d-15(e)) as of the end of the period covered by this quarterly report, have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Form 10-Q to ensure information required to be disclosed is recorded, processed, summarized and reported within the time period specified by SEC rules, based on their evaluation of these controls and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.

(b)

Changes in Internal Control over Financial Reporting:

There were no changes in the Company’s internal controls over financial reporting during the third quarter of 2021 that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

36

Part II. OTHER INFORMATION

Item 1. Legal Proceedings

See Note 11 - Commitments and Contingencies – Litigation - to our consolidated financial statements included in this Quarterly Report for information concerning our on-going litigation. In addition to the lawsuits described in Note 11, from time to time we may be involved in claims arising in the ordinary course of business. To our knowledge other than the cases described in Note 11 to our consolidated financial statements, no material legal proceedings, governmental actions, investigations or claims are currently pending against us or involve us that, in the opinion of our management, could reasonably be expected to have a material adverse effect on our business and financial condition.

Item 1A. Risk Factors

There have been no material changes from the risk factors disclosed in Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the SEC on March 11, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None

Item 3. Default Upon Senior Securities.

None

Item 4. Mine Safety Disclosures

None

Item 5. Other Information

None

37

Item 6. Exhibits

Exhibit 31.1

Section 302 Certification - Chief Executive Officer

 

 

Exhibit 31.2

Section 302 Certification - Chief Financial Officer

 

 

Exhibit 32.1

Certification of Principal Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.

 

 

101.INS

XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

 

 

101.SCH

XBRL Taxonomy Extension Schema Document

 

 

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

 

 

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

 

 

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

Exhibit 104

Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

38

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized:

 

22nd CENTURY GROUP, INC.

 

 

Date: November 4, 2021

/s/ James A. Mish

 

James A. Mish

 

Chief Executive Officer

 

(Principal Executive Officer)

 

 

Date: November 4, 2021

/s/ John Franzino

 

John Franzino

 

Chief Financial Officer

 

(Principal Accounting and Financial Officer)

39

EX-31.1 2 xxii-20210930xex31d1.htm EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, James A. Mish, Chief Executive Officer of 22nd CENTURY GROUP, INC., certify that:

1.     I have reviewed this quarterly report on Form 10-Q of 22nd CENTURY GROUP, INC.;

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.     The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules13a-15(f) and 15d-15 (f)) for the registrant and have:

a.     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.     Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.     Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.     The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing equivalent functions):

a.     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:

November 4, 2021

 

 

 

 

 

/s/ James A. Mish

 

 

James A. Mish

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)


EX-31.2 3 xxii-20210930xex31d2.htm EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, John Franzino, Chief Financial Officer of 22nd CENTURY GROUP, INC., certify that:

1.    I have reviewed this quarterly report on Form 10-Q of 22nd CENTURY GROUP, INC.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules13a-15(f) and 15d-15 (f)) for the registrant and have:

a.     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.     Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.     Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing equivalent functions):

a.     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:

November 4, 2021

 

 

 

 

 

/s/ John Franzino

 

 

John Franzino

 

 

Chief Financial Officer

 

 

(Principal Accounting and Financial Officer)


EX-32.1 4 xxii-20210930xex32d1.htm EX-32.1

Exhibit 32.1

Written Statement of the Principal Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. §1350

Solely for the purposes of complying with 18 U.S.C. §1350, I, the undersigned Chief Executive Officer of 22nd CENTURY GROUP, INC. (the “Company”), and I, the undersigned Chief Financial Officer of the Company, hereby certify, to the best of my knowledge, that the quarterly report on Form 10-Q of the Company for the quarter ended September 30, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

This certification is being furnished solely to accompany this Report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Date:

November 4, 2021

 

 

 

 

 

/s/ James A. Mish

 

 

James A. Mish

 

 

Chief Executive Officer

 

 

 

Date:

November 4, 2021

 

 

 

 

 

/s/ John Franzino

 

 

John Franzino

 

 

Chief Financial Officer


EX-101.SCH 5 xxii-20210930.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS AND OTHER LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - INVESTMENTS AND OTHER ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - FAIR VALUE MEASUREMENTS - Available-for-sale securities (Details) link:presentationLink link:calculationLink link:definitionLink 40604 - Disclosure - FAIR VALUE MEASUREMENTS - Maturity of available-for-sale securities by contractual maturity (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - SEVERANCE LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - COMMITMENTS AND CONTINGENCIES - Licenses (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - REVENUE RECOGNITION (Details) link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS AND OTHER LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - INVESTMENTS AND OTHER ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - INVESTMENTS AND OTHER ASSETS - Total carrying value (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - FAIR VALUE MEASUREMENTS - Recurring (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - FAIR VALUE MEASUREMENTS - Changes in fair value, Level 3 (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - CAPITAL RAISE AND WARRANT EXERCISE - Capital raise (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - CAPITAL RAISE AND WARRANT EXERCISE - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - COMMITMENTS AND CONTINGENCIES - MRTP, litigation (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - EQUITY-BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 41202 - Disclosure - EQUITY- BASED COMPENSATION - RSUs (Details) link:presentationLink link:calculationLink link:definitionLink 41203 - Disclosure - EQUITY- BASED COMPENSATION - Stock option activity (Details) link:presentationLink link:calculationLink link:definitionLink 41204 - Disclosure - EQUITY BASED COMPENSATION - Fair value assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 41205 - Disclosure - EQUITY-BASED COMPENSATION - Compensation expense and unrecognized compensation (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 41402 - Disclosure - EARNINGS PER SHARE - Anti-dilutive securities (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - PROPERTY, PLANT AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - INVESTMENTS AND OTHER ASSETS link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - SEVERANCE LIABILITY link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - CAPITAL RAISE AND WARRANT EXERCISE link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - EQUITY- BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - REVENUE RECOGNITION link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 20102 - Disclosure - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - CAPITAL RAISE AND WARRANT EXERCISE (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - COMMITMENTS & CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 31203 - Disclosure - EQUITY- BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 31303 - Disclosure - REVENUE RECOGNITION (Tables) link:presentationLink link:calculationLink link:definitionLink 31403 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 xxii-20210930_cal.xml EX-101.CAL EX-101.DEF 7 xxii-20210930_def.xml EX-101.DEF EX-101.LAB 8 xxii-20210930_lab.xml EX-101.LAB EX-101.PRE 9 xxii-20210930_pre.xml EX-101.PRE XML 10 xxii-20210930x10q_htm.xml IDEA: XBRL DOCUMENT 0001347858 xxii:KeygeneMember xxii:SponsoredResearchAgreementMember 2021-04-30 2021-04-30 0001347858 xxii:TwentySecondCenturyLtdMember 2021-01-01 2021-09-30 0001347858 xxii:BotanicalGeneticsMember 2021-01-01 2021-09-30 0001347858 xxii:NorthCarolinaStateUniversityMember xxii:LicenseAgreementMember 2021-01-01 2021-09-30 0001347858 xxii:ManufacturingFacilityAndWarehouseInNorthCarolinaMember us-gaap:SubsequentEventMember 2021-10-18 2021-10-18 0001347858 xxii:ResearchAndDevelopmentLaboratoryInRockvilleMdMember 2021-07-28 2021-07-28 0001347858 xxii:InvestmentInPanaceaLifeSciencesInc.Member us-gaap:WarrantMember 2019-12-03 0001347858 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001347858 us-gaap:WarrantMember 2020-01-01 2020-12-31 0001347858 xxii:ExactusMember 2021-06-30 2021-06-30 0001347858 xxii:NorthCarolinaStateUniversityMember xxii:LicenseAgreementMember 2020-01-01 2020-06-30 0001347858 xxii:CannametrixMember xxii:SponsoredResearchAgreementMember 2021-03-01 2021-03-01 0001347858 xxii:KeygeneMember xxii:SponsoredResearchAgreementMember 2021-01-01 2021-09-30 0001347858 xxii:InvestmentInPanaceaLifeSciencesInc.Member us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2019-12-03 0001347858 xxii:InvestmentInPanaceaLifeSciencesInc.Member us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2019-12-03 0001347858 xxii:InvestmentInPanaceaLifeSciencesInc.Member us-gaap:WarrantMember us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember 2019-12-03 0001347858 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001347858 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001347858 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001347858 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001347858 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001347858 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001347858 2021-06-07 2021-06-07 0001347858 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001347858 us-gaap:SubsequentEventMember xxii:ExactusMember 2021-10-28 2021-10-28 0001347858 us-gaap:RetainedEarningsMember 2021-09-30 0001347858 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001347858 us-gaap:RetainedEarningsMember 2021-06-30 0001347858 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001347858 us-gaap:RetainedEarningsMember 2021-03-31 0001347858 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001347858 us-gaap:RetainedEarningsMember 2020-12-31 0001347858 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001347858 us-gaap:RetainedEarningsMember 2020-09-30 0001347858 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001347858 us-gaap:RetainedEarningsMember 2020-06-30 0001347858 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001347858 us-gaap:RetainedEarningsMember 2020-03-31 0001347858 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001347858 2020-03-31 0001347858 us-gaap:RetainedEarningsMember 2019-12-31 0001347858 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001347858 us-gaap:CommonStockMember 2021-09-30 0001347858 us-gaap:CommonStockMember 2021-06-30 0001347858 us-gaap:CommonStockMember 2021-03-31 0001347858 us-gaap:CommonStockMember 2020-12-31 0001347858 us-gaap:CommonStockMember 2020-09-30 0001347858 us-gaap:CommonStockMember 2020-06-30 0001347858 us-gaap:CommonStockMember 2020-03-31 0001347858 us-gaap:CommonStockMember 2019-12-31 0001347858 2021-06-07 0001347858 2021-03-31 0001347858 us-gaap:ShareBasedPaymentArrangementNonemployeeMember 2021-01-01 2021-09-30 0001347858 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2021-01-01 2021-09-30 0001347858 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-07-01 2021-09-30 0001347858 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2021-09-30 0001347858 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-01 2021-09-30 0001347858 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-09-30 0001347858 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-07-01 2020-09-30 0001347858 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2020-09-30 0001347858 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-09-30 0001347858 us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0001347858 us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001347858 us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0001347858 us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0001347858 us-gaap:TransferredOverTimeMember 2020-07-01 2020-09-30 0001347858 us-gaap:TransferredAtPointInTimeMember 2020-07-01 2020-09-30 0001347858 us-gaap:TransferredOverTimeMember 2020-01-01 2020-09-30 0001347858 us-gaap:TransferredAtPointInTimeMember 2020-01-01 2020-09-30 0001347858 xxii:ProductsOtherThanModifiedRiskTobaccoProductsMember 2021-07-01 2021-09-30 0001347858 xxii:ModifiedRiskTobaccoProductMember 2021-07-01 2021-09-30 0001347858 xxii:ProductsOtherThanModifiedRiskTobaccoProductsMember 2021-01-01 2021-09-30 0001347858 xxii:ModifiedRiskTobaccoProductMember 2021-01-01 2021-09-30 0001347858 xxii:ProductsOtherThanModifiedRiskTobaccoProductsMember 2020-07-01 2020-09-30 0001347858 xxii:ModifiedRiskTobaccoProductMember 2020-07-01 2020-09-30 0001347858 xxii:ProductsOtherThanModifiedRiskTobaccoProductsMember 2020-01-01 2020-09-30 0001347858 xxii:ModifiedRiskTobaccoProductMember 2020-01-01 2020-09-30 0001347858 srt:MinimumMember us-gaap:EquipmentMember 2021-01-01 2021-09-30 0001347858 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2021-01-01 2021-09-30 0001347858 srt:MaximumMember us-gaap:EquipmentMember 2021-01-01 2021-09-30 0001347858 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2021-01-01 2021-09-30 0001347858 us-gaap:OtherMachineryAndEquipmentMember 2021-01-01 2021-09-30 0001347858 us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-09-30 0001347858 us-gaap:OtherMachineryAndEquipmentMember 2021-09-30 0001347858 us-gaap:LandMember 2021-09-30 0001347858 us-gaap:FurnitureAndFixturesMember 2021-09-30 0001347858 us-gaap:EquipmentMember 2021-09-30 0001347858 us-gaap:ConstructionInProgressMember 2021-09-30 0001347858 us-gaap:BuildingAndBuildingImprovementsMember 2021-09-30 0001347858 us-gaap:OtherMachineryAndEquipmentMember 2020-12-31 0001347858 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001347858 us-gaap:EquipmentMember 2020-12-31 0001347858 us-gaap:BuildingAndBuildingImprovementsMember 2020-12-31 0001347858 2020-05-12 2020-05-12 0001347858 2019-01-01 2019-12-31 0001347858 xxii:InvestmentInPanaceaLifeSciencesInc.Member 2019-12-03 2019-12-03 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001347858 xxii:UniversityOfKentuckyMember xxii:LicenseAgreementMember 2018-10-22 0001347858 xxii:NorthCarolinaStateUniversityMember xxii:LicenseAgreementMember 2018-06-22 0001347858 xxii:InvestmentInPanaceaLifeSciencesInc.Member 2021-06-30 2021-06-30 0001347858 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001347858 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001347858 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001347858 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001347858 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001347858 2021-01-01 2021-03-31 0001347858 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001347858 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001347858 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001347858 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001347858 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001347858 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001347858 2020-01-01 2020-03-31 0001347858 us-gaap:MoneyMarketFundsMember 2021-09-30 0001347858 2020-01-15 0001347858 2019-11-19 0001347858 xxii:AuroraCannabisIncMember us-gaap:WarrantMember 2021-09-30 0001347858 xxii:ExactusMember 2021-06-30 0001347858 xxii:InvestmentInPanaceaLifeSciencesInc.Member us-gaap:WarrantMember 2020-12-31 0001347858 xxii:InvestmentInPanaceaLifeSciencesInc.Member us-gaap:PreferredStockMember 2020-12-31 0001347858 xxii:AuroraCannabisIncMember us-gaap:WarrantMember 2020-12-31 0001347858 xxii:ResearchAndDevelopmentLaboratoryInRockvilleMdMember 2021-07-28 0001347858 xxii:ManufacturingFacilityAndWarehouseInNorthCarolinaMember us-gaap:SubsequentEventMember 2021-10-18 0001347858 xxii:ExactusMember us-gaap:SubsequentEventMember 2021-10-28 0001347858 xxii:ExactusMember 2021-09-30 0001347858 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-09-30 0001347858 us-gaap:CostOfSalesMember 2020-01-01 2020-09-30 0001347858 us-gaap:LicensingAgreementsMember 2021-09-30 0001347858 us-gaap:ContractualRightsMember 2021-09-30 0001347858 us-gaap:LicensingAgreementsMember 2020-12-31 0001347858 us-gaap:ContractualRightsMember 2020-12-31 0001347858 xxii:UniversityOfKentuckyMember xxii:LicenseAgreementMember 2018-10-22 2018-10-22 0001347858 xxii:NorthCarolinaStateUniversityMember xxii:LicenseAgreementMember 2018-06-22 2018-06-22 0001347858 us-gaap:LicensingAgreementsMember 2021-09-30 0001347858 us-gaap:IntellectualPropertyMember 2021-09-30 0001347858 us-gaap:LicensingAgreementsMember 2020-12-31 0001347858 us-gaap:IntellectualPropertyMember 2020-12-31 0001347858 xxii:InvestmentInPanaceaLifeSciencesInc.Member us-gaap:WarrantMember 2020-04-01 2020-06-30 0001347858 us-gaap:WarrantMember 2021-09-30 0001347858 us-gaap:WarrantMember 2020-12-31 0001347858 2021-04-01 2021-06-30 0001347858 2020-04-01 2020-06-30 0001347858 2021-06-30 0001347858 2020-06-30 0001347858 xxii:MinimumAnnualRoyalty2Member xxii:LicenseAgreementMember 2021-09-30 0001347858 xxii:MinimumAnnualRoyalty1Member xxii:LicenseAgreementMember 2021-09-30 0001347858 xxii:KeygeneMember xxii:SponsoredResearchAgreementMember 2021-09-30 0001347858 xxii:CannametrixMember xxii:SponsoredResearchAgreementMember 2021-09-30 0001347858 xxii:AnnualRoyaltyMember xxii:LicenseAgreementMember 2021-09-30 0001347858 xxii:SublicenseAgreementWithAnandiaLaboratoriesInc.Member 2021-09-30 0001347858 xxii:GrowingAgreementMember 2021-09-30 0001347858 xxii:ConsultingAgreementMember 2021-09-30 0001347858 xxii:InvestmentInPanaceaLifeSciencesInc.Member 2019-12-03 0001347858 2020-09-30 0001347858 2019-12-31 0001347858 us-gaap:CorporateBondSecuritiesMember 2021-09-30 0001347858 us-gaap:PreferredStockMember 2020-12-31 0001347858 us-gaap:NotesReceivableMember 2020-12-31 0001347858 us-gaap:CorporateBondSecuritiesMember 2020-12-31 0001347858 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:WarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:WarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:CommonStockMember us-gaap:FairValueMeasurementsRecurringMember 2021-09-30 0001347858 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:WarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:WarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:WarrantMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:ShortTermInvestmentsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:PreferredStockMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:NotesReceivableMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 us-gaap:CorporateBondSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001347858 xxii:InvestmentInPanaceaLifeSciencesInc.Member 2021-06-30 0001347858 us-gaap:RestrictedStockUnitsRSUMember 2021-07-01 2021-09-30 0001347858 us-gaap:OptionMember 2021-07-01 2021-09-30 0001347858 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-09-30 0001347858 us-gaap:OptionMember 2021-01-01 2021-09-30 0001347858 us-gaap:WarrantMember 2020-07-01 2020-09-30 0001347858 us-gaap:RestrictedStockUnitsRSUMember 2020-07-01 2020-09-30 0001347858 us-gaap:OptionMember 2020-07-01 2020-09-30 0001347858 us-gaap:WarrantMember 2020-01-01 2020-09-30 0001347858 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0001347858 us-gaap:OptionMember 2020-01-01 2020-09-30 0001347858 2021-07-01 2021-09-30 0001347858 2020-07-01 2020-09-30 0001347858 2020-01-01 2020-09-30 0001347858 us-gaap:BorrowingsMember 2021-07-01 2021-09-30 0001347858 us-gaap:BorrowingsMember 2021-01-01 2021-09-30 0001347858 us-gaap:BorrowingsMember 2020-07-01 2020-09-30 0001347858 us-gaap:BorrowingsMember 2020-01-01 2020-09-30 0001347858 2021-09-30 0001347858 2020-12-31 0001347858 2021-11-03 0001347858 2021-01-01 2021-09-30 shares iso4217:USD utr:acre iso4217:USD shares pure xxii:item utr:sqft xxii:subsidiary P5Y P5Y 0001347858 --12-31 2021 Q3 false P10Y 162735483 139061690 P42M P14M P3Y P1Y P5Y P2Y P1Y P9M P2Y http://fasb.org/us-gaap/2021-01-31#MeasurementInputPriceVolatilityMember http://fasb.org/us-gaap/2021-01-31#MeasurementInputPriceVolatilityMember P40Y 0.035714 10-Q true 2021-09-30 false 001-36338 22nd Century Group, Inc. NV 98-0468420 500 Seneca Street Suite 507 Buffalo NY 14204 716 270-1523 Common Stock, $0.00001 par value XXII NASDAQ Yes Yes Non-accelerated Filer true false false 162748483 1629000 1029000 53532000 21313000 1179000 2159000 2703000 2034000 3131000 1806000 62174000 28341000 4754000 2483000 478000 247000 8036000 8211000 7300000 6536000 3713000 5876000 86455000 51694000 1782000 539000 74000 247000 1443000 1116000 3440000 4830000 223000 339000 0 272000 6962000 7343000 407000 0 72000 241000 7441000 7584000 10000000 10000000 0.00001 0.00001 300000000 300000000 0.00001 0.00001 162735483 139061690 2000 1000 243087000 189439000 -27000 74000 -164048000 -145404000 79014000 44110000 86455000 51694000 7811000 7310000 22988000 20803000 7362000 6948000 21306000 19953000 449000 362000 1682000 850000 854000 906000 2287000 2676000 2000 4000 16000 158000 6821000 3169000 17827000 9809000 146000 173000 160000 461000 473000 168000 163000 471000 524000 8018000 4402000 21062000 13786000 -7569000 -4040000 -19380000 -12936000 -1900000 -429000 -2040000 -562000 1062000 2548000 52000 270000 272000 1344000 23000 23000 44000 54000 -1871000 -181000 736000 -333000 -9440000 -4221000 -18644000 -13269000 38000 -9440000 -4221000 -18644000 -13307000 -28000 87000 -101000 132000 -28000 87000 -101000 132000 -9468000 -4134000 -18745000 -13175000 -0.06 -0.03 -0.12 -0.10 162721000 138857000 153998000 138774000 139061690 1000 189439000 74000 -145404000 44110000 1196258 0 0 0 0 0 846342 1153000 1153000 11293211 1000 11781000 11782000 0 0 507000 0 0 507000 0 0 0 -32000 0 -32000 0 0 0 0 -5030000 -5030000 152397501 2000 202880000 42000 -150434000 52490000 200103 -469000 -469000 87879 106000 106000 10000000 38206000 38206000 1245000 1245000 -41000 -41000 -4174000 -4174000 162685483 2000 241968000 1000 -154608000 87363000 50000 1119000 1119000 -28000 -28000 -9440000 -9440000 162735483 2000 243087000 -27000 -164048000 79014000 138362809 1000 187735000 7000 -125693000 62050000 491384 0 0 480000 0 0 480000 0 0 0 -196000 0 -196000 0 0 0 3000 0 3000 0 0 0 0 -4029000 -4029000 138854193 1000 188215000 -186000 -129722000 58308000 376000 376000 241000 241000 -3000 -3000 -5057000 -5057000 138854193 1000 188591000 52000 -134779000 53865000 5000 306000 306000 87000 87000 -4221000 -4221000 138859193 1000 188897000 139000 -139000000 50037000 -18644000 -13307000 146000 1062000 745000 810000 187000 187000 214000 232000 -2040000 -562000 1000 2548000 -13000 222000 2871000 1162000 219000 -980000 692000 669000 264000 1494000 1754000 -212000 -228000 289000 -924000 -1422000 481000 -285000 -88000 -272000 -5000 -18207000 -12624000 239000 342000 470000 33000 52203000 28960000 84701000 15830000 -33207000 12755000 1417000 1269000 2653000 2195000 1259000 11782000 38206000 469000 1183000 1183000 52014000 926000 600000 1057000 1029000 485000 1629000 1542000 26000 19000 35000 19000 4000 9000 10000 497000 198000 22000 46000 12485000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 1. - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Basis of Presentation</span><i style="font-style:italic;"> -</i> The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring accruals considered necessary for a fair and non-misleading presentation of the financial statements have been included.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">These interim consolidated financial statements should be read in conjunction with the December 31, 2020 audited consolidated financial statements and the notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on March 11, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Principles of Consolidation</span><i style="font-style:italic;"> -</i> The accompanying consolidated financial statements include the accounts of (i) 22nd Century Group, Inc. (“22nd Century Group”); (ii) its four wholly-owned subsidiaries, 22nd Century Limited, LLC (“22nd Century Ltd”), NASCO Products, LLC (“NASCO”), Botanical Genetics, LLC (“Botanical Genetics”), and 22nd Century Group Canada, Inc. (“22nd Century Group Canada”); (iii) two wholly-owned subsidiaries of 22nd Century Ltd, Goodrich Tobacco Company, LLC (“Goodrich Tobacco”) and Heracles Pharmaceuticals, LLC (“Heracles Pharma”); and (iv) one wholly-owned subsidiary of Botanical Genetics, 22nd Century Holdings, LLC (“22nd Century Holdings”). This group of subsidiaries is referred to as collectively with 22nd Century Group as the “Company”. All intercompany accounts and transactions have been eliminated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Nature of Business</span><i style="font-style:italic;"> –</i> 22nd Century Group is a leading agricultural biotechnology and intellectual property company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. 22nd Century Ltd performs research and development related to the level of nicotine and other nicotinic alkaloids in tobacco plants and Botanical Genetics performs research and development related to hemp/cannabis plants. Goodrich Tobacco and Heracles Pharma are business units for the Company’s potential modified risk tobacco products. NASCO is a federally licensed tobacco products manufacturer, a subsequent participating member under the tobacco Master Settlement Agreement (“MSA”) between the tobacco industry and the settling states under the MSA and operates the Company’s tobacco products manufacturing business in North Carolina. 22nd Century Holdings and 22nd Century Group Canada are two newly formed subsidiaries where 22nd Century Holdings will own and operate the newly acquired Needle Rock Farm assets and 22nd Century Group Canada will allow for future international business opportunities in Canada.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications </span><i style="font-style:italic;">–</i> Certain prior period amounts have been reclassified to conform to the current period’s classification. None of these reclassifications had a material impact on our consolidated financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">COVID-19 Pandemic</span> – The COVID-19 pandemic has adversely impacted the U.S. economy and supply chains and created volatility in U.S. financial markets. The COVID-19 pandemic has had a minimal impact on the Company’s operations in 2020 and thus far in 2021, but there is a risk that state and federal authorities’ responses to the COVID-19 pandemic or another pandemic may disrupt our business in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During April 2021, the Company relocated its corporate headquarters into downtown Buffalo, NY. The new office, as well as all of our facilities, continue to operate in compliance with New York and North Carolina guidance (as applicable) related to the prevention of COVID-19 transmission and employee safety. We also continue to allow remote work arrangements by our employees where job duties permit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our executive leadership team and staff are monitoring this evolving situation and its impacts on our business. We will continue to monitor the local, state, and federal guidance regarding our business practices.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span><i style="font-style:italic;"> </i><b style="font-weight:bold;">-</b><i style="font-style:italic;"> </i>The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Intangible Assets</span> – Intangible assets are recorded at cost and consist primarily of (1) expenditures incurred with third-parties related to the processing of patent claims and trademarks with government authorities, as well as costs to acquire patent rights from third-parties, (2) license fees paid for third-party intellectual property, (3) costs to become a signatory under the tobacco MSA, and (4) license fees paid to acquire a predicate cigarette brand. The amounts capitalized relate to intellectual property that the Company owns or to which it has rights to use. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s capitalized intellectual property costs are amortized using the straight-line method over the remaining statutory life of the patent assets in each of the Company’s patent families, which have estimated expiration dates ranging from 2026 to 2041. Periodic maintenance or renewal fees are expensed as incurred. Annual minimum license fees are charged to expense. License fees paid for third-party intellectual property are amortized on a straight-line basis over the last to expire patents, which have expected expiration dates ranging from 2028 through 2036. The Company believes that costs associated with becoming a signatory to the MSA and costs related to the acquisition of a predicate cigarette brand have an indefinite life. As such, no amortization is taken. At each reporting period, the Company evaluates whether events and circumstances continue to support the indefinite-lived classification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Impairment of Long-Lived Assets </span>– The Company reviews the carrying value of its amortizing long-lived assets whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be recoverable. On at least an annual basis, the Company assesses whether events or changes in circumstances indicate that the carrying amount may not be recoverable. If any such indicators are present, the Company will test for recoverability in accordance with ASC 360-Property, plant, and equipment or ASC 350- Intangibles, Goodwill, and Other.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Intangible assets subject to amortization are reviewed for strategic importance and commercialization opportunity prior to expiration. If it is determined that the asset no longer supports the Company’s strategic objectives and/or will not be commercially viable prior to expiration, the asset is impaired. In addition, the Company will assess the expected future undiscounted cash flows for its intellectual property based on consideration of future market and economic conditions, competition, federal and state regulations, and licensing opportunities. If the carrying value of such assets are not recoverable, the carrying value will be reduced to fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Indefinite-lived intangible asset carrying values are reviewed at least annually or more frequently if events or changes in circumstances indicate that it is more likely than not that an impairment exists. The Company first performs a qualitative assessment and considers its current strategic objectives, future market and economic conditions, competition, and federal and state regulations to determine if an impairment is more likely than not. If it is determined that an impairment is more likely than not, a quantitative assessment is performed to compare the asset carrying value to fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Fair Value of Financial Instruments</span><i style="font-style:italic;"> </i><span style="font-style:italic;font-weight:bold;">-</span> The Company’s financial instruments include cash and cash equivalents, short-term investment securities, accounts receivable, investments, a convertible note receivable, a promissory note receivable, accounts payable, accrued expenses, and notes payable. The carrying values of these financial instruments approximate fair value. The Company carries cash equivalents, short-term investment securities, certain investments, and certain other assets at fair value which is described further in Note 6.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Investments</span><i style="font-style:italic;"> </i><span style="font-style:italic;font-weight:bold;">–</span> The Company’s equity securities are recorded at fair value with changes in fair value included within the statement of operations. Equity securities without a readily determinable market value are carried at cost less impairment, adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer. The Company considers certain debt instruments as available-for-sale securities, and accordingly, all unrealized gains and losses incurred on the short-term investment securities (the adjustment to fair value) are recorded in other comprehensive income or loss on the Company’s Consolidated Statements of Operations and Comprehensive Loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Right-of-use assets (“ROU”) and Lease Obligations</span> – The Company reviews any lease arrangements in accordance with ASU 2016-02, Subtopic ASC 842, Leases. Any lease having a lease term greater than twelve months will be recognized on the Consolidated Balance Sheets as a ROU asset with an associated lease obligation—all other leases are considered short-term in nature and will be expensed as payments are made over the lease term. The ROU assets and lease obligations are recognized as of the commencement date at the net present value of the fixed minimum lease payments for the lease term. The lease term is determined based on the contractual conditions, including whether renewal options are reasonably certain to be exercised. The discount rate used is the interest rate implicit in the lease, if available, or the Company’s incremental borrowing rate which is determined using a base line rate plus an applicable spread.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock Based Compensation</span> – The Company’s Omnibus Incentive Plan allows for various types of equity-based incentive awards. Stock based compensation expense is based on awards that are expected to vest over the requisite service periods and are based on the fair value of the award measured on the grant date. Vesting requirements vary for directors, officers, and employees. In general, time-based awards fully vest after <span style="-sec-ix-hidden:Hidden_h3ZwLe2HP0ekaniFP6ralw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">one year</span></span> for directors and vest in equal annual installments over a <span style="-sec-ix-hidden:Hidden_KzhsTAXd50OnvzpkAjY2cA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">three-year</span></span> period for officers and employees. Performance-based awards vest upon achievement of certain milestones. Forfeitures are accounted for when they occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Income Taxes</span><i style="font-style:italic;"> </i><span style="font-style:italic;font-weight:bold;">-</span><i style="font-style:italic;"> </i>For interim income tax reporting, due to a full valuation allowance on net deferred tax assets, no income tax expense or benefit is recorded unless it is an unusual or infrequently occurring item. The tax effects of unusual or infrequently occurring items, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, are reported in the interim period in which they occur.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Recent Accounting Pronouncement(s) – </span>In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments.” The standard replaces the incurred loss model with the current expected credit loss (CECL) model to estimate credit losses for financial assets measured at amortized cost and certain off-balance sheet credit exposures. The CECL model requires companies to estimate credit losses expected over the life of the financial assets based on historical experience, current conditions and reasonable and supportable forecasts. The provisions of the ASU are effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years—excluding small reporting companies (SRCs), based on a determination date as of November 15, 2019, which have an effective date beginning after December 15, 2022 and interim periods within those fiscal years. The Company is evaluating the expected impacts of the ASU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We consider the applicability and impact of all ASUs. If the ASU is not listed above, it was determined that the ASU was either not applicable or would have an immaterial impact on our financial statements and related disclosures.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Basis of Presentation</span><i style="font-style:italic;"> -</i> The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring accruals considered necessary for a fair and non-misleading presentation of the financial statements have been included.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">These interim consolidated financial statements should be read in conjunction with the December 31, 2020 audited consolidated financial statements and the notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on March 11, 2021.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Principles of Consolidation</span><i style="font-style:italic;"> -</i> The accompanying consolidated financial statements include the accounts of (i) 22nd Century Group, Inc. (“22nd Century Group”); (ii) its four wholly-owned subsidiaries, 22nd Century Limited, LLC (“22nd Century Ltd”), NASCO Products, LLC (“NASCO”), Botanical Genetics, LLC (“Botanical Genetics”), and 22nd Century Group Canada, Inc. (“22nd Century Group Canada”); (iii) two wholly-owned subsidiaries of 22nd Century Ltd, Goodrich Tobacco Company, LLC (“Goodrich Tobacco”) and Heracles Pharmaceuticals, LLC (“Heracles Pharma”); and (iv) one wholly-owned subsidiary of Botanical Genetics, 22nd Century Holdings, LLC (“22nd Century Holdings”). This group of subsidiaries is referred to as collectively with 22nd Century Group as the “Company”. All intercompany accounts and transactions have been eliminated.</p> 4 2 1 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Nature of Business</span><i style="font-style:italic;"> –</i> 22nd Century Group is a leading agricultural biotechnology and intellectual property company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. 22nd Century Ltd performs research and development related to the level of nicotine and other nicotinic alkaloids in tobacco plants and Botanical Genetics performs research and development related to hemp/cannabis plants. Goodrich Tobacco and Heracles Pharma are business units for the Company’s potential modified risk tobacco products. NASCO is a federally licensed tobacco products manufacturer, a subsequent participating member under the tobacco Master Settlement Agreement (“MSA”) between the tobacco industry and the settling states under the MSA and operates the Company’s tobacco products manufacturing business in North Carolina. 22nd Century Holdings and 22nd Century Group Canada are two newly formed subsidiaries where 22nd Century Holdings will own and operate the newly acquired Needle Rock Farm assets and 22nd Century Group Canada will allow for future international business opportunities in Canada.</p> 2 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications </span><i style="font-style:italic;">–</i> Certain prior period amounts have been reclassified to conform to the current period’s classification. None of these reclassifications had a material impact on our consolidated financial statements.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">COVID-19 Pandemic</span> – The COVID-19 pandemic has adversely impacted the U.S. economy and supply chains and created volatility in U.S. financial markets. The COVID-19 pandemic has had a minimal impact on the Company’s operations in 2020 and thus far in 2021, but there is a risk that state and federal authorities’ responses to the COVID-19 pandemic or another pandemic may disrupt our business in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During April 2021, the Company relocated its corporate headquarters into downtown Buffalo, NY. The new office, as well as all of our facilities, continue to operate in compliance with New York and North Carolina guidance (as applicable) related to the prevention of COVID-19 transmission and employee safety. We also continue to allow remote work arrangements by our employees where job duties permit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Our executive leadership team and staff are monitoring this evolving situation and its impacts on our business. We will continue to monitor the local, state, and federal guidance regarding our business practices.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span><i style="font-style:italic;"> </i><b style="font-weight:bold;">-</b><i style="font-style:italic;"> </i>The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Intangible Assets</span> – Intangible assets are recorded at cost and consist primarily of (1) expenditures incurred with third-parties related to the processing of patent claims and trademarks with government authorities, as well as costs to acquire patent rights from third-parties, (2) license fees paid for third-party intellectual property, (3) costs to become a signatory under the tobacco MSA, and (4) license fees paid to acquire a predicate cigarette brand. The amounts capitalized relate to intellectual property that the Company owns or to which it has rights to use. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s capitalized intellectual property costs are amortized using the straight-line method over the remaining statutory life of the patent assets in each of the Company’s patent families, which have estimated expiration dates ranging from 2026 to 2041. Periodic maintenance or renewal fees are expensed as incurred. Annual minimum license fees are charged to expense. License fees paid for third-party intellectual property are amortized on a straight-line basis over the last to expire patents, which have expected expiration dates ranging from 2028 through 2036. The Company believes that costs associated with becoming a signatory to the MSA and costs related to the acquisition of a predicate cigarette brand have an indefinite life. As such, no amortization is taken. At each reporting period, the Company evaluates whether events and circumstances continue to support the indefinite-lived classification.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Impairment of Long-Lived Assets </span>– The Company reviews the carrying value of its amortizing long-lived assets whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be recoverable. On at least an annual basis, the Company assesses whether events or changes in circumstances indicate that the carrying amount may not be recoverable. If any such indicators are present, the Company will test for recoverability in accordance with ASC 360-Property, plant, and equipment or ASC 350- Intangibles, Goodwill, and Other.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Intangible assets subject to amortization are reviewed for strategic importance and commercialization opportunity prior to expiration. If it is determined that the asset no longer supports the Company’s strategic objectives and/or will not be commercially viable prior to expiration, the asset is impaired. In addition, the Company will assess the expected future undiscounted cash flows for its intellectual property based on consideration of future market and economic conditions, competition, federal and state regulations, and licensing opportunities. If the carrying value of such assets are not recoverable, the carrying value will be reduced to fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Indefinite-lived intangible asset carrying values are reviewed at least annually or more frequently if events or changes in circumstances indicate that it is more likely than not that an impairment exists. The Company first performs a qualitative assessment and considers its current strategic objectives, future market and economic conditions, competition, and federal and state regulations to determine if an impairment is more likely than not. If it is determined that an impairment is more likely than not, a quantitative assessment is performed to compare the asset carrying value to fair value.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Fair Value of Financial Instruments</span><i style="font-style:italic;"> </i><span style="font-style:italic;font-weight:bold;">-</span> The Company’s financial instruments include cash and cash equivalents, short-term investment securities, accounts receivable, investments, a convertible note receivable, a promissory note receivable, accounts payable, accrued expenses, and notes payable. The carrying values of these financial instruments approximate fair value. The Company carries cash equivalents, short-term investment securities, certain investments, and certain other assets at fair value which is described further in Note 6.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Investments</span><i style="font-style:italic;"> </i><span style="font-style:italic;font-weight:bold;">–</span> The Company’s equity securities are recorded at fair value with changes in fair value included within the statement of operations. Equity securities without a readily determinable market value are carried at cost less impairment, adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer. The Company considers certain debt instruments as available-for-sale securities, and accordingly, all unrealized gains and losses incurred on the short-term investment securities (the adjustment to fair value) are recorded in other comprehensive income or loss on the Company’s Consolidated Statements of Operations and Comprehensive Loss.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Right-of-use assets (“ROU”) and Lease Obligations</span> – The Company reviews any lease arrangements in accordance with ASU 2016-02, Subtopic ASC 842, Leases. Any lease having a lease term greater than twelve months will be recognized on the Consolidated Balance Sheets as a ROU asset with an associated lease obligation—all other leases are considered short-term in nature and will be expensed as payments are made over the lease term. The ROU assets and lease obligations are recognized as of the commencement date at the net present value of the fixed minimum lease payments for the lease term. The lease term is determined based on the contractual conditions, including whether renewal options are reasonably certain to be exercised. The discount rate used is the interest rate implicit in the lease, if available, or the Company’s incremental borrowing rate which is determined using a base line rate plus an applicable spread.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock Based Compensation</span> – The Company’s Omnibus Incentive Plan allows for various types of equity-based incentive awards. Stock based compensation expense is based on awards that are expected to vest over the requisite service periods and are based on the fair value of the award measured on the grant date. Vesting requirements vary for directors, officers, and employees. In general, time-based awards fully vest after <span style="-sec-ix-hidden:Hidden_h3ZwLe2HP0ekaniFP6ralw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">one year</span></span> for directors and vest in equal annual installments over a <span style="-sec-ix-hidden:Hidden_KzhsTAXd50OnvzpkAjY2cA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">three-year</span></span> period for officers and employees. Performance-based awards vest upon achievement of certain milestones. Forfeitures are accounted for when they occur.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Income Taxes</span><i style="font-style:italic;"> </i><span style="font-style:italic;font-weight:bold;">-</span><i style="font-style:italic;"> </i>For interim income tax reporting, due to a full valuation allowance on net deferred tax assets, no income tax expense or benefit is recorded unless it is an unusual or infrequently occurring item. The tax effects of unusual or infrequently occurring items, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, are reported in the interim period in which they occur.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Recent Accounting Pronouncement(s) – </span>In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments.” The standard replaces the incurred loss model with the current expected credit loss (CECL) model to estimate credit losses for financial assets measured at amortized cost and certain off-balance sheet credit exposures. The CECL model requires companies to estimate credit losses expected over the life of the financial assets based on historical experience, current conditions and reasonable and supportable forecasts. The provisions of the ASU are effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years—excluding small reporting companies (SRCs), based on a determination date as of November 15, 2019, which have an effective date beginning after December 15, 2022 and interim periods within those fiscal years. The Company is evaluating the expected impacts of the ASU.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We consider the applicability and impact of all ASUs. If the ASU is not listed above, it was determined that the ASU was either not applicable or would have an immaterial impact on our financial statements and related disclosures.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 2. - INVENTORY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Inventories are valued at the lower of historical cost or net realizable value. Cost is determined using an average cost method for tobacco leaf inventory, hemp/cannabis inventory, and raw materials inventory. Standard cost is primarily used for finished goods inventory. Inventories are evaluated to determine whether any amounts are not recoverable based on slow moving or obsolete condition and are written off or reserved as appropriate. During the nine months ended September 30, 2020, the Company wrote off inventory totaling $219 on the Company’s Consolidated Statement of Operations and Comprehensive Loss ($58 included within research and development expenses and $161 included within cost of goods sold).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Inventories at September 30, 2021 and December 31, 2020 consisted of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Inventory - tobacco leaf</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 876</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 821</p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Inventory - hemp/cannabis</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Inventory - finished goods</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cigarettes and filtered cigars</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 331</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 171</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Inventory - raw materials</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cigarette and filtered cigar components</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,464</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,142</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: inventory reserve</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (100)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (100)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,703</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,034</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 219000 58000 161000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Inventory - tobacco leaf</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 876</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 821</p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Inventory - hemp/cannabis</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 132</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Inventory - finished goods</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cigarettes and filtered cigars</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 331</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 171</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Inventory - raw materials</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cigarette and filtered cigar components</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,464</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,142</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: inventory reserve</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (100)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (100)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,703</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,034</p></td></tr></table> 876000 821000 132000 331000 171000 1464000 1142000 100000 100000 2703000 2034000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 3. – PROPERTY, PLANT, AND EQUIPMENT, NET</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Property, plant, and equipment, net at September 30, 2021 and December 31, 2020 consisted of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Useful Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Land</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,665</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Building and leasehold improvements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">7 to <span style="-sec-ix-hidden:Hidden_rzrI0g8FUE2k8vwtN6up1Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:center;">40 years</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 309</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 123</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Manufacturing equipment</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3 to <span style="-sec-ix-hidden:Hidden_FNLVn4DvikGZKyhu5bv6xQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:center;">10 years</span></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,539</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,893</p></td></tr><tr><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Office furniture, fixtures and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="-sec-ix-hidden:Hidden__pW3LOb-gEyJ8oMHmrfhLw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:center;">5 years</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 129</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 20</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Laboratory equipment</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="-sec-ix-hidden:Hidden_Kq7w_pDY0UuynwyfOURkpg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:center;">5 years</span></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 198</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 117</p></td></tr><tr><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Construction in progress</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 42</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: accumulated depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,128)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,670)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property, plant and equipment, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,754</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,483</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Depreciation expense was $173 and $461 for the three and nine months ended September 30, 2021 ($160 and $473 for the three and nine months ended September 30, 2020).</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Useful Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Land</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1,665</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Building and leasehold improvements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">7 to <span style="-sec-ix-hidden:Hidden_rzrI0g8FUE2k8vwtN6up1Q;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:center;">40 years</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 309</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 123</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Manufacturing equipment</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3 to <span style="-sec-ix-hidden:Hidden_FNLVn4DvikGZKyhu5bv6xQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:center;">10 years</span></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,539</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,893</p></td></tr><tr><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Office furniture, fixtures and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="-sec-ix-hidden:Hidden__pW3LOb-gEyJ8oMHmrfhLw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:center;">5 years</span></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 129</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 20</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Laboratory equipment</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="-sec-ix-hidden:Hidden_Kq7w_pDY0UuynwyfOURkpg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:center;">5 years</span></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 198</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 117</p></td></tr><tr><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Construction in progress</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 42</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Less: accumulated depreciation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,128)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,670)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Property, plant and equipment, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,754</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.05%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,483</p></td></tr></table> 1665000 P7Y 309000 123000 P3Y 5539000 4893000 129000 20000 198000 117000 42000 3128000 2670000 4754000 2483000 173000 461000 160000 473000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 4. - RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company leases a manufacturing facility and warehouse in North Carolina, and a corporate headquarters in Buffalo, New York.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following table summarizes the Company’s discount rate and remaining lease terms:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:82.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:82.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average remaining lease term in years</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6.3</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:82.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average discount rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Future minimum lease payments as of September 30, 2021 are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 33</p></td></tr><tr><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 76</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 78</p></td></tr><tr><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 80</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 82</p></td></tr><tr><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 192</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 541</p></td></tr><tr><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: imputed interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (60)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 481</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On July 28, 2021, the Company signed a lease agreement for a new research and development (“R&amp;D”) laboratory in Rockville, MD. The new laboratory space has over four thousand square feet and will support the Company’s continued growth and R&amp;D partnerships. The lease has an initial monthly base rent of $12 (escalating 2.5% annually after the first year), a term of 51 months, and an expected commencement date of early fourth quarter of this year. The lease also calls for abatement of 100% of the base rent for the first five months following the lease commencement date. The Company will recognize the respective right-of-use asset and lease liability for the lease upon lease commencement, which is anticipated during the fourth quarter of 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On October 18, 2021, the Company signed a lease extension for its manufacturing facility and warehouse in North Carolina. The lease has a commencement date upon expiration of the current lease term, which is November 1, 2021. The lease has a monthly base rent of $17 and an initial term of twenty-four months—with one twenty-four month renewal option at the Company’s discretion. The Company will recognize the respective right-of-use asset and lease liability during the fourth quarter of 2021.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:82.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:82.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average remaining lease term in years</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6.3</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:82.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average discount rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table> P6Y3M18D 0.037 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 33</p></td></tr><tr><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 76</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 78</p></td></tr><tr><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 80</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 82</p></td></tr><tr><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 192</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total lease payments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 541</p></td></tr><tr><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: imputed interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (60)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 481</p></td></tr></table> 33000 76000 78000 80000 82000 192000 541000 60000 481000 4000 12000 0.025 P51M P5M 17000 P24M 1 P24M <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 5. – INVESTMENTS &amp; OTHER ASSETS </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The total carrying value of the Company’s investments and other assets at September 30, 2021 and December 31, 2020 consisted of the following:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Aurora stock warrants</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 239</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Panacea preferred stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,173</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Panacea stock warrant</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,124</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exactus common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,282</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Investments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,300</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,536</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible note receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,876</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Promissory note receivable</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,713</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="font-style:italic;font-weight:normal;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Investment in Panacea Life Sciences, Inc.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;font-weight:normal;">Initial Investment:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt;"><span style="font-weight:normal;">On December 3, 2019, the Company entered into a securities purchase agreement with Panacea Life Sciences, Inc. (“Panacea”) for consideration valued at </span><span style="font-weight:normal;">$13,297</span><span style="font-weight:normal;"> (</span><span style="font-weight:normal;">$12,000</span><span style="font-weight:normal;"> cash and </span><span style="font-weight:normal;">$1,297</span><span style="font-weight:normal;"> of the Company’s shares of common stock valued at </span><span style="font-weight:normal;">$1</span><span style="font-weight:normal;"> per share) in exchange for a </span><span style="font-weight:normal;">15.8%</span><span style="font-weight:normal;"> ownership interest. The Company’s investment consisted of </span><span style="font-weight:normal;">three</span><span style="font-weight:normal;"> instruments: shares of Series B preferred stock (“preferred stock”); a convertible note receivable with a </span><span style="font-weight:normal;">$7,000</span><span style="font-weight:normal;"> face value; and a warrant (“stock warrant”) to purchase additional shares of Series B preferred stock, to obtain </span><span style="font-weight:normal;">51%</span><span style="font-weight:normal;"> ownership of Panacea, at an exercise price of </span><span style="font-weight:normal;">$2.344</span><span style="font-weight:normal;"> per share. The convertible note receivable had a term of </span><span style="-sec-ix-hidden:Hidden_wZeQOmrHR0Snj-DRk380AA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">five years</span></span><span style="font-weight:normal;">, interest of </span><span style="font-weight:normal;">10%</span><span style="font-weight:normal;"> per annum, and could be converted to shares of Series B preferred stock at the Company’s discretion. The embedded conversion option was not considered a derivative instrument for accounting purposes. The preferred stock carried an annual </span><span style="font-weight:normal;">10%</span><span style="font-weight:normal;"> cumulative dividend, compounded annually, and had an implicit put option after </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">the fifth anniversary date so long that the stock warrants had not been exercised. The put option was not considered a derivative instrument for accounting purposes. The stock warrant was exercisable at any time after the fifth anniversary date and would be accelerated if Panacea achieved certain sales targets for </span><span style="-sec-ix-hidden:Hidden_ucaKZxY5zEObVQq0C3fJrw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">two</span></span><span style="font-weight:normal;"> consecutive years. The Series B preferred stock also included first priority equity preferences in the event of a liquidation, sale, or transfer of Panacea assets. These rights entitled the Company to the original Series B issuance price of </span><span style="font-weight:normal;">$7,000</span><span style="font-weight:normal;"> plus any unpaid accrued dividends.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">To allocate the cost of the stock warrant, the Company calculated a fair value based on the following assumptions: volatility of </span><span style="font-weight:normal;">70%</span><span style="font-weight:normal;">, discount of </span><span style="font-weight:normal;">25%</span><span style="font-weight:normal;"> for lack of marketability, and a risk-free rate of </span><span style="font-weight:normal;">2%</span><span style="font-weight:normal;">. The value of the stock warrant was allocated to the preferred stock and the convertible note receivable, equally, at a discount to the acquisition price. The discount on the preferred stock was determined to be for lack of control and the discount on the convertible note receivable was determined to be for issuing the note at a below market interest rate for similar instruments.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The convertible note receivable and the preferred stock investment were considered available for sale debt securities with a private company that was not traded in active markets. Since observable price quotations were not available at acquisition, fair value was estimated based on cost less an appropriate discount upon acquisition. The discount of each instrument is accreted into interest income over the respective term as shown within the Company’s Consolidated Statements of Operations and Comprehensive Loss. See Note 6 for additional information on these fair value measurements. The stock warrant was recorded at its cost basis in accordance with the practicability exception under ASU 2016-01.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;font-weight:normal;">Impairment of Panacea Investment:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">As a result of increased competition and other macroeconomic factors, the Company recognized an impairment of </span><span style="font-weight:normal;">$1,062</span><span style="font-weight:normal;"> on the Panacea stock warrant during the second quarter of 2020. The impairment is recorded within the Consolidated Statements of Operations and Comprehensive Loss as “Impairment of Panacea Investment.” During the fourth quarter of 2020, the Company entered into a non-binding agreement with Panacea to potentially restructure the investment and business relationship—including the transfer of an agricultural facility and other assets. As of December 31, 2020, the Company adjusted certain assets to represent the fair value outlined in the non-binding agreement.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;font-weight:normal;">Conversion of Panacea Investment:</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On June 30, 2021, the Company entered into a Promissory Note Exchange Agreement with Panacea and a Securities Exchange Agreement with Panacea, Exactus, Inc. (“Exactus”) (OTCQB:EXDI) and certain other Panacea shareholders. Pursuant to the Securities Exchange Agreement, Exactus fully acquired Panacea. These transactions effected the (i) conversion of all of the Company’s Series B Preferred Stock in Panacea into 91,016,026 shares of common stock in Exactus valued at $9,102 as of June 30, 2021 and (ii) the conversion of the Company’s existing debt in Panacea by converting the outstanding $7,000 principal balance convertible note receivable and all accrued but unpaid interest thereon for fee simple ownership of Needle Rock Farms (224 acres in Delta County, Colorado) and equipment valued at $2,248, $500 in Panacea’s Series B Preferred Stock (which was subsequently converted to Exactus common stock under the Securities Exchange Agreement), and a new $4,300 promissory note (the “Promissory note receivable”) with a maturity date of June 30, 2026 and a 0% interest rate. The Promissory note receivable is with a related party of Panacea and is fully secured by a first priority lien on Panacea’s headquarters located in Golden, Colorado. All other rights and obligations of the Company in Panacea and Panacea’s affiliate, Quintel-MC Incorporated, were terminated by this transaction—including all warrant rights and obligations for future investment. The conversion was recorded as a non-monetary transaction, based on the fair value of the assets received, and resulted in a gain of $2,548 which is included within the Consolidated Statements of Operations and Comprehensive Loss as “Gain on Panacea investment conversion.”</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Promissory note receivable was valued at $3,684 ($4,300 face value less $616 discount) and is included within the Consolidated Balance Sheets as “Other Assets.” The Company intends to hold the Promissory note receivable to maturity and the associated discount will be amortized into interest income over the term of the note. The ownership of Needle Rock Farms and related equipment is included within “Property, plant, and equipment, net” on the Consolidated Balance Sheets. The common shares of Exactus, Inc. are considered equity securities in accordance with ASC 321 and are recorded at fair value—changes in fair value will be included within the statement of operations. See Note 6 for additional information on the fair value measurements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On October 28, 2021, Exactus announced the completion of a 1 for <span style="-sec-ix-hidden:Hidden_uNAQN4-Mt0eAoLRoNgg1RA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">28</span></span> reverse stock split as well as an entity name change to Panacea Life Sciences Holdings, Inc (OTCQB: PLSH). Panacea Life Sciences Holdings, Inc. has been assigned a temporary stock </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">symbol of “EXDID” which will formally change to “PLSH” after twenty business days. As a result of the reverse stock split, our 91,016,026 shares were adjusted to 3,250,573 shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Investment in Aurora Cannabis, Inc.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The Company has an investment in Aurora Cannabis Inc. (“Aurora”) stock warrants that are considered equity securities under ASC 321 – Investments – Equity Securities and a derivative instrument under ASC 815 – Derivatives and Hedging. The stock warrants are not designated as a hedging instrument, and in accordance with ASC 815, the Company’s investment in stock warrants are recorded at fair value with changes in fair value recorded to unrealized gain/loss as shown within the Company’s Consolidated Statements of Operations and Comprehensive Loss. See Note 6 for additional information on the fair value measurements.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Aurora stock warrants</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 239</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Panacea preferred stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,173</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Panacea stock warrant</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,124</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Exactus common stock</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,282</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Investments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,300</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,536</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible note receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,876</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Promissory note receivable</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,713</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td></tr></table> 18000 239000 5173000 1124000 7282000 7300000 6536000 5876000 3713000 13297000 12000000 1297000 1 0.158 3 7000000 0.51 2.344 0.10 0.10 7000000 0.70 0.25 0.02 1062000 91016026 9102000 7000000 224 2248000 500000 4300000 0 2548000 3684000 4300000 616000 91016026 3250573 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 6. – FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">FASB ASC 820 - “Fair Value Measurements and Disclosures” establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A financial asset’s or a financial liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table presents information about our assets and liabilities measured at fair value as of September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Short-term investment securities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Money market funds</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18,481</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18,481</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Corporate bonds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,051</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,051</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">Total short-term investment securities</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18,481</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,051</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 53,532</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investment - Aurora stock warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investment - Exactus common shares</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,282</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,282</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Assets</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Short-term investment securities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Money market funds</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,636</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,636</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Corporate bonds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12,677</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12,677</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Total short-term investment securities</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,636</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12,677</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 21,313</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investment - Aurora stock warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 239</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 239</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investment - Panacea preferred stock</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,173</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,173</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Convertible note receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,876</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,876</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Money market mutual funds are valued at their daily closing price as reported by the fund. Money market mutual funds held by the Company are open-end mutual funds that are registered with the SEC that generally transact at a stable $1.00 Net Asset Value (“NAV”) representing its estimated fair value. On a daily basis the fund’s NAV is determined by the fund based on the amortized cost of the funds underlying investments.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Corporate bonds are valued using pricing models maximizing the use of observable inputs for similar securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The investment in the Aurora (“ACB”) stock warrants is measured at fair value using the Black-Scholes pricing model and is classified within Level 3 of the valuation hierarchy. The unobservable input is an estimated volatility factor of 94% and 137% as of September 30, 2021 and December 31, 2020, respectively. Therefore, changes in market volatility will impact the fair value measurement of our ACB investment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">A 20% increase or decrease in the volatility factor used as of September 30, 2021 would have the impact of increasing or decreasing the fair value measurement of the stock warrants by approximately $22. A 20% increase or decrease in the volatility factor used at December 31, 2020 would have the impact of increasing or decreasing the fair value measurement of the stock warrants by approximately $115.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The investment in Exactus common shares is considered an equity security with a readily determinable fair value. The fair value is determined using the quotable market price as of the last trading day of the fiscal quarter.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Panacea convertible note receivable and the preferred stock investment were considered available-for-sale debt securities with a private company not traded in active markets. Since observable price quotations were not available, fair value was estimated based on cost less an appropriate discount upon acquisition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table sets forth a summary of the changes in fair value of the Company’s Level 3 investments for the nine months ended September 30, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value at December 31, 2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,288</p></td></tr><tr><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unrealized gain (loss) on ACB stock warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (220)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of interest on Panacea preferred stock</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 142</p></td></tr><tr><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Panacea investment conversion</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,192)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value at September 30, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following tables set forth a summary of the Company’s available-for-sale debt securities from amortized cost basis to fair value as of September 30, 2021 and December 31, 2020:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Available for Sale Debt Securities</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Basis</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gains</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Losses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Corporate bonds</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,078</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (34)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,051</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Available for Sale Debt Securities</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrealized </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrealized </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Basis</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gains</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Losses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Corporate bonds</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,603</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 74</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,677</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible note receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,876</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,876</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investment - Panacea preferred stock</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,173</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,173</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23,652</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 74</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23,726</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The following table sets forth a summary of the Company’s available-for-sale securities at amortized cost basis and fair value by contractual maturity as of September 30, 2021 and December 31, 2020:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Available for Sale Debt Securities</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:18.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:18.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Cost Basis</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Cost Basis</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Due in one year or less</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,581</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,585</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,692</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,753</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Due after one year through five years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 31,497</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 31,466</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,960</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,973</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 35,078</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 35,051</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 23,652</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 23,726</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Assets</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Short-term investment securities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Money market funds</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18,481</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18,481</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 12pt;">Corporate bonds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,051</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,051</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 18pt;">Total short-term investment securities</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18,481</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,051</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 53,532</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investment - Aurora stock warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investment - Exactus common shares</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,282</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,282</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 1</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 2</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level 3</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Assets</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Short-term investment securities:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Money market funds</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,636</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,636</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;">Corporate bonds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12,677</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12,677</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">Total short-term investment securities</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,636</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 12,677</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 21,313</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investment - Aurora stock warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 239</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 239</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Investment - Panacea preferred stock</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,173</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,173</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Convertible note receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,876</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,876</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="visibility:hidden;">​</span></p> 18481000 0 0 18481000 0 35051000 0 35051000 18481000 35051000 0 53532000 0 0 18000 18000 7282000 0 0 7282000 8636000 0 0 8636000 0 12677000 0 12677000 8636000 12677000 0 21313000 0 0 239000 239000 0 0 5173000 5173000 0 0 5876000 5876000 1.00 0.94 1.37 0.20 22000 0.20 115000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value at December 31, 2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,288</p></td></tr><tr><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unrealized gain (loss) on ACB stock warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (220)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accretion of interest on Panacea preferred stock</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 142</p></td></tr><tr><td style="vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Panacea investment conversion</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,192)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Fair Value at September 30, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 18</p></td></tr></table> 11288000 -220000 142000 11192000 18000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Available for Sale Debt Securities</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrealized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Basis</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gains</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Losses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Corporate bonds</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,078</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (34)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 35,051</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Available for Sale Debt Securities</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gross</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Cost</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrealized </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unrealized </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Basis</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Gains</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Losses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Corporate bonds</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,603</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 74</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,677</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Convertible note receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,876</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,876</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Investment - Panacea preferred stock</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,173</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,173</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23,652</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 74</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 23,726</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p> 35078000 7000 34000 35051000 12603000 74000 0 12677000 5876000 0 0 5876000 5173000 0 0 5173000 23652000 74000 0 23726000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:39.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Available for Sale Debt Securities</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:18.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:18.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Amortized</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Cost Basis</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Cost Basis</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Due in one year or less</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,581</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,585</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,692</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,753</p></td></tr><tr><td style="vertical-align:bottom;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Due after one year through five years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 31,497</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 31,466</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,960</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 11,973</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:58.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 35,078</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 35,051</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 23,652</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.32%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 23,726</p></td></tr></table> 3581000 3585000 11692000 11753000 31497000 31466000 11960000 11973000 35078000 35051000 23652000 23726000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 7. - INTANGIBLE ASSETS </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Total intangible assets at September 30, 2021 and December 31, 2020 consisted of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intangible assets, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Patent and trademark costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,951</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,667</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Less: accumulated amortization</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,207)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,936)</p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Patent and trademark costs, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,744</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,731</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">License fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,876</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,876</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Less: accumulated amortization</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,136)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (948)</p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">License fees, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,740</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,928</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">MSA signatory costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,202</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,202</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">License fee for predicate cigarette brand</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 350</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 350</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,036</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,211</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Amortization expense relating to the above intangible assets for the three and nine months ended September 30, 2021 amounted to $168 and $471 ($163 and $524 for the three and nine months ended September 30, 2020). Impairment expense for the three and nine months ended September 30, 2020 amounted to $0 and $146 (cost of approximately $448 less accumulated amortization of approximately $302), respectively, and related to patent intellectual property that would be expired prior to expected commercialization.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Intangible assets, net</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Patent and trademark costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,951</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,667</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Less: accumulated amortization</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (3,207)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (2,936)</p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Patent and trademark costs, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,744</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,731</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">License fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,876</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3,876</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Less: accumulated amortization</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (1,136)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (948)</p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">License fees, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,740</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,928</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">MSA signatory costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,202</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2,202</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">License fee for predicate cigarette brand</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 350</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 350</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,036</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 8,211</p></td></tr></table> 5951000 5667000 3207000 2936000 2744000 2731000 3876000 3876000 1136000 948000 2740000 2928000 2202000 2202000 350000 350000 8036000 8211000 168000 471000 163000 524000 0 146000 448000 302000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 8. – NOTES PAYABLE</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">License Fees</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On June 22, 2018, the Company entered into the Second Amendment to the License Agreement (the “Second Amendment”) with North Carolina State University (“NCSU”) that amended an original License Agreement between the Company and NCSU, dated December 8, 2015, and the First Amendment, dated February 14, 2018, to the original License Agreement. Under the terms of the Second Amendment, the Company was obligated to pay NCSU milestone payments totaling $1,200, which originally amounted to a present value of $1,175. As of June 30, 2020, the Company paid the final milestone payment of $300. The cost of the of acquired license amounted to $1,175 and is included in Intangible assets, net on the Company’s Consolidated Balance Sheets, and is amortized on a straight-line basis over the last-to-expire patent, which is expected to be in 2036.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On October 22, 2018, the Company entered into a License Agreement with the University of Kentucky. Under the terms of the License Agreement, the Company is obligated to pay the University of Kentucky milestone payments totaling $1,200, of which $300 was payable upon execution, and $300 will be payable annually over three years on the anniversary of the execution of the License Agreement. The Company has recorded the present value of the obligations under the License Agreement as a note payable that originally amounted to $1,151. The cost of the of acquired licenses amounted to $1,151 and is included in Intangible assets, net on the Company’s Consolidated Balance Sheets and will be amortized on a straight-line basis over the last-to-expire patent, which is expected to be in 2033.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">D&amp;O Insurance</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the second quarter of 2021, the Company renewed its Director and Officer (“D&amp;O”) insurance for a <span style="-sec-ix-hidden:Hidden_a9S9gY90002DPc843sV_gg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">one-year</span></span> policy premium totaling $3,315. The Company paid $662 as a premium down payment and financed the remaining $2,653 of policy premiums over <span style="-sec-ix-hidden:Hidden_qywve93tjEG1swo-KO8btw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">nine months</span></span> at a 3.49% annual percentage rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the second quarter of 2020, the Company renewed its D&amp;O insurance for a one-year policy premium totaling $2,744. The Company paid $549 as a premium down payment and financed the remaining $2,195 of policy premiums over nine months at a 3.19% annual percentage rate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">CARES Act Paycheck Protection Program Loan</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On May 1, 2020, the Company received an U.S. Small Business Administration Loan (“SBA Loan”) from Bank of America, N.A. related to the COVID-19 pandemic in the amount of $1.2 million. On May 12, 2020, the Company repaid the SBA loan in full.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The table below outlines our notes payable balances as of September 30, 2021 and December 31, 2020:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">License Fees</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 299</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 293</p></td></tr><tr><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">D&amp;O Insurance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,483</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 246</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total current notes payable</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,782</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 539</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Accretion of non-cash interest expense amounted to $2 and $6 for the three and nine months ended September 30, 2021 and $4 and $17 for the three and nine months ended September 30, 2020.</p> 1200000 1175000 300000 1175000 1200000 300000 300000 3 1151000 1151000 3315000 662000 2653000 0.0349 P1Y 2744000 549000 2195000 P9M 0.0319 1200000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> <span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">License Fees</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 299</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 293</p></td></tr><tr><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">D&amp;O Insurance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,483</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 246</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total current notes payable</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,782</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$</b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 539</p></td></tr></table> 299000 293000 1483000 246000 1782000 539000 2000 6000 4000 17000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 9. – SEVERANCE LIABILITY</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 7.9pt;"><span style="font-weight:normal;">During the second quarter of 2020, the Company recorded severance benefits related to a resignation of </span><span style="font-weight:normal;">$306</span><span style="font-weight:normal;">. The benefits were provided over a twelve-month period. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 7.9pt;"><span style="font-weight:normal;">During 2019, the Company recorded severance benefits of </span><span style="font-weight:normal;">$881</span><span style="font-weight:normal;">. Consistent with certain contractual obligations, </span><span style="font-weight:normal;">$771</span><span style="font-weight:normal;"> of the related benefit will be provided over a period of </span><span style="-sec-ix-hidden:Hidden_Nw0v8_GTBkSWDnOoLnQaNw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">forty-two months</span></span><span style="font-weight:normal;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 7.9pt;"><span style="font-weight:normal;">The current and long-term accrued severance balance remaining as of September 30, 2021 was </span><span style="font-weight:normal;">$223</span><span style="font-weight:normal;"> and </span><span style="font-weight:normal;">$72</span><span style="font-weight:normal;">, respectively. The current and long-term accrued severance balance remaining as of December 31, 2020 was </span><span style="font-weight:normal;">$339</span><span style="font-weight:normal;"> and </span><span style="font-weight:normal;">$241</span><span style="font-weight:normal;">, respectively.</span></p> 306000 881000 771000 223000 72000 339000 241000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 10. – CAPITAL RAISE AND WARRANT EXERCISE</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On June 7, 2021, the Company entered into a placement agent agreement (the “Placement Agent Agreement”) with Cowen and Company, LLC (the “Placement Agent”) relating to the Company’s registered direct offering (the “Offering”) to a select investor (the “Investor”). In addition, on June 7, 2021, the Company and the Investor entered into a securities purchase agreement relating to the issuance and sale of shares of common stock pursuant to which the Investor purchased 10,000,000 shares of common stock at $4.00 per share. The net proceeds to the Company from the Offering, after deducting Placement Agent fees and offering expenses, was $38,206.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">During the first quarter of 2021, the Company’s warrant holders exercised all 11,293,211 outstanding warrants for cash in exchange for common stock. In connection with these exercises, the Company received net proceeds of $11,782. No warrants remain outstanding as of September 30, 2021. The following table summarizes the Company’s outstanding warrant activity since December 31, 2020:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding at December 31, 2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,293,211</p></td></tr><tr><td style="vertical-align:bottom;width:84.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants exercised in Q1 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,293,211)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding at September 30, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 10000000 4.00 38206000 11293211 11782000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td></tr><tr><td style="vertical-align:bottom;width:84.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding at December 31, 2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,293,211</p></td></tr><tr><td style="vertical-align:bottom;width:84.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants exercised in Q1 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (11,293,211)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants outstanding at September 30, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:12.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td></tr></table> 11293211 11293211 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 11. - COMMITMENTS AND CONTINGENCIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">License agreements and sponsored research</span><i style="font-style:italic;"> –</i> The Company has entered into various license, sponsored research, collaboration, and other agreements (the “Agreements”) with various counter parties in connection with the Company’s plant biotechnology business relating to tobacco and hemp/cannabis. The schedule below summarizes the Company’s commitments, both financial and other, associated with each Agreement. Costs incurred under the Agreements are generally recorded as research and development expenses on the Company’s Consolidated Statements of Operations and Comprehensive Loss.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="17" style="vertical-align:bottom;white-space:nowrap;width:44.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future Commitments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Commitment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Counter Party</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Product Relationship</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Commitment Type</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2025 &amp; After</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Research Agreement</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">KeyGene</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Hemp / Cannabis</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Contract fee</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 115</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 1,150</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 1,200</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 1,227</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 2,893</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 6,585</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(1)</p></td></tr><tr><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">License Agreement</p></td><td style="vertical-align:top;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">NCSU</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Tobacco</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Annual royalty fee</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 68</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 225</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 293</p></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(2), (3)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">License Agreement</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">NCSU</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Tobacco</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Minimum annual royalty</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 7</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 600</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 757</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(3)</p></td></tr><tr><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">License Agreement</p></td><td style="vertical-align:top;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">NCSU</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Tobacco</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Minimum annual royalty</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 14</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 500</p></td><td style="vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 664</p></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(3)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Sublicense Agreement</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Anandia Laboratories, Inc.</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Hemp / Cannabis</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Annual license fee</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 10</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 10</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 10</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 10</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 110</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 150</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(4)</p></td></tr><tr><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Research Agreement</p></td><td style="vertical-align:top;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Cannametrix</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Hemp / Cannabis</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Contract fee</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 51</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 101</p></td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(5)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Growing Agreement</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Various</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Various</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Contract fee</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 127</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 38</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 165</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(6)</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Consulting Agreement</p></td><td style="vertical-align:top;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Various</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Various</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Contract fee</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 119</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 286</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 405</p></td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(7)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 511</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 1,859</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 1,310</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 1,337</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 4,103</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 9,120</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">Exclusive agreement with the Company with respect to the </span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;text-align:left;">Cannabis Sativa L.</i><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;"> plant (the "Field"). The initial term of the agreement was </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">five years</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;"> with an option for an additional </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">two years</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">. On April 30, 2021, the Company and KeyGene entered into a First Amended and Restated Framework Collaborative Research Agreement which extended the agreement term, from first-quarter 2024 to first-quarter 2027, and preserves the Company’s option for an additional </span><span style="-sec-ix-hidden:Hidden_wBjYVurMSUK3YMm1xquc0w;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">2-year</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;"> extension, now through first quarter of 2029.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt 0pt 12pt 90pt;">The Company will exclusively own all results and all intellectual property relating to the results of the collaboration with KeyGene (the "Results”). The Company will pay royalties in varying amounts to KeyGene relating to the Company's commercialization in the Field of certain Results. The Company has also granted KeyGene a license to commercialize the Results outside of the Field and KeyGene will pay royalties in varying amounts to the Company relating to KeyGene's commercialization of the Results outside of the Field.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The license agreement also requires a milestone payment of </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">$150</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;"> upon FDA approval or clearance of a product that uses the NCSU licensed technology. The annual royalty fee is credited against running royalties on sales of licensed products.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The Company is also responsible for reimbursing NSCU for actual third-party patent costs incurred, including capitalized patent costs and patent maintenance costs. These costs vary from year to year and the Company has certain rights to direct the activities that result in these costs.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The Company is also responsible for the payment of certain costs, including, capitalized patent costs and patent maintenance costs, a running royalty on future net sales of products made from the sublicensed intellectual property, and a sharing of future sublicensing consideration received from sublicensing to third parties in all countries except for Canada. Anandia retains all patent rights, and is responsible for all patent maintenance, in Canada.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(5)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">On March 1, 2021, the Company entered into a </span><span style="-sec-ix-hidden:Hidden_wthyDk-vHk2X9lx8CpToYw;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">14-month</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;"> research agreement with Cannametrix for hemp/cannabis product development, formulation, and validation. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(6)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">Various R&amp;D growing and consulting agreements for hemp / cannabis and tobacco.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(7)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">General corporate consulting agreements.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Modified Risk Tobacco Product Application (“MRTP Application”)</span><b style="font-weight:bold;"> </b>– In connection with the Company’s MRTP Application for its Very Low Nicotine Content (“VLNC”) cigarettes with the FDA, the Company has entered in various contracts with third-party service providers to fulfill various requirements of the MRTP Application. Such contracts include services for clinical trials, perception studies, legal guidance, product testing, and consulting expertise. During the three and nine months ended September 30, 2021, the Company incurred expenses relating to these contracts in the approximate amount of $2 and $16, respectively, and $4 and $158 for the three and nine months ended September 30, 2020, respectively. The Company will continue to incur consulting and legal expenses as the MRTP Application continues through the FDA review process. The Company cannot currently quantify the additional expenses that the Company will incur in the FDA review process because it will involve various factors that are within the discretion and control of the FDA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Litigation</span><i style="font-style:italic;"> </i>-<i style="font-style:italic;"> </i>In accordance with applicable accounting guidance, the Company establishes an accrued liability for litigation and regulatory matters when those matters present loss contingencies that are both probable and estimable. In such cases, there may be an exposure to loss in excess of any amounts accrued. When a loss contingency is not both probable and estimable, the Company does not establish an accrued liability. As a litigation or regulatory matter develops, the Company, in conjunction with any outside counsel handling the matter, evaluates on an ongoing basis whether such matter presents a loss contingency that is probable and estimable. If, at the time of evaluation, the loss contingency related to a litigation or regulatory matter is not both probable and estimable, the matter will continue to be monitored for further developments that would make such loss contingency both probable and estimable. When a loss contingency related to a litigation or regulatory matter is deemed to be both probable and estimable, the Company will establish an accrued liability with respect to such loss contingency and record a corresponding amount of related expenses. The Company will then continue to monitor the matter for further developments that could affect the amount of any such accrued liability.<b style="font-weight:bold;"> </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Class Action </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On January 21, 2019, Matthew Jackson Bull, a resident of Denver, Colorado, filed a Complaint against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, and the Company’s then Chief Financial Officer, John T. Brodfuehrer, in the United States District Court for the Eastern District of New York entitled: Matthew Bull, Individually and on behalf of all others similarly situated, v. 22nd Century Group, Inc., Henry Sicignano III, and John T. Brodfuehrer, Case No. 1:19 cv 00409.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="white-space:pre-wrap;">On January 29, 2019, Ian M. Fitch, a resident of Essex County Massachusetts, filed a Complaint against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, and the Company’s then Chief Financial Officer, John T. Brodfuehrer, in the United States District Court for the Eastern District of New York entitled: Ian Fitch, Individually and on behalf of all others similarly situated, v. 22nd Century Group, Inc., Henry Sicignano III, and John T. Brodfuehrer, Case No. 2:19 cv 00553.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On May 28, 2019, the plaintiff in the Fitch case voluntarily dismissed that action. On August 1, 2019, the Court in the Bull case issued an order designating Joseph Noto, Garden State Tire Corp, and Stephens Johnson as lead plaintiffs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On September 16, 2019, pursuant to a joint motion by the parties, the Court in the Bull case transferred the class action to federal district court in the Western District of New York, where it remains pending as Case No. 1:19-cv-01285.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Plaintiffs in the Bull case filed an Amended Complaint on November 19, 2019 that alleges three counts: Count I sues the Company and Messrs. Sicignano and Brodfuehrer and alleges that the Company's quarterly and annual reports, SEC filings, press releases and other public statements and documents contained false statements in violation of Section 10(b) of the Securities Exchange Act and Rule 10b-5; Count II sues Messrs. Sicignano and Brodfuehrer pursuant to Section 10(b) of the Securities Exchange Act and Rule 10b5(a) and (c); and Count III sues Messrs. Sicignano and Brodfuehrer for the allegedly false statements pursuant to Section 20(a) of the Securities Exchange Act. The Amended Complaint seeks to certify a class, and unspecified compensatory and punitive damages, and attorney's fees and costs.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On January 29, 2020, the Company and Messrs. Sicignano and Brodfuehrer filed a Motion to Dismiss the Amended Complaint. On July 31, 2020, the Court heard oral arguments on the motion to dismiss. On January 14, 2021, the Court granted motion, dismissing all claims with prejudice. The Plaintiffs filed a notice of appeal on February 12, 2021 to the Second Circuit Court of Appeals. The Second Circuit has granted an expedited briefing schedule and Plaintiff’s/Appellant’s was filed on April 12, 2021 and the Company’s was filed on May 17, 2021. The Second Circuit heard oral arguments on September 2, 2021 and the matter remains pending with the Second Circuit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We believe that the claims are frivolous, meritless and that the Company and Messrs. Sicignano and Brodfuehrer have substantial legal and factual defenses to the claims. We intend to vigorously defend the Company and Messrs. Sicignano and Brodfuehrer against such claims.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Shareholder Derivative Cases</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 6, 2019, Melvyn Klein, a resident of Nassau County New York, filed a shareholder derivative claim against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, the Company’s Chief Financial Officer, John T. Brodfuehrer, and each member of the Company’s Board of Directors in the United States District Court for the Eastern District of New York entitled: Melvyn Klein, derivatively on behalf of 22nd Century Group v. Henry Sicignano, III, Richard M. Sanders, Joseph Alexander Dunn, Nora B. Sullivan, James W. Cornell, John T. Brodfuehrer and 22nd Century Group, Inc., Case No. 1:19 cv 00748. Mr. Klein brings this action derivatively alleging that (i) the director defendants supposedly breached their fiduciary duties for allegedly allowing the Company to make false statements; (ii) the director defendants supposedly wasted corporate assets to defend this lawsuit and the other related lawsuits; (iii) the defendants allegedly violated Section 10(b) of the Securities Exchange Act and Rule 10b 5 promulgated thereunder for allegedly approving or allowing false statements regarding the Company to be made; and (iv) the director defendants allegedly violated Section 14(a) of the Securities Exchange Act and Rule 14a 9 promulgated thereunder for allegedly approving or allowing false statements regarding the Company to be made in the Company’s proxy statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 11, 2019, Stephen Mathew filed a shareholder derivative claim against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, the Company’s Chief Financial Officer, John T. Brodfuehrer, and each member of the Company’s Board of Directors in the Supreme Court of the State of New York, County of Erie, entitled: Stephen Mathew, derivatively on behalf of 22nd Century Group, Inc. v. Henry Sicignano, III, John T. Brodfuehrer, Richard M. Sanders, Joseph Alexander Dunn, James W. Cornell, Nora B. Sullivan and 22nd Century Group, Inc., Index No. 801786/2019. Mr. Mathew brings this action derivatively generally alleging the same allegations as in the Klein case. The Complaint seeks declaratory relief, unspecified monetary damages, corrective corporate governance actions, and attorney’s fees and costs. On August 15, 2019, the Court consolidated the Mathew and Klein actions pursuant to a stipulation by the parties (Western District of New York, Case No. 1-19-cv-0513). We believe that the claims are frivolous, meritless and that the Company and the individual defendants have substantial legal and factual defenses to the claims. We intend to vigorously defend the Company and the individual defendants against such claims.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On June 10, 2019, Judy Rowley filed a shareholder derivative claim against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, the Company’s Chief Financial Officer, John T. Brodfuehrer, and each member of the Company’s Board of Directors in the Supreme Court of the State of New York, County of Erie, entitled: Judy Rowley, derivatively on behalf of 22nd Century Group, Inc. v. Henry Sicignano, III, Richard M. Sanders, Joseph Alexander Dunn, Nora B. Sullivan, James W. Cornell, John T. Brodfuehrer, and 22nd Century Group, Inc., Index No. 807214/2019. Ms. Rowley brings this action derivatively alleging that the director defendants supposedly breached their fiduciary duties by allegedly allowing the Company to make false statements. The Complaint seeks declaratory relief, unspecified monetary damages, corrective corporate governance actions, and </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">attorney’s fees and costs. We believe that the claims are frivolous, meritless and that the Company and the individual defendants have substantial legal and factual defenses to the claims. We intend to vigorously defend the Company and the individual defendants against such claims. On September 13, 2019, the Court ordered the litigation stayed pursuant to a joint stipulation by the parties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On January 15, 2020, Kevin Broccuto filed a shareholder derivative claim against the Company, the Company's then Chief Executive Officer, Henry Sicignano III, the Company's Chief Financial Officer, John T. Brodfuehrer, and certain members of the Company's prior Board of Directors in the District Court of the State of Nevada, County of Clark, entitled: Kevin Broccuto, derivatively on behalf of 22nd Century Group, Inc. v. James W. Cornell, Richard M. Sanders, Nora B. Sullivan, Henry Sicignano, III, and John T. Brodfuehrer, Case No. A-20-808599. Mr. Broccuto brings this action derivatively alleging three counts: Count I alleges that the defendants breached their fiduciary duties; Count II alleges they committed corporate waste; and Count III that they were unjustly enriched, by allegedly allowing the Company to make false statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 11, 2020, Jerry Wayne filed a shareholder derivative claim against the Company, the Company's then Chief Executive Officer, Henry Sicignano III, the Company's Chief Financial Officer, John T. Brodfuehrer, and certain members of the Company's prior Board of Directors in the District Court of the State of Nevada, County of Clark, entitled: Jerry Wayne, derivatively on behalf of 22nd Century Group, Inc. v. James W. Cornell, Richard M. Sanders, Nora B. Sullivan, Henry Sicignano, III, and John T. Brodfuehrer, Case No. A-20-808599. Mr. Wayne brings this action derivatively alleging generally the same allegations as the Brocutto case. The Complaint seeks unspecified monetary damages, corrective corporate governance actions, disgorgement of alleged profits and imposition of constructive trusts, and attorney's fees and costs. The Complaint also seeks to declare as unenforceable the Company's Bylaw requiring derivative lawsuits to be filed in Erie County, New York, where the Company is headquartered.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On March 25, 2020, the Court ordered the Brocutto and Wayne cases consolidated and stayed pursuant to a joint stipulation from the parties. We believe that the claims are frivolous, meritless and that the Company and the individual defendants have substantial legal and factual defenses to the claims. We intend to vigorously defend the Company and the individual defendants against such claims.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td colspan="17" style="vertical-align:bottom;white-space:nowrap;width:44.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Future Commitments</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Commitment</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Counter Party</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Product Relationship</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Commitment Type</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2025 &amp; After</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:6.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Research Agreement</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">KeyGene</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Hemp / Cannabis</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Contract fee</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 115</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 1,150</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 1,200</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 1,227</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 2,893</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 6,585</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(1)</p></td></tr><tr><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">License Agreement</p></td><td style="vertical-align:top;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">NCSU</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Tobacco</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Annual royalty fee</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 68</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 225</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 293</p></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(2), (3)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">License Agreement</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">NCSU</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Tobacco</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Minimum annual royalty</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 7</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 600</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 757</p></td><td style="background-color:#cceeff;vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(3)</p></td></tr><tr><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">License Agreement</p></td><td style="vertical-align:top;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">NCSU</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Tobacco</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Minimum annual royalty</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 14</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 500</p></td><td style="vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 664</p></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(3)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Sublicense Agreement</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Anandia Laboratories, Inc.</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Hemp / Cannabis</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Annual license fee</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 10</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 10</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 10</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 10</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 110</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 150</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(4)</p></td></tr><tr><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Research Agreement</p></td><td style="vertical-align:top;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Cannametrix</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Hemp / Cannabis</p></td><td style="vertical-align:top;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Contract fee</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 51</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 50</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 101</p></td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(5)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Growing Agreement</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Various</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Various</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Contract fee</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 127</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 38</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:6.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:0.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:5.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 165</p></td><td style="background-color:#cceeff;vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(6)</p></td></tr><tr><td style="vertical-align:top;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Consulting Agreement</p></td><td style="vertical-align:top;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Various</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Various</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">Contract fee</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 119</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 286</p></td><td style="vertical-align:top;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:1.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:6.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:top;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:0.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="vertical-align:top;white-space:nowrap;width:5.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 405</p></td><td style="vertical-align:top;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">(7)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:13.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:10.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 511</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 1,859</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 1,310</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 1,337</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:6.16%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 4,103</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:0.8%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.3%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:right;margin:0pt 2.5pt 0.05pt 0pt;"> 9,120</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:7pt;visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">Exclusive agreement with the Company with respect to the </span><i style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:italic;font-weight:normal;text-align:left;">Cannabis Sativa L.</i><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;"> plant (the "Field"). The initial term of the agreement was </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">five years</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;"> with an option for an additional </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">two years</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">. On April 30, 2021, the Company and KeyGene entered into a First Amended and Restated Framework Collaborative Research Agreement which extended the agreement term, from first-quarter 2024 to first-quarter 2027, and preserves the Company’s option for an additional </span><span style="-sec-ix-hidden:Hidden_wBjYVurMSUK3YMm1xquc0w;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">2-year</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;"> extension, now through first quarter of 2029.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-indent:0pt;margin:0pt 0pt 12pt 90pt;">The Company will exclusively own all results and all intellectual property relating to the results of the collaboration with KeyGene (the "Results”). The Company will pay royalties in varying amounts to KeyGene relating to the Company's commercialization in the Field of certain Results. The Company has also granted KeyGene a license to commercialize the Results outside of the Field and KeyGene will pay royalties in varying amounts to the Company relating to KeyGene's commercialization of the Results outside of the Field.</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The license agreement also requires a milestone payment of </span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">$150</span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;"> upon FDA approval or clearance of a product that uses the NCSU licensed technology. The annual royalty fee is credited against running royalties on sales of licensed products.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The Company is also responsible for reimbursing NSCU for actual third-party patent costs incurred, including capitalized patent costs and patent maintenance costs. These costs vary from year to year and the Company has certain rights to direct the activities that result in these costs.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The Company is also responsible for the payment of certain costs, including, capitalized patent costs and patent maintenance costs, a running royalty on future net sales of products made from the sublicensed intellectual property, and a sharing of future sublicensing consideration received from sublicensing to third parties in all countries except for Canada. Anandia retains all patent rights, and is responsible for all patent maintenance, in Canada.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(5)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">On March 1, 2021, the Company entered into a </span><span style="-sec-ix-hidden:Hidden_wthyDk-vHk2X9lx8CpToYw;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">14-month</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;"> research agreement with Cannametrix for hemp/cannabis product development, formulation, and validation. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(6)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">Various R&amp;D growing and consulting agreements for hemp / cannabis and tobacco.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:72pt;"/><td style="font-family:'Times New Roman';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(7)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">General corporate consulting agreements.</span></td></tr></table><div style="margin-top:12pt;"/> 115000 1150000 1200000 1227000 2893000 6585000 68000 225000 293000 7000 50000 50000 50000 600000 757000 14000 50000 50000 50000 500000 664000 10000 10000 10000 10000 110000 150000 51000 50000 101000 127000 38000 165000 119000 286000 405000 511000 1859000 1310000 1337000 4103000 9120000 P5Y P2Y 150000 2000 16000 4000 158000 3 3 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 12 – EQUITY- BASED COMPENSATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On May 20, 2021, the stockholders of 22nd Century Group, Inc. (the “Company”) approved the 22nd Century Group, Inc. 2021 Omnibus Incentive Plan (the “Plan”). The Plan allows for the granting of equity awards to eligible individuals over the life of the Plan, including the issuance of up to 5,000,000 shares of the Company’s common stock and any remaining shares under the Company’s 2014 Omnibus Incentive Plan pursuant to awards under the Plan. The Plan has a term of <span style="white-space:pre-wrap;">ten years</span><span style="white-space:pre-wrap;"> and is administered by the Compensation Committee of the Company’s Board of Directors to determine the various types of incentive awards that may be granted to recipients under the Plan and the number of shares of common stock to underlie each such award under the Plan. As of September 30, 2021, the Company had available 7,449,946 shares remaining for future awards under the Plan.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Restricted Stock Units (“RSUs”)</i>. We typically grant RSUs to employees and non-employee directors. The following table summarizes the changes in unvested RSUs from December 31, 2020 through September 30, 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:22.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unvested RSUs</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant-date</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$ per share</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unvested at December 31, 2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,938</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.85</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,995</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.20</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,234)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.85</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (216)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.67</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unvested at March 31, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,483</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2.21</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4.60</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (288)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.86</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (25)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1.04</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unvested at June 30, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,185</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2.35</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 190</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.71</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.80</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1.90</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unvested at September 30, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,315</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2.45</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The fair value of RSUs that vested during the nine months ended September 30, 2021 was approximately $5,057 based on the stock price at the time of vesting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Stock Options.</i> Our outstanding stock options were valued using the Black-Scholes option-pricing model on the date of the award. A summary of all stock option activity since December 31, 2020 is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Term</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">in thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">$ per share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at December 31, 2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 6,581</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.50</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 235</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercised</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (846)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.36</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at March 31, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,964</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.59</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.3</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">years</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 7,480</p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (88)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Forfeited</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (100)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 0.80</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,776</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 13,265</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expired</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (40)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2.58</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (500)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.04</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at September 30, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,236</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.65</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3.8</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">years</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 6,885</p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable at September 30, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,900</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.56</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3.7</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">years</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 6,848</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The intrinsic value of a stock option is the amount by which the current market value or the market value upon exercise of the underlying stock exceeds the exercise price of the option.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The weighted average of fair value assumptions used in the Black-Scholes option-pricing model for such grants were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate (1)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.54</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:83.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected dividend yield (2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility (3)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 87.92</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:83.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term of stock options (4)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4.09</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The risk-free interest rate is based on the period matching the expected term of the stock options based on the U.S. Treasury yield curve in effect on the grant date.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The expected dividend yield is assumed as zero. The Company has never paid cash dividends nor does it anticipate paying dividends in the foreseeable future.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The expected volatility is based on historical volatility of the Company’s stock.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The expected term represents the period of time that options granted are expected to be outstanding based on vesting date and contractual term.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Compensation Expense</i>. The Company recognized the following compensation costs, net of actual forfeitures, related to RSUs and stock options:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended</b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales, general, and administrative</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,073</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 278</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,750</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,051</p></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and Development</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 46</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 28</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 121</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 111</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total RSUs and stock option compensation</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,119</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 306</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,871</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,162</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As of September 30, 2021, unrecognized compensation expense amounted to $5,931 which is expected to be recognized over a weighted average period of approximately <span style="white-space:pre-wrap;">1.1</span><span style="white-space:pre-wrap;"> years. In addition, there is approximately $517 of unrecognized compensation expense that requires the achievement of certain milestones which are not yet probable.</span></p> 5000000 P10Y 7449946 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:22.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unvested RSUs</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant-date</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">$ per share</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unvested at December 31, 2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,938</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.85</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,995</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.20</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (1,234)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.85</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (216)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.67</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unvested at March 31, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,483</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2.21</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 15</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4.60</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (288)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.86</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (25)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1.04</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unvested at June 30, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,185</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2.35</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 190</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3.71</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Vested</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (50)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.80</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1.90</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:74.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unvested at September 30, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:11pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,315</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2.45</p></td></tr></table> 2938000 0.85 1995000 3.20 1234000 0.85 216000 0.67 3483000 2.21 15000 4.60 288000 0.86 25000 1.04 3185000 2.35 190000 3.71 50000 0.80 10000 1.90 3315000 2.45 5057000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Contractual</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Term</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">in thousands</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">$ per share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at December 31, 2020</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 6,581</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.50</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 235</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3.10</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercised</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (846)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.36</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (6)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2.76</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at March 31, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,964</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.59</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.3</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">years</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 7,480</p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (88)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.21</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Forfeited</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (100)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 0.80</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at June 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,776</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.60</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4.1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 13,265</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Expired</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (40)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 2.58</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (500)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.04</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Outstanding at September 30, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 5,236</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.65</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3.8</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">years</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 6,885</p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.02%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Exercisable at September 30, 2021</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 4,900</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.01%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 1.56</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 3.7</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:3.9%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">years</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.02%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:7.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"> 6,848</p></td></tr></table> 6581000 1.50 235000 3.10 846000 1.36 6000 2.76 5964000 1.59 P4Y3M18D 7480000 88000 1.21 100000 0.80 5776000 1.60 P4Y1M6D 13265000 40000 2.58 500000 1.04 5236000 1.65 P3Y9M18D 6885000 4900000 1.56 P3Y8M12D 6848000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:83.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:83.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk-free interest rate (1)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 0.54</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:83.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected dividend yield (2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:83.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility (3)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 87.92</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:5.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:83.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term of stock options (4)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4.09</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">years</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The risk-free interest rate is based on the period matching the expected term of the stock options based on the U.S. Treasury yield curve in effect on the grant date.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The expected dividend yield is assumed as zero. The Company has never paid cash dividends nor does it anticipate paying dividends in the foreseeable future.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The expected volatility is based on historical volatility of the Company’s stock.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman';font-size:9pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:9pt;font-style:normal;font-weight:normal;text-align:left;">The expected term represents the period of time that options granted are expected to be outstanding based on vesting date and contractual term.</span></td></tr></table><div style="margin-top:12pt;"/> 0.0054 0.8792 P4Y1M2D <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended</b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales, general, and administrative</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,073</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 278</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,750</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,051</p></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and Development</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 46</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 28</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 121</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 111</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total RSUs and stock option compensation</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,119</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 306</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,871</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 1,162</p></td></tr></table> 1073000 278000 2750000 1051000 46000 28000 121000 111000 1119000 306000 2871000 1162000 5931000 P1Y1M6D 517000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 13. – REVENUE RECOGNITION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company recognizes revenue when it satisfies a performance obligation by transferring control of the product to a customer. The Company’s customer contracts consist of obligations to manufacture the customer’s branded filtered cigars and cigarettes. For certain contracts, the performance obligation is satisfied over time as the Company determines, due to contract restrictions, it does not have an alternative use of the product and it has an enforceable right to payment as the product is manufactured. The Company recognizes revenue under those contracts at the unit price stated in the contract based on the units manufactured. Revenue from the sale of the Company’s products is recognized net of cash discounts, sales returns and allowances. There was no allowance for discounts or returns and allowances at September 30, 2021 and December 31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Contract Assets and Liabilities</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Unbilled receivables (contract assets) represent revenues recognized for performance obligations that have been satisfied but have not been billed. These receivables are included as Accounts receivable, net on the Consolidated Balance Sheets. Customer payment terms vary depending on the terms of each customer contract, but payment is generally due prior to product shipment or within extended credit terms up to twenty-one (21) days after shipment. Deferred Revenue (contract liabilities) relate to down payments received from customers in advance of satisfying a performance obligation. This deferred revenue is included as Deferred income on the Consolidated Balance Sheets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Total contract assets and contract liabilities are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unbilled receivables</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 494</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 349</p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (272)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net contract assets</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 494</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 77</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-style:italic;margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Disaggregation of Revenue</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s net sales revenue is derived from customers located primarily in the United States of America and is disaggregated by the timing of revenue recognition—net sales transferred over time and net sales transferred at a point in time. All revenue is related to contract manufacturing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended</b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net sales-over time</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,344</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,339</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 16,461</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,769</p></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net sales-point in time</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,467</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,971</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,527</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,034</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Revenue</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,811</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,310</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 22,988</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 20,803</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 0 0 P21D <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Unbilled receivables</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 494</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 349</p></td></tr><tr><td style="vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (272)</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:73.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net contract assets</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 494</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.48%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:9.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 77</p></td></tr></table> 494000 349000 272000 494000 77000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended</b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net sales-over time</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,344</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 4,339</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 16,461</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 12,769</p></td></tr><tr><td style="vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net sales-point in time</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,467</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,971</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 6,527</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,034</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total Revenue</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,811</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,310</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 22,988</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 20,803</p></td></tr></table> 5344000 4339000 16461000 12769000 2467000 2971000 6527000 8034000 7811000 7310000 22988000 20803000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOTE 14. – EARNINGS PER SHARE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The following table sets forth the computation of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2021 and 2020, respectively. Outstanding warrants, options, and RSUs were excluded from the calculation of diluted EPS as the effect was antidilutive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended</b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;width:1.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="13" style="padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:42.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in thousands, except for per-share data)</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,440)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,221)</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (18,644)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13,307)</p></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average common shares outstanding - basic and diluted</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 162,721</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 138,857</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 153,998</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 138,774</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss per common share - basic and diluted</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.06)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.03)</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.12)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.10)</p></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Anti-dilutive shares are as follows:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,293</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,293</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Options</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,236</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,259</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,236</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,259</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,315</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,878</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,315</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,878</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,551</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 21,430</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,551</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 21,430</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended</b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;width:1.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="13" style="padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:42.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in thousands, except for per-share data)</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,440)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,221)</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (18,644)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13,307)</p></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average common shares outstanding - basic and diluted</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 162,721</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 138,857</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 153,998</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 138,774</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss per common share - basic and diluted</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.06)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.03)</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.12)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.10)</p></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Anti-dilutive shares are as follows:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,293</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,293</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Options</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,236</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,259</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,236</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,259</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,315</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,878</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,315</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,878</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,551</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 21,430</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,551</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 21,430</p></td></tr></table> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Three Months Ended</b></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Nine Months Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td><td style="vertical-align:bottom;width:1.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:20.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">September 30, </b></p></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="13" style="padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:42.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(in thousands, except for per-share data)</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,440)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,221)</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (18,644)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (13,307)</p></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average common shares outstanding - basic and diluted</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 162,721</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 138,857</p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 153,998</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 138,774</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net loss per common share - basic and diluted</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.06)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.03)</p></td><td style="background-color:#cceeff;vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.12)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.10)</p></td></tr><tr><td style="vertical-align:bottom;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Anti-dilutive shares are as follows:</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,293</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 11,293</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Options</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,236</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,259</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 5,236</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 7,259</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,315</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,878</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 3,315</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 2,878</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:55.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,551</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 21,430</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.24%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 8,551</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.12%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:8.25%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0.05pt 0pt;"> 21,430</p></td></tr></table> -9440000 -4221000 -18644000 -13307000 162721000 138857000 153998000 138774000 -0.06 -0.03 -0.12 -0.10 11293000 11293000 5236000 7259000 5236000 7259000 3315000 2878000 3315000 2878000 8551000 21430000 8551000 21430000 XML 11 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2021
Nov. 03, 2021
Document and Entity Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Amendment Flag false  
Document Period End Date Sep. 30, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q3  
Entity File Number 001-36338  
Entity Registrant Name 22nd Century Group, Inc.  
Entity Central Index Key 0001347858  
Current Fiscal Year End Date --12-31  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 98-0468420  
Entity Address, Address Line One 500 Seneca Street  
Entity Address, Address Line Two Suite 507  
Entity Address, City or Town Buffalo  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 14204  
City Area Code 716  
Local Phone Number 270-1523  
Title of 12(b) Security Common Stock, $0.00001 par value  
Security Exchange Name NASDAQ  
Trading Symbol XXII  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   162,748,483
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 1,629 $ 1,029
Short-term investment securities 53,532 21,313
Accounts receivable, net 1,179 2,159
Inventory, net 2,703 2,034
Prepaid expenses and other assets 3,131 1,806
Total current assets 62,174 28,341
Property, plant and equipment, net 4,754 2,483
Operating leases right-of-use assets, net 478 247
Intangible assets, net 8,036 8,211
Investments 7,300 6,536
Other assets 3,713 5,876
Total assets 86,455 51,694
Current liabilities:    
Notes payable 1,782 539
Operating lease obligations 74 247
Accounts payable 1,443 1,116
Accrued expenses 3,440 4,830
Accrued severance, current 223 339
Deferred income 0 272
Total current liabilities 6,962 7,343
Long-term liabilities:    
Operating lease obligations 407 0
Severance obligations 72 241
Total liabilities 7,441 7,584
Commitments and contingencies (Note 11)
Shareholders' equity    
Common stock value 2 1
Capital in excess of par value 243,087 189,439
Accumulated other comprehensive (loss) income (27) 74
Accumulated deficit (164,048) (145,404)
Total shareholders' equity 79,014 44,110
Total liabilities and shareholders' equity $ 86,455 $ 51,694
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2021
Dec. 31, 2020
CONSOLIDATED BALANCE SHEETS    
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, par value $ 0.00001 $ 0.00001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares issued 162,735,483 139,061,690
Common stock, shares outstanding 162,735,483 139,061,690
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue:        
Sale of products, net $ 7,811 $ 7,310 $ 22,988 $ 20,803
Cost of goods sold (exclusive of depreciation shown separately below):        
Products 7,362 6,948 21,306 19,953
Gross profit (loss) 449 362 1,682 850
Operating expenses:        
Sales, general and administrative 6,821 3,169 17,827 9,809
Impairment of intangible assets 0     146
Depreciation 173 160 461 473
Amortization 168 163 471 524
Total operating expenses 8,018 4,402 21,062 13,786
Operating loss (7,569) (4,040) (19,380) (12,936)
Other income (expense):        
Unrealized gain (loss) on investments (1,900) (429) (2,040) (562)
Impairment of Panacea investment       (1,062)
Gain on Panacea investment conversion     2,548  
Gain on the sale of property, plant and equipment       1
Interest income, net 52 270 272 1,344
Interest expense (23) (23) (44) (54)
Total other income (expense) (1,871) (181) 736 (333)
Loss before income taxes (9,440) (4,221) (18,644) (13,269)
Income taxes       38
Net loss (9,440) (4,221) (18,644) (13,307)
Other comprehensive income (loss):        
Unrealized gain (loss) on short-term investment securities (28) 87 (101) 132
Other comprehensive income (loss) (28) 87 (101) 132
Comprehensive loss $ (9,468) $ (4,134) $ (18,745) $ (13,175)
Net loss per common share - basic and diluted $ (0.06) $ (0.03) $ (0.12) $ (0.10)
Weighted average common shares outstanding - basic and diluted (in thousands) 162,721 138,857 153,998 138,774
Products Other Than Modified Risk Tobacco Products [Member]        
Operating expenses:        
Research and development $ 854 $ 906 $ 2,287 $ 2,676
Modified Risk Tobacco Product [Member]        
Operating expenses:        
Research and development $ 2 $ 4 $ 16 $ 158
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Common Stock [Member]
Capital in Excess of Par Value [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Total
Beginning balance at Dec. 31, 2019 $ 1,000 $ 187,735,000 $ 7,000 $ (125,693,000) $ 62,050,000
Beginning balance (in shares) at Dec. 31, 2019 138,362,809        
Stock issued in connection with RSU vesting (in shares) 491,384        
Equity-based compensation $ 0 480,000 0 0 480,000
Equity-based compensation (in shares) 0        
Unrealized gain (loss) on short-term investment securities $ 0 0 (196,000) 0 (196,000)
Reclassification of losses (gains) to net loss 0 0 3,000 0 3,000
Net loss 0 0 0 (4,029,000) (4,029,000)
Ending balance at Mar. 31, 2020 $ 1,000 188,215,000 (186,000) (129,722,000) 58,308,000
Ending balance (in shares) at Mar. 31, 2020 138,854,193        
Beginning balance at Dec. 31, 2019 $ 1,000 187,735,000 7,000 (125,693,000) 62,050,000
Beginning balance (in shares) at Dec. 31, 2019 138,362,809        
Net loss         (13,307,000)
Ending balance at Sep. 30, 2020 $ 1,000 188,897,000 139,000 (139,000,000) 50,037,000
Ending balance (in shares) at Sep. 30, 2020 138,859,193        
Beginning balance at Mar. 31, 2020 $ 1,000 188,215,000 (186,000) (129,722,000) 58,308,000
Beginning balance (in shares) at Mar. 31, 2020 138,854,193        
Equity-based compensation   376,000     376,000
Unrealized gain (loss) on short-term investment securities     241,000   241,000
Reclassification of losses (gains) to net loss     (3,000)   (3,000)
Net loss       (5,057,000) (5,057,000)
Ending balance at Jun. 30, 2020 $ 1,000 188,591,000 52,000 (134,779,000) 53,865,000
Ending balance (in shares) at Jun. 30, 2020 138,854,193        
Stock issued in connection with RSU vesting (in shares) 5,000        
Equity-based compensation   306,000     306,000
Unrealized gain (loss) on short-term investment securities     87,000   87,000
Net loss       (4,221,000) (4,221,000)
Ending balance at Sep. 30, 2020 $ 1,000 188,897,000 139,000 (139,000,000) 50,037,000
Ending balance (in shares) at Sep. 30, 2020 138,859,193        
Beginning balance at Dec. 31, 2020 $ 1,000 189,439,000 74,000 (145,404,000) 44,110,000
Beginning balance (in shares) at Dec. 31, 2020 139,061,690        
Stock issued in connection with RSU vesting $ 0 0 0 0 0
Stock issued in connection with RSU vesting (in shares) 1,196,258        
Stock issued in connection with warrant exercises $ 1,000 11,781,000     11,782,000
Stock issued in connection with warrant exercises (in shares) 11,293,211        
Stock issued in connection with option exercises   1,153,000     $ 1,153,000
Stock issued in connection with option exercises (in shares) 846,342       846,000
Equity-based compensation $ 0 507,000 0 0 $ 507,000
Equity-based compensation (in shares) 0        
Unrealized gain (loss) on short-term investment securities $ 0 0 (32,000) 0 (32,000)
Net loss 0 0 0 (5,030,000) (5,030,000)
Ending balance at Mar. 31, 2021 $ 2,000 202,880,000 42,000 (150,434,000) 52,490,000
Ending balance (in shares) at Mar. 31, 2021 152,397,501        
Beginning balance at Dec. 31, 2020 $ 1,000 189,439,000 74,000 (145,404,000) 44,110,000
Beginning balance (in shares) at Dec. 31, 2020 139,061,690        
Net loss         (18,644,000)
Ending balance at Sep. 30, 2021 $ 2,000 243,087,000 (27,000) (164,048,000) 79,014,000
Ending balance (in shares) at Sep. 30, 2021 162,735,483        
Beginning balance at Mar. 31, 2021 $ 2,000 202,880,000 42,000 (150,434,000) 52,490,000
Beginning balance (in shares) at Mar. 31, 2021 152,397,501        
Stock issued in connection with RSU vesting, net of shares withheld for taxes   (469,000)     (469,000)
Stock issued in connection with RSU vesting, net of shares withheld for taxes (in shares) 200,103        
Stock issued in connection with option exercises   106,000     $ 106,000
Stock issued in connection with option exercises (in shares) 87,879       88,000
Stock issued in connection with capital raise   38,206,000     $ 38,206,000
Stock issued in connection with capital raise (in shares) 10,000,000        
Equity-based compensation   1,245,000     1,245,000
Unrealized gain (loss) on short-term investment securities     (41,000)   (41,000)
Net loss       (4,174,000) (4,174,000)
Ending balance at Jun. 30, 2021 $ 2,000 241,968,000 1,000 (154,608,000) 87,363,000
Ending balance (in shares) at Jun. 30, 2021 162,685,483        
Stock issued in connection with RSU vesting (in shares) 50,000        
Equity-based compensation   1,119,000     1,119,000
Unrealized gain (loss) on short-term investment securities     (28,000)   (28,000)
Net loss       (9,440,000) (9,440,000)
Ending balance at Sep. 30, 2021 $ 2,000 $ 243,087,000 $ (27,000) $ (164,048,000) $ 79,014,000
Ending balance (in shares) at Sep. 30, 2021 162,735,483        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net loss $ (18,644) $ (13,307)
Adjustments to reconcile net loss to cash used in operating activities:    
Impairment of intangible assets   146
Impairment of Panacea investment   1,062
Amortization and depreciation 745 810
Amortization of license fees 187 187
Amortization of ROU assets 214 232
Unrealized (gain) loss on investment 2,040 562
Gain on Panacea investment conversion (2,548)  
Gain on the sale of machinery and equipment   (1)
Accretion of non-cash interest expense (income) 13 (222)
Equity-based employee compensation expense 2,871 1,162
Inventory write-off   219
(Increase) decrease in assets:    
Accounts receivable 980 (692)
Inventory (669) (264)
Prepaid expenses and other assets (1,494) (1,754)
Increase (decrease) in liabilities:    
Operating lease obligations (212) (228)
Accounts payable 289 (924)
Accrued expenses (1,422) 481
Accrued severance (285) (88)
Deferred income (272) (5)
Net cash provided by (used in) operating activities (18,207) (12,624)
Cash flows from investing activities:    
Acquisition of patents and trademarks (239) (342)
Acquisition of property, plant and equipment (470) (33)
Sales and maturities of short-term investment securities 52,203 28,960
Purchase of short-term investment securities (84,701) (15,830)
Net cash provided by (used in) investing activities (33,207) 12,755
Cash flows from financing activities:    
Payment on note payable (1,417) (1,269)
Proceeds from note payable issuance 2,653 2,195
Net proceeds from option exercises 1,259  
Net proceeds from warrant exercises 11,782  
Net proceeds from issuance of common stock 38,206  
Taxes paid related to net share settlement of RSUs (469)  
Proceeds from SBA loan   1,183
Repayment of SBA loan   (1,183)
Net cash provided by (used in) financing activities 52,014 926
Net increase (decrease) in cash and cash equivalents 600 1,057
Cash and cash equivalents - beginning of period 1,029 485
Cash and cash equivalents - end of period 1,629 1,542
Net cash paid for:    
Cash paid during the period for interest 26 19
Non-cash transactions:    
Patent and trademark additions included in accounts payable 35 19
Property, plant and equipment additions included in accounts payable 4 9
Property, plant and equipment additions included in accrued expenses 10  
Right-of-use assets and corresponding operating lease obligations 497 198
Patent and trademark additions included in accrued expenses 22 $ 46
Panacea investment conversion $ 12,485  
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2021
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1. - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation - The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring accruals considered necessary for a fair and non-misleading presentation of the financial statements have been included.

Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements.

These interim consolidated financial statements should be read in conjunction with the December 31, 2020 audited consolidated financial statements and the notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on March 11, 2021.

Principles of Consolidation - The accompanying consolidated financial statements include the accounts of (i) 22nd Century Group, Inc. (“22nd Century Group”); (ii) its four wholly-owned subsidiaries, 22nd Century Limited, LLC (“22nd Century Ltd”), NASCO Products, LLC (“NASCO”), Botanical Genetics, LLC (“Botanical Genetics”), and 22nd Century Group Canada, Inc. (“22nd Century Group Canada”); (iii) two wholly-owned subsidiaries of 22nd Century Ltd, Goodrich Tobacco Company, LLC (“Goodrich Tobacco”) and Heracles Pharmaceuticals, LLC (“Heracles Pharma”); and (iv) one wholly-owned subsidiary of Botanical Genetics, 22nd Century Holdings, LLC (“22nd Century Holdings”). This group of subsidiaries is referred to as collectively with 22nd Century Group as the “Company”. All intercompany accounts and transactions have been eliminated.

Nature of Business – 22nd Century Group is a leading agricultural biotechnology and intellectual property company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. 22nd Century Ltd performs research and development related to the level of nicotine and other nicotinic alkaloids in tobacco plants and Botanical Genetics performs research and development related to hemp/cannabis plants. Goodrich Tobacco and Heracles Pharma are business units for the Company’s potential modified risk tobacco products. NASCO is a federally licensed tobacco products manufacturer, a subsequent participating member under the tobacco Master Settlement Agreement (“MSA”) between the tobacco industry and the settling states under the MSA and operates the Company’s tobacco products manufacturing business in North Carolina. 22nd Century Holdings and 22nd Century Group Canada are two newly formed subsidiaries where 22nd Century Holdings will own and operate the newly acquired Needle Rock Farm assets and 22nd Century Group Canada will allow for future international business opportunities in Canada.

Reclassifications Certain prior period amounts have been reclassified to conform to the current period’s classification. None of these reclassifications had a material impact on our consolidated financial statements.

COVID-19 Pandemic – The COVID-19 pandemic has adversely impacted the U.S. economy and supply chains and created volatility in U.S. financial markets. The COVID-19 pandemic has had a minimal impact on the Company’s operations in 2020 and thus far in 2021, but there is a risk that state and federal authorities’ responses to the COVID-19 pandemic or another pandemic may disrupt our business in the future.

During April 2021, the Company relocated its corporate headquarters into downtown Buffalo, NY. The new office, as well as all of our facilities, continue to operate in compliance with New York and North Carolina guidance (as applicable) related to the prevention of COVID-19 transmission and employee safety. We also continue to allow remote work arrangements by our employees where job duties permit.

Our executive leadership team and staff are monitoring this evolving situation and its impacts on our business. We will continue to monitor the local, state, and federal guidance regarding our business practices.

Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

Intangible Assets – Intangible assets are recorded at cost and consist primarily of (1) expenditures incurred with third-parties related to the processing of patent claims and trademarks with government authorities, as well as costs to acquire patent rights from third-parties, (2) license fees paid for third-party intellectual property, (3) costs to become a signatory under the tobacco MSA, and (4) license fees paid to acquire a predicate cigarette brand. The amounts capitalized relate to intellectual property that the Company owns or to which it has rights to use.

The Company’s capitalized intellectual property costs are amortized using the straight-line method over the remaining statutory life of the patent assets in each of the Company’s patent families, which have estimated expiration dates ranging from 2026 to 2041. Periodic maintenance or renewal fees are expensed as incurred. Annual minimum license fees are charged to expense. License fees paid for third-party intellectual property are amortized on a straight-line basis over the last to expire patents, which have expected expiration dates ranging from 2028 through 2036. The Company believes that costs associated with becoming a signatory to the MSA and costs related to the acquisition of a predicate cigarette brand have an indefinite life. As such, no amortization is taken. At each reporting period, the Company evaluates whether events and circumstances continue to support the indefinite-lived classification.

Impairment of Long-Lived Assets – The Company reviews the carrying value of its amortizing long-lived assets whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be recoverable. On at least an annual basis, the Company assesses whether events or changes in circumstances indicate that the carrying amount may not be recoverable. If any such indicators are present, the Company will test for recoverability in accordance with ASC 360-Property, plant, and equipment or ASC 350- Intangibles, Goodwill, and Other.

Intangible assets subject to amortization are reviewed for strategic importance and commercialization opportunity prior to expiration. If it is determined that the asset no longer supports the Company’s strategic objectives and/or will not be commercially viable prior to expiration, the asset is impaired. In addition, the Company will assess the expected future undiscounted cash flows for its intellectual property based on consideration of future market and economic conditions, competition, federal and state regulations, and licensing opportunities. If the carrying value of such assets are not recoverable, the carrying value will be reduced to fair value.

Indefinite-lived intangible asset carrying values are reviewed at least annually or more frequently if events or changes in circumstances indicate that it is more likely than not that an impairment exists. The Company first performs a qualitative assessment and considers its current strategic objectives, future market and economic conditions, competition, and federal and state regulations to determine if an impairment is more likely than not. If it is determined that an impairment is more likely than not, a quantitative assessment is performed to compare the asset carrying value to fair value.

Fair Value of Financial Instruments - The Company’s financial instruments include cash and cash equivalents, short-term investment securities, accounts receivable, investments, a convertible note receivable, a promissory note receivable, accounts payable, accrued expenses, and notes payable. The carrying values of these financial instruments approximate fair value. The Company carries cash equivalents, short-term investment securities, certain investments, and certain other assets at fair value which is described further in Note 6.

Investments  The Company’s equity securities are recorded at fair value with changes in fair value included within the statement of operations. Equity securities without a readily determinable market value are carried at cost less impairment, adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer. The Company considers certain debt instruments as available-for-sale securities, and accordingly, all unrealized gains and losses incurred on the short-term investment securities (the adjustment to fair value) are recorded in other comprehensive income or loss on the Company’s Consolidated Statements of Operations and Comprehensive Loss.

Right-of-use assets (“ROU”) and Lease Obligations – The Company reviews any lease arrangements in accordance with ASU 2016-02, Subtopic ASC 842, Leases. Any lease having a lease term greater than twelve months will be recognized on the Consolidated Balance Sheets as a ROU asset with an associated lease obligation—all other leases are considered short-term in nature and will be expensed as payments are made over the lease term. The ROU assets and lease obligations are recognized as of the commencement date at the net present value of the fixed minimum lease payments for the lease term. The lease term is determined based on the contractual conditions, including whether renewal options are reasonably certain to be exercised. The discount rate used is the interest rate implicit in the lease, if available, or the Company’s incremental borrowing rate which is determined using a base line rate plus an applicable spread.

Stock Based Compensation – The Company’s Omnibus Incentive Plan allows for various types of equity-based incentive awards. Stock based compensation expense is based on awards that are expected to vest over the requisite service periods and are based on the fair value of the award measured on the grant date. Vesting requirements vary for directors, officers, and employees. In general, time-based awards fully vest after one year for directors and vest in equal annual installments over a three-year period for officers and employees. Performance-based awards vest upon achievement of certain milestones. Forfeitures are accounted for when they occur.

Income Taxes - For interim income tax reporting, due to a full valuation allowance on net deferred tax assets, no income tax expense or benefit is recorded unless it is an unusual or infrequently occurring item. The tax effects of unusual or infrequently occurring items, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, are reported in the interim period in which they occur.

Recent Accounting Pronouncement(s) – In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments.” The standard replaces the incurred loss model with the current expected credit loss (CECL) model to estimate credit losses for financial assets measured at amortized cost and certain off-balance sheet credit exposures. The CECL model requires companies to estimate credit losses expected over the life of the financial assets based on historical experience, current conditions and reasonable and supportable forecasts. The provisions of the ASU are effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years—excluding small reporting companies (SRCs), based on a determination date as of November 15, 2019, which have an effective date beginning after December 15, 2022 and interim periods within those fiscal years. The Company is evaluating the expected impacts of the ASU.

We consider the applicability and impact of all ASUs. If the ASU is not listed above, it was determined that the ASU was either not applicable or would have an immaterial impact on our financial statements and related disclosures.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.21.2
INVENTORY
9 Months Ended
Sep. 30, 2021
INVENTORY  
INVENTORY

NOTE 2. - INVENTORY

Inventories are valued at the lower of historical cost or net realizable value. Cost is determined using an average cost method for tobacco leaf inventory, hemp/cannabis inventory, and raw materials inventory. Standard cost is primarily used for finished goods inventory. Inventories are evaluated to determine whether any amounts are not recoverable based on slow moving or obsolete condition and are written off or reserved as appropriate. During the nine months ended September 30, 2020, the Company wrote off inventory totaling $219 on the Company’s Consolidated Statement of Operations and Comprehensive Loss ($58 included within research and development expenses and $161 included within cost of goods sold).

Inventories at September 30, 2021 and December 31, 2020 consisted of the following:

    

September 30, 

    

December 31, 

    

2021

    

2020

Inventory - tobacco leaf

$

876

$

821

Inventory - hemp/cannabis

132

Inventory - finished goods

 

Cigarettes and filtered cigars

 

331

 

171

Inventory - raw materials

 

 

Cigarette and filtered cigar components

1,464

1,142

Less: inventory reserve

 

(100)

 

(100)

$

2,703

$

2,034

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.21.2
PROPERTY, PLANT AND EQUIPMENT
9 Months Ended
Sep. 30, 2021
PROPERTY, PLANT AND EQUIPMENT  
PROPERTY, PLANT AND EQUIPMENT, NET

NOTE 3. – PROPERTY, PLANT, AND EQUIPMENT, NET

Property, plant, and equipment, net at September 30, 2021 and December 31, 2020 consisted of the following:

September 30, 

December 31, 

    

Useful Life

    

2021

    

2020

Land

$

1,665

$

Building and leasehold improvements

7 to 40 years

309

123

Manufacturing equipment

3 to 10 years

5,539

4,893

Office furniture, fixtures and equipment

5 years

 

129

 

20

Laboratory equipment

5 years

 

198

 

117

Construction in progress

42

 

 

Less: accumulated depreciation

  

 

(3,128)

 

(2,670)

Property, plant and equipment, net

  

$

4,754

$

2,483

Depreciation expense was $173 and $461 for the three and nine months ended September 30, 2021 ($160 and $473 for the three and nine months ended September 30, 2020).

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.21.2
RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES
9 Months Ended
Sep. 30, 2021
RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES  
RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES

NOTE 4. - RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES

The Company leases a manufacturing facility and warehouse in North Carolina, and a corporate headquarters in Buffalo, New York.

The following table summarizes the Company’s discount rate and remaining lease terms:

Weighted average remaining lease term in years

6.3

Weighted average discount rate

 

3.7

%

Future minimum lease payments as of September 30, 2021 are as follows:

2021

$

33

2022

 

76

2023

78

2024

 

80

2025

82

Thereafter

192

Total lease payments

 

541

Less: imputed interest

 

(60)

Total

$

481

On July 28, 2021, the Company signed a lease agreement for a new research and development (“R&D”) laboratory in Rockville, MD. The new laboratory space has over four thousand square feet and will support the Company’s continued growth and R&D partnerships. The lease has an initial monthly base rent of $12 (escalating 2.5% annually after the first year), a term of 51 months, and an expected commencement date of early fourth quarter of this year. The lease also calls for abatement of 100% of the base rent for the first five months following the lease commencement date. The Company will recognize the respective right-of-use asset and lease liability for the lease upon lease commencement, which is anticipated during the fourth quarter of 2021.

On October 18, 2021, the Company signed a lease extension for its manufacturing facility and warehouse in North Carolina. The lease has a commencement date upon expiration of the current lease term, which is November 1, 2021. The lease has a monthly base rent of $17 and an initial term of twenty-four months—with one twenty-four month renewal option at the Company’s discretion. The Company will recognize the respective right-of-use asset and lease liability during the fourth quarter of 2021.

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.21.2
INVESTMENTS AND OTHER ASSETS
9 Months Ended
Sep. 30, 2021
INVESTMENTS & OTHER ASSETS  
INVESTMENTS & OTHER ASSETS

NOTE 5. – INVESTMENTS & OTHER ASSETS

The total carrying value of the Company’s investments and other assets at September 30, 2021 and December 31, 2020 consisted of the following:

September 30, 

December 31, 

2021

2020

Aurora stock warrants

    

$

18

    

$

239

Panacea preferred stock

5,173

Panacea stock warrant

1,124

Exactus common stock

7,282

Total Investments

$

7,300

$

6,536

Convertible note receivable

$

$

5,876

Promissory note receivable

$

3,713

$

Investment in Panacea Life Sciences, Inc.

Initial Investment:

On December 3, 2019, the Company entered into a securities purchase agreement with Panacea Life Sciences, Inc. (“Panacea”) for consideration valued at $13,297 ($12,000 cash and $1,297 of the Company’s shares of common stock valued at $1 per share) in exchange for a 15.8% ownership interest. The Company’s investment consisted of three instruments: shares of Series B preferred stock (“preferred stock”); a convertible note receivable with a $7,000 face value; and a warrant (“stock warrant”) to purchase additional shares of Series B preferred stock, to obtain 51% ownership of Panacea, at an exercise price of $2.344 per share. The convertible note receivable had a term of five years, interest of 10% per annum, and could be converted to shares of Series B preferred stock at the Company’s discretion. The embedded conversion option was not considered a derivative instrument for accounting purposes. The preferred stock carried an annual 10% cumulative dividend, compounded annually, and had an implicit put option after

the fifth anniversary date so long that the stock warrants had not been exercised. The put option was not considered a derivative instrument for accounting purposes. The stock warrant was exercisable at any time after the fifth anniversary date and would be accelerated if Panacea achieved certain sales targets for two consecutive years. The Series B preferred stock also included first priority equity preferences in the event of a liquidation, sale, or transfer of Panacea assets. These rights entitled the Company to the original Series B issuance price of $7,000 plus any unpaid accrued dividends.

To allocate the cost of the stock warrant, the Company calculated a fair value based on the following assumptions: volatility of 70%, discount of 25% for lack of marketability, and a risk-free rate of 2%. The value of the stock warrant was allocated to the preferred stock and the convertible note receivable, equally, at a discount to the acquisition price. The discount on the preferred stock was determined to be for lack of control and the discount on the convertible note receivable was determined to be for issuing the note at a below market interest rate for similar instruments.

The convertible note receivable and the preferred stock investment were considered available for sale debt securities with a private company that was not traded in active markets. Since observable price quotations were not available at acquisition, fair value was estimated based on cost less an appropriate discount upon acquisition. The discount of each instrument is accreted into interest income over the respective term as shown within the Company’s Consolidated Statements of Operations and Comprehensive Loss. See Note 6 for additional information on these fair value measurements. The stock warrant was recorded at its cost basis in accordance with the practicability exception under ASU 2016-01.

Impairment of Panacea Investment:

As a result of increased competition and other macroeconomic factors, the Company recognized an impairment of $1,062 on the Panacea stock warrant during the second quarter of 2020. The impairment is recorded within the Consolidated Statements of Operations and Comprehensive Loss as “Impairment of Panacea Investment.” During the fourth quarter of 2020, the Company entered into a non-binding agreement with Panacea to potentially restructure the investment and business relationship—including the transfer of an agricultural facility and other assets. As of December 31, 2020, the Company adjusted certain assets to represent the fair value outlined in the non-binding agreement.

Conversion of Panacea Investment:

On June 30, 2021, the Company entered into a Promissory Note Exchange Agreement with Panacea and a Securities Exchange Agreement with Panacea, Exactus, Inc. (“Exactus”) (OTCQB:EXDI) and certain other Panacea shareholders. Pursuant to the Securities Exchange Agreement, Exactus fully acquired Panacea. These transactions effected the (i) conversion of all of the Company’s Series B Preferred Stock in Panacea into 91,016,026 shares of common stock in Exactus valued at $9,102 as of June 30, 2021 and (ii) the conversion of the Company’s existing debt in Panacea by converting the outstanding $7,000 principal balance convertible note receivable and all accrued but unpaid interest thereon for fee simple ownership of Needle Rock Farms (224 acres in Delta County, Colorado) and equipment valued at $2,248, $500 in Panacea’s Series B Preferred Stock (which was subsequently converted to Exactus common stock under the Securities Exchange Agreement), and a new $4,300 promissory note (the “Promissory note receivable”) with a maturity date of June 30, 2026 and a 0% interest rate. The Promissory note receivable is with a related party of Panacea and is fully secured by a first priority lien on Panacea’s headquarters located in Golden, Colorado. All other rights and obligations of the Company in Panacea and Panacea’s affiliate, Quintel-MC Incorporated, were terminated by this transaction—including all warrant rights and obligations for future investment. The conversion was recorded as a non-monetary transaction, based on the fair value of the assets received, and resulted in a gain of $2,548 which is included within the Consolidated Statements of Operations and Comprehensive Loss as “Gain on Panacea investment conversion.”

The Promissory note receivable was valued at $3,684 ($4,300 face value less $616 discount) and is included within the Consolidated Balance Sheets as “Other Assets.” The Company intends to hold the Promissory note receivable to maturity and the associated discount will be amortized into interest income over the term of the note. The ownership of Needle Rock Farms and related equipment is included within “Property, plant, and equipment, net” on the Consolidated Balance Sheets. The common shares of Exactus, Inc. are considered equity securities in accordance with ASC 321 and are recorded at fair value—changes in fair value will be included within the statement of operations. See Note 6 for additional information on the fair value measurements.

On October 28, 2021, Exactus announced the completion of a 1 for 28 reverse stock split as well as an entity name change to Panacea Life Sciences Holdings, Inc (OTCQB: PLSH). Panacea Life Sciences Holdings, Inc. has been assigned a temporary stock

symbol of “EXDID” which will formally change to “PLSH” after twenty business days. As a result of the reverse stock split, our 91,016,026 shares were adjusted to 3,250,573 shares.

Investment in Aurora Cannabis, Inc.

The Company has an investment in Aurora Cannabis Inc. (“Aurora”) stock warrants that are considered equity securities under ASC 321 – Investments – Equity Securities and a derivative instrument under ASC 815 – Derivatives and Hedging. The stock warrants are not designated as a hedging instrument, and in accordance with ASC 815, the Company’s investment in stock warrants are recorded at fair value with changes in fair value recorded to unrealized gain/loss as shown within the Company’s Consolidated Statements of Operations and Comprehensive Loss. See Note 6 for additional information on the fair value measurements.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS
9 Months Ended
Sep. 30, 2021
FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS  
FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS

NOTE 6. – FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS

FASB ASC 820 - “Fair Value Measurements and Disclosures” establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:

Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities;
Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument; and
Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value.

A financial asset’s or a financial liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

The following table presents information about our assets and liabilities measured at fair value as of September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:

Fair Value

September 30, 2021

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

 

  

 

  

 

  

 

  

Short-term investment securities:

 

  

 

  

 

  

 

  

Money market funds

$

18,481

$

$

$

18,481

Corporate bonds

 

 

35,051

 

 

35,051

Total short-term investment securities

$

18,481

$

35,051

$

$

53,532

Investment - Aurora stock warrants

$

$

$

18

$

18

Investment - Exactus common shares

$

7,282

$

$

$

7,282

Fair Value

December 31, 2020

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

 

  

 

  

 

  

 

  

Short-term investment securities:

 

  

 

  

 

  

 

  

Money market funds

$

8,636

$

$

$

8,636

Corporate bonds

 

 

12,677

 

 

12,677

Total short-term investment securities

$

8,636

$

12,677

$

$

21,313

Investment - Aurora stock warrants

$

$

$

239

$

239

Investment - Panacea preferred stock

$

$

$

5,173

$

5,173

Convertible note receivable

$

$

$

5,876

$

5,876

Money market mutual funds are valued at their daily closing price as reported by the fund. Money market mutual funds held by the Company are open-end mutual funds that are registered with the SEC that generally transact at a stable $1.00 Net Asset Value (“NAV”) representing its estimated fair value. On a daily basis the fund’s NAV is determined by the fund based on the amortized cost of the funds underlying investments.

Corporate bonds are valued using pricing models maximizing the use of observable inputs for similar securities.

The investment in the Aurora (“ACB”) stock warrants is measured at fair value using the Black-Scholes pricing model and is classified within Level 3 of the valuation hierarchy. The unobservable input is an estimated volatility factor of 94% and 137% as of September 30, 2021 and December 31, 2020, respectively. Therefore, changes in market volatility will impact the fair value measurement of our ACB investment.

A 20% increase or decrease in the volatility factor used as of September 30, 2021 would have the impact of increasing or decreasing the fair value measurement of the stock warrants by approximately $22. A 20% increase or decrease in the volatility factor used at December 31, 2020 would have the impact of increasing or decreasing the fair value measurement of the stock warrants by approximately $115.

The investment in Exactus common shares is considered an equity security with a readily determinable fair value. The fair value is determined using the quotable market price as of the last trading day of the fiscal quarter.

The Panacea convertible note receivable and the preferred stock investment were considered available-for-sale debt securities with a private company not traded in active markets. Since observable price quotations were not available, fair value was estimated based on cost less an appropriate discount upon acquisition.

The following table sets forth a summary of the changes in fair value of the Company’s Level 3 investments for the nine months ended September 30, 2021:

Fair Value at December 31, 2020

$

11,288

Unrealized gain (loss) on ACB stock warrants

(220)

Accretion of interest on Panacea preferred stock

142

Panacea investment conversion

(11,192)

Fair Value at September 30, 2021

$

18

The following tables set forth a summary of the Company’s available-for-sale debt securities from amortized cost basis to fair value as of September 30, 2021 and December 31, 2020:

Available for Sale Debt Securities

September 30, 2021

Amortized

Gross

Gross

Cost

Unrealized

Unrealized

Fair

    

Basis

    

Gains

    

Losses

    

Value

Corporate bonds

$

35,078

$

7

$

(34)

$

35,051

Available for Sale Debt Securities

December 31, 2020

Amortized

Gross

Gross

Cost

Unrealized 

Unrealized 

Fair

    

Basis

    

Gains

    

Losses

    

Value

Corporate bonds

$

12,603

$

74

$

$

12,677

Convertible note receivable

 

5,876

 

 

 

5,876

Investment - Panacea preferred stock

 

5,173

 

 

 

5,173

$

23,652

$

74

$

$

23,726

The following table sets forth a summary of the Company’s available-for-sale securities at amortized cost basis and fair value by contractual maturity as of September 30, 2021 and December 31, 2020:

Available for Sale Debt Securities

September 30, 2021

December 31, 2020

Amortized

Amortized

    

Cost Basis

    

Fair Value

    

Cost Basis

    

Fair Value

Due in one year or less

$

3,581

$

3,585

$

11,692

$

11,753

Due after one year through five years

 

31,497

 

31,466

 

11,960

 

11,973

$

35,078

$

35,051

$

23,652

$

23,726

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.21.2
INTANGIBLE ASSETS
9 Months Ended
Sep. 30, 2021
INTANGIBLE ASSETS  
INTANGIBLE ASSETS

NOTE 7. - INTANGIBLE ASSETS 

Total intangible assets at September 30, 2021 and December 31, 2020 consisted of the following:

September 30, 

December 31, 

    

2021

    

2020

Intangible assets, net

 

  

 

  

Patent and trademark costs

$

5,951

$

5,667

Less: accumulated amortization

 

(3,207)

 

(2,936)

Patent and trademark costs, net

 

2,744

 

2,731

License fees

 

3,876

 

3,876

Less: accumulated amortization

 

(1,136)

 

(948)

License fees, net

 

2,740

 

2,928

MSA signatory costs

 

2,202

 

2,202

  

License fee for predicate cigarette brand

 

350

 

350

$

8,036

$

8,211

Amortization expense relating to the above intangible assets for the three and nine months ended September 30, 2021 amounted to $168 and $471 ($163 and $524 for the three and nine months ended September 30, 2020). Impairment expense for the three and nine months ended September 30, 2020 amounted to $0 and $146 (cost of approximately $448 less accumulated amortization of approximately $302), respectively, and related to patent intellectual property that would be expired prior to expected commercialization.

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.21.2
NOTES PAYABLE
9 Months Ended
Sep. 30, 2021
Debt Disclosure Abstract  
NOTES PAYABLE

NOTE 8. – NOTES PAYABLE

License Fees

On June 22, 2018, the Company entered into the Second Amendment to the License Agreement (the “Second Amendment”) with North Carolina State University (“NCSU”) that amended an original License Agreement between the Company and NCSU, dated December 8, 2015, and the First Amendment, dated February 14, 2018, to the original License Agreement. Under the terms of the Second Amendment, the Company was obligated to pay NCSU milestone payments totaling $1,200, which originally amounted to a present value of $1,175. As of June 30, 2020, the Company paid the final milestone payment of $300. The cost of the of acquired license amounted to $1,175 and is included in Intangible assets, net on the Company’s Consolidated Balance Sheets, and is amortized on a straight-line basis over the last-to-expire patent, which is expected to be in 2036.

On October 22, 2018, the Company entered into a License Agreement with the University of Kentucky. Under the terms of the License Agreement, the Company is obligated to pay the University of Kentucky milestone payments totaling $1,200, of which $300 was payable upon execution, and $300 will be payable annually over three years on the anniversary of the execution of the License Agreement. The Company has recorded the present value of the obligations under the License Agreement as a note payable that originally amounted to $1,151. The cost of the of acquired licenses amounted to $1,151 and is included in Intangible assets, net on the Company’s Consolidated Balance Sheets and will be amortized on a straight-line basis over the last-to-expire patent, which is expected to be in 2033.

D&O Insurance

During the second quarter of 2021, the Company renewed its Director and Officer (“D&O”) insurance for a one-year policy premium totaling $3,315. The Company paid $662 as a premium down payment and financed the remaining $2,653 of policy premiums over nine months at a 3.49% annual percentage rate.

During the second quarter of 2020, the Company renewed its D&O insurance for a one-year policy premium totaling $2,744. The Company paid $549 as a premium down payment and financed the remaining $2,195 of policy premiums over nine months at a 3.19% annual percentage rate.

CARES Act Paycheck Protection Program Loan

On May 1, 2020, the Company received an U.S. Small Business Administration Loan (“SBA Loan”) from Bank of America, N.A. related to the COVID-19 pandemic in the amount of $1.2 million. On May 12, 2020, the Company repaid the SBA loan in full.

The table below outlines our notes payable balances as of September 30, 2021 and December 31, 2020:

September 30, 

December 31, 

    

2021

    

2020

License Fees

$

299

$

293

D&O Insurance

 

1,483

 

246

Total current notes payable

$

1,782

$

539

Accretion of non-cash interest expense amounted to $2 and $6 for the three and nine months ended September 30, 2021 and $4 and $17 for the three and nine months ended September 30, 2020.

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.21.2
SEVERANCE LIABILITY
9 Months Ended
Sep. 30, 2021
Postemployment Benefits [Abstract]  
SEVERANCE LIABILITY

NOTE 9. – SEVERANCE LIABILITY

During the second quarter of 2020, the Company recorded severance benefits related to a resignation of $306. The benefits were provided over a twelve-month period.

During 2019, the Company recorded severance benefits of $881. Consistent with certain contractual obligations, $771 of the related benefit will be provided over a period of forty-two months.

The current and long-term accrued severance balance remaining as of September 30, 2021 was $223 and $72, respectively. The current and long-term accrued severance balance remaining as of December 31, 2020 was $339 and $241, respectively.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.21.2
CAPITAL RAISE AND WARRANT EXERCISE
9 Months Ended
Sep. 30, 2021
WARRANT EXERCISE AND CAPITAL RAISE  
CAPITAL RAISE AND WARRANT EXERCISE

NOTE 10. – CAPITAL RAISE AND WARRANT EXERCISE

On June 7, 2021, the Company entered into a placement agent agreement (the “Placement Agent Agreement”) with Cowen and Company, LLC (the “Placement Agent”) relating to the Company’s registered direct offering (the “Offering”) to a select investor (the “Investor”). In addition, on June 7, 2021, the Company and the Investor entered into a securities purchase agreement relating to the issuance and sale of shares of common stock pursuant to which the Investor purchased 10,000,000 shares of common stock at $4.00 per share. The net proceeds to the Company from the Offering, after deducting Placement Agent fees and offering expenses, was $38,206.

During the first quarter of 2021, the Company’s warrant holders exercised all 11,293,211 outstanding warrants for cash in exchange for common stock. In connection with these exercises, the Company received net proceeds of $11,782. No warrants remain outstanding as of September 30, 2021. The following table summarizes the Company’s outstanding warrant activity since December 31, 2020:

Number of

Warrants

Warrants outstanding at December 31, 2020

 

11,293,211

Warrants exercised in Q1 2021

(11,293,211)

Warrants outstanding at September 30, 2021

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Sep. 30, 2021
COMMITMENTS AND CONTINGENCIES  
COMMITMENTS AND CONTINGENCIES

NOTE 11. - COMMITMENTS AND CONTINGENCIES

License agreements and sponsored research – The Company has entered into various license, sponsored research, collaboration, and other agreements (the “Agreements”) with various counter parties in connection with the Company’s plant biotechnology business relating to tobacco and hemp/cannabis. The schedule below summarizes the Company’s commitments, both financial and other, associated with each Agreement. Costs incurred under the Agreements are generally recorded as research and development expenses on the Company’s Consolidated Statements of Operations and Comprehensive Loss.

Future Commitments

Commitment

 

Counter Party

 

Product Relationship

 

Commitment Type

 

2021

 

2022

 

2023

 

2024

 

2025 & After

 

Total

    

Research Agreement

KeyGene

Hemp / Cannabis

Contract fee

$

115

$

1,150

$

1,200

$

1,227

$

2,893

$

6,585

(1)

License Agreement

NCSU

Tobacco

Annual royalty fee

68

225

293

(2), (3)

License Agreement

NCSU

Tobacco

Minimum annual royalty

7

50

50

50

600

757

(3)

License Agreement

NCSU

Tobacco

Minimum annual royalty

14

50

50

50

500

664

(3)

Sublicense Agreement

Anandia Laboratories, Inc.

Hemp / Cannabis

Annual license fee

10

10

10

10

110

150

(4)

Research Agreement

Cannametrix

Hemp / Cannabis

Contract fee

51

50

101

(5)

Growing Agreement

Various

Various

Contract fee

127

38

165

(6)

Consulting Agreement

Various

Various

Contract fee

119

286

405

(7)

$

511

$

1,859

$

1,310

$

1,337

$

4,103

$

9,120

(1)Exclusive agreement with the Company with respect to the Cannabis Sativa L. plant (the "Field"). The initial term of the agreement was five years with an option for an additional two years. On April 30, 2021, the Company and KeyGene entered into a First Amended and Restated Framework Collaborative Research Agreement which extended the agreement term, from first-quarter 2024 to first-quarter 2027, and preserves the Company’s option for an additional 2-year extension, now through first quarter of 2029.

The Company will exclusively own all results and all intellectual property relating to the results of the collaboration with KeyGene (the "Results”). The Company will pay royalties in varying amounts to KeyGene relating to the Company's commercialization in the Field of certain Results. The Company has also granted KeyGene a license to commercialize the Results outside of the Field and KeyGene will pay royalties in varying amounts to the Company relating to KeyGene's commercialization of the Results outside of the Field.

(2)The license agreement also requires a milestone payment of $150 upon FDA approval or clearance of a product that uses the NCSU licensed technology. The annual royalty fee is credited against running royalties on sales of licensed products.
(3)The Company is also responsible for reimbursing NSCU for actual third-party patent costs incurred, including capitalized patent costs and patent maintenance costs. These costs vary from year to year and the Company has certain rights to direct the activities that result in these costs.
(4)The Company is also responsible for the payment of certain costs, including, capitalized patent costs and patent maintenance costs, a running royalty on future net sales of products made from the sublicensed intellectual property, and a sharing of future sublicensing consideration received from sublicensing to third parties in all countries except for Canada. Anandia retains all patent rights, and is responsible for all patent maintenance, in Canada.
(5)On March 1, 2021, the Company entered into a 14-month research agreement with Cannametrix for hemp/cannabis product development, formulation, and validation.
(6)Various R&D growing and consulting agreements for hemp / cannabis and tobacco.
(7)General corporate consulting agreements.

Modified Risk Tobacco Product Application (“MRTP Application”) – In connection with the Company’s MRTP Application for its Very Low Nicotine Content (“VLNC”) cigarettes with the FDA, the Company has entered in various contracts with third-party service providers to fulfill various requirements of the MRTP Application. Such contracts include services for clinical trials, perception studies, legal guidance, product testing, and consulting expertise. During the three and nine months ended September 30, 2021, the Company incurred expenses relating to these contracts in the approximate amount of $2 and $16, respectively, and $4 and $158 for the three and nine months ended September 30, 2020, respectively. The Company will continue to incur consulting and legal expenses as the MRTP Application continues through the FDA review process. The Company cannot currently quantify the additional expenses that the Company will incur in the FDA review process because it will involve various factors that are within the discretion and control of the FDA.

Litigation - In accordance with applicable accounting guidance, the Company establishes an accrued liability for litigation and regulatory matters when those matters present loss contingencies that are both probable and estimable. In such cases, there may be an exposure to loss in excess of any amounts accrued. When a loss contingency is not both probable and estimable, the Company does not establish an accrued liability. As a litigation or regulatory matter develops, the Company, in conjunction with any outside counsel handling the matter, evaluates on an ongoing basis whether such matter presents a loss contingency that is probable and estimable. If, at the time of evaluation, the loss contingency related to a litigation or regulatory matter is not both probable and estimable, the matter will continue to be monitored for further developments that would make such loss contingency both probable and estimable. When a loss contingency related to a litigation or regulatory matter is deemed to be both probable and estimable, the Company will establish an accrued liability with respect to such loss contingency and record a corresponding amount of related expenses. The Company will then continue to monitor the matter for further developments that could affect the amount of any such accrued liability. 

Class Action

On January 21, 2019, Matthew Jackson Bull, a resident of Denver, Colorado, filed a Complaint against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, and the Company’s then Chief Financial Officer, John T. Brodfuehrer, in the United States District Court for the Eastern District of New York entitled: Matthew Bull, Individually and on behalf of all others similarly situated, v. 22nd Century Group, Inc., Henry Sicignano III, and John T. Brodfuehrer, Case No. 1:19 cv 00409.

On January 29, 2019, Ian M. Fitch, a resident of Essex County Massachusetts, filed a Complaint against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, and the Company’s then Chief Financial Officer, John T. Brodfuehrer, in the United States District Court for the Eastern District of New York entitled: Ian Fitch, Individually and on behalf of all others similarly situated, v. 22nd Century Group, Inc., Henry Sicignano III, and John T. Brodfuehrer, Case No. 2:19 cv 00553.

On May 28, 2019, the plaintiff in the Fitch case voluntarily dismissed that action. On August 1, 2019, the Court in the Bull case issued an order designating Joseph Noto, Garden State Tire Corp, and Stephens Johnson as lead plaintiffs.

On September 16, 2019, pursuant to a joint motion by the parties, the Court in the Bull case transferred the class action to federal district court in the Western District of New York, where it remains pending as Case No. 1:19-cv-01285.

Plaintiffs in the Bull case filed an Amended Complaint on November 19, 2019 that alleges three counts: Count I sues the Company and Messrs. Sicignano and Brodfuehrer and alleges that the Company's quarterly and annual reports, SEC filings, press releases and other public statements and documents contained false statements in violation of Section 10(b) of the Securities Exchange Act and Rule 10b-5; Count II sues Messrs. Sicignano and Brodfuehrer pursuant to Section 10(b) of the Securities Exchange Act and Rule 10b5(a) and (c); and Count III sues Messrs. Sicignano and Brodfuehrer for the allegedly false statements pursuant to Section 20(a) of the Securities Exchange Act. The Amended Complaint seeks to certify a class, and unspecified compensatory and punitive damages, and attorney's fees and costs.

On January 29, 2020, the Company and Messrs. Sicignano and Brodfuehrer filed a Motion to Dismiss the Amended Complaint. On July 31, 2020, the Court heard oral arguments on the motion to dismiss. On January 14, 2021, the Court granted motion, dismissing all claims with prejudice. The Plaintiffs filed a notice of appeal on February 12, 2021 to the Second Circuit Court of Appeals. The Second Circuit has granted an expedited briefing schedule and Plaintiff’s/Appellant’s was filed on April 12, 2021 and the Company’s was filed on May 17, 2021. The Second Circuit heard oral arguments on September 2, 2021 and the matter remains pending with the Second Circuit.

We believe that the claims are frivolous, meritless and that the Company and Messrs. Sicignano and Brodfuehrer have substantial legal and factual defenses to the claims. We intend to vigorously defend the Company and Messrs. Sicignano and Brodfuehrer against such claims.

Shareholder Derivative Cases

On February 6, 2019, Melvyn Klein, a resident of Nassau County New York, filed a shareholder derivative claim against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, the Company’s Chief Financial Officer, John T. Brodfuehrer, and each member of the Company’s Board of Directors in the United States District Court for the Eastern District of New York entitled: Melvyn Klein, derivatively on behalf of 22nd Century Group v. Henry Sicignano, III, Richard M. Sanders, Joseph Alexander Dunn, Nora B. Sullivan, James W. Cornell, John T. Brodfuehrer and 22nd Century Group, Inc., Case No. 1:19 cv 00748. Mr. Klein brings this action derivatively alleging that (i) the director defendants supposedly breached their fiduciary duties for allegedly allowing the Company to make false statements; (ii) the director defendants supposedly wasted corporate assets to defend this lawsuit and the other related lawsuits; (iii) the defendants allegedly violated Section 10(b) of the Securities Exchange Act and Rule 10b 5 promulgated thereunder for allegedly approving or allowing false statements regarding the Company to be made; and (iv) the director defendants allegedly violated Section 14(a) of the Securities Exchange Act and Rule 14a 9 promulgated thereunder for allegedly approving or allowing false statements regarding the Company to be made in the Company’s proxy statement.

On February 11, 2019, Stephen Mathew filed a shareholder derivative claim against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, the Company’s Chief Financial Officer, John T. Brodfuehrer, and each member of the Company’s Board of Directors in the Supreme Court of the State of New York, County of Erie, entitled: Stephen Mathew, derivatively on behalf of 22nd Century Group, Inc. v. Henry Sicignano, III, John T. Brodfuehrer, Richard M. Sanders, Joseph Alexander Dunn, James W. Cornell, Nora B. Sullivan and 22nd Century Group, Inc., Index No. 801786/2019. Mr. Mathew brings this action derivatively generally alleging the same allegations as in the Klein case. The Complaint seeks declaratory relief, unspecified monetary damages, corrective corporate governance actions, and attorney’s fees and costs. On August 15, 2019, the Court consolidated the Mathew and Klein actions pursuant to a stipulation by the parties (Western District of New York, Case No. 1-19-cv-0513). We believe that the claims are frivolous, meritless and that the Company and the individual defendants have substantial legal and factual defenses to the claims. We intend to vigorously defend the Company and the individual defendants against such claims.

On June 10, 2019, Judy Rowley filed a shareholder derivative claim against the Company, the Company’s then Chief Executive Officer, Henry Sicignano III, the Company’s Chief Financial Officer, John T. Brodfuehrer, and each member of the Company’s Board of Directors in the Supreme Court of the State of New York, County of Erie, entitled: Judy Rowley, derivatively on behalf of 22nd Century Group, Inc. v. Henry Sicignano, III, Richard M. Sanders, Joseph Alexander Dunn, Nora B. Sullivan, James W. Cornell, John T. Brodfuehrer, and 22nd Century Group, Inc., Index No. 807214/2019. Ms. Rowley brings this action derivatively alleging that the director defendants supposedly breached their fiduciary duties by allegedly allowing the Company to make false statements. The Complaint seeks declaratory relief, unspecified monetary damages, corrective corporate governance actions, and

attorney’s fees and costs. We believe that the claims are frivolous, meritless and that the Company and the individual defendants have substantial legal and factual defenses to the claims. We intend to vigorously defend the Company and the individual defendants against such claims. On September 13, 2019, the Court ordered the litigation stayed pursuant to a joint stipulation by the parties.

On January 15, 2020, Kevin Broccuto filed a shareholder derivative claim against the Company, the Company's then Chief Executive Officer, Henry Sicignano III, the Company's Chief Financial Officer, John T. Brodfuehrer, and certain members of the Company's prior Board of Directors in the District Court of the State of Nevada, County of Clark, entitled: Kevin Broccuto, derivatively on behalf of 22nd Century Group, Inc. v. James W. Cornell, Richard M. Sanders, Nora B. Sullivan, Henry Sicignano, III, and John T. Brodfuehrer, Case No. A-20-808599. Mr. Broccuto brings this action derivatively alleging three counts: Count I alleges that the defendants breached their fiduciary duties; Count II alleges they committed corporate waste; and Count III that they were unjustly enriched, by allegedly allowing the Company to make false statements.

On February 11, 2020, Jerry Wayne filed a shareholder derivative claim against the Company, the Company's then Chief Executive Officer, Henry Sicignano III, the Company's Chief Financial Officer, John T. Brodfuehrer, and certain members of the Company's prior Board of Directors in the District Court of the State of Nevada, County of Clark, entitled: Jerry Wayne, derivatively on behalf of 22nd Century Group, Inc. v. James W. Cornell, Richard M. Sanders, Nora B. Sullivan, Henry Sicignano, III, and John T. Brodfuehrer, Case No. A-20-808599. Mr. Wayne brings this action derivatively alleging generally the same allegations as the Brocutto case. The Complaint seeks unspecified monetary damages, corrective corporate governance actions, disgorgement of alleged profits and imposition of constructive trusts, and attorney's fees and costs. The Complaint also seeks to declare as unenforceable the Company's Bylaw requiring derivative lawsuits to be filed in Erie County, New York, where the Company is headquartered.

On March 25, 2020, the Court ordered the Brocutto and Wayne cases consolidated and stayed pursuant to a joint stipulation from the parties. We believe that the claims are frivolous, meritless and that the Company and the individual defendants have substantial legal and factual defenses to the claims. We intend to vigorously defend the Company and the individual defendants against such claims.

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY- BASED COMPENSATION
9 Months Ended
Sep. 30, 2021
EQUITY- BASED COMPENSATION  
EQUITY- BASED COMPENSATION

NOTE 12 – EQUITY- BASED COMPENSATION

On May 20, 2021, the stockholders of 22nd Century Group, Inc. (the “Company”) approved the 22nd Century Group, Inc. 2021 Omnibus Incentive Plan (the “Plan”). The Plan allows for the granting of equity awards to eligible individuals over the life of the Plan, including the issuance of up to 5,000,000 shares of the Company’s common stock and any remaining shares under the Company’s 2014 Omnibus Incentive Plan pursuant to awards under the Plan. The Plan has a term of ten years and is administered by the Compensation Committee of the Company’s Board of Directors to determine the various types of incentive awards that may be granted to recipients under the Plan and the number of shares of common stock to underlie each such award under the Plan. As of September 30, 2021, the Company had available 7,449,946 shares remaining for future awards under the Plan.

Restricted Stock Units (“RSUs”). We typically grant RSUs to employees and non-employee directors. The following table summarizes the changes in unvested RSUs from December 31, 2020 through September 30, 2021.

Unvested RSUs

Weighted

Average

Number of

Grant-date

    

Shares

    

Fair Value

in thousands

$ per share

Unvested at December 31, 2020

 

2,938

$

0.85

Granted

 

1,995

$

3.20

Vested

(1,234)

$

0.85

Forfeited

(216)

$

0.67

Unvested at March 31, 2021

3,483

$

2.21

Granted

15

$

4.60

Vested

(288)

$

0.86

Forfeited

(25)

$

1.04

Unvested at June 30, 2021

3,185

$

2.35

Granted

190

$

3.71

Vested

(50)

$

0.80

Forfeited

(10)

$

1.90

Unvested at September 30, 2021

3,315

$

2.45

The fair value of RSUs that vested during the nine months ended September 30, 2021 was approximately $5,057 based on the stock price at the time of vesting.

Stock Options. Our outstanding stock options were valued using the Black-Scholes option-pricing model on the date of the award. A summary of all stock option activity since December 31, 2020 is as follows:

Weighted

Weighted

Average

Average

Remaining

Aggregate

Number of

Exercise

Contractual

Intrinsic

    

Options

    

Price

    

Term

    

Value

in thousands

$ per share

Outstanding at December 31, 2020

6,581

$

1.50

Granted

235

$

3.10

Exercised

(846)

$

1.36

Expired

(6)

$

2.76

Outstanding at March 31, 2021

5,964

$

1.59

4.3

years

$

7,480

Exercised

(88)

$

1.21

Forfeited

(100)

$

0.80

Outstanding at June 30, 2021

 

5,776

$

1.60

 

4.1

years

 

$

13,265

Expired

(40)

$

2.58

Forfeited

(500)

$

1.04

Outstanding at September 30, 2021

5,236

$

1.65

3.8

years

$

6,885

Exercisable at September 30, 2021

 

4,900

$

1.56

 

3.7

years

 

$

6,848

The intrinsic value of a stock option is the amount by which the current market value or the market value upon exercise of the underlying stock exceeds the exercise price of the option.

The weighted average of fair value assumptions used in the Black-Scholes option-pricing model for such grants were as follows:

    

2021

Risk-free interest rate (1)

 

0.54

%

Expected dividend yield (2)

 

%

Expected volatility (3)

 

87.92

%

Expected term of stock options (4)

 

4.09

years

(1)The risk-free interest rate is based on the period matching the expected term of the stock options based on the U.S. Treasury yield curve in effect on the grant date.
(2)The expected dividend yield is assumed as zero. The Company has never paid cash dividends nor does it anticipate paying dividends in the foreseeable future.
(3)The expected volatility is based on historical volatility of the Company’s stock.
(4)The expected term represents the period of time that options granted are expected to be outstanding based on vesting date and contractual term.

Compensation Expense. The Company recognized the following compensation costs, net of actual forfeitures, related to RSUs and stock options:

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2021

    

2020

    

2021

    

2020

Sales, general, and administrative

$

1,073

$

278

$

2,750

$

1,051

Research and Development

 

46

 

28

 

121

 

111

Total RSUs and stock option compensation

$

1,119

$

306

$

2,871

$

1,162

As of September 30, 2021, unrecognized compensation expense amounted to $5,931 which is expected to be recognized over a weighted average period of approximately 1.1 years. In addition, there is approximately $517 of unrecognized compensation expense that requires the achievement of certain milestones which are not yet probable.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.21.2
REVENUE RECOGNITION
9 Months Ended
Sep. 30, 2021
Revenue from Contract with Customer [Abstract]  
REVENUE RECOGNITION

NOTE 13. – REVENUE RECOGNITION

The Company recognizes revenue when it satisfies a performance obligation by transferring control of the product to a customer. The Company’s customer contracts consist of obligations to manufacture the customer’s branded filtered cigars and cigarettes. For certain contracts, the performance obligation is satisfied over time as the Company determines, due to contract restrictions, it does not have an alternative use of the product and it has an enforceable right to payment as the product is manufactured. The Company recognizes revenue under those contracts at the unit price stated in the contract based on the units manufactured. Revenue from the sale of the Company’s products is recognized net of cash discounts, sales returns and allowances. There was no allowance for discounts or returns and allowances at September 30, 2021 and December 31, 2020.

Contract Assets and Liabilities

Unbilled receivables (contract assets) represent revenues recognized for performance obligations that have been satisfied but have not been billed. These receivables are included as Accounts receivable, net on the Consolidated Balance Sheets. Customer payment terms vary depending on the terms of each customer contract, but payment is generally due prior to product shipment or within extended credit terms up to twenty-one (21) days after shipment. Deferred Revenue (contract liabilities) relate to down payments received from customers in advance of satisfying a performance obligation. This deferred revenue is included as Deferred income on the Consolidated Balance Sheets.

Total contract assets and contract liabilities are as follows:

September 30, 

December 31, 

    

2021

    

2020

Unbilled receivables

 

$

494

 

$

349

Deferred Revenue

(272)

Net contract assets

$

494

$

77

Disaggregation of Revenue

The Company’s net sales revenue is derived from customers located primarily in the United States of America and is disaggregated by the timing of revenue recognition—net sales transferred over time and net sales transferred at a point in time. All revenue is related to contract manufacturing.

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2021

    

2020

    

2021

    

2020

Net sales-over time

$

5,344

$

4,339

$

16,461

$

12,769

Net sales-point in time

 

2,467

 

2,971

 

6,527

 

8,034

Total Revenue

$

7,811

$

7,310

$

22,988

$

20,803

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.21.2
EARNINGS PER SHARE
9 Months Ended
Sep. 30, 2021
EARNINGS PER SHARE  
EARNINGS PER SHARE

NOTE 14. – EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2021 and 2020, respectively. Outstanding warrants, options, and RSUs were excluded from the calculation of diluted EPS as the effect was antidilutive.

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2021

    

2020

    

2021

    

2020

(in thousands, except for per-share data)

Net loss

$

(9,440)

$

(4,221)

$

(18,644)

$

(13,307)

Weighted average common shares outstanding - basic and diluted

 

162,721

138,857

153,998

138,774

Net loss per common share - basic and diluted

$

(0.06)

$

(0.03)

$

(0.12)

$

(0.10)

Anti-dilutive shares are as follows:

Warrants

11,293

11,293

Options

5,236

7,259

5,236

7,259

Restricted stock units

3,315

2,878

3,315

2,878

8,551

21,430

8,551

21,430

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.21.2
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Sep. 30, 2021
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Basis of Presentation

Basis of Presentation - The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q. Accordingly, they do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring accruals considered necessary for a fair and non-misleading presentation of the financial statements have been included.

Operating results for the nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by GAAP for complete financial statements.

These interim consolidated financial statements should be read in conjunction with the December 31, 2020 audited consolidated financial statements and the notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on March 11, 2021.

Principles of Consolidation

Principles of Consolidation - The accompanying consolidated financial statements include the accounts of (i) 22nd Century Group, Inc. (“22nd Century Group”); (ii) its four wholly-owned subsidiaries, 22nd Century Limited, LLC (“22nd Century Ltd”), NASCO Products, LLC (“NASCO”), Botanical Genetics, LLC (“Botanical Genetics”), and 22nd Century Group Canada, Inc. (“22nd Century Group Canada”); (iii) two wholly-owned subsidiaries of 22nd Century Ltd, Goodrich Tobacco Company, LLC (“Goodrich Tobacco”) and Heracles Pharmaceuticals, LLC (“Heracles Pharma”); and (iv) one wholly-owned subsidiary of Botanical Genetics, 22nd Century Holdings, LLC (“22nd Century Holdings”). This group of subsidiaries is referred to as collectively with 22nd Century Group as the “Company”. All intercompany accounts and transactions have been eliminated.

Nature of Business

Nature of Business – 22nd Century Group is a leading agricultural biotechnology and intellectual property company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. 22nd Century Ltd performs research and development related to the level of nicotine and other nicotinic alkaloids in tobacco plants and Botanical Genetics performs research and development related to hemp/cannabis plants. Goodrich Tobacco and Heracles Pharma are business units for the Company’s potential modified risk tobacco products. NASCO is a federally licensed tobacco products manufacturer, a subsequent participating member under the tobacco Master Settlement Agreement (“MSA”) between the tobacco industry and the settling states under the MSA and operates the Company’s tobacco products manufacturing business in North Carolina. 22nd Century Holdings and 22nd Century Group Canada are two newly formed subsidiaries where 22nd Century Holdings will own and operate the newly acquired Needle Rock Farm assets and 22nd Century Group Canada will allow for future international business opportunities in Canada.

Reclassifications

Reclassifications Certain prior period amounts have been reclassified to conform to the current period’s classification. None of these reclassifications had a material impact on our consolidated financial statements.

COVID-19 Pandemic

COVID-19 Pandemic – The COVID-19 pandemic has adversely impacted the U.S. economy and supply chains and created volatility in U.S. financial markets. The COVID-19 pandemic has had a minimal impact on the Company’s operations in 2020 and thus far in 2021, but there is a risk that state and federal authorities’ responses to the COVID-19 pandemic or another pandemic may disrupt our business in the future.

During April 2021, the Company relocated its corporate headquarters into downtown Buffalo, NY. The new office, as well as all of our facilities, continue to operate in compliance with New York and North Carolina guidance (as applicable) related to the prevention of COVID-19 transmission and employee safety. We also continue to allow remote work arrangements by our employees where job duties permit.

Our executive leadership team and staff are monitoring this evolving situation and its impacts on our business. We will continue to monitor the local, state, and federal guidance regarding our business practices.

Use of Estimates

Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

Intangible Assets

Intangible Assets – Intangible assets are recorded at cost and consist primarily of (1) expenditures incurred with third-parties related to the processing of patent claims and trademarks with government authorities, as well as costs to acquire patent rights from third-parties, (2) license fees paid for third-party intellectual property, (3) costs to become a signatory under the tobacco MSA, and (4) license fees paid to acquire a predicate cigarette brand. The amounts capitalized relate to intellectual property that the Company owns or to which it has rights to use.

The Company’s capitalized intellectual property costs are amortized using the straight-line method over the remaining statutory life of the patent assets in each of the Company’s patent families, which have estimated expiration dates ranging from 2026 to 2041. Periodic maintenance or renewal fees are expensed as incurred. Annual minimum license fees are charged to expense. License fees paid for third-party intellectual property are amortized on a straight-line basis over the last to expire patents, which have expected expiration dates ranging from 2028 through 2036. The Company believes that costs associated with becoming a signatory to the MSA and costs related to the acquisition of a predicate cigarette brand have an indefinite life. As such, no amortization is taken. At each reporting period, the Company evaluates whether events and circumstances continue to support the indefinite-lived classification.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets – The Company reviews the carrying value of its amortizing long-lived assets whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be recoverable. On at least an annual basis, the Company assesses whether events or changes in circumstances indicate that the carrying amount may not be recoverable. If any such indicators are present, the Company will test for recoverability in accordance with ASC 360-Property, plant, and equipment or ASC 350- Intangibles, Goodwill, and Other.

Intangible assets subject to amortization are reviewed for strategic importance and commercialization opportunity prior to expiration. If it is determined that the asset no longer supports the Company’s strategic objectives and/or will not be commercially viable prior to expiration, the asset is impaired. In addition, the Company will assess the expected future undiscounted cash flows for its intellectual property based on consideration of future market and economic conditions, competition, federal and state regulations, and licensing opportunities. If the carrying value of such assets are not recoverable, the carrying value will be reduced to fair value.

Indefinite-lived intangible asset carrying values are reviewed at least annually or more frequently if events or changes in circumstances indicate that it is more likely than not that an impairment exists. The Company first performs a qualitative assessment and considers its current strategic objectives, future market and economic conditions, competition, and federal and state regulations to determine if an impairment is more likely than not. If it is determined that an impairment is more likely than not, a quantitative assessment is performed to compare the asset carrying value to fair value.

Fair Value of Financial Instruments

Fair Value of Financial Instruments - The Company’s financial instruments include cash and cash equivalents, short-term investment securities, accounts receivable, investments, a convertible note receivable, a promissory note receivable, accounts payable, accrued expenses, and notes payable. The carrying values of these financial instruments approximate fair value. The Company carries cash equivalents, short-term investment securities, certain investments, and certain other assets at fair value which is described further in Note 6.

Investments

Investments  The Company’s equity securities are recorded at fair value with changes in fair value included within the statement of operations. Equity securities without a readily determinable market value are carried at cost less impairment, adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer. The Company considers certain debt instruments as available-for-sale securities, and accordingly, all unrealized gains and losses incurred on the short-term investment securities (the adjustment to fair value) are recorded in other comprehensive income or loss on the Company’s Consolidated Statements of Operations and Comprehensive Loss.

Right-of-use assets and Lease Obligations

Right-of-use assets (“ROU”) and Lease Obligations – The Company reviews any lease arrangements in accordance with ASU 2016-02, Subtopic ASC 842, Leases. Any lease having a lease term greater than twelve months will be recognized on the Consolidated Balance Sheets as a ROU asset with an associated lease obligation—all other leases are considered short-term in nature and will be expensed as payments are made over the lease term. The ROU assets and lease obligations are recognized as of the commencement date at the net present value of the fixed minimum lease payments for the lease term. The lease term is determined based on the contractual conditions, including whether renewal options are reasonably certain to be exercised. The discount rate used is the interest rate implicit in the lease, if available, or the Company’s incremental borrowing rate which is determined using a base line rate plus an applicable spread.

Stock Based Compensation

Stock Based Compensation – The Company’s Omnibus Incentive Plan allows for various types of equity-based incentive awards. Stock based compensation expense is based on awards that are expected to vest over the requisite service periods and are based on the fair value of the award measured on the grant date. Vesting requirements vary for directors, officers, and employees. In general, time-based awards fully vest after one year for directors and vest in equal annual installments over a three-year period for officers and employees. Performance-based awards vest upon achievement of certain milestones. Forfeitures are accounted for when they occur.

Income Taxes

Income Taxes - For interim income tax reporting, due to a full valuation allowance on net deferred tax assets, no income tax expense or benefit is recorded unless it is an unusual or infrequently occurring item. The tax effects of unusual or infrequently occurring items, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, are reported in the interim period in which they occur.

Recent Accounting Pronouncements

Recent Accounting Pronouncement(s) – In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments.” The standard replaces the incurred loss model with the current expected credit loss (CECL) model to estimate credit losses for financial assets measured at amortized cost and certain off-balance sheet credit exposures. The CECL model requires companies to estimate credit losses expected over the life of the financial assets based on historical experience, current conditions and reasonable and supportable forecasts. The provisions of the ASU are effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years—excluding small reporting companies (SRCs), based on a determination date as of November 15, 2019, which have an effective date beginning after December 15, 2022 and interim periods within those fiscal years. The Company is evaluating the expected impacts of the ASU.

We consider the applicability and impact of all ASUs. If the ASU is not listed above, it was determined that the ASU was either not applicable or would have an immaterial impact on our financial statements and related disclosures.

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.21.2
INVENTORY (Tables)
9 Months Ended
Sep. 30, 2021
INVENTORY  
Schedule of Inventories

    

September 30, 

    

December 31, 

    

2021

    

2020

Inventory - tobacco leaf

$

876

$

821

Inventory - hemp/cannabis

132

Inventory - finished goods

 

Cigarettes and filtered cigars

 

331

 

171

Inventory - raw materials

 

 

Cigarette and filtered cigar components

1,464

1,142

Less: inventory reserve

 

(100)

 

(100)

$

2,703

$

2,034

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.21.2
PROPERTY, PLANT AND EQUIPMENT, NET (Tables)
9 Months Ended
Sep. 30, 2021
PROPERTY, PLANT AND EQUIPMENT  
Schedule of Property, Plant and Equipment

September 30, 

December 31, 

    

Useful Life

    

2021

    

2020

Land

$

1,665

$

Building and leasehold improvements

7 to 40 years

309

123

Manufacturing equipment

3 to 10 years

5,539

4,893

Office furniture, fixtures and equipment

5 years

 

129

 

20

Laboratory equipment

5 years

 

198

 

117

Construction in progress

42

 

 

Less: accumulated depreciation

  

 

(3,128)

 

(2,670)

Property, plant and equipment, net

  

$

4,754

$

2,483

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.21.2
RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS AND OTHER LEASES (Tables)
9 Months Ended
Sep. 30, 2021
RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES  
Summary of discount rate and lease term

Weighted average remaining lease term in years

6.3

Weighted average discount rate

 

3.7

%

Schedule of future minimum lease payments

2021

$

33

2022

 

76

2023

78

2024

 

80

2025

82

Thereafter

192

Total lease payments

 

541

Less: imputed interest

 

(60)

Total

$

481

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.21.2
INVESTMENTS AND OTHER ASSETS (Tables)
9 Months Ended
Sep. 30, 2021
INVESTMENTS & OTHER ASSETS  
Schedule of carrying value of investments

September 30, 

December 31, 

2021

2020

Aurora stock warrants

    

$

18

    

$

239

Panacea preferred stock

5,173

Panacea stock warrant

1,124

Exactus common stock

7,282

Total Investments

$

7,300

$

6,536

Convertible note receivable

$

$

5,876

Promissory note receivable

$

3,713

$

XML 36 R26.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS (Tables)
9 Months Ended
Sep. 30, 2021
FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS  
Schedule of assets and liabilities measured at fair value

Fair Value

September 30, 2021

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

 

  

 

  

 

  

 

  

Short-term investment securities:

 

  

 

  

 

  

 

  

Money market funds

$

18,481

$

$

$

18,481

Corporate bonds

 

 

35,051

 

 

35,051

Total short-term investment securities

$

18,481

$

35,051

$

$

53,532

Investment - Aurora stock warrants

$

$

$

18

$

18

Investment - Exactus common shares

$

7,282

$

$

$

7,282

Fair Value

December 31, 2020

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

 

  

 

  

 

  

 

  

Short-term investment securities:

 

  

 

  

 

  

 

  

Money market funds

$

8,636

$

$

$

8,636

Corporate bonds

 

 

12,677

 

 

12,677

Total short-term investment securities

$

8,636

$

12,677

$

$

21,313

Investment - Aurora stock warrants

$

$

$

239

$

239

Investment - Panacea preferred stock

$

$

$

5,173

$

5,173

Convertible note receivable

$

$

$

5,876

$

5,876

Schedule of the changes in fair value of Level 3 investments

Fair Value at December 31, 2020

$

11,288

Unrealized gain (loss) on ACB stock warrants

(220)

Accretion of interest on Panacea preferred stock

142

Panacea investment conversion

(11,192)

Fair Value at September 30, 2021

$

18

Schedule of available-for-sale securities reconciliation

Available for Sale Debt Securities

September 30, 2021

Amortized

Gross

Gross

Cost

Unrealized

Unrealized

Fair

    

Basis

    

Gains

    

Losses

    

Value

Corporate bonds

$

35,078

$

7

$

(34)

$

35,051

Available for Sale Debt Securities

December 31, 2020

Amortized

Gross

Gross

Cost

Unrealized 

Unrealized 

Fair

    

Basis

    

Gains

    

Losses

    

Value

Corporate bonds

$

12,603

$

74

$

$

12,677

Convertible note receivable

 

5,876

 

 

 

5,876

Investment - Panacea preferred stock

 

5,173

 

 

 

5,173

$

23,652

$

74

$

$

23,726

Schedule of available for sale securities classified by contractual maturity

Available for Sale Debt Securities

September 30, 2021

December 31, 2020

Amortized

Amortized

    

Cost Basis

    

Fair Value

    

Cost Basis

    

Fair Value

Due in one year or less

$

3,581

$

3,585

$

11,692

$

11,753

Due after one year through five years

 

31,497

 

31,466

 

11,960

 

11,973

$

35,078

$

35,051

$

23,652

$

23,726

XML 37 R27.htm IDEA: XBRL DOCUMENT v3.21.2
INTANGIBLE ASSETS (Tables)
9 Months Ended
Sep. 30, 2021
INTANGIBLE ASSETS  
Schedule of Intangible Assets

September 30, 

December 31, 

    

2021

    

2020

Intangible assets, net

 

  

 

  

Patent and trademark costs

$

5,951

$

5,667

Less: accumulated amortization

 

(3,207)

 

(2,936)

Patent and trademark costs, net

 

2,744

 

2,731

License fees

 

3,876

 

3,876

Less: accumulated amortization

 

(1,136)

 

(948)

License fees, net

 

2,740

 

2,928

MSA signatory costs

 

2,202

 

2,202

  

License fee for predicate cigarette brand

 

350

 

350

$

8,036

$

8,211

XML 38 R28.htm IDEA: XBRL DOCUMENT v3.21.2
NOTES PAYABLE (Tables)
9 Months Ended
Sep. 30, 2021
Debt Disclosure Abstract  
Schedule of notes payable balances

September 30, 

December 31, 

    

2021

    

2020

License Fees

$

299

$

293

D&O Insurance

 

1,483

 

246

Total current notes payable

$

1,782

$

539

XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.2
CAPITAL RAISE AND WARRANT EXERCISE (Tables)
9 Months Ended
Sep. 30, 2021
WARRANT EXERCISE AND CAPITAL RAISE  
Schedule of warrant activity

Number of

Warrants

Warrants outstanding at December 31, 2020

 

11,293,211

Warrants exercised in Q1 2021

(11,293,211)

Warrants outstanding at September 30, 2021

 

XML 40 R30.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS & CONTINGENCIES (Tables)
9 Months Ended
Sep. 30, 2021
COMMITMENTS AND CONTINGENCIES  
Contractual Obligation, Fiscal Year Maturity [Table Text Block]

Future Commitments

Commitment

 

Counter Party

 

Product Relationship

 

Commitment Type

 

2021

 

2022

 

2023

 

2024

 

2025 & After

 

Total

    

Research Agreement

KeyGene

Hemp / Cannabis

Contract fee

$

115

$

1,150

$

1,200

$

1,227

$

2,893

$

6,585

(1)

License Agreement

NCSU

Tobacco

Annual royalty fee

68

225

293

(2), (3)

License Agreement

NCSU

Tobacco

Minimum annual royalty

7

50

50

50

600

757

(3)

License Agreement

NCSU

Tobacco

Minimum annual royalty

14

50

50

50

500

664

(3)

Sublicense Agreement

Anandia Laboratories, Inc.

Hemp / Cannabis

Annual license fee

10

10

10

10

110

150

(4)

Research Agreement

Cannametrix

Hemp / Cannabis

Contract fee

51

50

101

(5)

Growing Agreement

Various

Various

Contract fee

127

38

165

(6)

Consulting Agreement

Various

Various

Contract fee

119

286

405

(7)

$

511

$

1,859

$

1,310

$

1,337

$

4,103

$

9,120

(1)Exclusive agreement with the Company with respect to the Cannabis Sativa L. plant (the "Field"). The initial term of the agreement was five years with an option for an additional two years. On April 30, 2021, the Company and KeyGene entered into a First Amended and Restated Framework Collaborative Research Agreement which extended the agreement term, from first-quarter 2024 to first-quarter 2027, and preserves the Company’s option for an additional 2-year extension, now through first quarter of 2029.

The Company will exclusively own all results and all intellectual property relating to the results of the collaboration with KeyGene (the "Results”). The Company will pay royalties in varying amounts to KeyGene relating to the Company's commercialization in the Field of certain Results. The Company has also granted KeyGene a license to commercialize the Results outside of the Field and KeyGene will pay royalties in varying amounts to the Company relating to KeyGene's commercialization of the Results outside of the Field.

(2)The license agreement also requires a milestone payment of $150 upon FDA approval or clearance of a product that uses the NCSU licensed technology. The annual royalty fee is credited against running royalties on sales of licensed products.
(3)The Company is also responsible for reimbursing NSCU for actual third-party patent costs incurred, including capitalized patent costs and patent maintenance costs. These costs vary from year to year and the Company has certain rights to direct the activities that result in these costs.
(4)The Company is also responsible for the payment of certain costs, including, capitalized patent costs and patent maintenance costs, a running royalty on future net sales of products made from the sublicensed intellectual property, and a sharing of future sublicensing consideration received from sublicensing to third parties in all countries except for Canada. Anandia retains all patent rights, and is responsible for all patent maintenance, in Canada.
(5)On March 1, 2021, the Company entered into a 14-month research agreement with Cannametrix for hemp/cannabis product development, formulation, and validation.
(6)Various R&D growing and consulting agreements for hemp / cannabis and tobacco.
(7)General corporate consulting agreements.
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY- BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2021
EQUITY- BASED COMPENSATION  
Summary of changes in unvested restricted stock

Unvested RSUs

Weighted

Average

Number of

Grant-date

    

Shares

    

Fair Value

in thousands

$ per share

Unvested at December 31, 2020

 

2,938

$

0.85

Granted

 

1,995

$

3.20

Vested

(1,234)

$

0.85

Forfeited

(216)

$

0.67

Unvested at March 31, 2021

3,483

$

2.21

Granted

15

$

4.60

Vested

(288)

$

0.86

Forfeited

(25)

$

1.04

Unvested at June 30, 2021

3,185

$

2.35

Granted

190

$

3.71

Vested

(50)

$

0.80

Forfeited

(10)

$

1.90

Unvested at September 30, 2021

3,315

$

2.45

Schedule of stock option activity

Weighted

Weighted

Average

Average

Remaining

Aggregate

Number of

Exercise

Contractual

Intrinsic

    

Options

    

Price

    

Term

    

Value

in thousands

$ per share

Outstanding at December 31, 2020

6,581

$

1.50

Granted

235

$

3.10

Exercised

(846)

$

1.36

Expired

(6)

$

2.76

Outstanding at March 31, 2021

5,964

$

1.59

4.3

years

$

7,480

Exercised

(88)

$

1.21

Forfeited

(100)

$

0.80

Outstanding at June 30, 2021

 

5,776

$

1.60

 

4.1

years

 

$

13,265

Expired

(40)

$

2.58

Forfeited

(500)

$

1.04

Outstanding at September 30, 2021

5,236

$

1.65

3.8

years

$

6,885

Exercisable at September 30, 2021

 

4,900

$

1.56

 

3.7

years

 

$

6,848

Schedule of fair value assumptions

    

2021

Risk-free interest rate (1)

 

0.54

%

Expected dividend yield (2)

 

%

Expected volatility (3)

 

87.92

%

Expected term of stock options (4)

 

4.09

years

(1)The risk-free interest rate is based on the period matching the expected term of the stock options based on the U.S. Treasury yield curve in effect on the grant date.
(2)The expected dividend yield is assumed as zero. The Company has never paid cash dividends nor does it anticipate paying dividends in the foreseeable future.
(3)The expected volatility is based on historical volatility of the Company’s stock.
(4)The expected term represents the period of time that options granted are expected to be outstanding based on vesting date and contractual term.
Schedule of compensation costs related to restricted stock and stock options

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2021

    

2020

    

2021

    

2020

Sales, general, and administrative

$

1,073

$

278

$

2,750

$

1,051

Research and Development

 

46

 

28

 

121

 

111

Total RSUs and stock option compensation

$

1,119

$

306

$

2,871

$

1,162

XML 42 R32.htm IDEA: XBRL DOCUMENT v3.21.2
REVENUE RECOGNITION (Tables)
9 Months Ended
Sep. 30, 2021
Revenue from Contract with Customer [Abstract]  
Schedule of contract assets and liabilities

September 30, 

December 31, 

    

2021

    

2020

Unbilled receivables

 

$

494

 

$

349

Deferred Revenue

(272)

Net contract assets

$

494

$

77

Schedule of disaggregation of revenue

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2021

    

2020

    

2021

    

2020

Net sales-over time

$

5,344

$

4,339

$

16,461

$

12,769

Net sales-point in time

 

2,467

 

2,971

 

6,527

 

8,034

Total Revenue

$

7,811

$

7,310

$

22,988

$

20,803

XML 43 R33.htm IDEA: XBRL DOCUMENT v3.21.2
EARNINGS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2021
EARNINGS PER SHARE  
Schedule of computation of basic and diluted earnings per common share

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2021

    

2020

    

2021

    

2020

(in thousands, except for per-share data)

Net loss

$

(9,440)

$

(4,221)

$

(18,644)

$

(13,307)

Weighted average common shares outstanding - basic and diluted

 

162,721

138,857

153,998

138,774

Net loss per common share - basic and diluted

$

(0.06)

$

(0.03)

$

(0.12)

$

(0.10)

Anti-dilutive shares are as follows:

Warrants

11,293

11,293

Options

5,236

7,259

5,236

7,259

Restricted stock units

3,315

2,878

3,315

2,878

8,551

21,430

8,551

21,430

Schedule of anti-dilutive shares excluded from dilutive securities

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2021

    

2020

    

2021

    

2020

(in thousands, except for per-share data)

Net loss

$

(9,440)

$

(4,221)

$

(18,644)

$

(13,307)

Weighted average common shares outstanding - basic and diluted

 

162,721

138,857

153,998

138,774

Net loss per common share - basic and diluted

$

(0.06)

$

(0.03)

$

(0.12)

$

(0.10)

Anti-dilutive shares are as follows:

Warrants

11,293

11,293

Options

5,236

7,259

5,236

7,259

Restricted stock units

3,315

2,878

3,315

2,878

8,551

21,430

8,551

21,430

XML 44 R34.htm IDEA: XBRL DOCUMENT v3.21.2
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
9 Months Ended
Sep. 30, 2021
subsidiary
Condensed Financial Statements, Captions [Line Items]  
Number of subsidiaries 4
Directors  
Condensed Financial Statements, Captions [Line Items]  
Vesting period 1 year
Officers and employees  
Condensed Financial Statements, Captions [Line Items]  
Vesting period 3 years
Twenty Second Century Ltd [Member]  
Condensed Financial Statements, Captions [Line Items]  
Number of subsidiaries 2
Botanical Genetics [Member]  
Condensed Financial Statements, Captions [Line Items]  
Number of subsidiaries 1
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.21.2
INVENTORY (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Dec. 31, 2020
Inventory [Line Items]      
Inventory - tobacco leaf   $ 876 $ 821
Inventory - hemp/cannabis   132  
Inventory - finished goods   331 171
Inventory - raw materials   1,464 1,142
Less: inventory reserve   (100) (100)
Inventory, Net   $ 2,703 $ 2,034
Inventory write-off $ 219    
Research and Development Expense [Member]      
Inventory [Line Items]      
Inventory write-off 58    
Cost of Sales [Member]      
Inventory [Line Items]      
Inventory write-off $ 161    
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.2
PROPERTY, PLANT AND EQUIPMENT, NET (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Property, Plant and Equipment [Line Items]          
Less: accumulated depreciation $ (3,128)   $ (3,128)   $ (2,670)
Total property, plant and equipment 4,754   4,754   2,483
Depreciation expense 173 $ 160 461 $ 473  
Land [Member]          
Property, Plant and Equipment [Line Items]          
Property, Plant and Equipment, Gross 1,665   1,665    
Building and Leasehold improvements          
Property, Plant and Equipment [Line Items]          
Property, Plant and Equipment, Gross 309   $ 309   123
Building and Leasehold improvements | Maximum          
Property, Plant and Equipment [Line Items]          
Property, Plant and Equipment, Useful Life     40 years    
Building and Leasehold improvements | Minimum          
Property, Plant and Equipment [Line Items]          
Property, Plant and Equipment, Useful Life     7 years    
Laboratory equipment [Member]          
Property, Plant and Equipment [Line Items]          
Property, Plant and Equipment, Gross 5,539   $ 5,539   4,893
Laboratory equipment [Member] | Maximum          
Property, Plant and Equipment [Line Items]          
Property, Plant and Equipment, Useful Life     10 years    
Laboratory equipment [Member] | Minimum          
Property, Plant and Equipment [Line Items]          
Property, Plant and Equipment, Useful Life     3 years    
Office furniture, fixtures and equipment [Member]          
Property, Plant and Equipment [Line Items]          
Property, Plant and Equipment, Gross 129   $ 129   20
Property, Plant and Equipment, Useful Life     5 years    
Cigarette manufacturing equipment [Member]          
Property, Plant and Equipment [Line Items]          
Property, Plant and Equipment, Gross 198   $ 198   $ 117
Property, Plant and Equipment, Useful Life     5 years    
Construction in Progress [Member]          
Property, Plant and Equipment [Line Items]          
Property, Plant and Equipment, Gross $ 42   $ 42    
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.21.2
RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS AND OTHER LEASES (Details)
ft² in Thousands, $ in Thousands
Oct. 18, 2021
USD ($)
item
Jul. 28, 2021
USD ($)
ft²
Sep. 30, 2021
USD ($)
Lessee, Lease, Description [Line Items]      
Weighted average remaining lease term in years     6 years 3 months 18 days
Weighted average discount rate     3.70%
Lessee, Operating Lease, Liability, Payment, Due [Abstract]      
2021     $ 33
2022     76
2023     78
2024     80
2025     82
Thereafter     192
Total lease payments     541
Less: imputed interest     (60)
Operating Lease, Liability     $ 481
Manufacturing Facility And Warehouse In North Carolina | Subsequent Event [Member]      
Lessee, Operating Lease, Liability, Payment, Due [Abstract]      
Monthly base rent $ 17    
Initial lease term 24 months    
Number of renewal options | item 1    
Renewal term 24 months    
Research And Development Laboratory In Rockville, MD [Member]      
Lessee, Operating Lease, Liability, Payment, Due [Abstract]      
Area under operating lease | ft²   4  
Monthly base rent   $ 12  
Base Rent Annual Increase, as a percent   2.50%  
Initial lease term   51 months  
Rent abatement period   5 months  
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.21.2
INVESTMENTS AND OTHER ASSETS - Total carrying value (Details) - USD ($)
$ / shares in Units, $ in Thousands
Sep. 30, 2021
Jun. 30, 2021
Dec. 31, 2020
Dec. 03, 2019
Marketable Securities [Line Items]        
Investments $ 7,300   $ 6,536  
Note receivable 3,713   5,876  
Aurora Cannabis Inc [Member] | Warrant        
Marketable Securities [Line Items]        
Investments 18   239  
Investment in Panacea        
Marketable Securities [Line Items]        
Exercise price       $ 2.344
Investments       $ 13,297
Note receivable   $ 3,684    
Investment in Panacea | Warrant        
Marketable Securities [Line Items]        
Investments     1,124  
Investment in Panacea | Preferred stock        
Marketable Securities [Line Items]        
Investments     $ 5,173  
Exactus [Member]        
Marketable Securities [Line Items]        
Investments $ 7,282 $ 9,102    
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.21.2
INVESTMENTS AND OTHER ASSETS (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 28, 2021
shares
Jun. 30, 2021
USD ($)
a
shares
Dec. 03, 2019
USD ($)
item
$ / shares
Jun. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
shares
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Marketable Securities [Line Items]              
Long-term Investments         $ 7,300   $ 6,536
Note receivable         3,713   5,876
Impairment of Panacea investment           $ 1,062  
Gain on Panacea investment conversion         2,548    
Subsequent Event [Member] | Exactus [Member]              
Marketable Securities [Line Items]              
Reverse stock split, ratio 0.035714            
Investment in Panacea              
Marketable Securities [Line Items]              
Long-term Investments     $ 13,297        
Amount paid to acquire investments     $ 12,000        
Shares issued in purchase, value per share | $ / shares     $ 1        
Shares issued for Panacea, value     $ 1,297        
Ownership percentage (in percent)     15.80%        
Number of instruments comprising the investment | item     3        
Note receivable   $ 3,684          
Exercise price | $ / shares     $ 2.344        
Note receivable, face amount   $ 4,300 $ 7,000        
Note receivable term     5 years        
Note receivable interest rate   0.00% 10.00%        
Dividend rate     10.00%        
Number of years for acceleration of exercise date     2 years        
Area of Land | a   224          
Gain on Panacea investment conversion   $ 2,548          
Panacea conversion assets included in acquisition of property, plant and equipment   2,248          
Stock received in conversion, value   500          
Note receivable, discount   616          
Investment in Panacea | Preferred stock              
Marketable Securities [Line Items]              
Long-term Investments             5,173
Investment in Panacea | Warrant              
Marketable Securities [Line Items]              
Long-term Investments             $ 1,124
Ownership percentage (in percent)     51.00%        
Impairment of Panacea investment       $ 1,062      
Investment in Panacea | Warrant | Volatility              
Marketable Securities [Line Items]              
Warrants measurement input     0.70        
Investment in Panacea | Warrant | Discount for lack of marketability              
Marketable Securities [Line Items]              
Warrants measurement input     0.25        
Investment in Panacea | Warrant | Risk-free rate              
Marketable Securities [Line Items]              
Warrants measurement input     0.02        
Exactus [Member]              
Marketable Securities [Line Items]              
Long-term Investments   $ 9,102     $ 7,282    
Stock received in conversion, shares | shares   91,016,026          
Number of shares held in investee | shares         91,016,026    
Exactus [Member] | Subsequent Event [Member]              
Marketable Securities [Line Items]              
Number of shares held in investee | shares 3,250,573            
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS - Recurring (Details)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
Dec. 31, 2020
USD ($)
Money Market Funds    
Assets    
Net Asset Value Per Share | $ / shares $ 1.00  
Warrant    
Assets    
Equity Securities, FV-NI, Measurement Input 0.94 1.37
Equity Securities, FV-NI, Measurement Input [Extensible List] Volatility Volatility
Input increase (decrease) assumption, as a percent 20.00% 20.00%
Estimated change in fair value due to change in input $ 22 $ 115
Fair Value, Recurring [Member] | Short-term Investments [Member]    
Assets    
Assets at fair value 53,532 21,313
Fair Value, Recurring [Member] | Money Market Funds    
Assets    
Assets at fair value 18,481 8,636
Fair Value, Recurring [Member] | Corporate Bonds    
Assets    
Assets at fair value 35,051 12,677
Fair Value, Recurring [Member] | Warrant    
Assets    
Assets at fair value 18 239
Fair Value, Recurring [Member] | Common Stock [Member]    
Assets    
Assets at fair value 7,282  
Fair Value, Recurring [Member] | Preferred stock    
Assets    
Assets at fair value   5,173
Fair Value, Recurring [Member] | Notes Receivable [Member]    
Assets    
Assets at fair value   5,876
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | Short-term Investments [Member]    
Assets    
Assets at fair value 18,481 8,636
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | Money Market Funds    
Assets    
Assets at fair value 18,481 8,636
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | Corporate Bonds    
Assets    
Assets at fair value 0 0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | Warrant    
Assets    
Assets at fair value 0 0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | Common Stock [Member]    
Assets    
Assets at fair value 7,282  
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | Preferred stock    
Assets    
Assets at fair value   0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | Notes Receivable [Member]    
Assets    
Assets at fair value   0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 | Short-term Investments [Member]    
Assets    
Assets at fair value 35,051 12,677
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 | Money Market Funds    
Assets    
Assets at fair value 0 0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 | Corporate Bonds    
Assets    
Assets at fair value 35,051 12,677
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 | Warrant    
Assets    
Assets at fair value 0 0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 | Common Stock [Member]    
Assets    
Assets at fair value 0  
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 | Preferred stock    
Assets    
Assets at fair value   0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 | Notes Receivable [Member]    
Assets    
Assets at fair value   0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 | Short-term Investments [Member]    
Assets    
Assets at fair value 0 0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 | Money Market Funds    
Assets    
Assets at fair value 0 0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 | Corporate Bonds    
Assets    
Assets at fair value 0 0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 | Warrant    
Assets    
Assets at fair value 18 239
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 | Common Stock [Member]    
Assets    
Assets at fair value $ 0  
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 | Preferred stock    
Assets    
Assets at fair value   5,173
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 | Notes Receivable [Member]    
Assets    
Assets at fair value   $ 5,876
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS - Changes in fair value, Level 3 (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2021
USD ($)
FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS  
Fair value at beginning of the period $ 11,288
Unrealized gain as a result of change in fair value (220)
Accretion of interest on note 142
Panacea investment conversion (11,192)
Fair value at end of the period $ 18
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS - Available-for-sale securities (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Available-for-sale Securities - Amortized Cost Basis $ 35,078 $ 23,652
Available-for-sale Securities - Gross Unrealized Gains   74
Available-for-sale Securities - Gross Unrealized Losses   0
Available-for-sale Securities - Fair Value 35,051 23,726
Corporate Bonds    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Available-for-sale Securities - Amortized Cost Basis 35,078 12,603
Available-for-sale Securities - Gross Unrealized Gains 7 74
Available-for-sale Securities - Gross Unrealized Losses (34) 0
Available-for-sale Securities - Fair Value $ 35,051 12,677
Notes Receivable [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Available-for-sale Securities - Amortized Cost Basis   5,876
Available-for-sale Securities - Gross Unrealized Gains   0
Available-for-sale Securities - Gross Unrealized Losses   0
Available-for-sale Securities - Fair Value   5,876
Preferred stock    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Available-for-sale Securities - Amortized Cost Basis   5,173
Available-for-sale Securities - Gross Unrealized Gains   0
Available-for-sale Securities - Gross Unrealized Losses   0
Available-for-sale Securities - Fair Value   $ 5,173
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS - Maturity of available-for-sale securities by contractual maturity (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS    
Available For Sale, Maturities One Year or Less, Amortized Cost $ 3,581 $ 11,692
Available For Sale, Maturities One Through Five Years, Amortized Cost 31,497 11,960
Available for sale securities, amortized cost, total 35,078 23,652
Available For Sale, Maturities One Year or Less, Fair Value 3,585 11,753
Available For Sale, Maturities One Through Five Years, Fair Value 31,466 11,973
Available For Sale Securities, Fair Value $ 35,051 $ 23,726
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.21.2
INTANGIBLE ASSETS (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Intangible assets, net          
Intangible assets, net $ 8,036   $ 8,036   $ 8,211
Amortization expense 168 $ 163 471 $ 524  
Impairment of intangible assets 0     146  
Intangible assets written off, cost       448  
Intangible assets written off, accumulated amortization       $ 302  
MSA Signatory Costs          
Intangible assets, net          
Indefinite-lived intangible assets 2,202   2,202   2,202
Licensing agreements          
Intangible assets, net          
Indefinite-lived intangible assets 350   350   350
Patent and Trademark [Member]          
Intangible assets, net          
Gross 5,951   5,951   5,667
Less: accumulated amortization (3,207)   (3,207)   (2,936)
Total 2,744   2,744   2,731
Licensing agreements          
Intangible assets, net          
Gross 3,876   3,876   3,876
Less: accumulated amortization (1,136)   (1,136)   (948)
Total $ 2,740   $ 2,740   $ 2,928
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.21.2
NOTES PAYABLE (Details)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended
May 12, 2020
USD ($)
Oct. 22, 2018
USD ($)
item
Jun. 22, 2018
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Proceeds from SBA loan $ 1,200                 $ 1,183  
Directors And Officers insurance, policy term         1 year   1 year        
Annual premium         $ 3,315   $ 2,744        
Premium paid         662   549        
Proceeds from Notes Payable         $ 2,653   $ 2,195   $ 2,653 2,195  
Debt Instrument, Term         9 months   9 months        
Debt Instrument, Interest Rate, Stated Percentage         3.49%   3.19% 3.19%      
License fees, current       $ 299         299   $ 293
D&O insurance payable       1,483         1,483   246
Notes Payable, Current, Total       1,782         1,782   $ 539
License Agreement | North Carolina State University [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Aggregate milestone payments     $ 1,200                
Notes Payable     1,175                
Annual milestone payments beyond upfront amount               $ 300      
License acquired     $ 1,175                
License Agreement | University Of Kentucky [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Aggregate milestone payments   $ 1,200                  
Notes Payable   1,151                  
Annual milestone payments beyond upfront amount   300                  
License acquired   1,151                  
Upfront payment   $ 300                  
Number of installments | item   3                  
Borrowings [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Accretion of non cash interest expense       $ 2   $ 4     $ 6 $ 17  
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.21.2
SEVERANCE LIABILITY (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Sep. 30, 2021
Dec. 31, 2020
Postemployment Benefits [Abstract]        
Severance expense $ 306 $ 881    
Severance accrual   $ 771    
Severance period   42 months    
Accrued severance, current     $ 223 $ 339
Accrued severance, noncurrent     $ 72 $ 241
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.21.2
CAPITAL RAISE AND WARRANT EXERCISE - Capital raise (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
3 Months Ended
Jun. 07, 2021
Jun. 30, 2021
WARRANT EXERCISE AND CAPITAL RAISE    
Stock issued in connection with capital raise (in shares) 10  
Share Price $ 4.00  
Stock issued in connection with capital raise $ 38,206 $ 38,206
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.21.2
CAPITAL RAISE AND WARRANT EXERCISE - Warrants (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2021
Sep. 30, 2021
Dec. 31, 2020
WARRANT EXERCISE AND CAPITAL RAISE      
Warrants exercised (11,293,211)    
Net proceeds from warrant exercises $ 11,782 $ 11,782  
Warrant outstanding balance     11,293,211
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES - Licenses (Details) - USD ($)
$ in Thousands
9 Months Ended
Apr. 30, 2021
Mar. 01, 2021
Sep. 30, 2021
Contractual Obligation, Fiscal Year Maturity Schedule [Abstract]      
2021     $ 511
2022     1,859
2023     1,310
2024     1,337
2025 & After     4,103
Contractual Obligation, Total     9,120
Research Agreement | KeyGene      
Contractual Obligation, Fiscal Year Maturity Schedule [Abstract]      
2021     115
2022     1,150
2023     1,200
2024     1,227
2025 & After     2,893
Contractual Obligation, Total     $ 6,585
Agreement Term     5 years
Agreement extension period 2 years   2 years
Research Agreement | Cannametrix [Member]      
Contractual Obligation, Fiscal Year Maturity Schedule [Abstract]      
2021     $ 51
2022     50
Contractual Obligation, Total     101
Agreement Term   14 months  
License Agreement | Annual Royalty [Member]      
Contractual Obligation, Fiscal Year Maturity Schedule [Abstract]      
2021     68
2022     225
Contractual Obligation, Total     293
License Agreement | Minimum Annual Royalty 1 [Member]      
Contractual Obligation, Fiscal Year Maturity Schedule [Abstract]      
2021     7
2022     50
2023     50
2024     50
2025 & After     600
Contractual Obligation, Total     757
License Agreement | Minimum Annual Royalty 2 [Member]      
Contractual Obligation, Fiscal Year Maturity Schedule [Abstract]      
2021     14
2022     50
2023     50
2024     50
2025 & After     500
Contractual Obligation, Total     664
License Agreement | North Carolina State University [Member]      
Contractual Obligation, Fiscal Year Maturity Schedule [Abstract]      
Milestone payment upon approval of a product     150
Sublicense Agreement With Anandia      
Contractual Obligation, Fiscal Year Maturity Schedule [Abstract]      
2021     10
2022     10
2023     10
2024     10
2025 & After     110
Contractual Obligation, Total     150
Growing Agreement [Member]      
Contractual Obligation, Fiscal Year Maturity Schedule [Abstract]      
2021     127
2022     38
Contractual Obligation, Total     165
Consulting Agreement [Member]      
Contractual Obligation, Fiscal Year Maturity Schedule [Abstract]      
2021     119
2022     286
Contractual Obligation, Total     $ 405
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.21.2
COMMITMENTS AND CONTINGENCIES - MRTP, litigation (Details)
$ in Thousands, shares in Millions
3 Months Ended 9 Months Ended
Jun. 07, 2021
shares
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Jan. 15, 2020
item
Nov. 19, 2019
item
Other Commitments [Line Items]              
Number of shares issued in settlement | shares 10            
Number of counts | item           3 3
Modified Risk Tobacco Product [Member]              
Other Commitments [Line Items]              
Research and development expense | $   $ 2 $ 4 $ 16 $ 158    
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY-BASED COMPENSATION (Details)
9 Months Ended
Sep. 30, 2021
shares
EQUITY- BASED COMPENSATION  
Additional shares authorized during the period 5,000,000
Plan term 10 years
Number of shares remaining for future awards 7,449,946
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY- BASED COMPENSATION - RSUs (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2021
RSUs, Number of shares        
Nonvested, Number, Beginning Balance 3,185 3,483 2,938 2,938
RSUs granted, number 190 15 1,995  
RSUs vested, number (50) (288) (1,234)  
RSUs forfeited, number (10) (25) (216)  
Nonvested, Number, Ending Balance 3,315 3,185 3,483 3,315
RSUs, Weighted average grant-date fair value        
Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance $ 2.35 $ 2.21 $ 0.85 $ 0.85
RSUs granted, grant-date fair value 3.71 4.60 3.20  
RSUs vested, grant-date fair value 0.80 0.86 0.85  
RSUs forfeited, grant-date fair value 1.90 1.04 0.67  
Nonvested, Weighted Average Grant Date Fair Value, Ending Balance $ 2.45 $ 2.35 $ 2.21 $ 2.45
Fair value of RSUs that vested during the period       $ 5,057
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY- BASED COMPENSATION - Stock option activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2021
Number of Options        
Options, number, Beginning of Period 5,776 5,964 6,581 6,581
Options granted, number     235  
Options exercised, number   (88) (846)  
Options forfeited, number (500) (100)    
Options expired, number (40)   (6)  
Options, number, End of Period 5,236 5,776 5,964 5,236
Options exercisable, number, End of Period 4,900     4,900
Options, Weighted Average Exercise Price        
Options, Beginning of Period, weighted average exercise price $ 1.60 $ 1.59 $ 1.50 $ 1.50
Options granted, weighted average exercise price     3.10  
Options exercised, weighted average exercise price   1.21 1.36  
Options forfeited, weighted average exercise price 1.04 0.80    
Options expired, weighted average exercise price 2.58   2.76  
Options, End of Period, weighted average exercise price 1.65 $ 1.60 $ 1.59 1.65
Options exercisable, End of Period, weighted average exercise price $ 1.56     $ 1.56
Weighted Average Remaining Contractual Term        
Options, End of Period, weighted average remaining contractual term 3 years 9 months 18 days 4 years 1 month 6 days 4 years 3 months 18 days  
Options exercisable, End of Period, weighted average remaining contractual term       3 years 8 months 12 days
Aggregate Intrinsic Value        
Options, End of Period, aggregate intrinsic value $ 6,885 $ 13,265 $ 7,480 $ 6,885
Options exercisable, End of Period, aggregated intrinsic value $ 6,848     $ 6,848
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY BASED COMPENSATION - Fair value assumptions (Details)
9 Months Ended
Sep. 30, 2021
EQUITY- BASED COMPENSATION  
Risk-free interest rate (weighted average) 0.54%
Expected stock price volatility 87.92%
Expected life of options (weighted average) 4 years 1 month 2 days
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY-BASED COMPENSATION - Compensation expense and unrecognized compensation (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Equity-based employee compensation expense $ 1,119 $ 306 $ 2,871 $ 1,162
Unrecognized compensation 5,931   $ 5,931  
Unrecognized compensation, period for recognition     1 year 1 month 6 days  
Unrecognized compensation, options with milestone-based vesting 517   $ 517  
Selling, General and Administrative Expenses [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Equity-based employee compensation expense 1,073 278 2,750 1,051
Research and Development Expense [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Equity-based employee compensation expense $ 46 $ 28 $ 121 $ 111
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.21.2
REVENUE RECOGNITION (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Disaggregation of Revenue [Line Items]          
Allowance for discounts or returns and allowances $ 0   $ 0   $ 0
Payment period     21 days    
Unbilled receivables 494   $ 494   349
Deferred revenue 0   0   (272)
Contract asset (liability), net 494   494   $ 77
Sale of products, net 7,811 $ 7,310 22,988 $ 20,803  
Transferred over Time [Member]          
Disaggregation of Revenue [Line Items]          
Sale of products, net 5,344 4,339 16,461 12,769  
Transferred at Point in Time [Member]          
Disaggregation of Revenue [Line Items]          
Sale of products, net $ 2,467 $ 2,971 $ 6,527 $ 8,034  
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.21.2
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
EARNINGS PER SHARE                
Net loss attributed to common shareholders $ (9,440) $ (4,174) $ (5,030) $ (4,221) $ (5,057) $ (4,029) $ (18,644) $ (13,307)
Weighted average common shares outstanding - basic and diluted (in thousands) 162,721     138,857     153,998 138,774
Loss per common share - basic and diluted $ (0.06)     $ (0.03)     $ (0.12) $ (0.10)
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.21.2
EARNINGS PER SHARE - Anti-dilutive securities (Details) - shares
shares in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Securities outstanding but excluded from computation of earnings per share 8,551 21,430 8,551 21,430
Warrant        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Securities outstanding but excluded from computation of earnings per share   11,293   11,293
Options [ Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Securities outstanding but excluded from computation of earnings per share 5,236 7,259 5,236 7,259
Restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Securities outstanding but excluded from computation of earnings per share 3,315 2,878 3,315 2,878
EXCEL 69 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 70 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 71 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 72 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 237 399 1 false 66 0 false 8 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 00300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Sheet http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Statements 5 false false R6.htm 00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 10101 - Disclosure - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPolicies NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 10201 - Disclosure - INVENTORY Sheet http://www.xxiicentury.com/role/DisclosureInventory INVENTORY Notes 8 false false R9.htm 10301 - Disclosure - PROPERTY, PLANT AND EQUIPMENT Sheet http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipment PROPERTY, PLANT AND EQUIPMENT Notes 9 false false R10.htm 10401 - Disclosure - RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES Sheet http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeases RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES Notes 10 false false R11.htm 10501 - Disclosure - INVESTMENTS AND OTHER ASSETS Sheet http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssets INVESTMENTS AND OTHER ASSETS Notes 11 false false R12.htm 10601 - Disclosure - FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS Sheet http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAndShortTermInvestments FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS Notes 12 false false R13.htm 10701 - Disclosure - INTANGIBLE ASSETS Sheet http://www.xxiicentury.com/role/DisclosureIntangibleAssets INTANGIBLE ASSETS Notes 13 false false R14.htm 10801 - Disclosure - NOTES PAYABLE Notes http://www.xxiicentury.com/role/DisclosureNotesPayable NOTES PAYABLE Notes 14 false false R15.htm 10901 - Disclosure - SEVERANCE LIABILITY Sheet http://www.xxiicentury.com/role/DisclosureSeveranceLiability SEVERANCE LIABILITY Notes 15 false false R16.htm 11001 - Disclosure - CAPITAL RAISE AND WARRANT EXERCISE Sheet http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExercise CAPITAL RAISE AND WARRANT EXERCISE Notes 16 false false R17.htm 11101 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 17 false false R18.htm 11201 - Disclosure - EQUITY- BASED COMPENSATION Sheet http://www.xxiicentury.com/role/DisclosureEquityBasedCompensation EQUITY- BASED COMPENSATION Notes 18 false false R19.htm 11301 - Disclosure - REVENUE RECOGNITION Sheet http://www.xxiicentury.com/role/DisclosureRevenueRecognition REVENUE RECOGNITION Notes 19 false false R20.htm 11401 - Disclosure - EARNINGS PER SHARE Sheet http://www.xxiicentury.com/role/DisclosureEarningsPerShare EARNINGS PER SHARE Notes 20 false false R21.htm 20102 - Disclosure - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 21 false false R22.htm 30203 - Disclosure - INVENTORY (Tables) Sheet http://www.xxiicentury.com/role/DisclosureInventoryTables INVENTORY (Tables) Tables http://www.xxiicentury.com/role/DisclosureInventory 22 false false R23.htm 30303 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables) Sheet http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetTables PROPERTY, PLANT AND EQUIPMENT, NET (Tables) Tables http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipment 23 false false R24.htm 30403 - Disclosure - RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS AND OTHER LEASES (Tables) Sheet http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesTables RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS AND OTHER LEASES (Tables) Tables 24 false false R25.htm 30503 - Disclosure - INVESTMENTS AND OTHER ASSETS (Tables) Sheet http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTables INVESTMENTS AND OTHER ASSETS (Tables) Tables http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssets 25 false false R26.htm 30603 - Disclosure - FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS (Tables) Sheet http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAndShortTermInvestmentsTables FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS (Tables) Tables http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAndShortTermInvestments 26 false false R27.htm 30703 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://www.xxiicentury.com/role/DisclosureIntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://www.xxiicentury.com/role/DisclosureIntangibleAssets 27 false false R28.htm 30803 - Disclosure - NOTES PAYABLE (Tables) Notes http://www.xxiicentury.com/role/DisclosureNotesPayableTables NOTES PAYABLE (Tables) Tables http://www.xxiicentury.com/role/DisclosureNotesPayable 28 false false R29.htm 31003 - Disclosure - CAPITAL RAISE AND WARRANT EXERCISE (Tables) Sheet http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseTables CAPITAL RAISE AND WARRANT EXERCISE (Tables) Tables http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExercise 29 false false R30.htm 31103 - Disclosure - COMMITMENTS & CONTINGENCIES (Tables) Sheet http://www.xxiicentury.com/role/DisclosureCommitmentsContingenciesTables COMMITMENTS & CONTINGENCIES (Tables) Tables 30 false false R31.htm 31203 - Disclosure - EQUITY- BASED COMPENSATION (Tables) Sheet http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationTables EQUITY- BASED COMPENSATION (Tables) Tables http://www.xxiicentury.com/role/DisclosureEquityBasedCompensation 31 false false R32.htm 31303 - Disclosure - REVENUE RECOGNITION (Tables) Sheet http://www.xxiicentury.com/role/DisclosureRevenueRecognitionTables REVENUE RECOGNITION (Tables) Tables http://www.xxiicentury.com/role/DisclosureRevenueRecognition 32 false false R33.htm 31403 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://www.xxiicentury.com/role/DisclosureEarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://www.xxiicentury.com/role/DisclosureEarningsPerShare 33 false false R34.htm 40101 - Disclosure - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies 34 false false R35.htm 40201 - Disclosure - INVENTORY (Details) Sheet http://www.xxiicentury.com/role/DisclosureInventoryDetails INVENTORY (Details) Details http://www.xxiicentury.com/role/DisclosureInventoryTables 35 false false R36.htm 40301 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details) Sheet http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails PROPERTY, PLANT AND EQUIPMENT, NET (Details) Details http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetTables 36 false false R37.htm 40401 - Disclosure - RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS AND OTHER LEASES (Details) Sheet http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS AND OTHER LEASES (Details) Details http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesTables 37 false false R38.htm 40501 - Disclosure - INVESTMENTS AND OTHER ASSETS - Total carrying value (Details) Sheet http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails INVESTMENTS AND OTHER ASSETS - Total carrying value (Details) Details 38 false false R39.htm 40502 - Disclosure - INVESTMENTS AND OTHER ASSETS (Details) Sheet http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails INVESTMENTS AND OTHER ASSETS (Details) Details http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTables 39 false false R40.htm 40601 - Disclosure - FAIR VALUE MEASUREMENTS - Recurring (Details) Sheet http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails FAIR VALUE MEASUREMENTS - Recurring (Details) Details 40 false false R41.htm 40602 - Disclosure - FAIR VALUE MEASUREMENTS - Changes in fair value, Level 3 (Details) Sheet http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsChangesInFairValueLevel3Details FAIR VALUE MEASUREMENTS - Changes in fair value, Level 3 (Details) Details 41 false false R42.htm 40603 - Disclosure - FAIR VALUE MEASUREMENTS - Available-for-sale securities (Details) Sheet http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails FAIR VALUE MEASUREMENTS - Available-for-sale securities (Details) Details 42 false false R43.htm 40604 - Disclosure - FAIR VALUE MEASUREMENTS - Maturity of available-for-sale securities by contractual maturity (Details) Sheet http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails FAIR VALUE MEASUREMENTS - Maturity of available-for-sale securities by contractual maturity (Details) Details 43 false false R44.htm 40701 - Disclosure - INTANGIBLE ASSETS (Details) Sheet http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails INTANGIBLE ASSETS (Details) Details http://www.xxiicentury.com/role/DisclosureIntangibleAssetsTables 44 false false R45.htm 40801 - Disclosure - NOTES PAYABLE (Details) Notes http://www.xxiicentury.com/role/DisclosureNotesPayableDetails NOTES PAYABLE (Details) Details http://www.xxiicentury.com/role/DisclosureNotesPayableTables 45 false false R46.htm 40901 - Disclosure - SEVERANCE LIABILITY (Details) Sheet http://www.xxiicentury.com/role/DisclosureSeveranceLiabilityDetails SEVERANCE LIABILITY (Details) Details http://www.xxiicentury.com/role/DisclosureSeveranceLiability 46 false false R47.htm 41001 - Disclosure - CAPITAL RAISE AND WARRANT EXERCISE - Capital raise (Details) Sheet http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseCapitalRaiseDetails CAPITAL RAISE AND WARRANT EXERCISE - Capital raise (Details) Details 47 false false R48.htm 41002 - Disclosure - CAPITAL RAISE AND WARRANT EXERCISE - Warrants (Details) Sheet http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseWarrantsDetails CAPITAL RAISE AND WARRANT EXERCISE - Warrants (Details) Details 48 false false R49.htm 41101 - Disclosure - COMMITMENTS AND CONTINGENCIES - Licenses (Details) Sheet http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails COMMITMENTS AND CONTINGENCIES - Licenses (Details) Details 49 false false R50.htm 41102 - Disclosure - COMMITMENTS AND CONTINGENCIES - MRTP, litigation (Details) Sheet http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesMrtpLitigationDetails COMMITMENTS AND CONTINGENCIES - MRTP, litigation (Details) Details 50 false false R51.htm 41201 - Disclosure - EQUITY-BASED COMPENSATION (Details) Sheet http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationDetails EQUITY-BASED COMPENSATION (Details) Details 51 false false R52.htm 41202 - Disclosure - EQUITY- BASED COMPENSATION - RSUs (Details) Sheet http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails EQUITY- BASED COMPENSATION - RSUs (Details) Details 52 false false R53.htm 41203 - Disclosure - EQUITY- BASED COMPENSATION - Stock option activity (Details) Sheet http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails EQUITY- BASED COMPENSATION - Stock option activity (Details) Details 53 false false R54.htm 41204 - Disclosure - EQUITY BASED COMPENSATION - Fair value assumptions (Details) Sheet http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationFairValueAssumptionsDetails EQUITY BASED COMPENSATION - Fair value assumptions (Details) Details 54 false false R55.htm 41205 - Disclosure - EQUITY-BASED COMPENSATION - Compensation expense and unrecognized compensation (Details) Sheet http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationCompensationExpenseAndUnrecognizedCompensationDetails EQUITY-BASED COMPENSATION - Compensation expense and unrecognized compensation (Details) Details 55 false false R56.htm 41301 - Disclosure - REVENUE RECOGNITION (Details) Sheet http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails REVENUE RECOGNITION (Details) Details http://www.xxiicentury.com/role/DisclosureRevenueRecognitionTables 56 false false R57.htm 41401 - Disclosure - EARNINGS PER SHARE (Details) Sheet http://www.xxiicentury.com/role/DisclosureEarningsPerShareDetails EARNINGS PER SHARE (Details) Details http://www.xxiicentury.com/role/DisclosureEarningsPerShareTables 57 false false R58.htm 41402 - Disclosure - EARNINGS PER SHARE - Anti-dilutive securities (Details) Sheet http://www.xxiicentury.com/role/DisclosureEarningsPerShareAntiDilutiveSecuritiesDetails EARNINGS PER SHARE - Anti-dilutive securities (Details) Details 58 false false All Reports Book All Reports xxii-20210930x10q.htm xxii-20210930.xsd xxii-20210930_cal.xml xxii-20210930_def.xml xxii-20210930_lab.xml xxii-20210930_pre.xml xxii-20210930xex31d1.htm xxii-20210930xex31d2.htm xxii-20210930xex32d1.htm http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021 http://fasb.org/srt/2021-01-31 true true JSON 75 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "xxii-20210930x10q.htm": { "axisCustom": 0, "axisStandard": 23, "contextCount": 237, "dts": { "calculationLink": { "local": [ "xxii-20210930_cal.xml" ] }, "definitionLink": { "local": [ "xxii-20210930_def.xml" ] }, "inline": { "local": [ "xxii-20210930x10q.htm" ] }, "labelLink": { "local": [ "xxii-20210930_lab.xml" ] }, "presentationLink": { "local": [ "xxii-20210930_pre.xml" ] }, "schema": { "local": [ "xxii-20210930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd" ] } }, "elementCount": 515, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 14, "http://www.xxiicentury.com/20210930": 6, "http://xbrl.sec.gov/dei/2021": 5, "total": 25 }, "keyCustom": 60, "keyStandard": 339, "memberCustom": 21, "memberStandard": 39, "nsprefix": "xxii", "nsuri": "http://www.xxiicentury.com/20210930", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "role": "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES", "role": "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeases", "shortName": "RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - INVESTMENTS AND OTHER ASSETS", "role": "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssets", "shortName": "INVESTMENTS AND OTHER ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS", "role": "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAndShortTermInvestments", "shortName": "FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - INTANGIBLE ASSETS", "role": "http://www.xxiicentury.com/role/DisclosureIntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - NOTES PAYABLE", "role": "http://www.xxiicentury.com/role/DisclosureNotesPayable", "shortName": "NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - SEVERANCE LIABILITY", "role": "http://www.xxiicentury.com/role/DisclosureSeveranceLiability", "shortName": "SEVERANCE LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11001 - Disclosure - CAPITAL RAISE AND WARRANT EXERCISE", "role": "http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExercise", "shortName": "CAPITAL RAISE AND WARRANT EXERCISE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11101 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11201 - Disclosure - EQUITY- BASED COMPENSATION", "role": "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensation", "shortName": "EQUITY- BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11301 - Disclosure - REVENUE RECOGNITION", "role": "http://www.xxiicentury.com/role/DisclosureRevenueRecognition", "shortName": "REVENUE RECOGNITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "reportCount": 1, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "lang": null, "name": "us-gaap:ShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11401 - Disclosure - EARNINGS PER SHARE", "role": "http://www.xxiicentury.com/role/DisclosureEarningsPerShare", "shortName": "EARNINGS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20102 - Disclosure - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - INVENTORY (Tables)", "role": "http://www.xxiicentury.com/role/DisclosureInventoryTables", "shortName": "INVENTORY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables)", "role": "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetTables", "shortName": "PROPERTY, PLANT AND EQUIPMENT, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30403 - Disclosure - RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS AND OTHER LEASES (Tables)", "role": "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesTables", "shortName": "RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS AND OTHER LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30503 - Disclosure - INVESTMENTS AND OTHER ASSETS (Tables)", "role": "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTables", "shortName": "INVESTMENTS AND OTHER ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30603 - Disclosure - FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS (Tables)", "role": "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAndShortTermInvestmentsTables", "shortName": "FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30703 - Disclosure - INTANGIBLE ASSETS (Tables)", "role": "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsTables", "shortName": "INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30803 - Disclosure - NOTES PAYABLE (Tables)", "role": "http://www.xxiicentury.com/role/DisclosureNotesPayableTables", "shortName": "NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31003 - Disclosure - CAPITAL RAISE AND WARRANT EXERCISE (Tables)", "role": "http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseTables", "shortName": "CAPITAL RAISE AND WARRANT EXERCISE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31103 - Disclosure - COMMITMENTS & CONTINGENCIES (Tables)", "role": "http://www.xxiicentury.com/role/DisclosureCommitmentsContingenciesTables", "shortName": "COMMITMENTS & CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31203 - Disclosure - EQUITY- BASED COMPENSATION (Tables)", "role": "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationTables", "shortName": "EQUITY- BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31303 - Disclosure - REVENUE RECOGNITION (Tables)", "role": "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionTables", "shortName": "REVENUE RECOGNITION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31403 - Disclosure - EARNINGS PER SHARE (Tables)", "role": "http://www.xxiicentury.com/role/DisclosureEarningsPerShareTables", "shortName": "EARNINGS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "us-gaap:ConsolidationPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": "INF", "first": true, "lang": null, "name": "xxii:NumberOfSubsidiaries", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_subsidiary_B5_Mkc5CdUWIrwXjknYSRA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40101 - Disclosure - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "role": "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails", "shortName": "NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:ConsolidationPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": "INF", "first": true, "lang": null, "name": "xxii:NumberOfSubsidiaries", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_subsidiary_B5_Mkc5CdUWIrwXjknYSRA", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "xxii:InventoryTobaccoLeafGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - INVENTORY (Details)", "role": "http://www.xxiicentury.com/role/DisclosureInventoryDetails", "shortName": "INVENTORY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "xxii:InventoryTobaccoLeafGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details)", "role": "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails", "shortName": "PROPERTY, PLANT AND EQUIPMENT, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_pyMDeKePKkmIIx8bCCXVEQ", "decimals": "-3", "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS AND OTHER LEASES (Details)", "role": "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails", "shortName": "RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS AND OTHER LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermInvestments", "reportCount": 1, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - INVESTMENTS AND OTHER ASSETS - Total carrying value (Details)", "role": "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails", "shortName": "INVESTMENTS AND OTHER ASSETS - Total carrying value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:InvestmentTableTextBlock", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_xxii_AuroraCannabisIncMember_us-gaap_FinancialInstrumentAxis_us-gaap_WarrantMember_MtRQ55N54E-vcavyqH_5mw", "decimals": "-3", "lang": null, "name": "us-gaap:LongTermInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermInvestments", "reportCount": 1, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40502 - Disclosure - INVESTMENTS AND OTHER ASSETS (Details)", "role": "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "shortName": "INVESTMENTS AND OTHER ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_12_3_2019_To_12_3_2019_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_xxii_InvestmentInPanaceaLifeSciencesInc.Member_rCczuQE9ikCKO7LyXC1hGg", "decimals": "-3", "lang": null, "name": "us-gaap:PaymentsToAcquireInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_41vjDGCcj0yrQphljcWxTA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS", "role": "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_41vjDGCcj0yrQphljcWxTA", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_FairValueByAssetClassAxis_us-gaap_MoneyMarketFundsMember_O3lDBu7YcEGc0_IYpSOS8w", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:NetAssetValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_oENUtU8dYUqBvUWnJRc59Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - FAIR VALUE MEASUREMENTS - Recurring (Details)", "role": "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails", "shortName": "FAIR VALUE MEASUREMENTS - Recurring (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_us-gaap_FairValueByAssetClassAxis_us-gaap_MoneyMarketFundsMember_O3lDBu7YcEGc0_IYpSOS8w", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:NetAssetValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_oENUtU8dYUqBvUWnJRc59Q", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_pyMDeKePKkmIIx8bCCXVEQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40602 - Disclosure - FAIR VALUE MEASUREMENTS - Changes in fair value, Level 3 (Details)", "role": "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsChangesInFairValueLevel3Details", "shortName": "FAIR VALUE MEASUREMENTS - Changes in fair value, Level 3 (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_pyMDeKePKkmIIx8bCCXVEQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40603 - Disclosure - FAIR VALUE MEASUREMENTS - Available-for-sale securities (Details)", "role": "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails", "shortName": "FAIR VALUE MEASUREMENTS - Available-for-sale securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_pyMDeKePKkmIIx8bCCXVEQ", "decimals": "-3", "lang": null, "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40604 - Disclosure - FAIR VALUE MEASUREMENTS - Maturity of available-for-sale securities by contractual maturity (Details)", "role": "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails", "shortName": "FAIR VALUE MEASUREMENTS - Maturity of available-for-sale securities by contractual maturity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill", "reportCount": 1, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - INTANGIBLE ASSETS (Details)", "role": "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails", "shortName": "INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_41vjDGCcj0yrQphljcWxTA", "decimals": "-3", "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_5_12_2020_To_5_12_2020_q5LK2nn4oE-p-8RVWRvdhw", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - NOTES PAYABLE (Details)", "role": "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails", "shortName": "NOTES PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_5_12_2020_To_5_12_2020_q5LK2nn4oE-p-8RVWRvdhw", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_4_1_2020_To_6_30_2020_MJomnABLwkG_1TCFnwqAgw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PostemploymentBenefitsPeriodExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40901 - Disclosure - SEVERANCE LIABILITY (Details)", "role": "http://www.xxiicentury.com/role/DisclosureSeveranceLiabilityDetails", "shortName": "SEVERANCE LIABILITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:PostemploymentBenefitsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_4_1_2020_To_6_30_2020_MJomnABLwkG_1TCFnwqAgw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PostemploymentBenefitsPeriodExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_6_7_2021_To_6_7_2021_DVczQTKs3EewGI-J_L_L4w", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41001 - Disclosure - CAPITAL RAISE AND WARRANT EXERCISE - Capital raise (Details)", "role": "http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseCapitalRaiseDetails", "shortName": "CAPITAL RAISE AND WARRANT EXERCISE - Capital raise (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_6_7_2021_fLBH_2k-2UCwEHmtb7eLsA", "decimals": "2", "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_oENUtU8dYUqBvUWnJRc59Q", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_wFpwFQo4DUWo0Z_s2mYb1w", "decimals": "0", "first": true, "lang": null, "name": "xxii:NumberOfWarrantsExercised", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41002 - Disclosure - CAPITAL RAISE AND WARRANT EXERCISE - Warrants (Details)", "role": "http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseWarrantsDetails", "shortName": "CAPITAL RAISE AND WARRANT EXERCISE - Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_wFpwFQo4DUWo0Z_s2mYb1w", "decimals": "0", "first": true, "lang": null, "name": "xxii:NumberOfWarrantsExercised", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "us-gaap:CommitmentsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41101 - Disclosure - COMMITMENTS AND CONTINGENCIES - Licenses (Details)", "role": "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Licenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "us-gaap:CommitmentsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_GWXT6R73i0yO4B5h1-bT8Q", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY", "role": "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2020_To_3_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_wSWBBYTSIk6qv0OiP5Vszw", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_6_7_2021_To_6_7_2021_DVczQTKs3EewGI-J_L_L4w", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41102 - Disclosure - COMMITMENTS AND CONTINGENCIES - MRTP, litigation (Details)", "role": "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesMrtpLitigationDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - MRTP, litigation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_1_15_2020_IkVH_2LvqUeALhxslTfOtA", "decimals": "INF", "lang": null, "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_item_8Nq_gmiEiEuMpBgiTVWJYw", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41201 - Disclosure - EQUITY-BASED COMPENSATION (Details)", "role": "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationDetails", "shortName": "EQUITY-BASED COMPENSATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_6_30_2021_jcyhC6HFV02Zfl4vK3Eilw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41202 - Disclosure - EQUITY- BASED COMPENSATION - RSUs (Details)", "role": "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails", "shortName": "EQUITY- BASED COMPENSATION - RSUs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_41vjDGCcj0yrQphljcWxTA", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_6_30_2021_jcyhC6HFV02Zfl4vK3Eilw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41203 - Disclosure - EQUITY- BASED COMPENSATION - Stock option activity (Details)", "role": "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails", "shortName": "EQUITY- BASED COMPENSATION - Stock option activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_wFpwFQo4DUWo0Z_s2mYb1w", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_PAD-xcEQWECu03p1MM3Z6g", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41204 - Disclosure - EQUITY BASED COMPENSATION - Fair value assumptions (Details)", "role": "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationFairValueAssumptionsDetails", "shortName": "EQUITY BASED COMPENSATION - Fair value assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_PAD-xcEQWECu03p1MM3Z6g", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_41vjDGCcj0yrQphljcWxTA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41205 - Disclosure - EQUITY-BASED COMPENSATION - Compensation expense and unrecognized compensation (Details)", "role": "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationCompensationExpenseAndUnrecognizedCompensationDetails", "shortName": "EQUITY-BASED COMPENSATION - Compensation expense and unrecognized compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_41vjDGCcj0yrQphljcWxTA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_9_30_2021_5PvYguFaVEmImCdkUjWKHw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41301 - Disclosure - REVENUE RECOGNITION (Details)", "role": "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails", "shortName": "REVENUE RECOGNITION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:AllowanceForDoubtfulAccountsReceivable", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "As_Of_12_31_2020_pyMDeKePKkmIIx8bCCXVEQ", "decimals": "-3", "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_41vjDGCcj0yrQphljcWxTA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41401 - Disclosure - EARNINGS PER SHARE (Details)", "role": "http://www.xxiicentury.com/role/DisclosureEarningsPerShareDetails", "shortName": "EARNINGS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R58": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_41vjDGCcj0yrQphljcWxTA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41402 - Disclosure - EARNINGS PER SHARE - Anti-dilutive securities (Details)", "role": "http://www.xxiicentury.com/role/DisclosureEarningsPerShareAntiDilutiveSecuritiesDetails", "shortName": "EARNINGS PER SHARE - Anti-dilutive securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_7_1_2021_To_9_30_2021_41vjDGCcj0yrQphljcWxTA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_g-t_gtjx-UiYfNM0PZD8Zg", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_k8Q5UAfQ-kqBp2hhiEiMMw", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPolicies", "shortName": "NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - INVENTORY", "role": "http://www.xxiicentury.com/role/DisclosureInventory", "shortName": "INVENTORY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - PROPERTY, PLANT AND EQUIPMENT", "role": "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipment", "shortName": "PROPERTY, PLANT AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "xxii-20210930x10q.htm", "contextRef": "Duration_1_1_2021_To_9_30_2021_lqhzCEOK1UunBKZWHKq93g", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 66, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r539" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.xxiicentury.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_CondensedFinancialStatementsCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Financial Statements, Captions [Line Items]" } } }, "localname": "CondensedFinancialStatementsCaptionsLineItems", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r549" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsContingenciesTables" ], "xbrltype": "textBlockItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r44", "r46", "r103", "r104", "r238", "r258", "r561" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails", "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r237", "r257", "r313", "r314", "r435", "r436", "r437", "r438", "r439", "r440", "r459", "r503", "r505", "r533", "r534" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r237", "r257", "r313", "r314", "r435", "r436", "r437", "r438", "r439", "r440", "r459", "r503", "r505", "r533", "r534" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r150", "r289", "r292", "r465", "r502", "r504" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesMrtpLitigationDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r150", "r289", "r292", "r465", "r502", "r504" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesMrtpLitigationDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r237", "r257", "r304", "r313", "r314", "r435", "r436", "r437", "r438", "r439", "r440", "r459", "r503", "r505", "r533", "r534" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r237", "r257", "r304", "r313", "r314", "r435", "r436", "r437", "r438", "r439", "r440", "r459", "r503", "r505", "r533", "r534" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": { "auth_ref": [ "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r563" ], "lang": { "en-us": { "role": { "documentation": "Information by name of property.", "label": "Name of Property [Axis]" } } }, "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "stringItemType" }, "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": { "auth_ref": [ "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559" ], "lang": { "en-us": { "role": { "documentation": "Name of the property, for example, but not limited to, ABC Shopping Center.", "label": "Name of Property [Domain]" } } }, "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r45", "r46", "r103", "r104", "r238", "r258" ], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails", "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedFinancialStatementsTable": { "auth_ref": [ "r105", "r366", "r560", "r562", "r564", "r565" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.", "label": "Condensed Financial Statements [Table]" } } }, "localname": "ScheduleOfCondensedFinancialStatementsTable", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r33", "r427" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r5", "r17", "r153", "r154" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionExpense": { "auth_ref": [ "r218", "r219", "r220" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.", "label": "Accretion Expense", "terseLabel": "Accretion of non cash interest expense" } } }, "localname": "AccretionExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r31", "r213" ], "calculation": { "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r20", "r50", "r51", "r52", "r491", "r510", "r511" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive (loss) income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r49", "r52", "r60", "r61", "r62", "r107", "r108", "r109", "r373", "r506", "r507", "r566" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r18", "r347", "r427" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Capital in excess of par value" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r107", "r108", "r109", "r344", "r345", "r346", "r381" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Capital in Excess of Par Value [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r88", "r205" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r155", "r179", "r181", "r182" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance for Doubtful Accounts Receivable", "terseLabel": "Allowance for discounts or returns and allowances" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r88", "r197", "r205" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "verboseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Securities outstanding but excluded from computation of earnings per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land held.", "label": "Area of Land" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Arrangements and Non-arrangement Transactions [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails", "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r100", "r139", "r142", "r148", "r175", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r368", "r374", "r400", "r425", "r427", "r470", "r489" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails", "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r7", "r43", "r100", "r175", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r368", "r374", "r400", "r425", "r427" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r385" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Assets at fair value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r160" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax", "verboseLabel": "Available-for-sale Securities - Gross Unrealized Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r161" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax", "negatedLabel": "Available-for-sale Securities - Gross Unrealized Losses" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r158", "r187" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale, Amortized Cost", "totalLabel": "REPLACED Available For Sale Securities, Amortized Cost", "verboseLabel": "REPLACED Available-for-sale Securities - Amortized Cost Basis" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails", "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": { "auth_ref": [ "r165" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost", "terseLabel": "Available For Sale, Maturities One Through Five Years, Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": { "auth_ref": [ "r162", "r165", "r485" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value", "terseLabel": "Available For Sale, Maturities One Through Five Years, Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": { "auth_ref": [ "r164" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost", "verboseLabel": "Available For Sale, Maturities One Year or Less, Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": { "auth_ref": [ "r162", "r164", "r484" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value", "verboseLabel": "Available For Sale, Maturities One Year or Less, Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r157", "r159", "r187", "r475" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails": { "order": 3.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 }, "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-sale", "totalLabel": "Available For Sale Securities, Fair Value", "verboseLabel": "Available-for-sale Securities - Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails", "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "verboseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BorrowingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Obligations to pay to another in accordance with an expressed or implied agreement.", "label": "Borrowings [Member]" } } }, "localname": "BorrowingsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building and Leasehold improvements" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r84", "r90", "r95" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents - end of period", "periodStartLabel": "Cash and cash equivalents - beginning of period", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r84", "r401" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrant outstanding balance" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseWarrantsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r39", "r223", "r477", "r495" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies.", "terseLabel": "Commitments and contingencies (Note 11)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsDisclosureTextBlock": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.", "label": "Commitments Disclosure [Text Block]", "verboseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r107", "r108", "r381" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r15", "r271" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r15", "r427" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock value" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r55", "r57", "r58", "r70", "r481", "r499" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r96", "r370" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "verboseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Schedule of contract assets and liabilities" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r277", "r279", "r290" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails": { "order": 1.0, "parentTag": "xxii_ContractAssetLiabilityNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, Net, Current", "verboseLabel": "Unbilled receivables" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r277", "r278", "r290" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails": { "order": 2.0, "parentTag": "xxii_ContractAssetLiabilityNet", "weight": -1.0 }, "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "negatedLabel": "Deferred revenue", "terseLabel": "Deferred income" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails", "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligation": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.", "label": "Contractual Obligation", "totalLabel": "Contractual Obligation, Total" } } }, "localname": "ContractualObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInNextTwelveMonths": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails": { "order": 2.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation, Due in Next Fiscal Year", "terseLabel": "2022" } } }, "localname": "ContractualObligationDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInSecondYear": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails": { "order": 3.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation, Due in Second Year", "terseLabel": "2023" } } }, "localname": "ContractualObligationDueInSecondYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInThirdYear": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails": { "order": 4.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation, Due in Third Year", "terseLabel": "2024" } } }, "localname": "ContractualObligationDueInThirdYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationFiscalYearMaturityScheduleAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contractual Obligation, Fiscal Year Maturity Schedule [Abstract]" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails": { "order": 5.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in remainder of current fiscal year.", "label": "Contractual Obligation, Future Minimum Payments Due, Remainder of Fiscal Year", "terseLabel": "2021" } } }, "localname": "ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualRightsMember": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).", "label": "MSA Signatory Costs" } } }, "localname": "ContractualRightsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateBondSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).", "label": "Corporate Bonds" } } }, "localname": "CorporateBondSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails", "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": { "auth_ref": [ "r66", "r67" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "xxii_GrossProfitExcludingDepreciation", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.", "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization", "terseLabel": "Products" } } }, "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization [Abstract]", "terseLabel": "Cost of goods sold (exclusive of depreciation shown separately below):" } } }, "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInventoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure Abstract" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r98", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r247", "r248", "r249", "r251", "r254" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "NOTES PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r38", "r236" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss": { "auth_ref": [ "r163" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss", "terseLabel": "Available-for-sale Securities - Amortized Cost Basis", "totalLabel": "Available for sale securities, amortized cost, total" } } }, "localname": "DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails", "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsMaturityOfAvailableForSaleSecuritiesByContractualMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r88", "r211" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense", "verboseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r289", "r292", "r293", "r294", "r295", "r296", "r297", "r298" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of disaggregation of revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure of Compensation Related Costs, Share-based Payments [Text Block]", "terseLabel": "EQUITY- BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EQUITY- BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r319", "r342" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of share-based payment arrangement.", "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]", "terseLabel": "Schedule of compensation costs related to restricted stock and stock options" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EARNINGS PER SHARE" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r120" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Net loss per common share - basic and diluted", "verboseLabel": "Loss per common share - basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r122", "r123", "r124", "r125" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "verboseLabel": "EARNINGS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "terseLabel": "Unrecognized compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationCompensationExpenseAndUnrecognizedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized compensation, period for recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationCompensationExpenseAndUnrecognizedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Laboratory equipment [Member]" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r60", "r61", "r62", "r107", "r108", "r109", "r111", "r116", "r118", "r126", "r178", "r271", "r273", "r344", "r345", "r346", "r358", "r359", "r381", "r402", "r403", "r404", "r405", "r406", "r408", "r506", "r507", "r508", "r566" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentsPolicy": { "auth_ref": [ "r29", "r83", "r174", "r400" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.", "label": "Equity Method Investments [Policy Text Block]", "verboseLabel": "Investments" } } }, "localname": "EquityMethodInvestmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesFvNiMeasurementInput": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Measurement Input" } } }, "localname": "EquitySecuritiesFvNiMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_EquitySecuritiesFvNiMeasurementInputExtensibleList": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Indicates measurement input for investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Measurement Input [Extensible List]" } } }, "localname": "EquitySecuritiesFvNiMeasurementInputExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": { "auth_ref": [ "r170" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.", "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount", "negatedLabel": "Impairment of Panacea investment", "terseLabel": "Impairment of Panacea investment" } } }, "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "auth_ref": [ "r392" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.", "label": "Fair Value, Assets Measured on Recurring Basis, Change in Unrealized Gain (Loss)", "verboseLabel": "Unrealized gain as a result of change in fair value" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsChangesInFairValueLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r385", "r386" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of assets and liabilities measured at fair value" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAndShortTermInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails", "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r390", "r394" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "verboseLabel": "Schedule of the changes in fair value of Level 3 investments" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAndShortTermInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails", "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r385", "r394" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails", "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r385", "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails", "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r246", "r252", "r253", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r386", "r432", "r433", "r434" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value, Hierarchy [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r393", "r394" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r385", "r386", "r388", "r389", "r395" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "verboseLabel": "FAIR VALUE MEASUREMENTS AND SHORT-TERM INVESTMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAndShortTermInvestments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r246", "r305", "r306", "r311", "r312", "r386", "r432" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r246", "r252", "r253", "r305", "r306", "r311", "r312", "r386", "r433" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r246", "r252", "r253", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r386", "r434" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": { "auth_ref": [ "r391" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements", "negatedLabel": "Panacea investment conversion" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsChangesInFairValueLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "auth_ref": [ "r390" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "periodEndLabel": "Fair value at end of the period", "periodStartLabel": "Fair value at beginning of the period" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsChangesInFairValueLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r246", "r252", "r253", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r432", "r433", "r434" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r393", "r395" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r396", "r397" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "verboseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r166", "r167", "r169", "r170", "r171", "r180", "r183", "r184", "r185", "r186", "r188", "r189", "r190", "r191", "r250", "r269", "r380", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r541", "r542", "r543", "r544", "r545", "r546", "r547" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r204" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Less: accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r198", "r201", "r204", "r207", "r466", "r467" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r204", "r467" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails", "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r198", "r203" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r204", "r466" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net [Abstract]", "verboseLabel": "Intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [ "r199" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.", "label": "Finite-lived Intangible Assets Acquired", "terseLabel": "License acquired" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Office furniture, fixtures and equipment [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusAxis": { "auth_ref": [ "r315", "r316", "r340" ], "lang": { "en-us": { "role": { "documentation": "Information by status of recipient to whom award is granted.", "label": "Grantee Status [Axis]" } } }, "localname": "GranteeStatusAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Status of recipient to whom award is granted.", "label": "Grantee Status [Domain]" } } }, "localname": "GranteeStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r88", "r208" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.", "label": "Impairment Of Intangible Assets Excluding Goodwill", "verboseLabel": "Impairment of intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r210", "r216" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "verboseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r65", "r139", "r141", "r144", "r147", "r149", "r468", "r478", "r483", "r500" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r215", "r221" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationCompensationExpenseAndUnrecognizedCompensationDetails", "http://www.xxiicentury.com/role/DisclosureInventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationCompensationExpenseAndUnrecognizedCompensationDetails", "http://www.xxiicentury.com/role/DisclosureInventoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r101", "r117", "r118", "r138", "r353", "r360", "r361", "r501" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r59", "r351", "r352", "r354", "r355", "r356", "r357" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r87" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r87" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r87" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r87", "r460" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred income" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredCompensation": { "auth_ref": [ "r87" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.", "label": "Increase (Decrease) in Deferred Compensation", "terseLabel": "Accrued severance" } } }, "localname": "IncreaseDecreaseInDeferredCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r87" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Assets [Abstract]", "verboseLabel": "(Increase) decrease in assets:" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r87", "r416" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Operating lease obligations" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Liabilities [Abstract]", "verboseLabel": "Increase (decrease) in liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r87" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r200", "r206" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r206" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Indefinite-lived intangible assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r200", "r206" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r209" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "INTANGIBLE ASSETS" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r97", "r203", "r462", "r463", "r464", "r466" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "verboseLabel": "Intangible Assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r196", "r202" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "totalLabel": "Intangible assets, net", "verboseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails", "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntellectualPropertyMember": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.", "label": "Patent and Trademark [Member]" } } }, "localname": "IntellectualPropertyMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r64", "r137", "r410", "r411", "r482" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r81", "r85", "r91" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Net", "terseLabel": "Cash paid during the period for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryCurrentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Current [Table]" } } }, "localname": "InventoryCurrentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVENTORY" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "INVENTORY" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r41" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureInventoryDetails": { "order": 4.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Inventory - finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Inventory [Line Items]" } } }, "localname": "InventoryLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInventoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r42", "r427" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventory, net", "totalLabel": "Inventory, Net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInventoryDetails", "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r42", "r193" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureInventoryDetails": { "order": 5.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Less: inventory reserve" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r192" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "verboseLabel": "Inventory write-off" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInventoryDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r72", "r74" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Net", "terseLabel": "Interest income, net" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentInterestRate": { "auth_ref": [ "r163", "r166" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest on investment.", "label": "Investment Interest Rate", "terseLabel": "Note receivable interest rate" } } }, "localname": "InvestmentInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentOwnedBalanceShares": { "auth_ref": [ "r514", "r515" ], "lang": { "en-us": { "role": { "documentation": "Balance held at close of period in number of shares.", "label": "Investment Owned, Balance, Shares", "terseLabel": "Number of shares held in investee" } } }, "localname": "InvestmentOwnedBalanceShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_InvestmentTableTextBlock": { "auth_ref": [ "r168", "r172", "r176", "r177" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment.", "label": "Investment [Table Text Block]", "terseLabel": "Schedule of carrying value of investments" } } }, "localname": "InvestmentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "verboseLabel": "Schedule of available for sale securities classified by contractual maturity" } } }, "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAndShortTermInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INVESTMENTS & OTHER ASSETS" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r168", "r469", "r486", "r520", "r548" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "terseLabel": "INVESTMENTS & OTHER ASSETS" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Summary of discount rate and lease term" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of future minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r420" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, Payments, Due", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r420" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r420" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r420" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r420" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r420" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r420" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r420" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "verboseLabel": "RIGHT-OF-USE ASSETS, LEASE OBLIGATIONS, AND OTHER LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeaseRenewalTerm": { "auth_ref": [ "r423" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Renewal Term", "terseLabel": "Renewal term" } } }, "localname": "LessorOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r423" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Term of Contract", "terseLabel": "Initial lease term" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r35", "r100", "r143", "r175", "r225", "r226", "r227", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r369", "r374", "r375", "r400", "r425", "r426" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r23", "r100", "r175", "r400", "r427", "r472", "r493" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and shareholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r37", "r100", "r175", "r225", "r226", "r227", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r369", "r374", "r375", "r400", "r425", "r426", "r427" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Long-term liabilities:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicensingAgreementsMember": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).", "label": "Licensing agreements" } } }, "localname": "LicensingAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r29" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-term Investments", "terseLabel": "Investments" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails", "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by category of items purchased under a long-term purchase commitment.", "label": "Category of Item Purchased [Axis]" } } }, "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment.", "label": "Long-term Purchase Commitment, Category of Item Purchased [Domain]" } } }, "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyPendingClaimsNumber": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Number of pending claims pertaining to a loss contingency.", "label": "Loss Contingency, Pending Claims, Number", "terseLabel": "Number of counts" } } }, "localname": "LossContingencyPendingClaimsNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesMrtpLitigationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_MarketableSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Marketable Securities [Line Items]" } } }, "localname": "MarketableSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecuritiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in marketable security.", "label": "Marketable Securities [Table]" } } }, "localname": "MarketableSecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using amount by which value of business ownership interest is reduced to reflect lack of ability to convert business interest into cash quickly.", "label": "Discount for lack of marketability" } } }, "localname": "MeasurementInputDiscountForLackOfMarketabilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Risk-free rate" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetAssetValuePerShare": { "auth_ref": [ "r383", "r384", "r395", "r512", "r513" ], "lang": { "en-us": { "role": { "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.", "label": "Net Asset Value Per Share" } } }, "localname": "NetAssetValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r84" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r84" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r84", "r86", "r89" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r53", "r56", "r62", "r68", "r89", "r100", "r110", "r112", "r113", "r114", "r115", "r117", "r118", "r119", "r139", "r141", "r144", "r147", "r149", "r175", "r225", "r226", "r227", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r382", "r400", "r479", "r497" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Net loss attributed to common shareholders", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "netLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetRentableArea": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net rentable area for properties owned.", "label": "Net Rentable Area", "terseLabel": "Area under operating lease" } } }, "localname": "NetRentableArea", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "areaItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "verboseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Non-cash transactions:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": { "auth_ref": [ "r92", "r93", "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired", "verboseLabel": "Panacea conversion assets included in acquisition of property, plant and equipment" } } }, "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r73" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "verboseLabel": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r13", "r471", "r490" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Notes Payable", "terseLabel": "Notes Payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r34" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable, Current", "terseLabel": "Notes payable", "totalLabel": "Notes Payable, Current, Total" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails", "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.", "label": "Notes Receivable [Member]" } } }, "localname": "NotesReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails", "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NotesReceivableRelatedPartiesNoncurrent": { "auth_ref": [ "r9", "r16", "r102", "r424" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amounts due from parties associated with the reporting entity as evidenced by a written promise to pay, due after 1 year (or 1 business cycle).", "label": "Notes Receivable, Related Parties, Noncurrent", "terseLabel": "Note receivable", "totalLabel": "Note receivable" } } }, "localname": "NotesReceivableRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r139", "r141", "r144", "r147", "r149" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r415", "r421" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Lease, Cost", "terseLabel": "Amortization of ROU assets" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r413" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r413" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease obligations" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r413" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease obligations" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r412" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating leases right-of-use assets, net" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r418", "r421" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r417", "r421" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term in years" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OptionMember": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received).", "label": "Options [ Member]" } } }, "localname": "OptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r3", "r106", "r134", "r378" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]", "terseLabel": "NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r32" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Commitments [Line Items]" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails", "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesMrtpLitigationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails", "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesMrtpLitigationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax": { "auth_ref": [ "r47", "r48" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments, after Tax", "terseLabel": "Unrealized gain (loss) on short-term investment securities" } } }, "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r52", "r60", "r61", "r63", "r402", "r404", "r408" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "Reclassification of losses (gains) to net loss" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r54", "r57", "r60", "r61", "r63", "r69", "r271", "r402", "r407", "r408", "r480", "r498" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r47", "r50" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax", "verboseLabel": "Unrealized gain (loss) on short-term investment securities" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherMachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other tangible personal property, nonconsumable in nature, with finite lives used to produce goods and services.", "label": "Cigarette manufacturing equipment [Member]" } } }, "localname": "OtherMachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r79" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedLabel": "Taxes paid related to net share settlement of RSUs" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r75" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Acquisition of patents and trademarks" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r76" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "terseLabel": "Amount paid to acquire investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r75" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Acquisition of property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireShortTermInvestments": { "auth_ref": [ "r76" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.", "label": "Payments to Acquire Short-term Investments", "negatedLabel": "Purchase of short-term investment securities" } } }, "localname": "PaymentsToAcquireShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PostemploymentBenefitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Postemployment Benefits [Abstract]" } } }, "localname": "PostemploymentBenefitsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PostemploymentBenefitsDisclosureTextBlock": { "auth_ref": [ "r302", "r303" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for postemployment benefits, which may include supplemental unemployment benefits, obligations recognized for all types of benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement. Disclosure may also include discussion that an obligation for postemployment benefits is not accrued in accordance with regulation only because the amount cannot be reasonably estimated.", "label": "Postemployment Benefits Disclosure [Text Block]", "terseLabel": "SEVERANCE LIABILITY" } } }, "localname": "PostemploymentBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureSeveranceLiability" ], "xbrltype": "textBlockItemType" }, "us-gaap_PostemploymentBenefitsLiabilityCurrent": { "auth_ref": [ "r36", "r300", "r301" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureSeveranceLiabilityDetails": { "order": 2.0, "parentTag": "us-gaap_PostemploymentBenefitsLiabilityCurrentAndNoncurrent", "weight": 1.0 }, "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For a classified balance sheet, the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement that is payable within one year of the balance sheet date.", "label": "Postemployment Benefits Liability, Current", "terseLabel": "Accrued severance, current" } } }, "localname": "PostemploymentBenefitsLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureSeveranceLiabilityDetails", "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PostemploymentBenefitsLiabilityCurrentAndNoncurrent": { "auth_ref": [ "r300", "r301", "r476", "r496" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureSeveranceLiabilityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount as of the balance sheet date of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.", "label": "Postemployment Benefits Liability", "totalLabel": "Severance liability, total" } } }, "localname": "PostemploymentBenefitsLiabilityCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureSeveranceLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PostemploymentBenefitsLiabilityNoncurrent": { "auth_ref": [ "r300", "r301" ], "calculation": { "http://www.xxiicentury.com/role/DisclosureSeveranceLiabilityDetails": { "order": 1.0, "parentTag": "us-gaap_PostemploymentBenefitsLiabilityCurrentAndNoncurrent", "weight": 1.0 }, "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For a classified balance sheet, the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement that is payable after one year (or beyond the operating cycle if longer).", "label": "Postemployment Benefits Liability, Noncurrent", "terseLabel": "Accrued severance, noncurrent", "verboseLabel": "Severance obligations" } } }, "localname": "PostemploymentBenefitsLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureSeveranceLiabilityDetails", "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PostemploymentBenefitsPeriodExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Period expense related to postemployment benefits.", "label": "Postemployment Benefits, Period Expense", "terseLabel": "Severance expense" } } }, "localname": "PostemploymentBenefitsPeriodExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureSeveranceLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock, Dividend Rate, Percentage", "terseLabel": "Dividend rate" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails", "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r14", "r255" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r6", "r27", "r28" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Policy [Policy Text Block]", "verboseLabel": "Reclassifications" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r77" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "verboseLabel": "Net proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r78" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Proceeds from SBA loan" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r78" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from Notes Payable", "terseLabel": "Proceeds from note payable issuance" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale, maturities, repayments and calls of securities classified as trading securities and held for investment purposes. Excludes proceeds from trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).", "label": "Proceeds from Sale and Maturity of Trading Securities Held-for-investment", "terseLabel": "Sales and maturities of short-term investment securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r77", "r343" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Net proceeds from option exercises" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r77" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Warrant Exercises", "terseLabel": "Net proceeds from warrant exercises" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseWarrantsDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesMrtpLitigationDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r2", "r53", "r56", "r62", "r82", "r100", "r110", "r117", "r118", "r139", "r141", "r144", "r147", "r149", "r175", "r225", "r226", "r227", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r367", "r371", "r372", "r376", "r377", "r382", "r400", "r483" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PROPERTY, PLANT AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r31", "r214" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r217", "r521", "r522", "r523" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "verboseLabel": "PROPERTY, PLANT AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r30", "r212" ], "calculation": { "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r10", "r11", "r214", "r427", "r487", "r494" ], "calculation": { "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Total property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails", "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r10", "r214" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "verboseLabel": "Schedule of Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r10", "r212" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r80" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedLabel": "Repayment of SBA loan" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r80" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Payment on note payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r350", "r461", "r535" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development", "verboseLabel": "Research and development expense" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesMrtpLitigationDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationCompensationExpenseAndUnrecognizedCompensationDetails", "http://www.xxiicentury.com/role/DisclosureInventoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted stock units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r19", "r273", "r347", "r427", "r492", "r509", "r511" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r107", "r108", "r109", "r111", "r116", "r118", "r178", "r344", "r345", "r346", "r358", "r359", "r381", "r506", "r508" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue:" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r135", "r136", "r140", "r145", "r146", "r150", "r151", "r152", "r288", "r289", "r465" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "xxii_GrossProfitExcludingDepreciation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "verboseLabel": "Sale of products, net" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r291", "r299" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "REVENUE RECOGNITION" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognition" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "verboseLabel": "Schedule of anti-dilutive shares excluded from dilutive securities" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.", "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]", "verboseLabel": "Schedule of available-for-sale securities reconciliation" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAndShortTermInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of notes payable balances" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "verboseLabel": "Schedule of computation of basic and diluted earnings per common share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "terseLabel": "Schedule of Intangible Assets" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r8", "r24", "r25", "r26" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r31", "r214" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosurePropertyPlantAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]", "verboseLabel": "Schedule of stock option activity" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r319", "r342" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationCompensationExpenseAndUnrecognizedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Summary of changes in unvested restricted stock" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "verboseLabel": "Schedule of fair value assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r275", "r317" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Schedule of warrant activity" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r71" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Sales, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationCompensationExpenseAndUnrecognizedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r87" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Compensation", "terseLabel": "Equity-based employee compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationCompensationExpenseAndUnrecognizedCompensationDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]", "terseLabel": "Weighted Average Remaining Contractual Term" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails", "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "RSUs forfeited, number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "RSUs forfeited, grant-date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "RSUs granted, number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "RSUs granted, grant-date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Nonvested, Number, Ending Balance", "periodStartLabel": "Nonvested, Number, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "RSUs, Number of shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Nonvested, Weighted Average Grant Date Fair Value, Ending Balance", "periodStartLabel": "Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "RSUs, Weighted average grant-date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "RSUs vested, number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r334" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Fair value of RSUs that vested during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "RSUs vested, grant-date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationRsusDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "verboseLabel": "Expected stock price volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "verboseLabel": "Risk-free interest rate (weighted average)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationFairValueAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationCompensationExpenseAndUnrecognizedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Additional shares authorized during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Number of shares remaining for future awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]", "verboseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "verboseLabel": "Options exercisable, number, End of Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Options exercisable, End of Period, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period", "negatedLabel": "Options expired, number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Options forfeited, number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Options granted, number" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r342" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "verboseLabel": "Options, End of Period, aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r324", "r342" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options, number, End of Period", "periodStartLabel": "Options, number, Beginning of Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "verboseLabel": "Number of Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Options, End of Period, weighted average exercise price", "periodStartLabel": "Options, Beginning of Period, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "verboseLabel": "Options, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "verboseLabel": "Options exercised, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "verboseLabel": "Options expired, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Options forfeited, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Options granted, weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r319", "r321" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]", "verboseLabel": "Stock Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedPaymentArrangementEmployeeMember": { "auth_ref": [ "r316", "r340" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Officers and employees" } } }, "localname": "ShareBasedPaymentArrangementEmployeeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": { "auth_ref": [ "r315", "r340" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Directors" } } }, "localname": "ShareBasedPaymentArrangementNonemployeeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseCapitalRaiseDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r337", "r348" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "verboseLabel": "Expected life of options (weighted average)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationFairValueAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r342" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "verboseLabel": "Options exercisable, End of Period, aggregated intrinsic value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "verboseLabel": "Options exercisable, End of Period, weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Options, End of Period, weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r12", "r473", "r474", "r488" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-term Investments", "terseLabel": "Short-term investment securities" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermInvestmentsMember": { "auth_ref": [ "r516", "r517", "r518", "r519" ], "lang": { "en-us": { "role": { "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.", "label": "Short-term Investments [Member]" } } }, "localname": "ShortTermInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsAvailableForSaleSecuritiesDetails", "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r40", "r60", "r61", "r62", "r107", "r108", "r109", "r111", "r116", "r118", "r126", "r178", "r271", "r273", "r344", "r345", "r346", "r358", "r359", "r381", "r402", "r403", "r404", "r405", "r406", "r408", "r506", "r507", "r508", "r566" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r107", "r108", "r109", "r126", "r465" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r14", "r15", "r271", "r273" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Stock issued in connection with capital raise (in shares)", "verboseLabel": "Number of shares issued in settlement" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseCapitalRaiseDetails", "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesMrtpLitigationDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r271", "r273" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Stock issued in connection with RSU vesting (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r14", "r15", "r271", "r273" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures", "terseLabel": "Equity-based compensation (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r14", "r15", "r271", "r273", "r326" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Options exercised, number", "terseLabel": "Stock issued in connection with option exercises (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationStockOptionActivityDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r14", "r15", "r271", "r273" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Stock issued in connection with capital raise" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseCapitalRaiseDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.", "label": "Stock Issued During Period, Value, Purchase of Assets", "terseLabel": "Shares issued for Panacea, value" } } }, "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r14", "r15", "r271", "r273" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Stock issued in connection with RSU vesting" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r14", "r15", "r273", "r318", "r333" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures", "terseLabel": "Equity-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r40", "r271", "r273" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Stock issued in connection with option exercises" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r15", "r21", "r22", "r100", "r156", "r175", "r400", "r427" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "verboseLabel": "Shareholders' equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r99", "r256", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r270", "r273", "r276" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "CAPITAL RAISE AND WARRANT EXERCISE" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExercise" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "terseLabel": "Reverse stock split, ratio" } } }, "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "pureItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r409", "r428" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r409", "r428" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r409", "r428" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability for amount due employees, in addition to wages and any other money that employers owe employees, when their employment ends through a layoff or other termination. For example, a company may provide involuntarily terminated employees with a lump sum payment equal to one week's salary for every year of employment.", "label": "Supplemental Unemployment Benefits, Severance Benefits", "terseLabel": "Severance accrual" } } }, "localname": "SupplementalUnemploymentBenefitsSeveranceBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureSeveranceLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r289", "r297" ], "lang": { "en-us": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing of Transfer of Good or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [ "r289", "r297" ], "lang": { "en-us": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.", "label": "Timing of Transfer of Good or Service [Domain]" } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredAtPointInTimeMember": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred at point in time.", "label": "Transferred at Point in Time [Member]" } } }, "localname": "TransferredAtPointInTimeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred over Time [Member]" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r166", "r167", "r169", "r170", "r171", "r250", "r269", "r380", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r541", "r542", "r543", "r544", "r545", "r546", "r547" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Type of Arrangement and Non-arrangement Transactions [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails", "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r88" ], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "negatedLabel": "Unrealized (gain) loss on investment", "terseLabel": "Unrealized gain (loss) on investments" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r127", "r128", "r129", "r130", "r131", "r132", "r133" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "verboseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareAntiDilutiveSecuritiesDetails", "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WARRANT EXERCISE AND CAPITAL RAISE" } } }, "localname": "WarrantsAndRightsNoteDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and Rights Outstanding, Measurement Input", "verboseLabel": "Warrants measurement input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Weighted average common shares outstanding - basic and diluted (in thousands)" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEarningsPerShareDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" }, "xxii_AccelerationOfExerciseDatePeriodOfSalesTargetAchievementInConsecutiveYears": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of consecutive years of meeting sales targets which would result in acceleration of the exercise date.", "label": "Acceleration Of Exercise Date, Period Of Sales Target Achievement, In Consecutive Years", "terseLabel": "Number of years for acceleration of exercise date" } } }, "localname": "AccelerationOfExerciseDatePeriodOfSalesTargetAchievementInConsecutiveYears", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "durationItemType" }, "xxii_AccretedInterestIncomeOnConvertibleNoteReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents accreted interest income on convertible note receivable.", "label": "Accreted interest income on convertible note receivable", "terseLabel": "Accretion of interest on note" } } }, "localname": "AccretedInterestIncomeOnConvertibleNoteReceivable", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsChangesInFairValueLevel3Details" ], "xbrltype": "monetaryItemType" }, "xxii_AccretionIncome": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for the passage of time, typically for assets, including, but not limited to, investment bond discount/premium or interest on other investment assets.", "label": "Accretion Income", "negatedLabel": "Accretion of non-cash interest expense (income)" } } }, "localname": "AccretionIncome", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "xxii_AggregateMilestonePaymentsToBeMade": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of milestone payments that is to be made under license agreement.", "label": "Aggregate Milestone Payments to be Made", "terseLabel": "Aggregate milestone payments" } } }, "localname": "AggregateMilestonePaymentsToBeMade", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "xxii_AgreementTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement term expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Agreement Term" } } }, "localname": "AgreementTerm", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "durationItemType" }, "xxii_AmortizationAndDepreciationExcludingAmortizationOfIntangibles": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets to periods that benefit from use of the assets.", "label": "Amortization And Depreciation Excluding Amortization Of Intangibles", "terseLabel": "Amortization and depreciation" } } }, "localname": "AmortizationAndDepreciationExcludingAmortizationOfIntangibles", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "xxii_AmortizationOfLicenseFees": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of costs associated with license fees.", "label": "Amortization Of License Fees", "terseLabel": "Amortization of license fees" } } }, "localname": "AmortizationOfLicenseFees", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "xxii_AnnualRoyaltyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to commitment to pay annual royalty fee.", "label": "Annual Royalty [Member]" } } }, "localname": "AnnualRoyaltyMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "domainItemType" }, "xxii_AuroraCannabisIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aurora Cannabis, Inc.", "label": "Aurora Cannabis Inc [Member]" } } }, "localname": "AuroraCannabisIncMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "domainItemType" }, "xxii_BotanicalGeneticsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to Botanical Genetics.", "label": "Botanical Genetics [Member]" } } }, "localname": "BotanicalGeneticsMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "xxii_CannametrixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to Cannametrix.", "label": "Cannametrix [Member]" } } }, "localname": "CannametrixMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "domainItemType" }, "xxii_CollaborativeArrangementMilestonePaymentSubsequentToUpfrontPayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of milestone payment beyond the upfront payment, in one or more installments, due from the entity to the counterparty under the collaborative arrangement.", "label": "Collaborative Arrangement, Milestone Payment Subsequent To Upfront Payment", "terseLabel": "Annual milestone payments beyond upfront amount" } } }, "localname": "CollaborativeArrangementMilestonePaymentSubsequentToUpfrontPayment", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "xxii_CollaborativeArrangementUpfrontPayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the upfront payment due from the entity to the counterparty upon execution of the collaborative arrangement.", "label": "Collaborative Arrangement, Upfront Payment", "terseLabel": "Upfront payment" } } }, "localname": "CollaborativeArrangementUpfrontPayment", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "xxii_ConsultingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to consulting agreement.", "label": "Consulting Agreement [Member]" } } }, "localname": "ConsultingAgreementMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "domainItemType" }, "xxii_ContractAssetLiabilityNet": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net amount of contract assets less contract liability at balance sheet date.", "label": "Contract Asset (Liability), Net", "totalLabel": "Contract asset (liability), net" } } }, "localname": "ContractAssetLiabilityNet", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "xxii_ContractAssetPaymentPeriodAfterShipment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time, after shipment, in which payment is due from customers for contract assets.", "label": "Contract Asset Payment Period After Shipment", "terseLabel": "Payment period" } } }, "localname": "ContractAssetPaymentPeriodAfterShipment", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRevenueRecognitionDetails" ], "xbrltype": "durationItemType" }, "xxii_ContractualObligationDueAfterFourthYear": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails": { "order": 1.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation due after the fourth fiscal year following the latest fiscal year.", "label": "Contractual Obligation Due After Fourth Year", "terseLabel": "2025 & After" } } }, "localname": "ContractualObligationDueAfterFourthYear", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "monetaryItemType" }, "xxii_ConversionOfDebtSecuritiesNumberOfEquityInstrumentsReceived": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of equity instruments received by the entity as part of consideration in the conversion of debt securities during the period.", "label": "Conversion Of Debt Securities, Number Of Equity Instruments Received", "terseLabel": "Stock received in conversion, shares" } } }, "localname": "ConversionOfDebtSecuritiesNumberOfEquityInstrumentsReceived", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "sharesItemType" }, "xxii_ConversionOfDebtSecuritiesValueOfEquityInstrumentsReceived": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of equity instruments received by the entity as part of consideration in the conversion of debt securities during the period.", "label": "Conversion Of Debt Securities, Value Of Equity Instruments Received", "terseLabel": "Stock received in conversion, value" } } }, "localname": "ConversionOfDebtSecuritiesValueOfEquityInstrumentsReceived", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "xxii_DebtSecuritiesRealizedGainLossOnConversion": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The realized gain (loss), during the period, on conversion of debt securities into other instruments.", "label": "Debt Securities Realized Gain (Loss) On Conversion", "negatedLabel": "Gain on Panacea investment conversion", "terseLabel": "Gain on Panacea investment conversion" } } }, "localname": "DebtSecuritiesRealizedGainLossOnConversion", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "xxii_DirectorsAndOfficersInsurancePayableCurrent": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails": { "order": 1.0, "parentTag": "us-gaap_NotesPayableCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of premium for directors' and officers insurance, as of the balance sheet date, that is due within one year or the operating cycle if longer.", "label": "Directors And Officers Insurance Payable, Current", "terseLabel": "D&O insurance payable" } } }, "localname": "DirectorsAndOfficersInsurancePayableCurrent", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "xxii_DirectorsAndOfficersInsurancePolicyTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time over which the Directors And Officers Insurance policy is in force.", "label": "Directors And Officers Insurance, Policy Term", "terseLabel": "Directors And Officers insurance, policy term" } } }, "localname": "DirectorsAndOfficersInsurancePolicyTerm", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "durationItemType" }, "xxii_DirectorsAndOfficersInsurancePremium": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The annual premium for the Directors And Officers insurance policy.", "label": "Directors And Officers Insurance Premium", "terseLabel": "Annual premium" } } }, "localname": "DirectorsAndOfficersInsurancePremium", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "xxii_DirectorsAndOfficersInsurancePremiumPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of Directors And Officers insurance premium paid.", "label": "Directors And Officers Insurance, Premium Paid", "terseLabel": "Premium paid" } } }, "localname": "DirectorsAndOfficersInsurancePremiumPaid", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "xxii_Employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptionswithmilestonebasedvesting": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for options under share-based payment arrangement whose vesting is based on achievement of milestones.", "label": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptionsWithMilestoneBasedVesting", "terseLabel": "Unrecognized compensation, options with milestone-based vesting" } } }, "localname": "Employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptionswithmilestonebasedvesting", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationCompensationExpenseAndUnrecognizedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "xxii_EquitySecuritiesFairValueEstimatedChangeDueToChangeInInput": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated amount of change in the fair value of the equity securities resulting from the assumed percentage change in the measurement input.", "label": "Equity Securities Fair Value, Estimated Change Due To Change In Input", "terseLabel": "Estimated change in fair value due to change in input" } } }, "localname": "EquitySecuritiesFairValueEstimatedChangeDueToChangeInInput", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "monetaryItemType" }, "xxii_EquitySecuritiesFairValueSensitivityAnalysisPercentChangeAssumed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percent change (increase or decrease) in the measurement input that is assumed when calculating the sensitivity of the estimated fair value.", "label": "Equity Securities Fair Value Sensitivity Analysis, Percent Change Assumed", "terseLabel": "Input increase (decrease) assumption, as a percent" } } }, "localname": "EquitySecuritiesFairValueSensitivityAnalysisPercentChangeAssumed", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureFairValueMeasurementsRecurringDetails" ], "xbrltype": "percentItemType" }, "xxii_ExactusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to investment in Exactus.", "label": "Exactus [Member]" } } }, "localname": "ExactusMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "domainItemType" }, "xxii_FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentAccumulatedAmortization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The accumulated amortization attributable to finite-lived intangible assets that have been written off due to impairment.", "label": "Finite-Lived Intangible Assets Written Off Due To Impairment, Accumulated Amortization", "terseLabel": "Intangible assets written off, accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentAccumulatedAmortization", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "xxii_FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cost basis of finite-lived intangible assets that have been written off due to impairment.", "label": "Finite Lived Intangible Assets Written Off Due To Impairment, Cost", "terseLabel": "Intangible assets written off, cost" } } }, "localname": "FiniteLivedIntangibleAssetsWrittenOffDueToImpairmentCost", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "xxii_GainLossOnSaleOfPropertyPlantAndEquipmentNonoperating": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on the sale or disposal of property, plant and equipment assets not within normal operating activities.", "label": "Gain Loss On Sale Of Property Plant And Equipment, Nonoperating", "negatedLabel": "Gain on the sale of machinery and equipment", "terseLabel": "Gain on the sale of property, plant and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantAndEquipmentNonoperating", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "xxii_GrossProfitExcludingDepreciation": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and serviced sold or operating expenses, excluding depreciation, directly attributable to the revenue generation activity.", "label": "Gross Profit Excluding Depreciation", "totalLabel": "Gross profit (loss)" } } }, "localname": "GrossProfitExcludingDepreciation", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "xxii_GrowingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to growing agreements.", "label": "Growing Agreement [Member]" } } }, "localname": "GrowingAgreementMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "domainItemType" }, "xxii_IntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclosure reportable information associated with domain members defined in one or many axes to the table.", "label": "Intangible Assets [Line Items]" } } }, "localname": "IntangibleAssetsLineItems", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "xxii_IntangibleAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about intangible assets, both finite-lived and indefinite-lived.", "label": "Intangible Assets [Table]" } } }, "localname": "IntangibleAssetsTable", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "xxii_InventoryHempCannabisGross": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureInventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials in the form of hemp/cannabis, expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Hemp Cannabis, Gross", "terseLabel": "Inventory - hemp/cannabis" } } }, "localname": "InventoryHempCannabisGross", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInventoryDetails" ], "xbrltype": "monetaryItemType" }, "xxii_InventoryRawMaterialsExcludingTobaccoLeaf": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials, excluding tobacco leaf, expected to be sold or consumed within one years or operating cycle, if longer.", "label": "Inventory Raw Materials Excluding Tobacco Leaf", "terseLabel": "Inventory - raw materials" } } }, "localname": "InventoryRawMaterialsExcludingTobaccoLeaf", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInventoryDetails" ], "xbrltype": "monetaryItemType" }, "xxii_InventoryTobaccoLeafGross": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials in the form of inventory tobacco leaf expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory Tobacco Leaf Gross", "verboseLabel": "Inventory - tobacco leaf" } } }, "localname": "InventoryTobaccoLeafGross", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInventoryDetails" ], "xbrltype": "monetaryItemType" }, "xxii_InvestmentInPanaceaLifeSciencesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Member representing information pertaining to Investment in Panacea Life Sciences, Inc.", "label": "Investment in Panacea" } } }, "localname": "InvestmentInPanaceaLifeSciencesInc.Member", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails", "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsTotalCarryingValueDetails" ], "xbrltype": "domainItemType" }, "xxii_InvestmentNumberOfTypesOfInstrumentComponents": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of types of instruments, such as warrants, shares and notes, that make up the investment.", "label": "Investment, Number Of Types Of Instrument Components", "terseLabel": "Number of instruments comprising the investment" } } }, "localname": "InvestmentNumberOfTypesOfInstrumentComponents", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "integerItemType" }, "xxii_InvestmentOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee.", "label": "Investment Ownership Percentage", "terseLabel": "Ownership percentage (in percent)" } } }, "localname": "InvestmentOwnershipPercentage", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "percentItemType" }, "xxii_KeygeneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to keygene.", "label": "KeyGene" } } }, "localname": "KeygeneMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "domainItemType" }, "xxii_LesseeOperatingLeaseAnnualIncreaseInBaseRentAsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The annual percentage increase in the base rent payable by lessee under the operating lease.", "label": "Lessee, Operating Lease, Annual Increase In Base Rent, As A Percent", "terseLabel": "Base Rent Annual Increase, as a percent" } } }, "localname": "LesseeOperatingLeaseAnnualIncreaseInBaseRentAsPercent", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "percentItemType" }, "xxii_LesseeOperatingLeaseMonthlyBaseRent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of monthly base rent payable by lessee under the operating lease.", "label": "Lessee, Operating Lease, Monthly Base Rent", "terseLabel": "Monthly base rent" } } }, "localname": "LesseeOperatingLeaseMonthlyBaseRent", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "monetaryItemType" }, "xxii_LesseeOperatingLeaseNumberOfRenewalOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of renewal options available at the option of the lessee under the operating lease.", "label": "Lessee, Operating Lease, Number Of Renewal Options", "terseLabel": "Number of renewal options" } } }, "localname": "LesseeOperatingLeaseNumberOfRenewalOptions", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "integerItemType" }, "xxii_LesseeOperatingLeaseRentAbatementPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time for which the abatement of base rent applies.", "label": "Lessee Operating Lease Rent Abatement Period", "terseLabel": "Rent abatement period" } } }, "localname": "LesseeOperatingLeaseRentAbatementPeriod", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "durationItemType" }, "xxii_LicenseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "License Agreement Member.", "label": "License Agreement" } } }, "localname": "LicenseAgreementMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails", "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "xxii_LicenseFeesPayableCurrent": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails": { "order": 2.0, "parentTag": "us-gaap_NotesPayableCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the portion of the carrying values, as of the balance sheet date, of license fees payable that are due within one year or the operating cycle if longer.", "label": "License Fees Payable, Current", "terseLabel": "License fees, current" } } }, "localname": "LicenseFeesPayableCurrent", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "xxii_ManufacturingFacilityAndWarehouseInNorthCarolinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to manufacturing facility and warehouse in North Carolina.", "label": "Manufacturing Facility And Warehouse In North Carolina" } } }, "localname": "ManufacturingFacilityAndWarehouseInNorthCarolinaMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "domainItemType" }, "xxii_MilestonePayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Milestone payment upon approval of a product.", "label": "Milestone Payment", "terseLabel": "Milestone payment upon approval of a product" } } }, "localname": "MilestonePayment", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "monetaryItemType" }, "xxii_MinimumAnnualRoyalty1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to commitment to pay minimum annual royalty, the first one of such commitments in the disclosure.", "label": "Minimum Annual Royalty 1 [Member]" } } }, "localname": "MinimumAnnualRoyalty1Member", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "domainItemType" }, "xxii_MinimumAnnualRoyalty2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to commitment to pay minimum annual royalty, the second one of such commitments in the disclosure.", "label": "Minimum Annual Royalty 2 [Member]" } } }, "localname": "MinimumAnnualRoyalty2Member", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "domainItemType" }, "xxii_ModifiedRiskTobaccoProductMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to modified risk tobacco products.", "label": "Modified Risk Tobacco Product [Member]" } } }, "localname": "ModifiedRiskTobaccoProductMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesMrtpLitigationDetails", "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "domainItemType" }, "xxii_NatureOfOperationsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for nature of business.", "label": "Nature Of Operations [Policy Text Block]", "terseLabel": "Nature of Business" } } }, "localname": "NatureOfOperationsPolicyTextBlock", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "xxii_NetCashPaidForAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Cash Paid For", "label": "Net Cash Paid For [Abstract]", "terseLabel": "Net cash paid for:" } } }, "localname": "NetCashPaidForAbstract", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "xxii_NoncashInvestmentConversion": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of noncash effect of the conversion of certain investment components, such as debt and equity instruments, into other instruments, such as debt and equity instruments, fixed assets, etc. during the period.", "label": "Noncash Investment Conversion", "terseLabel": "Panacea investment conversion" } } }, "localname": "NoncashInvestmentConversion", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "xxii_NorthCarolinaStateUniversityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North Carolina State University [Member]" } } }, "localname": "NorthCarolinaStateUniversityMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails", "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "xxii_NoteReceivableLongTermPrincipalAmount": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_NotesReceivableRelatedPartiesNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The principal amount, or face value, of the long-term note receivable, without consideration of discount or premium at issuance.", "label": "Note Receivable, Long Term, Principal Amount", "terseLabel": "Note receivable, face amount" } } }, "localname": "NoteReceivableLongTermPrincipalAmount", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "xxii_NoteReceivableTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after which the note receivable is due.", "label": "Note Receivable Term", "terseLabel": "Note receivable term" } } }, "localname": "NoteReceivableTerm", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "durationItemType" }, "xxii_NoteReceivableUnamortizedDiscount": { "auth_ref": [], "calculation": { "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_NotesReceivableRelatedPartiesNoncurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The difference between the face value and fair value of the note receivable, to be amortized over the term of the note.", "label": "Note Receivable Unamortized Discount", "terseLabel": "Note receivable, discount" } } }, "localname": "NoteReceivableUnamortizedDiscount", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "xxii_NumberOfInstallments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of installments in the payment schedule.", "label": "Number Of Installments", "terseLabel": "Number of installments" } } }, "localname": "NumberOfInstallments", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "integerItemType" }, "xxii_NumberOfSubsidiaries": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of subsidiaries of the entity.", "label": "Number Of Subsidiaries", "terseLabel": "Number of subsidiaries" } } }, "localname": "NumberOfSubsidiaries", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "integerItemType" }, "xxii_NumberOfWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of warrants exercised during the period.", "label": "Number Of Warrants Exercised", "negatedLabel": "Warrants exercised" } } }, "localname": "NumberOfWarrantsExercised", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCapitalRaiseAndWarrantExerciseWarrantsDetails" ], "xbrltype": "sharesItemType" }, "xxii_PatentAndTrademarkAdditionsIncludedInAccountsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Patent and trademark additions included in accounts payable during the reporting period.", "label": "Patent and Trademark Additions Included In Accounts Payable", "terseLabel": "Patent and trademark additions included in accounts payable" } } }, "localname": "PatentAndTrademarkAdditionsIncludedInAccountsPayable", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "xxii_PatentAndTrademarkAdditionsIncludedInAccruedLiabilitiesCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of patent and trademark additions included in accrued liabilities, current, during the period.", "label": "Patent And Trademark Additions Included In Accrued Liabilities, Current", "terseLabel": "Patent and trademark additions included in accrued expenses" } } }, "localname": "PatentAndTrademarkAdditionsIncludedInAccruedLiabilitiesCurrent", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "xxii_PeriodOfAgreementExtension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time for which the agreement may be extended.", "label": "Period Of Agreement Extension", "terseLabel": "Agreement extension period" } } }, "localname": "PeriodOfAgreementExtension", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "durationItemType" }, "xxii_PostemploymentBenefitPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time over which the postemployment benefits are in force.", "label": "Postemployment Benefit Period", "terseLabel": "Severance period" } } }, "localname": "PostemploymentBenefitPeriod", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureSeveranceLiabilityDetails" ], "xbrltype": "durationItemType" }, "xxii_ProductsOtherThanModifiedRiskTobaccoProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to products other than modified risk tobacco products.", "label": "Products Other Than Modified Risk Tobacco Products [Member]" } } }, "localname": "ProductsOtherThanModifiedRiskTobaccoProductsMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "domainItemType" }, "xxii_PropertyPlantAndEquipmentAdditionsIncludedInAccountsPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant and equipment additions, during the period, that are included in accounts payable at end of period.", "label": "Property Plant And Equipment Additions Included In Accounts Payable", "terseLabel": "Property, plant and equipment additions included in accounts payable" } } }, "localname": "PropertyPlantAndEquipmentAdditionsIncludedInAccountsPayable", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "xxii_PropertyPlantAndEquipmentAdditionsIncludedInAccruedExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant and equipment additions, during the period, that are included in accrued expenses at end of period.", "label": "Property Plant And Equipment Additions Included In Accrued Expenses", "terseLabel": "Property, plant and equipment additions included in accrued expenses" } } }, "localname": "PropertyPlantAndEquipmentAdditionsIncludedInAccruedExpenses", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "xxii_ResearchAndDevelopmentLaboratoryInRockvilleMdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to research and development laboratory in Rockville, MD.", "label": "Research And Development Laboratory In Rockville, MD [Member]" } } }, "localname": "ResearchAndDevelopmentLaboratoryInRockvilleMdMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureRightOfUseAssetsLeaseObligationsAndOtherLeasesDetails" ], "xbrltype": "domainItemType" }, "xxii_RightOfUseAssetsAndCorrespondingOperatingLeaseObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Right of use assets and corresponding operating lease obligations.", "label": "Right of use assets and corresponding operating lease obligations", "verboseLabel": "Right-of-use assets and corresponding operating lease obligations" } } }, "localname": "RightOfUseAssetsAndCorrespondingOperatingLeaseObligations", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "xxii_RightOfUseAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for right of use assets and lease obligations.", "label": "Right of Use Assets [Policy Text Block]", "verboseLabel": "Right-of-use assets and Lease Obligations" } } }, "localname": "RightOfUseAssetsPolicyTextBlock", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "xxii_ShareBasedCompensationArrangementPlanTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time for which the share-based compensation plan is authorized.", "label": "Share Based Compensation Arrangement, Plan Term", "terseLabel": "Plan term" } } }, "localname": "ShareBasedCompensationArrangementPlanTerm", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureEquityBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "xxii_SponsoredResearchAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to sponsored research agreement.", "label": "Research Agreement" } } }, "localname": "SponsoredResearchAgreementMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "domainItemType" }, "xxii_StockIssuedDuringPeriodPurchaseOfAssetsValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The value per share attributed to stock issued during the period as consideration for purchase of assets.", "label": "Stock Issued During Period, Purchase Of Assets, Value Per Share", "terseLabel": "Shares issued in purchase, value per share" } } }, "localname": "StockIssuedDuringPeriodPurchaseOfAssetsValuePerShare", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureInvestmentsAndOtherAssetsDetails" ], "xbrltype": "perShareItemType" }, "xxii_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfSharesWithheldForTaxes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited but net of shares withheld for taxes, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period Shares Restricted Stock Award Net Of Shares Withheld For Taxes", "terseLabel": "Stock issued in connection with RSU vesting, net of shares withheld for taxes (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfSharesWithheldForTaxes", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "xxii_StockIssuedDuringPeriodSharesWarrantsExercise": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock for exercise of warrants.", "label": "Stock Issued During Period Shares Warrants Exercise", "verboseLabel": "Stock issued in connection with warrant exercises (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesWarrantsExercise", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "xxii_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfSharesWithheldForTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to restricted stock award, net of shares withheld for taxes.", "label": "Stock Issued During Period Value Restricted Stock Award Net Of Shares Withheld For Taxes", "terseLabel": "Stock issued in connection with RSU vesting, net of shares withheld for taxes" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfSharesWithheldForTaxes", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "xxii_StockIssuedDuringPeriodValueWarrantsExercise": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock for exercise of warrants.", "label": "Stock Issued During Period Value Warrants Exercise", "verboseLabel": "Stock issued in connection with warrant exercises" } } }, "localname": "StockIssuedDuringPeriodValueWarrantsExercise", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "xxii_SublicenseAgreementWithAnandiaLaboratoriesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to a sublicense Agreement with Anandia Laboratories, Inc.", "label": "Sublicense Agreement With Anandia" } } }, "localname": "SublicenseAgreementWithAnandiaLaboratoriesInc.Member", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureCommitmentsAndContingenciesLicensesDetails" ], "xbrltype": "domainItemType" }, "xxii_TwentySecondCenturyLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents 22nd Century Ltd.", "label": "Twenty Second Century Ltd [Member]" } } }, "localname": "TwentySecondCenturyLtdMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "xxii_UniversityOfKentuckyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the University of Kentucky.", "label": "University Of Kentucky [Member]" } } }, "localname": "UniversityOfKentuckyMember", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "xxii_UnusualOrInfrequentItemsCovid19PolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the entity's policies related to the COVID-19 pandemic.", "label": "Unusual Or Infrequent Items COVID-19 [Policy Text Block]", "terseLabel": "COVID-19 Pandemic" } } }, "localname": "UnusualOrInfrequentItemsCovid19PolicyTextBlock", "nsuri": "http://www.xxiicentury.com/20210930", "presentation": [ "http://www.xxiicentury.com/role/DisclosureNatureOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r106": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r125": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r134": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563" }, "r168": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714" }, "r172": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "321", "URI": "http://asc.fasb.org/topic&trid=75115024" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r176": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "http://asc.fasb.org/topic&trid=2196965" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "325", "URI": "http://asc.fasb.org/topic&trid=2197064" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r194": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r209": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r217": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r222": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r254": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r276": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r299": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410138&loc=d3e79691-111665" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410138&loc=d3e79708-111665" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410195&loc=d3e80090-111668" }, "r303": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "http://asc.fasb.org/topic&trid=2197446" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=SL116886442-113899" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4549-113899" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r349": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=d3e5283-111683" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r378": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "83", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125514181&loc=d3e34841-113949" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=122636397&loc=SL7495116-110257" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "59", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=122636397&loc=SL6740821-110257" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r422": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r469": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "http://asc.fasb.org/subtopic&trid=2176304" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(a)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803" }, "r486": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/subtopic&trid=2209399" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r520": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "http://asc.fasb.org/subtopic&trid=2324412" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 5))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r536": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r537": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r538": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r539": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r540": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r541": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r542": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r543": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r544": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r545": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r546": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r547": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r548": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1403" }, "r549": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r550": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r551": { "Footnote": "5", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r552": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r553": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r554": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r555": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r556": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r557": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r558": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r559": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r560": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "a", "Publisher": "SEC", "Section": "12", "Subsection": "04" }, "r561": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08" }, "r562": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "5", "Subparagraph": "Schedule I", "Subsection": "04" }, "r563": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "5", "Subparagraph": "Schedule III", "Subsection": "04" }, "r564": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "7", "Subparagraph": "Schedule II", "Subsection": "05" }, "r565": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "9", "Subsection": "06" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(2)(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(2)(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" } }, "version": "2.1" } ZIP 76 0001558370-21-014427-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-21-014427-xbrl.zip M4$L#!!0 ( #'AI:2TR,#(Q,#DS,"YX MK8HLRTYFQM[)G*)E.E$=W9:2,Y.G4Q )2:CP MH@% VSJ_?AO@1:1$@A[X][ M"-]J2W^W0YXVP902Q]'N*;$W6--N+W^Z_/GVZI?+ZYO![:W6ZT4EW2,&.7U/ MDT5>7PZ2E&%4JN_=:8-!_WW_^NIZH-W>??AP]^%&TR<)X02X7)-2RE=FWS%K MBUVD@:P>NWMUB/?MX\66\]U=O__R\G+Y(''J=% M.<+$3 ;&=S2?6J1D2$6JS;/$$>\?^F%B3.HA8K'\8F52E@5B%7! K PA?K6V M^90B)4,*6LGW.WS@88W82G(;ITCRWM6@=Y-DLC')+QX2LAQ3?EHP?,PI\T2/ MLI"+Y!6H>8KO#4*[7+9%0J8&CN@&\RER,=LA"V>K>27$@@X8T/VEY;LRW]7M MC>BZ#A8]\]&G[@->H\ !6?X,D"/[24K"H@9,DG*DA7Z4UVE U$'_C\EX(;M8 M0@PL5N0YPM\+W.L\_;N^ @W@V&-DY>">(,,4<1BM6._Z,LEN$"NC3=1W"K1)IN2T!<7K0N!_ZD-JTEE\#S@N80J(>E(N8J4Q*F K2N MWO$@:N,=Q585O@Z4!X%XN3#\ F8039-S"/(\GTO-D]_BK[L=\=9^] D^BEY_ M)[(OH14U\>/)'"F[@JSK@3#+\5E \0)$M!&U=<\>!HS[KOY*V(/O(N)%+<@N M- (2U\N2Q1;C&,,*="K@H'M(X))BX/=P-EW,QJ,'?6D\:/?Z M6)\.#6WQV3"6BPZJJE E']EL/=O%,X[H7[X+[;(5\]$S'OM,A6.-0M0@7ZM! M7BSAOXDQ72ZTV:,VFQNFOAP!@:9/'X!R,C>-S\9T,?IB:./9HM."1EHP1&S[ MZ/@O50$_T*NQ?5\'VZ&^^*P]CF>_=R"J)]&1]PR)/MT_8(Z(]F:/O:>%H>F+ M!=A#[[2QH<-?L_OQZ%-JSIPM/QMFF+;H=*'&D,NXG/UBQ$(\%4.PDEZ-\(>K MZ[PA>;$,)\L#C"'4'8P587Q$A'Y!3H GT-W@[Q"@9V@ZM'+$.GZ!'+S 5D"! MQ<(^W; 4->0_7=T<0_ZHCTSMBSY^,K0)=-EI266_MTQZ#ZC26U-=I MPSG:,$%K7: M:]:!)21JA'XY16@Z6X(1-M>_Z@*D#IV*3F3\C*EP(HX)6A&G>.PM)E0C M=7N*U,+X8IC2VS@>Z?>C\6C9K8VKXC7T79/=7( MJ41T,#A%=#B;3$8I@WHXFRY'TT_&=#@RQ+P85]#!7'6]#+W-"^ _R]^$7!2M MB0L)U2#FN#M,Z)93L&E,8SC[-!V)56Z'UYF;-W-$(7F+.0'!JN[D9#.5;>M\ MJ+ZMH_TE4W0':C,'_Q9,2LQ&WF(+K;GU'1M3)AR.?%_5Y:\H00WW3:U-@,]@ MLL+X.YH"_KII?)Z-'PQS\5_2B;G\VJ'_AB[+I;!=S_181F6H-.#FZOVI;Z.Q MPS*LL!L&&OHK\S$O(U?#^^$47K6WLL.P[B(T'[8<"C52OYPB=;0$[:"I!(UP M?>'9^CY@Q,-,=)I%X+J([F?K!0&C=@VVBL=U2T:NPIIE#E.J5>Q1/KL\]7HV M9_4SU9=/IB%FW/NGQ6AJ+,)^NGB:3'3SJ_B^&(%!_3@:REW$X7#V))='VAPF M;KE"ZLSL@]I5=Y3@\]?EHJ8\U4Q^)-1<,\K_KIBFF=^,/PQR*CT 4 MUJ11454'_YO '_U9Z.2NE;D,]I.^7PGVN)8.\?/W-":4[\; 6.@OJ;^SD9^_ M;'_C%/>2_8V)N9R_TYRDH@[ZBM"'3D]YQE/$NF./J8 NH5;#FA.:&_I!>_?Z MP@CCWXWI0N_V/<['SV1!T0A=(4<9CB?=,\)1RP$2;/'%4S<4GXGG@OO6M]E. M_-0M3IZ+PP3J%U"&]HF738FVK$CS94T:BJKJX#\/_F3II#,6N+)M:W9O50EE M"G 2?Q[33B6I'F O/+I=@ICJTW+5]LZ/*E0\HEV!3]UAR MA]<;!O6=%\Y7@FSCD\?O3B+Y.M";18U4#@XI@;)F#$@'5X.#Q6"?;'W*EYBZ M*9BJ'2VV'69$>JXN92"5;%,2$YNXL=4#6/+)>?52Z!I]HAY0Z76MLZ93LW)9A4 MVG/K(/D^7OPW]^97\NK#*'FZ(_<&AY[BRKMMNHH._N(#I^ED%90W5SD!5:D; M2KLCB^=>4)J/484<:MAN3F&KQSS\6U0@AKO&E<8%GL?._R;N2&+ MQME<*C6./^<-MR=7R74PG>]]R0>M4AXEA(.K4P@KG /J,*WKDLDX60K05%.K M<1SDX)ARS/PGGH(_E4ZF!RKE9*B^:^O\/3N(?\2Z?B=>:?.WQ3CQX]O&"$7_5?=W$/?RU75B$E&^XOT_"?%Q"T45QT4@:IV4L(OC9*!8I25ZJL;K51* >MZ@H%6;#S?>3YM7_\ M!%[T)?M4GGPH#T2#-;/FY;]H6?!6:OANZ]BW9&&*+.*OY'G GOC4&USW;@:7 M4'7,KYJ-_"=/*S(09Q U?ZA>9]DCBE5J=RC-Y!(LW KA!S^] 2,5FR#%!&_$ M0,&3K'EULR)R\4/VE(9RYSX26L1!64[Y-ZO.B?K5464[Y+XCV\<.9TEAO4-A MS5@Z>9_V#([$E_,8.GZ.MQHS<:Z0$?&,JH*)Z"5=R86X^M6WOHT8"[#]$(@+ MH, "([XM78/QO2#9"'QQPN+8IOP M^/-.\K64#-@!C;;BPE25 M=G*AW0TZ;[JO5M;6B,]HL_CPTJC]@@Y62Y")XC M8Y2)!L: ^A0-82F 5D2,#!/LKC!-*6$AQ3$.MGQPNG%O.E/M0G'B)Z#$"]@I M&;*?&PP!-K^SB2M> O:EA&_._J&Y-QLJEP@3 A8A!\V P3G"#6:K8\-"CL9T14$/\SDB-3LJ,73JG:2]$\U&*/^WE3[(LM( M!\V2*7%?#\4N3"T9H<\<&9H*DSPU)ZN_.!HBDJ_M9#[6_@541VR"*#E8LP5I MBDY!/(XWF'[W&7+Y G_N%]CR/7L8^M''W,YJ40E-.^'X&]YOL(>SDAQ_;"?K M27<5D3"'R2/[4:$[<2W?77G$@RV!(_:5"\8?%4$[VS[NJ2,Q43I.=&HRVXN/ MTEK0BV%<<8Z&^M\)W^H>\F"T&:,5&(1@Y1)QL;-UF<6H8=YVPK?8B3>$P)@Q M,<.(6ML"Q:Q UTX!)\@+UN(55&$%/R)+GF4+(W7PU@\8'GE3G_+M$%%8EGDH M*W;CW.ULC RO\I6G)X\\8\I JJS@E2C;*>0A%'+DS9&'+(S&9(T7%L%@0.9T MZ#H9VB[R[,4#D+9D-X>EA-COW>!3,?.)2D3;A;1OL992SN46+*VX<-UQ#*L< M@,3R73SS8&9\%OM_P*$X)VQB"Y/GM#NP2<;V.D:/?4;RD" %N6 0ONP<_T!N5\]\GAS!8QH#97A!V$ MC#\$>.F'/T?>R-L%O+0MJI3PS^H2:N7/.29P4/+\Q/.WB&Q^M]T+F(,5SO.W8VD>-JMJ>_QQ&D:+_@K4K=X MMBJ2X=A1+)QY^,] N&3\>JU1JZ06MY0,,#@)34\)*L[OI9U8=3*TP<%EN#O' MWV/,,'TFL'82[(M0/3M]N;7GRZD8V^@%41MPYD'.3D0!IUF3#V15]S$ME^5<5/8IB.A@KUII$W)GH98+ ZB+(88D#+Q6&=Q*B5R%#:ZV>K*L^/>PS-O,6R,&S M=?&=.K[GQ[LG";P-,[=X]'P41Q#QF#S+/;6,!^YW2C@L,6!FD&[2D;M#A(8> M=)9806?D;^]$VD0HW;("5QQ2Q79ZO^6<=BHNLL4*]>0%3 P0=.2M:>B^DV[< MH?],[,%M0?1\[5RM"::O>D %V+1C;P3![&@Q<78I+=:(<,]>3,YRLSZ[E9_^ MW&89/ _4T_3WR#D.HLE/:N>$/X%1R W<#,N#(_>,DN1?1ZSK_AY[,)9:J5HP5Q&S!_P3<:1=7$ MIWH>8"*/7?5BD<"6B&XPF');@I]Q&'XHXK^Q)1^<%.LEEIH1WZ[$-BR6Y6D[ M%W-*7H\BX',2VCE 5/\21F!@Y8HOPL! , P_3&S6UT=V&O*)8SVZ%%JUK!ICHIH;],D?LG/V-W%IVWS#Q?G4;3657GHM;-UMH?' M$3_^=HIB_F5HW5DM4*&$]NI\UEG]!+)*9PVVQ35X M8E#+]VKG$[;7=9KE?NQ[&^&7GU/B662''-TM%K68N+4=WG@5GNZCC?SCC^VT M60HNOID'U-J*8P#KT.\H^]P\>=!#>6E.6=[R58>D_.YCU-3W+,2VAS#P4_M, M3=+>4>;>!U4F%G(^P6*($^M(-8N3VZFD>MO& M:UKF#[ZV(SF=*\[[/&/'EPN'Y$PRV$\FR/$,7.))P:*.;^Y;7XZ MOVRW;F^51B-HZMS3?=H%5D?U9:K8NKB\OF94NY_7Q]_?FZ MK:@/FX(/I)=SF%G2@O9_/]-_GL@C%0+7=CZ_.?#KV<)U5Y\O+EY?7\]?V^<( M/Y/ZS=;%KP^#B;D 2Z,!;< MMINT>W^?N$3EE%-=9#O(@C/*@#O#HHU/%@"XSIE"6W\<]^/=(2V9I)J'W\]- MM+R@92YX&KLX2(\W'SKZ7%\!["O54>U9%RU7&"R [< 7,$!.83@B3SH\UJ[A M+.XM]%HJK$BCA1'TH&-:R/$PZ-LOI'F$WWO -: ETN.T1DKLX0@CHE#W?40( MZQ*-:O_SX(K*9 C<(IWF:K=$'&/XO'#U^:,#5,4-6W5T M['_N%$&6\TDEL\IQ?>*&#UMWI2C+TALM$<&] ?$/P_+ Q$2^7O]V!?R'./) M O<(3PP+3(#I8>C"8NK*^ZA#HWTP7/K(=WW.[LS=.YFN7&R8KF=88872A5&\ M)Z5RFZSQSY#TH0Q*,]HJL;]#Y )G9+Q3J17I:V([)?9S HC936V2 32>H%60 M1RFME=AG8ETLX69*H@0D^P2R7R!\'-#>%9S(19HO%$'_1[ZE3K*7?J0!UV-67R7=.FD[6!3[IN(3/6O$5W+@C'94TQ. 2$ MOUF8&\Z3OV,@F\EGPUCYF[0+8+E.^(FOED:S%>Q5_AY\_/MZB@B;)K,@L/P' M_KY;X**ZWG4]C(GT=CJ96.;W3OOFIM5I=:ZO6U?DE_9M,]+U""=4'$=A8#-L MG_RZ3Y/8EBPH<>%XRZ7?6@,2!8?UYQ@MDV48/!")=![A&0/J$5 M?9YAG2FO@%ID_C>5Z(9N'>C_U,1](:LFF4_&Q)3"T"2#A7Y!9I?X!Y&2#%T6 M:E,>W?-K=Y\1Y8N AT$K#!&U;;Z>759$I\D"87<*\#)BD3-8DE3T.)3/C2S0 MZ:5TLX)JFLCS.6L"PDIBUI&=;\8$GE+E.-0JC#!0;ULZ]6Z<,@0 0YW1(G%P MEYU.^[*&ZLM$%*CK2CIUC3!8&7"FO:VH71]W<*0/2HZ:QZ';3,9U$+8^%92JLWCX+S!_O9]Z_N.&,9:DVM4S>]BH/A642WBJUN M18U[ZPA-M3?3\NCA\#>$9J_0LI@K;7;5NJDY-R:>-7BK[79%VAX@^YEODY-0 MLFZZY(7 LY16K[J(73!$MIEJ/266K9OZ^$$$"NS(O82&3GL(J.-[XB+SOPMD MD9X[U$9PWU.2D'Z]28O-*!B@QAU=5"W\$1?I6;+^@/*KD M54FJ$CFV69RZO*I(E]%CS'1E)I2,XVYW.E=M>;29IIM]I?*BD_90([[+V!SS MINLTO=(1J3<'4.D=U5RC-KGP$6E6 *"TOFF" 7M@QKVN,LL?EUX%,,KKQT8. MD/R^BJ<].YJAT1 MBH$5.T:I:@>>Z+R:/ @45D;1> M1 6=]NVNLH&NPCB\9I8](FR((I1V49 OI+:G(P3HT)G;Y ML6^;Q*2D5R"'P-7G4^.-O=D6:>682% "D+E,OR SF9(?#]IP.E'T M>T4?:6-UVB<%%'78(R4?1F/MNS:<]']HRD"?5'.#)F$\9\R%J36JBVW(-[&+ MSVG7G4[E4=P<2ML+A<@#LAYW+UCP'FT,# O^ 6;?R:Q'([#(-$8QZ_;VCJR* MH4.^ZI$_[><1(&!F.2E3]''RT2PW;_@I>!"AU8.V!,)6G*SS]F@9^0@B. ]E MHZF'^VX-@H ,PNX#GQ0SSC6QM'S:S%;/ODI%P&4.RX9$VJ4RN"?B6=\P]\C$ ML[48[\ <8;"!#ASMS<4&@0=M [_WB8#]D$-Z>($LTL'GONT"#)QTAASDB2CU9XPEHE)*QZ6!Q;8VMK966'\F?4 MDH\\8JK;5WT>P/4@P-KMLS6LZ;DZ\MPQ,&;0HME@ %Z2\4-S"84YA_K+%?F5 M J>"4&W;,RQU2:.M&'0I]1G'1Z[#BR=S\2IH9NVGR:&?_-X#3^X6UGAO!)%) M/,@AND,=-XCK"X1=N$?: MS8I!//!NG.5WP\0F'6$TA]NT4BE#D:N.Q!KDML/S ZW'BASDBP]WK+M7(C=P MZ4)#_INQ@]=RM"0/0?*K.3E75&W,8/HKD6#ZKCKYKMP/]%\JBIHO MDN9^'<%*%C=,;S;WP/HG^7M-#L*2!=DX@#$1A#:? Y.9#."#.U%5E"SM.1F1 M+Y"PYN[]D4S&??L>VH9MTOG9))ONM!QR_ W$1]PG,N*J=E%40[.=D-TBTJM' M_K,Q6!GOP:P5S0'&M*&2B\O'GX+:2[*:!* +^KNKRHQ*I&,",///@SBTSRI^ M MH7@BZVLY)!^?X%2=WOIZ.] 6Q"9VNFI+ @L=Z)T8%?!O5P<$:Q_6)@;-!C MGC4LEJ&15N7$V, %OQXISZ.P^H[CT9?HD;W--M$%!QL2ZYT8)?AE4(] IU%@ M!XV!?Q%^BJ;&&W4@+=;7&.F[6!<&!OX[[.DU.6 [:7Z4O,V= HO*%(U@T)5< MLT[X1@(:,RPT[40KG@)C\@DAX,:-W!-/= O&00A6\1.@@1#T0/F?) _.8@AI M'41=SO7MG^ZP8M(3VQ-7Y0X+%]PI4DTBO_U7LF?8,,QZ\C&J MH#[9QHJ8#&H2&;H'CGE5A9[VKL^G MV*!S[_;^VW=@S>:DQYL[,3SN-_%63X%=!Y!035QWN^-*X-W<7'5/@3VYY9#I MU9-C6F)(;!-ZEM>.3FA /KI(:T?S2J\>2;W7440I%^:V!>3C2$$-)2Y(:6#K M$4=7\=6(HR1&<7G4(XBWWLE7/C4[G9:D+L+\W#N\O YL,S,N"D0#2?W+BMMX MTVUD^1<3!>^H#&_#K@'V8R(%3XE;6<#K\=I M=OQE2S1XG;' [!<\8G4+@J['2\<.GP3P.$F01P*9)\J-8AM5F5*Q'9?6RY"$ MX)&R<*R)_,G9CI 3Y0DEH,?M!T\.])VZ_GVS]>W:1-,N7N385< 'BJ>TS%9E=ZI)6*3QM]_(?T /?3*TOE^P3CLR_;M3=4) M ,IW,?*!#G4M^9V5_;,7,H-1!Q0Q44P 7U(N+_%4/0D^Y!1#R!"V.T^.96 ? M8#@$V">:J75VI-&YK/QU=A] BBS\(1MX#[OE8<,(@Y4!9UE96M.KG20G.$00 MTH+M\Y.5%HQWKG/S@U'_)(DB(HN0,:FN0TDX$JZ4Z;>D,^N=)"=X9!!R0?)K M*(G@L =FD3>_BW!CI^JITH-'#"%#V(Y%21G2 W. ,9=K@J]R7#SM3J?YZ?A9 MPBV(D"=L#Z.D/$E*R"9NC*2VO5(3>'-Z M],7D%E]^L:OF9;.E-)1M,^2/_O"'-ISJX]^4?P1M_;.2=&(;1.GO0MD6*>4D M8-/DV'A],%R H6%M(^ZFZ,D@Y@JQ7N=)9P34;:4G2WAP&%,,E%L5:UNN8 M-GV.=,_/8YBJN-W"=544%XX#9R/*4LQWL%QU#=LF^TP._ MI&Q6615JK$T^+)FABQ^7;'9KM;'C+8 K9@^V]^W!T5@?:>/I;S\IHX$ZG"KJ ML*=H_W[LCVC>V9^4H3:MV%!,0\\@<'J5JBY&)7TO-S-_'DO1;-*5!6\_5GT$$E(9ANH/TAB\&8/EJ?/SK!=3'_ MJ$5_LN"SWS)-O:Z["X#]SQVQY>%J?WD8][]]GS;T^\;C1%/4R42;3GY2!II* M_M+O!OUOZK2O#R?^JJ%/OVOC]7>3BM>, 7U_ 6 <1X47O7L>ZR2'OWHELPM7 M]\9@:4"B9:S/[XE"#>LW8. B>!,;E&\&$55]=#8I60[UN-_+*[ AF3:FK\!Z M 0_(=A#KD;!&""EYM/."1.&";\>[^\3P7J/O$*V3J29N,2N.YW+UHD0AHF^'O=[>:&J9DBR#GG>&#GZ\'MUK##?1Z>RVV@;YN7B:=MT^FZY=X;7?)ZYUT MQ;MD_WTFV^C_(-GXR, TXF*(;-/#F.V$XJY=RK$B?=KV88^VL?;J@!D5=D)V M&+Y*\@U109ULSA_S03UT$E8N989YJD<8VB9<,=+]\%<\5J6*P,VY93SH'+M) M)_1 U@[R]WJV?2'SGY]L"&%ZNWA[]UQLYNTTV[LS[[W:'RL_U,&CICQHZN1Q M'+Q*L:%L'MJ8(]QPR&,59_/RW##BS51S4)+> MS:UWWS\1BN>CN -$>X#]WM]2VI9O,LE+D-BQR<%$4Y.TWGD%0-,@'(IWL;;_ MY)V8:.KA(TU;[:*2X&06JWI<0IU.Y^88R2.$/J=;].,-HFW&N_OH$V$8+O&"R) M;\F-GB;)!&11#TMIQT#8$4/,8/ 'F&I9Z)6^](Z4Z&(P2TU"7U;C]1ES,4QE MCKM8P_*-O7)I5'AD9DN+9]Z7FG:LY:Y,!G(]XT\REBDXGE7C0\[IXB]+$-OT MW"1=AYVJPV_]NX$FQYG<+L A<+E?LL%5M9+)@UZE&F+X@S,V?#X%TBQ9N0C2MXEIA3D,L84^)$506HQ M,5OPT[XM.-2GVD09J;^IU!R4(#8K -;-CL/:+5G..Q4@!B8I[(?$S>=$#]CI MVT18=$^2VC?1ZO*-M!3Y;]^54!#@@:TXAE8C;^_)UB&S<#TU)@9'Q@EO EZ MSZ]-[*W8M'>[/^U-M!_:6!UV-6705^_Z@_ZTZMQ0(^00-:\LY$<5WP&;+%ZN MLT$CJ#P_]R.6%KCZ<]H??M&&W MK]' D/!!%:\7D6B8;28$QB!@E"W%M$IL.[P30Z]3N8N$6_@B5>/L_-3I-*^K M?K%ZFNPWAE<1>/68F5D(^S;GQ7G^!FI(@I) UB-V@0UR DQDSU(RM_4/$JUIZ.KQ\7T1'3W'K';P .TX=);1J['BJ3E*=[P ML7&F./B<=]^\T/ZMPI4,VFA7>[QO-2)^ZA^:H*<^@XU-4TJ@3A5D]W'=1?\5SX!),DILZH7R[6HB?_/!D.^/G_4$L#!!0 ( #'AI:2TR,#(Q,#DS,%]D968N>&UL[7U;<^,XDN[[ MB=C_H%/S*!$" UU2/(SJZ9 F7_/ E;HE$XJ?_?%V[G2VB/B;>S^]NWG]XUT&>31SL M+7]^%_I7EF]C_.X__^/?_L]/__?JZG]NI\..0^QPC;R@8U-D!U+)=Z7SLW-]0_7'S]\O.E\_O+CCU]^_-3I/AX3/C(I%S@WI8N] M[U_X_YY9E1T&U_._O/KXYW>K(-A\N;Y^>7EY__+I/:%+EO_#S?7_/ YG]@JM MK2OL^8'EV>A=G.LLQ^LS=0]Y/ET?BG]W*)_]Z@3'#,G$/U['/QZ3\KPB85AS M?;Z.?F5)??S%CX0:$ML*(JYRA>E(4_"_K@[)KOA75SL1SRD/1"GD^WJ(A M\?UW'5[UTW1P+BNKQF;90[I[;Y/U-4]S7;JFZ]JQ]E:6MT3^P)NM+%8Y<1W6 MD_N_ASC850E464UIE'?8MUWBAQ2-+"88&B]N0Q][R.?-.@O7:XONQHL97GJL MN]N6%W1MFX1>P(:H"9/6QLB_0X&%71-RJZRTPA88>%LF*:&[,HBRA50HX802 MIO;!;N+R1O$F5;3!,I: M,-6!X-["-&J>1Z8*[.^HVBFR0[:F\I9E8&B67#>6[I;58SV[Z)[0F>6B&9< M!R5'\*)55:I[;'6SQ*RZ*E1.4E:5,RT)D#^Q=KR!2DV>HG(JE).MJM;XV/W8 M^H1/P&R#PF@<#ZI$&FR%3TWANJ F;I)(*$<:+PVB3QQ?&K"6C MJI*?^Z_\(V*R/7D4V82MM/XX3UT&?;4"5+GN0&QQ%K)_H@K+PE245B6;%O68 M\O@31*,=0)?ITAUVPX!M=:H9P@UKV&.+Q+>H?<"X_YBN&_EKZST*V0*3_Q/M M?J^1CQ;7^_37+YAM:*X\MD A+XB^RVTKT2[7I?18'J_P:O\':].;?US=W%Q] MC+;7?TG7E81RP%&@ =EVS7,LZO"N'OH!67=?L7]'UA9F&K&P0C?P]?DV*.R\ MD41@=!K3/QA)%I;_'#5GZ%\M+6L3F72N$:N0?\.+]".AKS[<[.T5?T'(66=U M+E-03 Q+>]U_#?@NG@3>%UV%O%%15VNT?BXZAHB% M/2^W DE73"AJA\_HZM@0%#H'.<=O M<< K.&7O)/)WXK&M\QBUL6\J;K7#LU+^SY\_?_C0N>J<2F9_' KOL-([&W.C 09W^MYM4@VCEN&X->%*:N[-A+(4XFU *59ST'.-):;OT'"T;! [E M+BA9F[4YR9,B]%D59,,KMH[3X'[<*3-)Q2UP0O5%0^K.G'34TA+*UF(_OZM2 M0WP:)+2#_976#/;5;Q-*G- .QG2&Z)8-&X*>($N6T0I5PE9010;T6 Y?J/+* MM"I\XM2%%5^CB8E&_8VIO%Q>KNFY(Z0D4DX+PK12T-+4U4T..200#6':FR/$PB?G":G0U?4>']GOEV1[[2 < MZPS[$*E*O-I'^+(1!2OBG [$LM\B-++6LM5,F>*$ MJX*R!3;;FC)II$LD=09AB^1G*;58JHA!HBMLHRNK@7[+FH@(JVET-DF(=9@:4N) F <>6$]@$Q3?'X6J+7@FG71X$Z8$ E"Y MT1:DU -9X29;U#99HZ-9X.!3K^@!BAQ2-V7I0D)43N32]">PJSW1S22":HC1_HBL3/3DE*T6&T&?NL6=YK&^[ \\/ M:)ACB)>DEBJ/(GV+)P_<]KI ].2B@KWE>"&0U>=\^>*?E-VLRBKDYQP55U*Z M,^=K!ZE/^L;[OQ1MLO]7C1+$D'&XZGB[.W[\BA%E;;G:#=$6N:H11"NS?$#1 MS@Z@?9)70;/2*@<0HS+R6TNWE/)#@"F]I(2TS7=Y373)$< 8%80NGI!UX&W" MO*6T++E4,5498*%6]E)Y!B/D%?8_#2:(KC"-=R^Y\,D.I18:0N])#!,)8>]I MM!&P1>8L@YPZ4Z,J+X!F$8EG/!NF5^MBMQ8R-@$I->QZVXNOQFKZ'"*H<(J1:)!H8:L+0YFJ2Q"\>0&C"7 M&GBRH0KX-[\]\L!MXCL2F=\S2BM,4;ULPAXJ2*&6KX)^H&H1(JVN,545B,=5 M4R(6B&F,BXZ&>(N<=, F-FE;_R0T=V+3+T%EY#4I V1SG<24WH33[FX"", @-OWPBE1@+#4A3N=L;E@&TZ@U&A0$E% MF["VT:&X"I#2PK?@\6@(]MP+LA!("*-%8B$^Q-8S6S('.X/M;S:/SA98G M M(QP$XP$)B^XUSL'I[8?KJC>?C#IKKG*'K%0TT2ZY3F!M;I=%#2'<,M?9 &WY MC/9XO'-$-Q8-=HI[W:)D0M=$6<*F'3_/!5-X:FKFE;AF M&N0NY8N90PDI($^C/I5B^4^ND@9RM]5YYAS8>,$6*WB+G= 2^65(TPG51YJR M96#?<+":(C>.9;_"FSE1! $I4()>8^274:I'Y=%$"HO5:,>2P#CTK +B0UA6 M[X.[?8ON> =C&CVXH%A22]-+5W#*'," ZX09%.4P U_APE.'CFS@09DXC2\7 M%>(+(A#*Q(;0C[C#-':P17?\P02-*)VR]$J'=FF.%H&?A(GO6"1"1*A=^G,S MRIM"*VLE3OYY'!%3J5KQ]Y>@.//XUY(>0E<;$F\Y1W0]V:]D3X\UW.YZ5H"6 MA#\_-0C0,86CZ(@%2Y/J9HGR(#:I1&1ESRY86H$FS2VO]!A07CU()4 :'S8* M T\.*B4 0QAI^(5DB?5&E$1^E3R5J'U$ZEOS9XER455Y%U[+_9C3R$1#@&;C.8H%/I@ZE()"&+>[+Q9U;06MD,Y:WD.IS1]B MD%,>A$ O+]AF48=QT,E;M&DJ[)MF!)("(C8?8%D'TEFD!5TH$/HJ?UK4R3PM MVG^UW=!!SCTCEZ\1PL"*PS6E7R:]W8D+4"W3ZZM1ONBOMTYH].5N!_*R&39D MUJGZZ3I$[9'_&OY1X(?+T?!WQ?.)BA\=\ M.W[ICQ?CS?Z-RO@1[_6&HA5OURT:$E_OS<@/'SY&;T8>BV6?>^/1;#P>R/YK/.^+XSGO2GW?F )>AT1W-DVO_:'\T&O_0[P_%L=GI& MLHV7P^;7^,CY M^5U PXH63L8L3=$6>2&*U_GZS'WTGH4X[-X0>IL>L-B1P M'2Y'\GA+Q_9N_,HF^\^96Z_%:!67!&%&,]1F ][%F,'I0(_X06P(3*RQCK*? MAT??N"@BR7.Z:T(#_$=\/J?N\556T*C&?"HS*%2)^D^H,[7I"HQ1I?I.5:UN M-;#N?J#$]]F*(#]G6%>D M;Y2D'\N,T@H0X B:(A_Q.,BL*]_Q.,HD>K=H+[AT6:;, V&HS-6[\R67$@\X MSF;(984N'Y#'0+I\$';6K*']R%5BB]3DZ6:&L%,R8E$7&#@Z!^N-A2E7.7[[ M]CR@S7&>?; <= M148F5&//H$@/82%B1(T""SB>,L!T%XH-\_*W"G@18(#+1_S^;-+O0,9(,B4$ M3@P7[4GQP=$Q(AXY%W2O.SG[*HU\C5+U]S)4:8 !1]R31Y'EXC^0\\":@VO7 MV!MX6Q2/R[(^E9L+PEY+6R>3'.8B \<@?]0WV)T\QKA5GO! ;I:#W=T="A!E M^PU^#'<,#'=:M7* 7<_C07?6/%R5A.^*ZX"PARND'16W0^UFR3OT')RDG68T MNT>8:E-?8J TR0UAYV9$J3'"^FW(QVKCD"'2U[N3.(6&Y6(%0=C:F5-8$"RX M8?PTR<2X1T@V& M30MC\%1I2A6@ LL.&=B:GVH:9205AFU&0E102<(Q(89GN M-&#L, JQI, $CJ_3]O7@0H*]D%_0.MXEN$4+0E&<;FZ]\DL6##EK-K:BHKMH MU\4 $6>8P@M8H(4C=* M[^?R] H@@*.&S>RYQKI4FF;-"!]*&7_.)0?7^I&;^ME=K9.X3/;Q@JG0A)O@ M61,' <7/8<#WL7,RL2B/.Y'C'U%5ZQX4.J>A1('.)XRU]XM']O<;XU?:#]=_DX?*^3E:I:O M4B[PN5C E^[HX?^ MK#,8=69?N]/^U_'PKC^=_;]._[^?!O-?_[6"-Q27-":(SPS$XSRJGD%0Y[F$ M\ Z:4" ,I2G)E$%_)&E;COE@I&O9(_$,' BL\*#HQ(M>7E &@1"D@[!Q5"I5 M:JF8EA]"\W<=!\<"3"SL#+R>M<&!Y2JIR,D#89.F34L.%A 4V7:X#EV^.I!M M$-5TZ>>'X""B3YT^+@@T3E' @"#GL =1,H6R _?"[( J';[:0F29 7 M=V8L@NI2UE&1ED6_C2/YCA!D1ZD%RKD@/\D"Z"Z%Z5A3*Z!:6= %>4@6@7Q.'5"G3K;!'-,EPJ M$) 9,'#4JAS0NUL+NU'4#$+Y+?[$)85CB+#XDN(4V:[E^WB![3AP\/'W,K< M*JZ_6:4J%;*HP5:Y*(T4XRJC8[DE-JLUI:X4E\()3@_ WTLM=3_8^%YJY<[H M=]CG_AXA12.+_<(FJ=O09R+[43SW<+VVZ&Z\F.&E%ZF+%W1MF\='XE,<<;'- M!IP[[N[CZKTL^,.'FP\WG:O.J5KVQZ@[?YKVN2OZ[=-L,.K/XG<$9T^/C]WI MK_S[V>!A-+@?]+JC>:?;ZXV?1O/!Z*$S&0\'O4%_UOGWO0S_OPIG=:W'Y&;V M"CDACVG3(PRGQY9O]]BS/!M;[LF77^2];IR[1+_SD?U^2;9,:7 ,B7V(T$0X MV!^_#='2HGT80;3>N&2'U%KQCX>V-=CFKDS,]Y] MS!KO!J-?^J/Y>/IKM48XX^YP1-0+*1[/F6.]HUS M6H1D@V1*\$ 8:24"*O=_.7F [ 0UE$^#*4B[0^6SC#E7KS5R0M@):JFC]E.5 MD':"\6O"_#A;?4M>D ["OLZ8& $."#0<1V[9SDV5L+T[\G*QTT\:"*8E,#NO MHWQS\FS9-ADB:R&ZTYF7&$:'4#&2AZ#V\XYCW5_1>M.S/,]ZQGY^6PM20[CH M;M+8 @C@]K='8>_Y@[PKY$2OS.>-1*G$$"ZL&XY+*03-]8*I]?+(IB[*-L:G MYW$3W5+9*?(S0[A$;M)'\A'![3+<[S1:>_"E']U*[TZH,D"X!6[8=00HX'*D M?D/JE 3"56Q#'J ^$[47[QL3"]V1%_G>/9L0PF5J0Q82TK=J:Y0_^H8",_/C MIZSY<3(=3_K3^:]_[4R&D7?@Z"Z*6SOAX6W_VAGUYRW;)4_G/])V4,:XU<[> M2I^2"G6[F[/*%59,K9QPK)FF-"9[I!94"".D'!JK6FGNU,H)Q.AIH+-:+"8A M0F!Q:'EB]TA1 @@&30.U2Q*2A &AW6]#'+WGPA H@MGCY:]8KL2NDOB4K*5GPV"Q:@@9_G@(##''R ):&AS(08>@[ID MJI5W]*;* L%F5) Q-;"V_"NGW+5(L(M*_=:^SW^9?5(*3*MM+53^S*\M[V2$ MFG'6DFWK[:/UBM?A6MJ:J=_;W(5(J#\T9TK2UAJ4-8NR0<]_;]L#5]6@YY)" MF >E0U7&T*IK]AA"<(C0AW7FY:H]@E_L\P)28*K@V7F90._-E8SG(0-WDI-X M >8.;2BR<>QHA38NBMK=<[IK_A3K']'W4GP2IJLK'K1)0*D3U;4!..U1G4>9 M]OWF3VA-;0O%>C[,$URIN$\^6H3N$"]DQVA:.4';&XKQF(0'CL[DP"+A[3P) M:/."DJ!S'*T>QT_Y0[GC!=.,.!S=$/'8=,\N7L;!H!BFR'H5?6\8W.>'[ '] M=/#P=7XUOK]ZFO4[W=FL/Y_]M3/L=]E?X]OAX*$['XQ'<<"?\?QK?QK_5G%( M'_,S-,3:!D5-<(=\F^*(']5!O3)'>'" MLH,HPNB]96.71V7RG&_1,^&LQH$W8FOR5<]BK88]2QZ_IVA)K1OJ2BKYTB:4E[$;>%-B?]]BUT6/BL!7A8IIW5!8%:&%T$-8!?,P ^CW MD-_(V^Y/J51/Q\M2PSD"TIQJ6$D\=(DB< M%H+W6ZZ**2B!-(Z)NWW>"4INKO:.3S0!G;DDJH:^BSTN&;,IP.*Q2R)@WQ W M(""GNV7?+M$4<5T]_#A'="V+)F->#(0CE0):8 X4G&E."8';=W@,Z"E;J$W8 MZD!^DF)>#(03DZHI%P(%3OD06\]\3X21OX]DY-^%J/OL!Y3MFK3HSBL"PK%) M::KS0(*C.48L!K$[0(@'*8='0;MGRFNYO[*]E7(&+U8@A/57$;W/SOG%\%^F M=MSQU^1>@_D+%MV&$B5!<'YHRE-2$&_6'4HJ0$P@I\T1?JE\?SD.7O#!G+ZKS9_,FS- M_RI"NKPL"(%7:M4 .71PZB!!8&0-VC5,J>1]OK*42L&!(VV$@BD#Q,\@NA19 M$K(RJ2 LO I8YS(X:H^?)^KW?% \-.L=5P_&X0UCP$)^L!:8:7K>:'E M#CR;\K\&WD&X^ ';=$3+*KS"YV,$-8C M!4^F\Z"UTBDC97K>A\R.'\?0[8;"K! 6%U5T/"&X5A@ZO(?#)$(OECN.7TK1 M)4F6N]FCGP_U$24#>!'#XEYH/A(8C(EGN9HELEI?'26PUA_H\8-H)W*XD!-? MUYF3P')[%J4[)C0/>(O,KNC\*'["9S;G 3.3]W#BNSKLYZC&CKVOLK/E=;9\ M/>?1HM]1M,B?(3NDT<9-=3E'D;ZQ^QFG>_7\REBP>T3!BC@GGK/?(L0]GR4W M<\H5!^=B3BZ5V8?TB@!NZU:.3"KIW9N\# !NV%2AR0=6\^#6L%(@U8>!-+,^RD<5O(,]LC#P;\=K?RUO< M('/;=U<,.3! 5OLZO__*[SXI'GA/)6C[[4;#IDY)#VXI?GR!BI3? M^9&FAG/G1VL6S\4#@9HYM3Q_@2A?=L\0W6*;+7JYUUY&9I]?U?#%/RDO"55; M!9![13DJG>2_6OP0E.:;Q1^!55]!2J6!X/I:AZXGB4Y!AL#4A!6&*$7.+"#V M=R5AXJ00'%/KYDV,' )]HGDF8^71V/P/(5PPTP*3Y$4QRU[LY;)(Q5;$90WE MQZN\$0E0].ULX^*@1]ARC_*):,HO@TN?*CX<;<"9& 8X8/)?X4V0AO.;8IBB)Q3"S*\8V(9\@@KP;?SB;?SB;?SB3_/^<1E6;U;.JV :_6&?KS4TC$%P..E1V3Q#7.\;MJ$ M>=$\Y5* MY?BGF1?"1):OABK2), @\G<(?'=/Z-"ROX\7A['$G$Z]HB#,>N78U<,)D>PI M]K_?4X0&7H HV_/R:(=&%*L* '%B5XI8%3H(=%YN&'*#0[JW(.0P%BUO0<@1 M+$] 6$'(?62_7Y+MM8-PS 3[$!$0-3W[X[G:OX?XS,E'9L-79@&QES+E2@VI]B/HZ$A@X/LAQ(8L=@I++)%OU$1 M%^D;:0:Q]KYZ&AG&+QZB_@IO]K&JK*6P4^9D@!"$S:SWY0!JD(%#<)S]^=[I M6*]'UAOB">:P(@5 "+96E"$M@. &QC^CJ[@DV%J;KN)O5W/:"-]V>5=S).,P MU\23(AZV.TP@S\8;RQ6&:S;)""*&F]G JXFL86H$\=>DJ4#$6RO3Z+K1U1H> M_)(>SZWV$&>DWA7+[O"-\O:+'^5&4>T ML-4^IG5M&[E1.$7BC1>'^>\N%H-M",>+F>5R4RE=HJ!KKS#:[L_'>\3S&=0 M;Z-'4(1[@BI+;Y;F2BPJ5<('UZ\/BZ,NT]IH=30. S^P/ =[R[0CA:1_FQ71 MK )496@QPPB.Y?A>S GK-QRL2!A,D>5@=W>'V-2SQAYOCWL+T\A\-%AOV$<. M:DA\/PY&KGQEI.(ZFM63LL:?FAH!G"+QEQW&BR%3?(D6)!,T2V%9ZY (0>T3 M]QUZ#DYR,35Q\1_(>6#XN#*,O5-4$='$;)*[63+*6G2,X8'K*=S<9/FK,>7F MI_T?T0&:'[7]/7Y%3FR8WQ^K.3)[3J&2FJ6[*G-.(:BU=]*3GHT7YSIY,"'' MPW[BZDR\YT;"!Q5*%=?L<7\EAI]2>%LD-YJ=*^,VO[1FJ:W$O%0&;L.&OB?/ M6A,:\!GDX.F?;_<39FJ6I[*6)EU4X";0?Y'P=%59HOX$\>G.#\^=6\NU/!M% M'BHR'P]UEF:9K"IDF1I3JU&NCIO6A,V##^DAY'5L@-O=D1>$@@=*P@V33A7\2B]K.T%'3J(E MB+VGT54#6^3G;Y033I0K$_K.XI+HP(0PA(HZZ%%,Y=4EK9Q +C$9Z*N0115$ MJ"R>AEGE32>]K! N/AFH:AZ)68"@6+S='3]^Q8BRUEKMAFB+7+V!59D93J"G M"L96)5)0E":5+RNU\4"K* />D*NAS+D=5HX7%,W1>9X?P;O1&W9%.:".MKF: M*Z11A! J:1^-2?O8"FEY0VJ5I'V$3MHG8](^M4*:Q')3"VF?0))VNXL.8R(G M7+VU3#H]G&!;%2Q?TN! <14?F^UUTAE[QR7SK>5C_\DCSSZBD7DX#IJ";.+9 MV,61VU,2F][BIO+JX*V#Q+HOU(W*6P.":LU6A :I6[SJ*!R*#*#62#7UE3-S MO:(M()#[2#RTBTW7]Z'GJ(F5)89 :KZ6G@48D""!0$F/T VA5H!N"8_J>3A+ M4#*3DP?"(M>,H!Q $'BZT)BQ38Y^ ./']LAZ3;S\*,V"=*!V'0VP)V@"" Q> M5JAMR6EQDSS"#;N=NLBKY%*2%D(\AR;)E#0#!#9/>R;!QOH8>'P6L%D]NGYO M1>+FAK4J7VQ[D:^J:A*))4)AP;C8.%E[O]]G/Z"6+;N$DDX$:F%5(==IG.!\ MN6(!C]!/;CY*XH3I(>PBQOM3+"F&+DD^7'I:+9*_/W2!]S"-?8+\,E^F"(&Q:JF$VC:S^U^W2 M0AT&[QF7(\!;'M"65;=C:_3]=?[>RO*6?#D?KL470,J7"6'C(B>T(I#M<=OW M [SF8:%BB>Y"-"?QQX$G&F=+EP8AB%U1/C7@P?-'[VXM[$97K GED1E.N$P= MU#_I.Z@?*[U:$'KELVH[_K'>-Z?U-R^$QAS4W[P0WKP0WKP0WKP0_@Q>")=^ MY%V)3\(%''E?VGD-@"-PP.+%H2BN?5:3%%T MRX9PX-*"]N@VSY]&I?BH69=*II9(G#$F$FEHCSP[A[*@) MQ9"W0*O'2P,OL+PE/Y&.-Y%FYT=_SP8X&HSFW='#X';8[W1GL_Y\5O1D2/K\ MT[G HJ,=5<)V]JB<*#3D40'38MWN'JU_LF5LWM&.20GM'_;D4W6VMS0!!V%T M5 A\$G=DK=5/J1N7 N5HQER;-=D6PX; .'^[Q'61'826.Z&$=81@IS0;JC) M,- 75.'S*'YRB! X&_*)SV=3>'=)$OGE+397& MI;0?8,ILNC0&> '<&DR;A4H",G46U' #]N%.H3WB1;YY;+:('YC).>.6I(8P M>990YO-C;PE&&5TMSCX50:YK!M+<+1QL>=QBL4. MO_&BOB*GF[G-?J7/KRDJ<+9$A>"15=2B U*ZYV%S4KHU&&)0^7ENBK9F!KOXNK0/*-51P@IH>+ MZ&[I27+NI"8R0Q0OJU%.)>^?FG-:$C1(;O5V0]47WZ@&2)Y$;5 #2NR<:O2I MB>Z]3*P=-\&9^=/\(^M/,QK/^[/.I/MKE[O4M'O+>F:OD!.Z:+SH$9?I,+^R MQ?CJ\DB7R_W-=,_AC]I*?IZS3SXCGWM/J>YDUU%1VS>XA]AZQB[328-;W*(\ M[3OWU*\.DHLGHN: L'P[BG@0,+J[6/ VUCE(O4O@]=4+Y-Q4JQ\)M::^IH&@ M>;>$4O+"@*@/4[/)0)C.F^HV2<7(-@4$'N>LAO$B,30JY@=)VO:]6)J=%R3- M ('-+%)+#$[9:8U+ 3)6*W7YS$QC"K".W5WLD(".[@A"2I0I(0RE!37NN/F2 M8:NA-_DT2/0D]E>Z%[&O?NOQ%]L1W5@TV'&'$L%P*$\&Y\6E>D=">0NT1=L4 M;4)JKZR$)J4%%"YH#?.V/-#E*>B!&P-$=8QL(T*#5<]BT+!G19>7GCRF7=3' M$M=U[5QMCGB%U.PXSNF@JX.+4RWCQ7]QRY']7<&!*G6;7A#EVEZ%"MR)3 7C M]3 GPDBU5;07;:2.ICJ+X%7#)-J\7Z1D8.@N62]:LG'H$;O(#XB')M8NPC0G MM^C1/]OM8]+7*M:Z>/U]6/9!CCD;<$=A/R K6,C@,(M MKS =! >I6GD2PP8ZNE[Z[1&)MU0SH^I%W3&94&(CY/CWK*$&OA_R@#SCQ9!X M2QY.F ?/D3"NDQ&"?U3=G.NT0^UC[QV;L&V6F(,:+Q;81M1G TU(N303XF)[ MQZ41#/$PL)WG_3S M-DMG&[8G_;8 /;]J6*/DR9MEN273E!P^.&+YS,[7\C2,$&9G5U7"9LELV/2D M @Z<1AYCBR(_F%H!BLXKG?UK<]92UF--"FB6]I9,2R8-4OL,O/>TN4?'H:07 M4BJQ*2D2-\M<&W8D!?B6UTFYO!EE;Y;)-BQ-1LT!;D!.3OMBSI4IFZ6W)3N3 M$#DX)KNV31&7H/^ZX4.+S/$VDZQ9#ENR&V5AMWJ+KD?6:QP< /)0:9@A\FR, M_/W,8!:L^N8F>[FN-WY\',SC!TZ[HSOV]V@^&#WT1[U!GS]Y>JBHY7MWXV"% M:*(]5%?G)&G?;C64O>VF).'M8L+;Q82*EZ"S#:N 4.1,D8\8Y)7&%87\/'^& MRPKY*)O:Q5W*K1&)B13DK1%9=PB?W51UWW"PZGJ6YV!K&*]\&.F([2SL]XHN M4J@<"%YXI;M-(>2U=Z6'^#JF1E>2I83@-5>6'!FV>GROGM^MK;]37%*/5?:,>V^^*'MD4)+O=26@K(VUW 9NZC MM747L&=Y'I,JH/A5,>UF$[6Y!BW7T@(PX&S#!_^XR1[C:>:ZW?68;BP)W8T7 MW'AZ2.$HK%F%2X-S=UW;WE48*VS:):(K S(5+@V(A:QD)]#3BIRFJ&/([7H> M?V.%["Q7-=\)DT&PF)74TM.521' VG?XCZS9UN'ZK/(;.0O*Y!#,9E6QH03: M"BL?S5CY"&%IT@0K'\$N6]*S]# GZ( B?7L1!')!)"<6R;KD8E\Z2CP"-GYV M\3**9W>/?=MR?T46?;0"_E+T[A %(>?IH\*E01A8C?2@,%)P?5B,)&3RH_U@ M= ALB*>(-ZO"+>R>P1LI@5C"$Y4_)+I*O-69-",V^,U?D+M% MCRS-2AZ*1K\ " -%W0HA@7Y!Q,]X>%3'=&S(9(6PL&N$["3H"Z)YOL*T&,N) MG!#.3QLA.8&Y@4 28BFZBP#1>Q+28"7@S2PKA /8"H@S WT9O=.D/T*)"5)O M#VR@SQW/)617RU,)(,QN6GL>D?"UM^8$L1J<\>)8;Y][5OM9YM'@D0:;(2M_/QL97C?X:'K=X'$ZG_RU MXQXK?+MVH.VZ,Z'$">U@3&>(;AG;$J&MYW]O*('ZW) M20O *4JE0ZFV%R& L!;=BZ>\OI%*T[;?5*[^I,(Q)&6O908F#EY@Y$RQ_WU. MGBW;)JI6U<*NNY^;D M@6"?-N(T!P^X7C<+B/V=!Y9#SEW('^B*-TRSE461/T(OT4^R+JB;^6*VYJ; MP-$Y)+Y_VO3L)FPWPS[V7 NO_3A$J-39+3_CQ>S\34"UNEOM_QZRJF^Y PO# MQ,>(:*N8_+P?.MAX\N119).EA_\X3VVVD_WXX;J*B#8EDZEN=TPH0T'3N9"LJSME%OS;1M\H[1[>Z49F^^ MZ+Y8U-%[S;9T^:V,$ ./D17'2N+R#'E57&RY^[,R!YS==N7$GSU1KVH#" ._ M1$"E@W-.'B!NS!H*J\$4I'W]#+FLT.4#\A"U7#:R=YTU:V!^!,/#O>Q'?'78 M!L,R(.Q8M53T;!5FAA$"M[KPAFS;R3!55%-R> M3:.Z9A$_!%9ZNKY8@XD8N9$2P1@3:E(1"6)PN^[^>N.2'4)[D[=8[A'QML@/ MD!,!]^0X\W5A)5J+$^"*::>K2IQD;[UU'(V YV3^C^ M*YY.]AQ6TT) ,$]=F.I*6K)VQY@#(']_1L@!/7- 24.2=P!D18 "#BCYN\T M>238H>!DB?*YX386UG_!P6I]\$Z)2N?%L0V%Z-"O;8D@./U4J[P@FK55Z^Z4 M[78\?O'DV+?,3+6?LC%.I_U?^J.G/ONW-WX8#2(C;;OV5B:>M7^[E0$<+_:@ M5294=99V@IOB-=.7\2(*,K7@=X0>"'%4#DA&.>%8277H.HM_J@,/PI(G1U"E M(50S+Q"#J(&N&C )R4!Z$)$B9[Q%E$FNMITITD,P?!JIYAEEQ9*74AG[\@H)\*+-2EV79>\\):R?J53NB'F>&,)5W7)CY#D> M/HA>^FRWYV.!J.'66?2GW9F7[O3 M/ON2UW7E["OK^,?:P'BB<@&=3&/$+"(G9GF]"8.]AJ3;4L\=M9I*VMFTE!/] M=B>E3P;$M59T-"F,'$\DE?#]#/!L2:W$#?R]>7RIX?J(CT M;]&[(^J;MZDT$ S-NKJ:)"0% T+KCZ/JE8U_G@2"/:I(VY^C@-#T4^0'%-L! M4>.I2#WUUS"WP]2G@H&^X448TN5M1,A6P(/UW'Q+'_<>^K__A?4$L#!!0 M ( #'AI:2TR,#(Q,#DS,%]L86(N>&UL M[+UK<^0XDB#X_U>],[L6DD)9LE$J-)*R:NO*SMHH M!D+B%(.,)AEZ]*\_., '2 (@^ @ZE'5F,UV9&>X.=]#= 3@<[O_ZOUYW(7FF M21K$T;_]Z<-W?_D3H9$?;X+H\=_^=$A/O-0/@C_]K__Y?_X?__I?3D[^]^GM M%=G$_F%'HXSX"?4RNB$O0?9$[N/]WHO(9YHD01B2TR38/%)"?OSNOW_W?_WX ME__[NX\_?/CQ1W)RDE,Z]5*&&4>$D_SXW8?RE[.<:AS]C7SX\/V_?/_Q+Q\_ MD!__]M>__NVO/Y#EYQ+P,^-R&W1"AD'T^]_@?Q[8D(2)&Z5_>TV#?_O34Y;M M__;]]R\O+]^]_/!=G#PR_+]\^/Y_?[ZZ\Y_HSCL)HC3S(I_^26#5,%X?DK# M^>'[@OR?"OKP#ZH1V!S\^#W_E8&FP=]2/M)5['L9_P"=(Q M!/SMI [@7\Z M^?#QY(_IO?TJ#W3X$6OS?GA*Z50\=)LGW@/]]1!_ARP/O/P+O'_X[\/Y?\W^^\AYH M^"<"D%]N+[52_%BCE2-]/RF769O#K"]W69TSH:3P3U?L3S4&Z6M&HPW=%"P" M <,WY/2Y@G'*0#OV:P1#T+8X:8N<%M\XI?YWC_'S]QL:<)N"/YS '[BT["]_ M/XN9SU@^I%GB^5E!B?/_;W]2_/Y]R0N +),Z0U[B%R38'SODRR&^]V-FF?OL M)!3S*-"W2;Q3,I /%RM^_'OX$#8YK+&7T#0^)#[M]0%DKG3S(D9FIL8@P-W2 MZ.3+W9_^YWGA7[UH0U91%F1OY#+:QLF..XE_%<2/^74+#NX91840]9_G_[8J M]HI/*_\VZY=M#ZS_L SXV?\CX.79#0)WV[I/DY4YJJ%Q/NX&J:;W[D!AO+) ME3SHOWX)3@3\G :=>%$:@!?I5(4V***A:]AN&7T##L@]*F1I_#[_EU! ;\T"F&W;-@3 9_S\%T'J>^&OU$LNV+^D!H%: MD'@JH&&ZJ00-,!0U4/*@5P0!3@"><(3954&HHITRU&"QU4'!N%HA)$!$E6AQ MT:D4N9.82RW$&?(B".GU8?= $X5$;9#YE4#'9O'MF[_/^LG5@[>^='YSO5^J\&P_K.:G;KW[H.@_"]50SHOGD%2P!XMN]^QAQ+ MXH67T8:^_CM]T\K2@L/Z\AJ&ZY^^ 83P[94S>*-?%SJPL)R%E3!UUV%$07 D%OSHW$H-=4$X,HD3DA,@0&$VO;KW M7B\W3+N#;2"N*SMVDUIX+%WJ$*"N11I@!/TQ7FPV;BS3_ MSU40T0]:$96P6&IB8+RN(@I !/70"K1Y*%3 M(0 !=AZ ,K:,>K8';D0[^61G,7-\1.T0/--S+_-R?@RW)6IPO LH$_O-FR<5+,J5DYX1_5U3B0/WE5ZA.;,F M*"5G7D8?XT2?QM" PDQ3:C';SE0J09"2E1KCF_*5$E+ SO;%[W9>&)X>TB"B MJ7[I:$!A?7$EL_4O7@-!^.**\75?G(.2 G:V+[[:T>21+4*?DO@E>SJ+=WLO MTMNZ!AI+ XS,US5!"8J@$08^=)I1H!"!0W*D^9S"$PW#+LVH Z&Y! 6K#8\@ M06 XA-;P6G\ D+-_:S;>#G)B8O_WNR>/R;\^9/#F'@XT^EVP$0GM0&$A2N-8 M8<# .%QTLJ,]8G!,PE$71" 3"7NT.FV]]('+G>G6+ F8?"9)@_Q%"QR('0#RD.25G;4@L4T)PWC;:MJ "(9EY(+ MC5(LRBL&-XS-CO>"9X_C_ U1L\^\] G^?_6/0_#LA8RI])8RW@,_HQOX81EM MZO\@06IF8B1-'$N99")DBQI%<';+FX#;MI8S*&:?['^)!+P@%1WQ(U0::_Z; MA' 4<]X7935,)GVL2>$2^_ '6L&3$T+9/\=;(G@[HMAL@YID+@G^0!^#*(*P M[W'%[W3BLPJ.>4Y\BI/LGB:[R^B9B;,S>',U*-)9T)OC'F-H'40')U7L2GKN/S[[#K='KSUY4L0KKDX"MN/385:3L-FG'GA=&PJ M9G-&Z[E)Z-X+-JO7/8U2RO:!Z^R))K53OT9**TP<6^LAE&R"%FBS6Z8U3RT5 MRS%)CLKWZAR9-&),.+8\7C J4%,N6!H]/V7K[A2VWX(,TD]"!@V/L5H+(UFY$F-W<+;AI:5:)0SC2@G"TDWA[ MPA#%'@['X,<)$P)22I)"F -L3?.5'#N0D#&6@X=02)(RHU^]^N$!TBT_Q?'F M)0CU)SX;5*S @[U8]8!$-QY"H,*6*<61NT M#T ,FWQ;XI."P)^QP@93R&:P MI4G$L,A^.;H@,SJ%JSAZM+M14D+BF+R!:=G"%6"S&[26!T4%C>C1DZ8- MK,ZY#:Q"*]=,>XS1"0TLTK;/Q'AMNZ<"G'^;I^>BO2.JA>(J<*0]76_.T<,8 M@EMC6 8WN*:/JB&%TWKEHK=$5[2KP'H*07_TOHPU_D?44AQMF4A ? MR-XZ,F?MT9$V"SW%J^T@+''GWU;T8JR]UZC0RSA;]H:>C#M6JLOEZ>75Y?WE MZHXLK\_)W4_+V]5/ZZOSU>W=-V3U'U\N[W]UP\[L[ M7&\)P9UD]=Y2%(R'%2)FVOIUG-'TQGN#M!KS':(2$D?G#4S+RJX FUW+M3RT M%(-#DAP4^::\+]=[ 8JSH1L[Q0O"=WW.W)D4+N7-;(]=2"[3LF3E0J _!$=1Q! MT_A!$A39C)B)87&:T=T^C-_@PN*41G0;9*GE#L@6&2E9K)=HM;0Q*\SY$\AZ ML-7.OZHADP+;F8W2*.$*@TKI,]LY,S0YK%.YI8 M&I8=*M+S\AYBU5Z16^#-_UC72!8Z] M+&5>F".W.)HP7W?F53>>4V'DCHRL+B17@LG=^4Z&>#)ZWM9HF5R**G><^SHM MJ >^DV$(LT59([L6C.C41HMX!+:AC151$96(CBN21:+^6*'N"F$<\1_2]J%[ M@^' =K-CS>.*(?F8QG)3?.2%#%/Q#I_\MH R$,MN32R-B<,RPC=%,O0RRY+@X9#!33W)8G+CS1%"L-C5]![Y3@"// (B9.[/9\#XS7GCC!9O+Z,S;!VQ+ILN7T$$CY6N[:Q$*+LGQ^3>AO0Y 6_S+^EF9> M$-'-RDN@2'LJ\7U.MX$?Z(XB-H@XAFDODFR+W5BSFY\M2RWE*Q!)@4F^E?4Q M1SY2A9M5,0+\EZB-"Z^J("^*8R=PD>3JKU%9Z>XB3X)]WH;GH[D-#JM%N(TBC1 M;L# J,[>R8ZJ?GF>CUSO[ETAHE5D'R-,*H1)A3">5A@T4V&;H77"N]AN>"SU MAB9<2*OIT".[8#I=HNE-2(>);$IFMKI-BN&3."&"@@CD$T9#F)H+YC58P-S, M7(AY2I<3ELN0$0/]^LIF 3* 8UYJ67KK^OV6(^O.8#$<7'$D67HN-U:8Z";2 M9Z&Q0,,TF9X>N&XZ#JXOHT5S>641=_"V#J2 1C<7%?/&U42 XJ\D,A]6JX@S M:1+V_->7CT#)/J;.KP]9FGD\,&HK=@W%$>U7B&$T 0D>WPY:S%@:@X3GB$58 M2U(WBU@OR*RM.>"NF*]HN^Y7IEIHK 8<1N;K/3>4H AM-@Q\M!5G?7VWOKH\ M7]ZOSLG=/?O/Y]7U_1U97Y#US>IV>7_) 'C%V;/UYYO;U4^KZ[O+GU?D:GUW M-YU2I4DF*13[6U.9V#]!AZ?-P<_8[H@FSX%/EZ]!,Q-?#S:O^G2Q"WJC@YE- M8 ;R4+SZ,'_'9 \)&>QSLOB/3RJ6#1-$+/>$,MVH 8 MNJ'CPDY!!,:$*C(@D,S9^DQW#S31^,P&#%I3Q#:CC2Z(%0!&V\/FZ%H5^$U M#?KLKZ]!P+_E7W[\X2_\2\*_E-K(D]ONG[SH<[P)M@'=W ;I[_?Q@^?[<0&C M_-:#JJYUQMF-PZ"&=H*4AI=%P*.B=EQU<.@G#*>@=(9S6*454R6XLPKMETP M=5353^LX1UMC8R4[]Q*NGO%LA8J0]MR#+T7N,\Q6FVWD+W62D642[R,AF^$,1N_ M_!ES$S%^AHXV]>_7^QS'Z[Q#;S.+EWFOKJ4CZC5A".M3$J'U]8OZ]R2$NA-^;0WB[X2$-F[$@A0G M)"Z+K!;-71:$EI:VJ5G:)F!_R=CBY#6><&9/U<"/-.(4V:+&%L?@.9@Z4 M#9Q#CD8$GL;9S/M0;+PP>R&,*&;@0K7I5:YC'><4 SQR=6F= ,JJTDU@O&K2 M:DZ4JV_^,#)'0-^G]Q5AW?)GN(&XE#(U>V+K^SGSCV&\!^^?BZ*-;QAQL()K M%H+4PV@&!(2 62:8I49HR(@^ M?N(;GQ"V\IM=$ 7@IMC^AYJMW189J21)+]%J94JL,.2%L_A\EV;P:.F9N]6[O!0G8^WI[R8Y/T6/ CAX0X<_2C@92'/4306G9V'P+SYVSWYZZ=KE'2(.LMJ:@0048ZNA6$L-:Y MB:5E!_F@DM;C9!!MTA F4H/@6)0N"*3Z?79[L#C)'S_^T+6J]&12MR.;R^I& MSNFL18C_\Y#R"O@7<6)Q<6* QRI$W"% O12Q!ABA&+&1DW9TU7"E@!E%LPV9 M.!,ULXJ6X4?).D-+*TT?]./&@_OR*RJ%M0/\+JAP5:BW2T@9$EF-VTPK%;D" MPU/E)@\&9:[5=T;6Z!YLPYT&HB9?QU%$%[*% M+.[XD-U2;Q.$;^<4^F4'$>287'A!PHM$5=$PF(1E%!V\D)W.#MINNQ./@>-D MCC)1LDN:=(#9'=@1N&_7?A>UZZM!^!L)-@K)AR'R. 0&*EMS51%<&&Q!Q'!$ MC(?E(N>8M'KL^L:+/)]ZZ,[41TX>L$N:VM4Z1?K, M\[I71,'&Y+^7K$'ZPWI[D\ I.WN[85QERV@#BP7/,Y+/WRK)!Q+"R)0?(W*5 M/C^$"E)._7!655=!![&H-XY4X&Q3_IXT(9L@W<5D.+ M ?-+?!+%XLTMHQA!*0HY:I\GT1^ML[?6&4\Y;=RL@1@X7_[L=KTE!4'"*;)M ML>C'PFDNB$P5Q4E/+G]-2[9DY_GL@]/DK:X3"%[[V)(:;0"U8F>QN(B(ZC75 M5^M40&)5ZM0R7:_2V0)#J-"IX4%1@J=UOO=> M:;IZS1(O3C9!Y"5OEQG=I6PN?"B#$_/4_\*^M4[BB"-B5BX_ZB2VJY\?93BD M"NI'E$6Q_$BY1E71*3$LJ<8E#WS@PMWPH?F14!J*%&/A^*#Y)X^?G_.)R;U8 M!F31/1@3+O>_IS2B6VU/>BTTIN?0,M^V^A8HDL5J^-!9&P,O-J?DVQP#J;G\ M(/ZQE9P= #O351LP2!M2%:.U3:@,<)Q@+/N<40#N[],AV$#'<9L)T^T\:292 M<(IZ(W0#U4;\O >,U/)XMLAH7_;K"]ZR43?EADEPM!0 8P?Y/M./M,&< M&>UPJ#B+=WNFB\RC!<^TXIJQM]XR9W<#ST?B2/[Z]['X]EV%4*:BCI0Y/^WD MU++MIR$]?X;^E'QKLGUKY.LNB,=5(2;/AEF0?""-7\*O_3+#7/FUN2J" _Q: M#S-)6B=ZE=/Y$UOYX/EP=7=3WKLODR"%,E$\#>2&9X 4T]5SIL5"UN[7;OF"$*).&J$[L9">"]D)4WL 9$:9_TF/#3_M1SHY%NS]1)?K M!>&8HH2CP$5Z=#)(H#( NA?K2QGV)"?DH11LLMEU)J56[G+(82P_$AXT277Y^6MZN?EI?G:]N[[XAJ__XZ-R\W&Y[NXX4W7K"YC,Z\?9!YH5$W.G"P:IE: M"%*O9VI 0*AIVLE-6Y<$#&%[[=6K#PVC>+&*O'*)$]KE^X?=(82W+[KXO%G3 M[/&1M*ZO@#4-M$6>7QO[<=9^9EWA$\/=D0,:>DLSMB+331$%,ZJC#ABKIX^) M]7HS'Q4D0A647&-YNV3*]$H.S!"R&CF@?'1!SM.&G\@G=VL$V, M.<2VW)_2QR"*+ 68-8+"]M"7:7J@&SF]AF]^;FF:)8'/G >'6KYXR8;W5-1& M 0;1PHJXC!"\'HD90 @A0C.8R[;[X.'91< ML6\K-GL9>+%W>#\6/F8.K$Q\[%*N*9E1[4Y[IN"[S)8K!"!M-E - J),V MUV19>=YN53J^/]8O+],XY('TW?'(HR:HRR4/(NZ43QXA@:;&3U0F6N5FD=N2 MHB1R$!5]0G-09CA;&H ?>CADG=:U(%Y*//#SAY!#JOV8(PY]RIDV>/3<6[][ MES[]=$WDTQ'VV[]X2>)%T+&6)G[0*L\V -\=_VP4T&I+W$1VRK\:.&RIZ<_E M5C;/T"PVM3H/RO[H9>S7LCI'\0XE8\.EGB\*.071ZZSA?BZ5T<# MZ#AU:]$ML.U]I)*(*W<571P.N8<4(#F]TI*1WA9-*[?>GF-.9MSN8XXKR EL MV$C(*2.V$-GZVM%I,^YD49V.=/+@,0B>XDC9;D24Y()UZ9$_+"$/;T2&N_'> M^#_GMX[Y2(O2Q&$CDSL#K&+TD\U/X;X*@X8;%+[[<\J-#?CN/?W8.]B67-,7 M_LN0%"D)URG/I1;,=LM1(KKBGU1<#=E:,!("P*ULAQ[BZ2W/SQ]%))[BW(-O M:L+5#+2U%K)3QJ81S7IKX)RY*=D:E''DJ,'U$=#2XHZ>W&Q1T624M*W@5"5X M2K,LI,A-SXPGL;Q^"]W(>]$A1SH-(:?\C87(UL$%)157_% GBX/""YJ32UFC M[$).7B YVN3<,J6C6+:+L=-?%>LU\#&R->\ OQ YUHZ6IEX^>T$(=\G,/T+O9*EN]^8_#Z+ MMF@#=DO]T$O38!OXW-E4OX^I;SWQ^.X5R3[*!-M6VIYT<*?*=1]!LB$UOZMA M%Z1DZ80->P*MP]F_E8,MBL9W37XD&$C)W3)G=;P:XF,:ELPQY5]=Z7_UA(SQ MF)T4W?.!EI-@Z]4ZR#GEIZQX'>)Y--XD/7X?@C$^9-ATM%PF$P\< ]PJ@IM@ M'B*+>>8YWD.;0W6UJ%_#7_&FDKD/D MK*W8N^S 2D3DO8UTB+N/V8Z,S5\0TEJ3V_MXFF7J.$-A564]WK35B[E./PY" M#=AC"=$N@5$-!>Z@'(RTFUZSG]_;PHHWD4DYD<5YC'<\A_D[B"F;;G'6O+); M[L#G_U.$GJ+-.64G43_@?UV]YNN"#+/>,N_/1 K8TJ L[C"2(,(KO$FFH'R5 M-XH:SBN]"5AN%VAXHL0K*^?05[AWI5SA'R,>LN0M7RCQ#PGO/BV_W/-"KL', M-7"(..4QFF)$XO&K)0*F(K!2@?9 (\IV!F)3>Q 794! P,_\=.\8@SP3L)252/Y!W7VZO !RV^H-V>KP&,[-64K"L] M5@T2WQLIV%%[FEU\B+B7Z.=IV+H$<@P *LAOHS3[$L*69Q[R_*O9C5]1+Z1E3$EUD7P&(=-ND M9;EVB=2"FO]N2,-"NYTD_+X@ (%T;6/+:5.+;]=?\OW(E*N4[R<41A '%J7U M-4$P5B0UF]4Z5/\=:?51,:'ZK+#>2(L,K]D$%2C8UX4&B+#W#'9,21FO@<^6 MEC<.(KZ]5(YL(SX%^P"44YR(=_:/\2\46+JPXC?LUW.+CCL"",5Y%$X MN/"/^1VHA(6SY[6;NP(JCQS,_6IU$*OL=MGA9E=T'0LM32D!"8<\V3!0K.=\ YA^X4S'VRVJ M'K.EAEG:.17_E:/+?"WON ;J@8^E]3T%K!N#)3*"C?3B3*&% H]\6U#X,P0L MI(L2$>T\\B6)E6&-D_3;@L"?R28G 9**G2IFOD%;,+;O@]UV>DM]&CS#+;CU MG*A073$XO5AF6VOC.6!F.J9L+:S )Q4!K/HY(X0KI4BT4J!:4K'(!MKB%1TX MKMB.0A"ST4@(#EA+BQM;,Y$0W3$/&VGRS9U3UG"3T+T7;%;BU&0M;A/-%9M0 MBV,VBSJ. Y:A8LC6.')HC[^<>@J\!Z" MT"8UKB\15^S*1E3+TY&"@@,VU\U>_W.21,KMP](0F3>RS&%%P*UC4_U6K)#S M;< 4-?#=,TRE@+8V64-VRAP5G VP1/YK208GTCU6RDJ_81([MB@G9"55ROU=SCVTOR8%M MIZLUM(_T+52'K$8C5J?A-/#85(I90VR'*T-,5Q'B.%8'C8U-5C>)I#R/=2]+ M>B@D53TX=<\H+Z.\B>[8@E-:1O+_.,:47QDQNZ\Y+?,9?!EES, M;["%.GN[86)DRV@#R?I[ +&=& ,!1\RJ4T2C?6FQ\0VM@S4KBRMH+ BGLN"J M6A)RQOSZBMJTPU+*/1#@0E*=D/.6*/,IW:073(.AO"^3[+.7077=M_7VGCD, MMOQ6)7]_HN%F&R?5\SS=[(VEBE8,;8K):%10&T,2H^S:>'X5"5J"JMC7 5UN M 5E7KA6T"85<0+4>57MBCY:H;8C3 I0$@OS3A +\I;P[M:\;GG%.^#UGK%Z M67)JO0M6XSJR9)L$,Z[6*D3\A5K/E=4:?5>II$3 F;6YCW12[Q&'#,\B*(O,B?(()K).24D5J(;&&L M!BJN&&TGBWV-MR3X#B*X_85O1G"WI;1N1'!OZ3[?.ZRWUW%&.Y)-]> XUMC% MOFQS.MC9+'!$Y2:T6P(&NC^L]?P"Q>J6) M'[#%SB;PH\;#-PFC0-I8I H)-]JHYZ@KGLA;CN:HI,3%MYL^(L&^<5\3*][G ME:D$(FK<3Q+J%R])O"@KY#&T-C&@X%N-3@R=P33A46U%S4R'F>1(I8$@/248 M($?;-EYR65PSCLM\K5MOS^+=+HZX!["8" T>OID8!=+9BA()U6 ,''5838$) MIQ&!*]8;K/?80Z5JVU @2>8+R5*59 CW2[JR?@"SN6P$=?_LY0JR[TR4)8V]0BY8C!+,M3$8/ MCA_,[C(/'2QJ,-M"9^K![&.J_[!H=A\10 ('M-[^KFKT99?[EZ[C+EL=OF2= M[G+5J, G$@'T?+()!81^86&<'A+Q-L(O$LR8+9;TINPB76S@ WIE] MX5;E%*+>]6ZBR)&:]BRL.XK-Y$1)LR"G"9T5WG6P%[?*1H55\! M:\$J6^3Y8U7].&O[4H$OO=:!4T,5H>(TT'=J$T@I6HDRH"B%6%0<#; PY#$36QC+ TFHV2,R& I=E+9(;G#R"2PHBC)#9"E7&7+8*QYM'CI4QU$O M"76O\V9@S0O^\>3<]Y(J\8=Z29G6N_"2;881O&2ME\$[\Y(6$SC,2_))66D: M/+CG)7O,0T\O.;K3A<9+W@:/3]EZ^R7-BS\R&<_BA$WD/H[@:K/>$FI=M7A2 MS=8(8@@>=^\G.\63B)MR=3S<(,P;U&HZ&S V.U57MR$HH.!_S,D] []*%BD]I8NA#G<3Y;=_E*<9PK^ MP_!+(CR7B9TO/*9"4NU)/]ZQ%5AD;J8'_XDMT&1#'ZKC!SN8!5&:)9Q[!A1$ M69QW.J_]NQ7R-GAEFBOV M",_\[=._6?][K]ZQ\%BL)'G4Z^N M!SH)9LQ<6">/7A3\D]L($R*-PV C\O>BS0V;N,)^UMO\RM@+[]B_\,R]KJR& MB6CC9#Q,.C%R-L0DA&?/E)B0Z[9U+^^_W*[(^H**X.^ M"QZC8!OX$-P2D7CFI&\8/9]M9>[I:W8:ZLN,S,_&.[3*$=,]F0$/X.%]V?I@ M =L][24V%J3&"-_MR*S 5JMDAE3:=BQ,!*-NX4HIYXK 5'2$+NX*6=D'S]\^KZ?GW[JUM: MT[7JFE&GPW/D02!XQ ?\=J=J 6>&B5>NP$:A3J M,2-AU.FQX:@==KA=WZQN[W]=D)LKOE"S-7SU'U\N;SXS57-1S^R=;S\2CFF? MI7/N@^^.3MJ[O$9;P'I7P%D=NEU1QM'RFLQQ0:Y7F#;)[Y:[8GI-(!R[4K,J M6TX=8G;;4 W?OJ6__/33_?EO>7ZVOV M3Z EZ_N?5K?B1\RCU15-4TKKZ0B=P:DN)"P=LA&EKE,F# 0=ZV:GI7,":4%* M-"+PG/"P@R1ZAU8D=;"#HFSY6I*]5>TE+>(5M@3PCJ']1&P>2NVP48ZH?5A3 M'O/N[F'!OR/_S=OM_T>NE4)UW=#*RRB7[;.7_$XS> W0DC+:G(F[[;PWJLA< MZQ<\.D8V%:TQ$$40:+\N$@K^>\2)RHAB1B3+E#\;< D8]; M=C 6(__9O:#3G+/IJB>[\(+D9R\\T$J6KA75C(+C46S$D+V""7YVR^YFIJ5/ M%\O+6_+S\NK+BGQF6[0OMRNA6_SBZ:?U[?W)_>KV,Y'4SC$=ZUKR.G#S M[DD#QZX&"2K;62\"L]O= .X4&XC[Y?6GR].K%?Z>02]$]T'& A.M8IFM4(TJ M9EUH&)7-['A253O+,?-=NVN;]L&".60^<-JP]M\Z8!PC,;,NVX4:ZW*L6V@5M,;I1#2BROG1YE:;"X'O(?OQ?K^]7=^1F^>N2 M.4;,%(AN'\:\L@VZ'PRT86$E,9@)4HM<<&(,7^J@@4[[ZR0=ZN?5[?+Z[,5N;I< MGEY>7=YCYD3F_8LA7L[K*J37<4:M][K6V#AFUE,XV<@L46$UKQ&Q_%N]V M@;A5Y^',J&L%C*NO%H"<-I.9C0P2M]0[K0V#^UE_]N6LKZOKSY\O[ZI;E M;,T?OZVND5^^2;+9+PI=2.A::.G^S1B8>M;# U9(KJ6_#Y/'44.I)%AOY7[K M>7_V,W: 27E'=MY)ONC>WA76'DD4*: YR534XIZC*,X?'IV W9;BPZN.^U]/ MR.GR;@5J__EF=7W'4Y'?@]:?RI)V!NC'4G5<[\V3,4CQU23=U7P3O^T+A&K= MBK=$IDMRPH137A!.^X2;%2FH.W",.;,RVN+-;;3_&VN]E!#J!F2(% ?+"*)""A ,V.%;( MU<^KZR\KWEZS@\D=N5G=DKN?EK>8H:8F[UUNV #OAL88':T6&%UG.I?T'!X:L(O- MC!,G]=YBN*3[;$\5I.MMHV+5F_C?+D.P1<:QBGZBR29BASF[O?1AJZ5U'!E. M"!7Z0A1B>R._Y?]UP)BFD5&NW(8:'Y8*RMF9E!D%*S;<+48],JR'1X@+=S&C MB I+*"X:R0"9;I(@\H-]2%,1)9 (3%E>W<=KP^\,A#2*:SMW/9JAP H^LMZ3"G,W" M.XJ=CQ.)?8O3_%N@%AP+XN2&5[N_I7[HI2DOC39_3U$^"O4)Q MAY/!*CPV3-QZ\;%^-! *D UA4!$0J^.ZN, >2=0I.YE\B0[IP0O7R66T3>@_ M#HPAWES^+'X.-A]^M%AW^U) 6(2'"5FNR/W0<9;G(3PJWMRQU7@G+GWVHL@$ M;SD2\ZXCC&20O7V3BI4;:FPD^<50#G"V_OGR_.3#CV3O11NZ"_R95_%)YB G M0M8)J<@03J<2T(TE?A)Y2YEN\H^&N-Q_2=F&995F =/!5@]A'1#.4JUF55Z( MZQ"S+[.JX=O*GO*=7@GFXB(Z2!"'GJ1?,">:T:O@F6[$I&KDM,!SXSFZ5B#3 M8_06$OI3= U'W0_1%T2@GG!<%TUF,E$QS6BW]X($]CSKY#Q(]W'*5KKM51P] MI]W;+QD!LKT[IE"TQCS4CF($M(K_>%"U][K M]RW$TX(5 L@IZT)08VX^O&. MWGNOEN$@+3A6?-7,?CVLJH9%B*::&%%L^ "<,'@73W^#A4&]:+BF+U)^:Q)' M[(\^E3;?=N;0GPR.F0P55S:?OC1F-ZMA#+:3N.A+K5%VC9"+%CB1W+<4UC&] MZ)A;3O^);@XA76_+)K-GAR1A?[J'-A^=-:"LT9$VESW%J^TH+7'GWT;V8JR] M5XY 2.OG<:Z;#B('97-,H1+NSIA()N9;C:7;H#@=IG5\*/2'ZPW S[6.=Y;XZ"?!W6&W\Y(W6+DW0MMZ]^"KP'H(0;C7A,13[KZ5U#*#D3A=M2Z&[6FMWD'&B MW[85C[9-N)E[+\@M2$'0(7.=2GQY%[X]\$>"NR *=H==;LC[O*06HC%7;5.K MAJFF/;@!'LQ2;K6^5>#.+-X])9!7:-]+ MDC?8HSP7B:G!N)R[J7/ 14K19[9S8#N)S3JZ!9M-&,>\^DZ7@?0G@YP9WE-< M99*X)0V\?/%>#!KRJ!=%)EQ!BO JM#DQ(NHSN6*D$TDO&Z^UU&^T/&?F:FP\3BF4,3V;K]*$Z[@KZ3-H'5&==R0PSX[5G)JUF)JD1=^+PGI[EA9CHYO2MJ'!^\,(B MD'KN9;3G 7\(2>P@P/!I4 <*^M-##"8,9=;T"(Y4-,G#&Y&H5C<*0-O 1AV#OITYH2]F:BM]"Z M5%!+,JA9H;UX[$@0;=1>X^)'6G2@ MO&8FH?GYGOTI9>X(WCB:+A^/,1"V\4\]96K?,-4HB*YC6A$4M< 3=HKW(E)'PK^-G6".NBYOIQT"JZ[^]--4K\,_'7V$NOU3,W\46W/C MEKIR3^?TH>^[)!4*]G*D%T.]L+3A$9<('3/&G10@.;A9'"1+%&?LK+?WWK@T M#QX#]%&?3U7R\%?P3W&X85,@"N!<,V9_\<#8LW2=\"(8G;?8(^AA6]; "5"; M74]BB#8YB%.CDLL4OR%YQ2<@NB %6:AH* @[:-G3S\B+P"6P_#Y/&LI)DTPR M=O:WIJ&S?_J[%,&JBM5J%E!E9+(B"@6$@2P!NGU2QG&6.F7IF%N:9DG@9W3#'<"7*&!;:F:YFV5N MM3UWCQ.-@KXL3CE9FL5RBB$PE]#I^#=6:\H[?,L'L 6IAA$++X&!%J08Q,7U M]9C35;W.DE(X#OQFA\U04DU6"J,X[(ZDCWSZUNKRSF=&%+M*?^:RP?/SUST% MV>YC^*?U(4LS=EX/HL=)/-6Q1K6OBR:XVA8M9 MI3L&?HKJ>>F"")Y$'8><*^@G!/_,H"K.'+KZ=N^#2*"KU_%='CA0R;P[.Z!V8 MV#Y6;JP8CDCC.>ZSCCIU4B*P5Y%!=$15;6D+OYWJ''>7)YI\%!Q7=*3)DGW1 MQ$/,[HR.PG]'1?3Q.R]G3KCS3%_M2:0\87Z<9K4&ELW#+M^1RILI3-]5Q!%_ M";*GLP/C:D<3GBC%MHYE-0>KG=(@2EAY#8.%KJ_9ZO!&>;"!L]S'UE&G> M$4\T"N;+XDE%,+\UEH:27QD7@Q'XF.2L;JMM)^:DQYIQ&CTVU$DYC]Q+I836 MYK#ZM61EYD0U^3%)M*%1RB:A:#YZQV9!1$Y4+Y!Z8\^?A#9 N"+EK ?JK EF MO?E2'>X%GM1EML*<[,4.T^CO'N/G[S^\O?K]AV/EPQ(\G> MEJ]!\W&-$F)>%3(P"6JB^'DV5=".K2@XRZ"( "._ > \4GEWV;]GNV!V[U\\\\H@ 9]2$W;V_L79OUO=U M8W/&_GA(WJZR MS6>Z>Z!)@U<+>(2&MS8"E-UN3< XK6Z[.5+TJ=HS5KC3_OB1G9%R-,+P9NY: M.X!Y@4($CLPZ^4W@3:GP% *V[M# MJMAD&>!P @-:AN5S?0MH]F.YAH.65N1P1 !.M?V:2!^4NS,CI ,ZT=ZS&GMW>$B#3>!!SU_5*44-AW!8-3%S[3X_\"++.A*3Y,@WGSH M7#:G& )[3S/=-*EW/>/I(^Z+IF)^T+O*CF>5(L<_'XV(X9!>L!]_O@HQ]THQ M9RX0'C'B;V>')*%YMR;-O&A@\4IZ:QEOUNIN :(4X=9PH:RNS6'9AD] .U#1 M\C+RXQTM-Z-7,!18A3Z\:\3 4II.(>JJHP5'4* .7A1J!!C5^8$4./@188TP MQMAP!XY3"J6/%QL17%$J8PS9H%;XX>1;FE+V^9X@&Q@:^,1['OQYA57<'+>S MPL11LAY"R:IF@3:[PEGSI,@[$)@B.[W")3FR"Q>?T%N>'3.]D*KO^@UP6.\4 M-0S77R$V@!#>&"HY4(3/THR_-09(%Q2BW,GI K8F0.1]M3($JX?"VU%W!55+ MP&-%3=K)=!5"TD3B2U@YV6$BQW\0%" M$'0;)Y07]Q![%EA-KBXOUO"(GB;/(KJ:>"_0C8>=S;V0UY6#<"ND#!7-B(4Z M96)H$K*Q"94J0#U0DL;A!HK?L@^0,DDV_%$SHQ0S!7R#VIGLMYB=_CT>!O#? M_) N2+ E81P]TF3FH&[?R:PL*D<@@$$XRMR/+48*<%+[BL=P"C_1W?[,BR+O M(4B[O8("&M,M:)EO^X46*+)CT/!S1,_PQ$;\WL^'7'P='L%V%J68%:"0LW(: MCN<5S+<^PT5@3J'V*5W80%X$49 ^4=ZGJG,3V0!&WD@J65=N)FN0>!M*!1LF M?2_ ></A>.4SQ\A!*1U7)M-.%N9,Q%TE:T M]IK9A8F\A-JQ-^&*NLA?JHIL_&I?UGLQ3=U<30=.:&6IC I*9"21&T?CKG6 MCA;PI*X0+BR]94W)VUQMNYRO @%Y"=:*H%R&6]!X2[&&%8,"5=5,"Y1I[>%' MP7T$58'HQFHQMA7BBJ;IWZ3X0NXFG2@R;AC'4+T,^N7P^+M=F] N M=.R"(';BJ(#J0AZ 5ZO3MG@UNR$>PPL11 MQ!Y"R3IH@3:[^EGSU$_S%@2P\3,7]#;%AC;F+UAA.J9^;:&LU*]"@A!.3DR!BS]> M[O9)_"P>@AB_OR4NCFKT$DS6&BO$V16J!U?MM_LY@@B+4"^ET(J2!!(^H@:6 MGL^H:RTH'*W2,"OK3P-D=DU1CJ_P/[RO-AS^:+7GQO='%XS$S(AX.A(MPBRNNBA9]><+E8TKUC)ML!;D&V.)MZUNJ18O*W\9\]_"B*: MO,G[-:-Z=:/A*)FM.+*J=>',KG!V#+63[X)'+Z%91LG.BPY;:!V;P/+FE+Z= MQ5&:)0*CUGZ<];,J M1FY]V!QF[B\:1.8O6O\=X8NJ&"R_J/SCO%^T/7+[BPH8%^/H5QTO)6P0'8NB MMT2R"J)?H;VLL&6I[]WAU;C7%\?6/%5RMBV28QK72M6VPW!'TTQYNAT7-U-)]2/F+[6BSW,5)%OR3_[MV"C13-AUY')V= M>GID[9Z*]NQV,"WC[83,BCR1Z2](.0*W(GF,!6G8V:)N:%A954>>*I&#Y4D3 MMI%&<7'9^I+2[2&\"K:Z+"PK3,<6L+905JM8A>;.4M;DJ>]Z)O )$)@[1$*] M<)5"G01)Z^D$.H(%CM8,9[6&RB5S=:B-5MPJK MC#!FL>5 "_+Y?&:#G6X:RE)>RT8I+RG][;(AK O)(U _FO[C 7+GO.,8S[?(WZX#_X: AB;CZCAG5"<0PM952 V IC7,%:RN+ ZK0NJAWPMP2_T.#Q MB9UZE\_L7Q_I+=V)S0;_\9XF.UTW@/YDD%)M!XI;2[WM26/^5-Q!#+8SPLM" M&!QT00I*)"=%2EH"@@ UG!(V$XE<2NCE$B:EA"&7D#&R@RTUKQ;BJMF>!ZD/ MM51NO8S>4#;5VFOA_F0<-%N#N-9FJZ#AEMEJ&1Q@M@4M L06)"?GH.':"]TR MW$TA(Z..60NC+M]5X#U D"F@:=X!)#T_T.5#FB6>;V>D721<,% [,?7&:<9' M-DP;YI0) I396LLX"VIPCRNH+0@CQTZ@.4'45^.<:[7X;X7P8G7=0*NL"V9T M7O@K6QLU,SF&(-*K]-%34'O%/IC:_*_>1[(ZQ@32!2DIPRV:H$V .,XJ-?ED M@,&Y;MC,#5W3U^S^A8;/]',<94^ZH.5P<@X;M4'\WB:MH.6F06L9'6G.L*0! M82(H$T':86.VGPAF8A_?@2F#,[I_B4?.24G%;<-M"#O$7G,2SIIIC;\)K!/H M,>N,W;9)L]3,1'YX+Z;(1M:EW@Z@\P[,419XL$$"$;=-LN)P,J,$DN_ + V2 M,X/YEW=BF!=L%B>8#4'&?;.4Q1UJE4##::.L&)S*)H&B^R9ID)M9RE_?@44N MMVQ"N"C!\]CELD'+;=M4"C[$0&N$G+52!9>#3%74^;_Q@LV">$ S-]>@71#; M+7.UF8#[)YI0+M4[L-R1\^&Z?8XQ26>M<*HU\CBF%F=>.(6IZ:P+Z.?7_/L< MVE4[^Q(5]YMTLWKU&:CHGC)D9O2T'+3 +L&MS5%'R"W;-',YR%!EDD30)((H MUMOLJ6?@;U -]P#B!0R+,=V2#/W^_ZW73?.;6[?Z;RICTX Z&-*@!"%FZ0TREZ7K]7-S-T5K2.1Q D!45XN%KZ(/8K M.Y+AI&5//@.E5$V1%\1+B5",5.I&:\ MQ(R%$ARQ84EI>'&B,#S AHU/@8]W*S!(KLLHR((R3)DIWEM-O.9S&W_P,MY: MB)EZ$&]L7882U9%UW2"6<257X+FS=FN94Z[6>PX MI %.TJV<4)>G@+_B2_! M7D$&?J]6;6^_#P.:.K BV\LJL)N>(%^32C$%"4<66WOAN!35Q]HKI9C8)5P? MX-'R>LO&IB]>N.;EW)JIX;VQ'7$,9N&,OD&-ZHY[,/&G]! 11P /D @4MC/G M.,1[]H*0[]^]+-^R\_(TX$S8W][!CK[79&BW\8(*66])3H?DA!QQ)+VDO-9] M;L MRX]B&/@=571+H[&555Q&-U[D^=2#POMW?D"9S@"7W^EUN ZC"&O%=;:"MU%J-QAN1BO%X=P92C(AA36,G02G6A(:U M>H7RS.I.NRH ! -1LE@:0>U7'$57L-"CQ'!0^\(YK9FUU$:"',:%DHH70>1% M?@"WI=!^&.;.4/!7"XW4\-[,?*W;O1IT_E;W)CY:BE)"DPH)%Z98F MZ3+:W-'D.?"9_4$=F99H*5283=4_&4L$3SL$CG8>8YIDE9Z2_NQV,#WS5L:3 MNE#N^!9GB=TI;IV>[WJBN#8?0F4['A*(570Y*4H#%K'H.XS_%X89Y01'?NHXSRO_U M;A\&V5G,MK-)RK:YM[#9U56S[D\&J5;Z0'%K9=1[TIB_POH@!MO%UR4RWQ!! MB "E!>$_$4YL02IRA-/#N9::2.A;"E!4V"5)A82)2JP9C?0L]%*V^I VGAF.LHP66;'41H=L,=P65+D3DM2$W( M$4B<$(ZQ( 5%PDE*,&D)A%1H<,H)**7< Q[FZT3FA]);ZM/@&1* ;BEODWCC M)5 0^9H9P2%)VD]!>F,CO6;L)USME:,=ZORO'_OPU$BKN$_:'KEYG>G SL M]FUF1'%M58(3#N](PS.5&,9PI@G!'?71AQKUT$ZHD#$,J%,B_#A@4Q2^R_HY M9OZ45W4PAHHL<=U0+J-@)CU3(J*KG(&KEO958 XI6M&JYB).KCS_]_7VLY?\ M3K.\FD@OO;,CY88:]A';I)4V=-"5U)[)ELZ6+9?@F57(D'GQ!1G=(5V^#=+? M+Q)*+_/R2=!^J9<&FPBXH;?=(IJT58^-KJ-=K+5#A SA9,LPL#ME%17Z[N.E M_X]#D- JN4AW@#"C(%WR6(A1N^PQP,]_Z=/)3/OR)T>!9*$<2R_8@"A>+DJ@%V5$7AL/Y%^FZ8%NS@])$#V*1YXW;"*>O)2NM\LTI5GZ MLQ<>H/'=W9.7- NJCJ"#D"4W1N RF6X($9RT$*>O!$4U!<$$X3( BGBO!4T^/I!5'[915-K MCI+OOGZ)F*1/P?ZF+/JC$K@# 36OW2""(I== 8V=OZYE25?VH:C.Q&P_+G#A M+WZ\VS'_(/P):BE)O40B%1:"_0^1 MHF)=^H+?!E'QUS\?Q;Z+!^1YPF"5]7<6[_9QI-B;#R& :O\]1%3X PML;/]@ MS6)'$0A@EM_!!U7NYX*D!_\)]A@O^47V0JPV*?&B#8G@8FO!'(:7D9WW.R6' MO>0]@ *:_Q@^*[4WD&4!"$X'_B"EE5>D4)W,<%&KDA#2-X=U8I\$:;'/K#[F MA"X(+C6K&]&K.'J$Y_@W;+,$*U&H+'??!Q'!Y?02J70U5E@X+J8':^JM2 &9 M%Z1=P*9CZ_GY@6=1EI-AE$^@U +W)])5]X*\!-E3?,@:)QR&5_9_A\-.0G?! M80>U:F"?[+'/-+/;&3-3_'I?SL =%XQ8T%*"D: :Z8&@1HVB5"_ M9@"_TNQ.6[>F=ZA??G9<75-H8KDZ8)SPOIEU.;"OAIP]I&]BPW14+J A"QZI M=UHOUILJ7O1^0;_6JKVC.0^>V38EVH @VI!9/U07WC*9Q=*_;5+C(;]U,C%E M>/O$<1>DP.9VLT"+,TT@6BG)4 O2U??Q?1KF6_7UMDAL/QGOGA32] M]Y)'FBW]IX ^Y_?;9VR73_U#%CSS]J;*T-.4U#&J"$T^.57AH0%\OP)'Z+HRPMGG%L M&-MSETXZ]OS) T DK'RS]?=@3O?L7P3V!1$B45F05E;X40SWF28/L7G/,Z6P.TFH0"74C(8(7=_6 MVRLFB$9P&0#'B-HLRB92_3J[ 32'5K?48UX70%"?5T:^ESZM$WC]E?^%Y["E M :P+%\$KW8CLD#RS;:-[&CV($M:SR\%"UY]@]B:#\!QS((^*@ ='A@L.H$6* MOTO4%H33RS.?BO3,XW2YL/#+T\E>%%#TJV(-(HL-.HZ%AXU(A?(JVF#9^P3: M$$ /Y'T(3\AA'8,4E_W$5Y=5;8;U]IP^9'=L/Y@$_"EG?A$K*CI()91$$)0"9P5I MA)/H]!,ATF5+K6'J4*E"D;PSBS?DZ:V3.<-N:D[Y0EOA+5QA%RG7/*$=OX9$ M^/_?#PZ?Q0XW*'+CWY$7'#@-9B?(U>QH"2A?(F\7)UGP3[HIGH5V7^XKD=#3 M4PRB:+)5%!@N)*]HV5*ZH4VPW=($2J23!YJ]4"I<296ZQL\66R](*H^E2')9 MP.N=!Y[P)(8F\7/>,"W+VY066*B),/:3T\R+D3!)@8J>)]-3'/E[;30RH.3. MP(N S:D70CZC> ;4F4>A0L'.H]&+H2&LUU^CDXX/BD(D-\X"=0.$)6(TGW3 M1<).+6S3\&;J!F&#B:Z$74)I=%"'AJF"9IZ,E:]*>/SJ::5 *G&,9=2L,)$5 MKELHI<+IT? 4KHLG6X7#K[2F$@E.W8ERG>7?_PIH G[QD]O5_29J8K5\FI$1E]A+433++(&3,QUMI,M MHP:62&XNM6E;NMZ+KH&&0YZP2]!.EZ@CX(9O-'-G4%%90QU:FWF*6\HM[8/= MDJS"0-8_O1!*;6N#X^F6CA>CLQ-("\+1R ?'].AC;SWZZ)X>?>RG1Q\=TJ./ M _7HHV-Z]$-O/?K!/3WZH9\>_>"0'OTP4(]^<$&/3M]XGB!OL&*WW6_"H^_P MU0)H-O5U8,Q]O(J3=BXU !'1L\>=#;M(+YMU5!YK3[TT2+]$\4-*$W[1 M)RKI4OB@01CP*V193#(:OLD:9/J?$3CX5G,$<1Q&QO^,>/NZ=&%-JDY"BM25BR!B_Q9XX5W&=)H7V/3VL)%+KX*(7K)_ZCZH M#B6+?9X=-QWJ8^\PFHBGXS$,&T,PZDPG>-Z94R5+0)[_!"(0/@6DRX@A4 M3A*DW(8Q'('@9*<.$P'J MO%:Y]YB;"IIQCDQM7#I@D385)L9KFPH5X/R;"CT7[4T%5!SBX9*.-B SZHEX MO%3MF2^>KP/+PCIVJ#A:U$M?]BIGY:/IXGP''.JB2A?:XXE MB/.8..GU#>.2TA&RK^_.?B,7FK6IAH?1*D4)X&!B(O3S0B MOA?Z!VABG#\M3RLNRT*1:1;L/.CP5FUE9WX$>J1);?D0^<0AD28%[;*(+A'D M24X?X2'ID:9$.,Q2L[ZM](JKS5[4&U)%-+K"SI,-X\X[ M@RFFJ^LIPI@QG'BM,%X XYV#?**#-EM$'BM/"B7UT>2G8GS A1QK.XHO$E69 M5M'&%$>><_;R^B\9@9EV3.S< #?0RB")3!. _NY8(6J]*7 MB&W#0R@4\\D+HJLX[;R_'4[7Z>S.[@D9D,:I)^IJOF87QT9_FE].%;1)'+6] MY5FYB:F&(# &^19&:?7XG61B+"KW'FM^)"D?04I^Q,T[:-1.#N/N\_2-:!+* M]I5%=ZG+R(]W=!V):G,91"[KE:-4V]T!1'#:R@P35>X>TX\"6I.8(6RV-/.6 M[ADZ3X7UIN\W=WF43PY3!I<9JT3"AQ7@"TE)K]%41T M8;,R?L]V1[,L%$^AI_=&/ M8@8C^@AQJ)D.6MT36;1!J#JP2V5L$3U7O43O\MD+0I#[(DZ@;=:RJ+YY%J?9 M$OH +\,P?H$$1P9QQO:5068X:TU%',:AO+LGF=*MMLM+)OUK4OZ M)]LX.8$1%J0<@\ @B[PU=3D.[\TF1B(P%$XJY%&GJ3XKT-M0OG8X:"?G$]#*NE.52[X%],EV?8F@Y2&/5#< M6G9V3QKS)VT/8K"OWTL5?@_'GB>2]W9U<[4\6YU7@1[ML=O^7[AQTD1]'-IX3YZGHL\90R$>F]]SIL:FUI.^GA^DU,#[=G1]@U M7]B'ZX$.LAJ"\#&:4?D%>>#C$#:0H\YDU"QU.1;EI+Q'UP*;PF.YE@;M]^5: ME!,SA6NI$7XWKD7!]1%<"XQR/-=B'\LZYBSU=BU =%ACNB/YEHK=^KQ83J8> MW0T/T26>R0GH<-'MW,S8$%-VX]C44ZZ.4U(5GW=E4S-4/HUST0OHC#_Y[&7Y MW^#V((C6$?V5>DGM<#AH\NP(N^B#^DR)O7>RH>J8W[)G>=CF)*?_MN!!<%^D M\T<;C M$O=Z8)\Y0P0XXL8Z3VBXN][)#!-KX;[Z3X^#3JSFU\NLC"D7"XFHVV[*/!6C MMTHE16<=D8E=E"V2ZR>L@5/7>VOTK@YB.J\[E7.QH.^VG[&>H"FW0NY['TO. M\;= 1_9*1]_^3.">^DW+B+*/$ASI[(-HB"C)Z$3%^$X071 MALK_./,SD#XR5[#%XS0'6B?SJ;N"F6N*#@)TE;1!Z@\_Y^0DNM(>QF]P)6XU]Z.FKO&]*7BG.*: MA+547A4)EQ18SU]/)5[45!B(N="V!=[1A2'ULX,7WB3QGB;9F[$0O@D!1S^[ M19!540\]N]9UL:)X^I/!/":7=K7\, M\#@JU"F K$%:X-D5J(.3EOZ4\,0K$5!]3[%K'K/UZTT%RTL-$K;NNGJ10/!G M _A3'%#J9RG%=A!]_]=30*@M]) D*:K60%PR[PR4SU,* M=5S"PX97=B$>R7B-&G+_Q. K&"^AY) RF"PFFRHDRNC&"<>HAT;3-&9CP)T# MK]VPX;Z*[+B^IH2[.S%>'/&"V3LO>B/>*TV!/E2$RQ JY?2=7\6FX\J)SDJ& M4 6T1'E(N1OI'^>H(3L7:%*(9AE?DC!="BNUV.H=38*F-K\5-%H:.5=*P2@1 M):F*^Y6(HE;QU4O#WZ;TGX0Z!$2H[= M, [I65B>,ZC:Z(PAY)P!=8AL:5(:*BX9F9'%WF8GOX&4R:&5[II*<,AM^QN4 MC2S%\PSBN6&V;(4>M*P[:(Z2*/8;0Y?,K&1GR$80YT'B(&GND0LH=83V5J]P M7@ZBQT]QO'D)PH$10@49)X.V6G%[1&Q;-%P+UVH8''+S\&U)BQ3$CE.?NW,3 M>2R96SEOF$G:T@JZWC9%U$Q,%Q)2.K65*+4<:2/&_(G/%NRTDV\E)$BQ;!D4 MVDN(T=+0USV-TBFS@PW+Z2])D&64<;KE#90N=WLO2'A?^?:CS)&T$(+V8P4O M8_I#">&$_,=QJ^S$!C4JR0.4>@-K,_MUT:7RR7NFY('2B+R(,1GBMFBO%93C MSARMGWAJ!#FBRR[-21)&L^BH5I%=(#P-/<8 J=9$:XF59$CPG0Q5MN,>M>,YC28W]@^[9".OM M,DD8B_S)B&'YU\#BJ(21<5DOE("S*X>!B_8!AL%"A$>"YJ_"KN/HQ)/^[9[] M,?5\\$X.[ $D;M-EM&',2KS*K!H]3F\J2 '_8<+6;@#ZD9C_2F (?^VHND3% M0HE'K(R:6)5X%4?+-W1*[3-"(D20S$R7P2 U&$Y SAU#& M\3R=KTV33/*S[&]-'\O^Z>]G\0$:F>Z])'N#=T2*A5H/-J\.=[$+"JR#F@M6*)$UXJR:U9,K M&W6;?FV\CI/LZ#SIB@$72EF_E21_2@./NL+GX4 M5Q/5ZSXH0L)\""2XY:_U)"5A)\Z"X,S[L-XR25RO*ZZ/H>;+1^:^(<_\N.]\=/,?7Q*/WL;984_&RP$M;<7IE3_;A0<,[#E2WD[S'.?X2*.K;&@ M]KN"!MGG1,3%;\ ?M3Y0LF/TR"':T(2$^3&@K+$RLZT,%KQ$)"4FN2G%Y6(" M-L+U[ 0BM;\@8B3L.LYHRD10U/]4@^#$L%1LR@$J^??9HT_MP16;'@9"+@ :(092R!3CD M?GK!$ZG@6W)4]D^PJ\MWI[Y\"A;KK_AG248B19-G7HN/-M).* M.J1@Y?2+7Q&6\Z/-RC**#FS?IMBMY;I7Z)U04_17F:'ZW>D_#D%"-Q]T*0M6 MJ)@O-.W$:K_3-.,AO=:T84J7&*E[1E:@8]8?&"17<<7A:00XPG9E^);$X6W' MP*V%R]N' 5L$Q4[ ?JW?\T=8U#\4C\O>P[H_=FUW=^VVDNQ+_6-/>5%Q@+@> M/.6K-H[* +H2#N,RPL!P=?V@ ,*Q>CTG2AN/.+CHJE$AP"X?K+2P]=1_HIO# M[+7@>L@B0"&$+ ,CF%U_GAMS/Z&MG;.5WV? D/2SWF[9EB!)&5\'Y@M\>A.' M@?]V3Y.=2@QK5 2+["E6::26>#AVVXLYI2GO:1+$&[[ !CMV0G]FNO7R%/A/ MW)1+^H0-0(H12#D$V?,Q(%#.C'\;,_EFMO9Q,] EWX(($@1H(/B%HT@75-+E MGR]32'WKS6SU-UZP&2J/P'74^F7!>GD 0'37"U3<=9SU MNXT_]Q9[1M%!%V 0U&*/D,L&1!QU!@;Y;J0O@Q@RAWZ@]:$H!';78U&2W7D9YBN/FAK)98C[N49=G MT8> "TID(Z)>N4S8R$K7S5JW,A8TR"WO?"S(D(K.]*^&+FB9WG%V2!+-#84! M&._MD)[UYO.A-B3J"R(=.RW]N&.+5GXQ *TLY'L"+TG>(,GU&9Y@IPOBI<5/ M#U[(]R/I$Z49V7!%8C\567U;-C@$,$5Y&,@!A/89<&L!W3#R-(:WO.$]T(.^ M?DPB-I;_YD,O#48KCAZQGC)93UYQU0<(17;2@N0X")N8H?S#!UL07\WWT4XS MG2ZA%[IS9QJSV^B!Z^+)QD:[ZH<;.=*Q*6A_PU^SQHJ@FMG9%(G%[\"GC)_' M[A *ON>90,K_YNWV_V,MGW:'IWM.]1K?]Q,*!K(2E4PUF[0V&-)[>@V[M0?S M#9CY7\0K&6A'V HPLE)7D9TG#Z@WM\QI1>P_OI<^024\L=4>40AW(DV^RZ^1 MU]MSNJ7,#C=G\0Z8XOY?RE'XA7G3RV@3/ <;:+DE,GV./THLUOTL41HGU7R@7BL-!^*R&/5BKWPSGO5<' +*0]( MBA');WQ,S*HO$\S;E:8!Y7&&P(KR3#]-]3C0=/01(D53,Z^()4UG5P ML>[H,Q6G(P?VE(?]/N1V[85?HK8\):_%/^CV#_WI(.T(API5E6R<=I=3B=@ M995A@;T0)6<0[9-7'E]O?^&/YK)U7O\Y_ &X,W5Z< (!PB".\S\U5*EV]TL0/4JH\ MW1F $5_J:EEO/==M0>*^V=6PT_%P]R7'@D?V HUL#@DO#%F>_I >[MH*5+W> M+3!(B3(MYS\*SB->:VZC/<#U%>"7UC=P;5U?'[(T\R+H--UG":JA.;2V*\3I M7-TE'#?6]Q9#]BO\@DC(.-'*@2*5DE20178=HLVLF:],SN+=+LCX*WS3>4H# MBV,=1L9EDU "SFX'!BY:FL)AB00\YLRDV>[<[>,HC1.ZN:4I9=/^9-%=I!L' M8?-C*TBY!^I"P-D*V7'5HS)V6A D24X1K=[O0-D*Z''M2G3Z?W@(&ZU3($EC M&8%G]JY$ :$X"6AZ&?G?&6QB$!T,.QDA<&4[ X@@V=-@3GO8F$?2)8&-FIDLK4H/AV(F) MEQZ6\"C(5$M,.K.:]Y(C!Y:T^ AM%\[8HG<(,SLE-@"C%(7L8%VJ ZF!Q"K] M:&1'L<78P^Y(=$N >W^=?OLE8;1=5%_9*OCCZOF_T[='&E&];C< $/19R6*I MP[5?T5+WB4X%WI67\71(Q0FN6U'7,Q%DH;+*W*WMK,7* MBUCFH,J(T;2 MGV5[>^&T2;'3*)NP,_(+4@X ^RG)LI#2=8\U-V"GKOD#)L)E=$U?L_L7&C[3 MSPSF2?NBK07VD9)K_T4D+N^-' MQKYK:@O5-:MJBV5G3Q6>0Y;49*JO#0E\)\VG4S2FT#\X:3CW3T$RS&XD3-?, MIB64G=64: X938.GOC;#T9TTF2[!F";_R[3)GTI&EELFPP43/'M26$$_5)S$ MT#YBR6FB-GAH2:/VS+7O\NH]3"VH\WPMR/[3@DRZ?IDA#US7?;@!@Y-"H6*RR9^1?D?)F MVBRTEZ0RW9]G4M%7>.0 .5)LA_;-3?1K]#DZOX]^8O^Y^X:(.]0%[PQ#7YEO M@U8FW]Q\^/6OGS_\I/)-A?XP1ZEFV9PL"J5W1^812"9TIV_#R_X)UE M,K;GRBAE2Z#W-O=[H'[S-+1'H*Y6**\]LMZ6 ZQ>,QJENNJ6!FB,2J&=S%>% M0K6@2'5"._BQ*1,*=E!5"2T?^Y"=]T8>H/ SH[BA6Z2U97FA[O94>_Y0X M&)5!^PI0L4T+R!$E0K4)/R';;#,7EE\!J/,OFC HJ3UJ1J5\GCH 5A*/B@M% M@DH.!KDY_!L?]NSS>OM]$C_#Z6E+/,+^O#GX<[^RZRU!#H=@4D>8;-1W VD* M&U%V#J:1_W9#>86*L! MY@,1/I(#18,[ITDW2U<=&:Y3$$8L(3O)E+1*SXZBBE.R=@*6U:5N.RRGPW"N M]%F[\ZRR[W1RWH-K*:JU+C>; %"\D,.ERT/V%"?!/UO%BV<9\9TY(_M)G,1+ M=0_W?MR7K2S3FVYQ<(#M136Z@$])-?X[BM*MB3UE'L4O4 M&\:G[KZG!S)&Q<2^HE5E$FTQD6HC]F.O?]0\EHO7TL=ZT= M[IUNA3JF;])]D&:L][<),@IRW!U0L>TIQN;NF(_^3O<__>:RFHA\[Y/P5SRP MYX&)V(JW2AX,@!JJ'3HKJW\<@NSM,DJSA"_L*7^<>__D1>L]D$BOX^B9IAG= MW,9AR"8+D*;^- .9>&<><-143^(7!W'P?KSE"/&.X4,%.T3BAXB7[QGCB.0L M,5=;,*7PNK\!HR3G]+W%V*;\'+=W7U)Y?H0S_KH=KO%F>L;QOUHWJ[\GGVWP MK]&Y&J^W$?WJ4=RGB%6L(F7;,U;P7]LRHY[>>5:9^MA?T2*C$@QQC1'LP-N' M&^7EQWO?H5M--^S-R2- @@^-E&OM5^$P?^;+!)K#; [_M3E,]?3.XS#K8W]% M#E,E&*+#%.PU]D: M_BORGAK9$!UHR='7[$-MIYV[T6T!_%5[TC)*\0N%EN!TLWRFB?=(^0[]G'VJ M"R](?O;" W7BGJX?EU^;1Q[UL6:.0_=A\2OR["/D=R.F7?!-_\1UY(7%T] M_I!+QOM;)[[JN]&AWZOW+/[!KE5GG-<_XHVL>TMQ;_Z^MO5XX ?"N/3](ZW, M@R1WZ-H8=95VYGIYZ'>KWS__</]1UHM!DGN MT)WY'W6UF.:[U:[>_SB+17ZE=F#?W+V5HA]S7]LR,>33S'JU;\795[1 ]!<; M/R$ F/VC+@P3?*]F)L$?9V&HKZJ\++\K1X8F,U^;X[>9>HS#0)V3K\BQ=XOI MU#;_Z_78 S[$1>F&X?TO]]=L_K)\*S]-'2IL9YW/SOJ0I9G';Y*.F,S5,=@[ M<[964S>),S6.]'ZWI&'KE^T?DKB=/**\::1WJ>7-DS:E'Y:,F@%,.\.P>EE>&H#DH:]?T[ M*/LI+!P4!8ROQ#W1Q ]2*&=]U "<8ISWZIHT$S:M8VH,\@[=DE*"(SNE7&S[E M1[J'L.3BW?G)H2+.=Y/12@PL&".N"_+2+*]#B^G:'WFZYKQF'C-ABDOGWM/F MTC*D[>YN\_YWDJ5H2@[^O^ZNK#=N&PC_%3XFP+9(VZ>^%-CX" (X=K"V4Q1^ MTDI<+Q&MY(J2C_[ZDI0H4=9%:7GN2Y!L.)Q#PV^&PZ'D:#A2;^19(4D=>_?" MDFK=%H4FO/PXW$: .OZ@7+O5.P?H)PRQW!Y647:F$)X"[2)3*\7:61+X![<+ MU-.+N+5 MD%717W%A/7?5;I/''M[>B9LH.]L,3S%WX7F5HK ,V7P#X,7*:@7 MA7O[K$XU^55C_YX>K1/&X9[6$#M9\$PQ/,7AA>96G G/DL$_'%ZDH.YLN*>= M[)3S815/H-.,YC$.R[?#6#AUE.;N*.JJ-:ZF/C>_,%:E7N9ZXGS%4ZW6[FVA M.^[\T0=D74<1HD.#^ M,B%+Q.<)AG&*Z/> =/:J?EQQ/SU!TCB&58*<,0W\0 M4UX;'3C9< <5>R#P]_<32$=8M1,D-O 0(-9:<)8FC+(@9KJ#V<$V[FVG+;.= MW791JRMH2Y7]?>P9F9;$(D;:,7H'.AHL0=.'FB,9J9./ 7ISKBL M-F(H&#'W&ZV',_PA._ZFZ8DNDL1/M#["Z"K1>H$8WJ'U8ATMU@Y.#ZW5/85% M-05WD?N(VDRS$3%07Y#CZ5E]88XA5=9F1QGZ4U^0UT8KE@J%!H,%!@/%UR6& M73\^9NRU#N K 3J48!3VOZS:(Z 34OU:*2UOPI_FYR? 31I0TW6W-C/O@&U" M$W/;^8FE[ N>S;7GT,8\J#$.U89QXE,@:A+DMFT,[+8[#+W?5 ^84-/>^1TW MG[?(O:J8VPF[!'0F#2JSJ:U1+W((]NKO@ZPQACE>)]$5"K8H)GDKQ-]@0%/6 MZ";9P+#(Z*= R(#K-,GX/TFD0)C2,P/?P7"?H'\+B.^H!08>CEZ6=J#/A!E% M\-/)SSC\Z5>F_[,WC">H&+#>Q!6HF0"2YP"1S0K4/$##!#PP-ITMJO]+^ HE M\&L.#T.O--?/]J26%>K.=+"=.@O.VH&Q,V0T4K-A_=GP"<"#^54-NLY%X>G.'V#\!9FSR1I MZ$]AKM.D_/PZ6\R8?<==_/^S%.?7:?X/S#JN_1GYVUH1V XKK M1QLSXVM-LR;=2%+Q Q5#,!2K5Z#F6L9D$GQ;L9PR)6-R\ 9ST/"U<^?0M!GO M:9VZ&@)"88Y3A+#RG/PRS:J?Z+BA;8=I(4X,[$9-;00!>R4X'5@<46]T&U-O M3YHDOX.0JR%,7%6M)O3]8T!@?&)8.<>V@P"Z D^-K;)A6\D Z^LK0@PM/_WY MQR>&E?27V@"X- "NMVJB' DW0, ,D%,#B/\?$@,D:4X>=*,(JSI56[,7E.\/ M*"93I$DY.YV.I,3OGHH3$IE%42=4;B#5 7&TX&N4A@7%*2::>UXW=,WBD!8$ M9],=H#.#/ 5;" 2LH+# JQ]%$L$,8 &FGRJ8#H1"T\L^Q1!47 '"H!Q*4M@@ MW"/X7(XB#&LQ\:]:D+DOX+G[(+2%B5LJ5-67^3<1ZAL7BLW^HQ3*;&AT]RF, MQ$F^"NB4C>]6"^&YWXP&MR/G"//&6B+FS6Y#5EI2P+$&U'$2.ZF^C!IB8CXV MWG@:/2U,Q^':)!06*R('&BKOT('X],WNCH [WL'L9OE?Z?4@,1[7JMZH#,X[(#G*;T,O\PX MG-9))VPK-L,-2T+7'%&4:JDKEG-8=<9*/-JP^PPS(C<AFO$@)02 4KAPYB4(MLZ_IRC)OR9SO*B7R+HKC:@RX$\]%#:= M:E"<4<\* /,/+-#M/BVV^*^)U&-)B$M[ $*+GD8VG++$=OYNGFNA]U; ; I[!0DSY..:Y-^:PM!F>N!BWWGU6^PU2ZAOE90?+7 M#JS,HK03EF(3N/DQYE/2#?DVB%DNA_>03!$%.;09&R6T?1<-/]0D']E2UA, Z1&J7 "< MHT%0:A +&B1=#4S>C@CW,"IB>+-C!^"?W\YB(N/8<>@HA:6;#]-*M.XY# \W M?ZMA2I9N_U]%05<]HZ%WEAB5 V>A3(Y*EZF"VL!82VG3F."M1*EOH/G4:%B* M+O@PWZB]Q9'*6./XZR1'$8H+>OOFEKYGA;WUY>(UC(L(1I?D,='>G2*O2H,7 M04;?[(V_TXU&D(VV;JAF8AO>5)JJ'Q%5<+ (HNK$'\5=D0UH^ #.J*Q'"*PH M$6=&M_'E!1<' /M(@WU^ZY]@I.E%*T=+I7#]1FS5S_6Q,U]TUZU+MY@]L':M MM_'T:W(=',8[>*;)7%H4776F/;NA<<0]WPLDZV-DNQHZS ??\_L [+<];"#.,T3?U\#V ?<)RO'F]G[4!R9H[#B% ME"*BEXP2&'<;"6FZ;UFK::IW"!64RKE8)1VVITH#ZJ9W*?8M-X_"[,]>S4*M MX-)YW>P]F1OUD2.M55Y8T_,D^-Q>KJVV810NK')BWU:5*+6N);4")1=+G4\: M#238)&T^=@.V10Y@RT9AVT:0V^B)WQ05;4/^7NM!P.@G^9'_1/Z@-^G^^A]0 M2P,$% @ -S)D4S/V65&E4@ ,,0% !4 !X>&EI+3(P,C$P.3,P7W!R M92YX;6SM?>MSXSB2Y_>+N/]!UQMQMQLQU:6'35ES,WE M@J8@B]L4J>'#9<]??P I2J)(@ )"""E?715V0"(S/P!2"3R\;?_^[&Q&N_ M]4S'_OLOK5^;OS2 ;3A+TW[[^R^!]T7W#-/\Y?_^G__^W_[V/[Y\^<_[V;BQ M=(Q@ VR_8;A ]\&R\=/TUXV%L]WJ=N,)N*YI68U[UUR^@4:C]ZOV:[?7O/NU MW6GU>HTO7W8CW>L>[.G8C7#(]J^M_6\&NU$=^Z^-5NOKS==VL]UJ]/YZ>_O7 MVTZC_[1O^ 1GN3)S6UJF_>=?T7]>X2<;D%S;^^N'9_[]E[7O;__Z]>O/GS]_ M_=GYU7'?8/]FZ^M_/HWGQAIL]"^F[?FZ;8!?HEZ)'A^OKA7WZ7R-A_\E'A_] M(.L+D >]K^%O85//_*L7?FGL&+H?"B#W"PUL"_2O+W&S+^A'7UKM+YW6KQ_> M,IY7:EHY9,#?FH3V>P9!/C<:?W,="\S JA'2]U?_=I"*_^S;RZ'MF_[GR%XY[B9DSB\--/[+;)2< M$!S+@#T"]_-7P]E\16V^T@WWM>RLYSX$*AI_X-B>8YE+A-M[W4(LF:\!\#V& M.=,,=H89/^LN_/4:^*:A6URG?S*R&%KV/_2FJ^D6N*&H/2C_@;/9NF -;,]\ M!V/'*RT:EB^)IW6PUNTWX(WL^1JR>>U82[BE#_\10,SS))3XF3-0J7OK1\OY MR55X1X.6IN#!] S+\0(73'0X#3!=W0>>:0,/ 6,>;#:Z^SE=SG8=N#C]SV=+C\X! M"-8MDGRA.1)&XSCGF?FV]J>K%P_T/0_NG&, S^3IJV6^[3>9*=Q(W?#GQ0## M^@G.*/'\,8[F#D%;ZA%3TKB>!SG'2E%X2T7*810&V2^Q.2/Q?/,@2"T _B'X4!UH?!4 MLX;AR57=M:&\O&?@AAIH,7:F!E%![Y.C_XG5 Q=HRRU^KB?&.(=.. %^B2G3 M#"M-2RQ!5[$/G4-C+(DOXIB2M,<2)!7YC$!-LI1PLH<2I%66F&G6,&?3W4K, MFVY@,7I<0NDJ0T/.D.*UN1*3SQE1J&97YBS #B90RRO#9LQ0*FA\#\#73>O, M"M_^HR+TO3(4I0")]0EQ'2H\97'' M^IES4"F$)A$49*J=\( (7!@E:'.VFY'Q)^)WF' MWT$GY*/CSG4+S!&OX2E?;BLI^BG1U#ZA,Q0J8=,5?C+WGTBU='7##W0K[L"= M&>5G(O >5VXCPHPEZ"972J7*&D?H:T&9V1)&.]O]\_BW96@I\)6ST;C[9ZE5 MP/B%\[R>C-&,2RJ)+,.?AZHGU]^.X7X9::F":,-\1+R]H0P]>4.*G_W,"TJA MC698\53,?"J/_S[\ M0']%N_.+[4;&K7\*7WL%)R#4-EC*9H ?3:!UL)1@<&,)G&\?GB0/IA7 5N3KW8N^:8,WY#XYUE^!]4LN5[+&LEPW,11R5.\A1_66 M%O(M^87R4UT UP/BYWO\F=VDMR[PH,S"M3N&']E]"@W&RX/]F"#PX0-["9;[ MGYH^^E 33K?9^-*(!SK^JVXO&]&HC>-AP^DCKCM&X@L6BE)PW#3//$A)R# / M&+^^.>]?E\ ,8S'07\)E$;(*_N/'P('7EOZK%UYDXY$LQ+>__Y+Q^Z\BYQ+S M80%'S)C*\:]_:)UNMZ6UM-O;UJUVJVG-YM'DCB7==Y,3U5TC'AO^-2W\1#S% MKL77;>@J_\58F]9>GBO7V63R://]386V-JBRF0X\VI_&@(V$E0JYP$(W#2R?"H;56EF$?"3H[="L@QNKP\FA:8!)M7X&:( M[[1)DF3T/VU%I48U\YVP[B2J&]$\9^#-1'38_D3?9)UD6\$TJO, MZAD ]*ILC>PE^/AW\(F5W$F[JHF.9OKQU;A9 >$- M=-',QX'1+7M#HB9*(@ MEF(5+!RQ3<]P7'BCW+W\0,(&R&O3_1PX2_Q62NQ5'=D6)286LTPS2#3WA?XQ M6D+R0Y];-(D<9033OFHB8R$C%I9,LT@TZ_YRZ2)_Z>B/L6F#%E90&6VK)B1: M$F(!9=E.9 NHS2"@=O4%E$U"+* L XD4 0V0OZ*[<'[:>>(YM*RH<'((B$63 M9?F0(IKP_)RZSZ[S;D;IRXCR.6E>42'14!%+*LNV(452SX[GZ];_,[=$32^K M<46EE$]#+".9)@VTX/LNT#%2.?YU=>20.^N8\UFVBW-Q'F5"M)[7CHVWZ)TV M2=+2[3;;MXI*@&KF\>MNEA'B7%+8.0U]MMJO"^1&DB&%TR;5D0+5S&,I9!D1 MSBV%X8<1!@9A#*M9S:HGC=S9QQ*1>=]?N#I*C#O_W+PZ5H8H$K^OC@SRIQTS M/^O^KJ9-;6Z3FU1$A,Q6Q1.5?^$>V#Q!)YCMXT'U]1P/! M[)G5O&J28J BEI3\FS]ZBW0'\)KU%F;I)+RU[EM532[YDX_%404_AXBF^4:W MK#A1!%9LB595$UO^Y&.Q5<>M8;@![AOQ4'F>SV87+A;$OWC3P M45$"I-#BM3U"IZK)BIF6V$.9JY?#W[Z>AKMP"(*A*8EP+ !L"$RKB4)@]L/! MOP^FD_ET/'KH+X8/C?O^N#\9#!OSWX;#Q;Q$_,M*]UY#+@7>ES==WT;(!9;O MQ3\)(?REV=K5Y?B7W8]_[.7;!5C>7A_PJ M1^DPR;L!1<\DYWJ:UI,4 \8#$D7IY12ZJ=;>0 .0^D*!6NAE7T%\E&17[O: MS^",W1?P711% ?-.P$BA4 7R5A(T=E4][;L!"5K"A&J5LN1_I%%/'-L@:I>9;>N! 7K2>*F92BD6<9%4PJ6B M'G(FT,(IRXCT^T.] R?*(N>\P!&VUT9/'!Z#RU%MX#;AFSLT#V7 MXCLH@P\N B;BA8;RNCRI'M>D(-NB,EJJC D:(:910$NDT)=-61;)Y+U[7_:# M# MRIP3SNDU-0_Z4E49( 7IK_?A)M7=D-ZX?.!CHK.5[)Z3?#>#,4WS$XR*[ M?2VAP4"J@+=1^>A H?E@L[6<3Z32WP,;K$S?HSQGZ#K7#S8.&4DOV.2B6WMIBDI0S(W%!6D^4*T5VJMM7[ H*21U\N?0A;[3.V^ MH,^KAIU]8O*6DS%W/(=?7P#>-@T:;F\;KECZ-5^-?$Y_XM]JF]6IU M95D[GV/H'66?ZP?^&AY)_SR(+QU53^BDS-HO)H8,,SD[N76YOB9)AZMQZH:< M7(8W]V?@AMR@@@FN<\WAPD1V7:ZZJ826N5L*H4?M ,)*JX#;JFQ4,.XD%#WK MC)(B>TCED_ZD5LG(\P+Z_2-JG>101],2BE:U49%+IP#O5#60@,\/3=.E_IC( M(U: W^FY+Z+['WK3U"F=/C:F MS\-9?S&"#1K]R0-L^?0\&_XVG,Q'OP\;X^E<3@+JR/B])R'G"1K3&@)&Z]UJ M=[<0,KV>=M-.1!Q*N7@O4*0/UB1YW$B9I5V$R5FVR%SB.%TT+7[;N^?Z1S*& M_SJ5+_P1RDZU# P?:C7 ?8=+OO]AGOK6X)HI)V,**1U$RT050;BP_.1C=/JP<3VRHC/B9)9 J0DCBL%&4ERT-S?P(9I3DSVZ@H,$K.9]EF M\BCC)"VDR80B:/8ZS5 Z"?[^8;UJ;[H"E&(-87*U47A[06,X%^Q">E3#963 M'Y.^PD@7)P,V1W6T@!O-.[ #\ AYEA78F7.KHNRM+BC(\LURI"E.<"VK5^0P M9)\[$R56@_^WQ+OZ%1A).5R5@0N1@KQG MR@. U!EF*'WX=PN$,+"7_0VJ-/Q/G>#0P/\#R@&U\ 8HF"="XWWE15B5Y9DP M@":%<*-U.QVYP!2,+Q& SN2AT,.>>SX@=7P"7V40P>;D+.T=U9JZ^)&.0>6AK2>V M0:O&BBIE(VM+Z2__*XCJMSPZ+L7M&MN^=HA@HY3@:"E;*TTQ@O:.4CN1TE%8 MEYJ(>VH/$?%YDC^T3'+F5KOMM:I^+\TAKB[AO!/'=I(DQZ5@R2:*W'[U@40Q M4CGM"PKD(7JQ7:!;*-CHFV[::$5,[?Q:=CF]E(-',2FGT5*$[EIFVHSBVN? M"-PP[!V]NSJ!/P/ZTK0^'P"<+;R>(X^21WC)"L.4#O^;0?P'K]!Y1LP M(./ZC=I"4CR7RMI/>A& ;?"&0C7*7W-"O5@HEW'/>GIJY;H'I"E\4^XBCF6]\10:J)V[XL4+H,Y"LQ\&#>D58VAD$]GV=M6I@*BUH6<]2)>6SRP M45R72BD'>U3LS&K: >3 (9;Y'JP<=Y?0ZO?L96CQ0@G[D M!NN$+Z7QPL+N+\*^F)24IFGM;D6-0^=F4KW@#/FQ6[N[6A)$**9:UPU&= 3N M('!7=1\7J-+EOC4DVM1'W/ED[832Z'0?-\U7P,?&:(63I3( M,<]1DL_H]0&62(;$5NJF&A8ZYYI(+=_TPI\; ['G%[UP441 M0F-LU,NI_3LPW]:0Y#X\/?4W, E0/I#I*N3*419#.OP4&RS);<1NZ15R"L** M(_TQVL0\[^[1)B=?Y&"MVV_ &]DA9S++7>0DB^RP)(L<_-:??!O.&Z-)8_Y; M?S;\;3I^&,[F_ZLQ_(^7T>(/V44-J&L78M*5DFII:%U)^TKIW)$2]X&"?$[O M!Q3TJ9<^LKBH(Z8@GB'NN#J43] M2:+8LQO74L8,I&(](B6Z_.]ISLSU3&Q;2W'24XIU9JQV"M,[3;M118Z%-&(R M735(85H(Z?OP+K6#6"#S?RA49(R7JP MP; G6G2<0,%N:Z!M7QTW-#K^@11O(>O M/L;.PA&AX5J\@D"95QD?V!4:O]ZXX\<2 14,2X2.%MCNONNNJ]LH[QQP#3,5 M#L;94T!-F3PM1;:A$G#('J#>>&"@F5-XC0*)>TAK(_S=-*1MSPZ< MFQ3S.-7'$E_2>07SR([8(BXN#H@B#%1[2+'2+C8:1S%K0;C>)N!G^)LB=JA] MWR0O>UJW=5,O'%&0R\UK/!,ZMVI!)UI7!;%STKGVX*&A5ZQ?N6+HB0[ZGN ML8:\F:ZB"@8%-K#3(6H/*WJJ8SS5*Q,9*6JU_ZZ;5I@UU'%19K^C@.I],OPH M^>;*-"(P[']?)K"8Z_?K@V2Y+(N7@1A#NXK+()M?98"=,^)E0+4( M$V+PE-WMM0E!9GKWOK1KW75ZW<[=[8UVV[F3=S:CV3V[ MSKL)A73_^>*!Y5Q'J&[[Y'BG8.?5TF =2=\W32BSSO.?!A;I4@8V*9Q/4 MOD,#Y=# 291IC.30++26CORZB]["@7?9N'>M M6(S!;_&:O2H \VSX24.W/.,$Y\64=1VO=B&S"T>U>,:JM1-C?(F/*Q*C3&Y' M]:OW:_NXS?$6D!G#4&K *T"%<5%H#"&O.( JPBH%ZKJI5$OVKJ5UM=[% M(8@'R\K&^9VI1+%"!6@O&6S\N%!0/+:;R""A7(NI!F!%00T.L!O+,8 MP'PGU)>@Z:H=X MQL%XHN&$4 E8 MR"13M797=KTP88%%)7G"Z]1T?-V2>4_$L"%R(^,0;TL82#FLB8NW9>6" #5? M3KRM_KFS!?6-?P2F"T[CH'!AN'G]E,,.)\&G$56,%?5YNDG1C_4XQN&OW*@G M"T3JNNH!3 * '#VP?G:* D&NC6HH]!6APS2\'-$P<4"M?AXB[($,A MKMQ^EPDB>E8(?8[N*("F7: MW6JI\,V$UWO.NYN94@7<.WEDCLP MUI=U<_GHN!C9$UJJ)^<20CJ(G)5BH6'7\B(;X7S@/HD8 'F!#3!+M%(&$*PB M3*]W&LIJ*?B)8QN0:P=W,GNYOT"'!2'SW*EH^R=9VM/N>MW*GQ+EB"]KZQ)U M3CQ#OH3N^L@[&FQT]\_^E[QJDW#2#1*6;'+%Y99O:;$<%=PL3"F$H6/9N;; M&JH%+]XN&!+2/7#@W+RM$Q:[3F9IFKY:YELHX$QH%1ZLWL#BRQ9.IFMN+C4E M5:N3##N#P'73H8 <1DSPLM>$]QS9L:DRU"T&W@C-!,)K^THP<5?+GE#DAM"\ MWOA@)9R393A'^'_[>LS7,9QQ]./3G^ZH2;,6DF; AH'[^:OA;*)O/IB>83E> MX(()"GX%T]5]X)DV0(4SE_-@ Q?'YW0U-]]L@/!M.7R6(T^=9XGHY'@]%P_HN46G7NFV[O MRO5!8'B0#!\?W =_T>W 2+NW\-[(YYZ&,ENB("REK5Q*<%B Q>,LV^V^Q@?E]ME.;Y^CR>_#R6(Z M^T/*-K@GX$B2>EKQ>\Y$]M3*>F),B-J;\& M;OASV@O.37H?F(V^_;;X,GW\\C(?-OKS^7 Q_TMC/.S#?TWOQZ-O_<5H.H$_ M0OO#=/';,DF$SWF+-G;;*5ZOD#G]/QH649K5YJ>O:,11HI,3=9>#N"QI9OV+DE;)'$V#5[$ MYY39-XHCY_0R<#8V";U(=,^T&SWJION[;@7@"6ZZ\-_QOD1*GI>S06GI#>JQ M/YHU?N^/7X:-)Z@LO,R&A\UJ_MMTMOBR&,Z>CO3SEG"W2P=8]&??!O=CX-><+H;SQG/_CSY%'N]V4=[=/SBEO ML6):*[- &;B=7I0LQ E=B'=G6HAS $]XE$XD5=LH9SGVTLMQ/OQ]..M/!L/& M>-2_'XU'"SDO9L^.YX/-UG+"K!?WP 8K,[>8?5XG.6;WS$DQV-QI^RFKULSW?30:_])9CVZA=UJIA?VH/\\6O3'C5E_ MA.SK\ +\O3^;H0>WX7\.9P/X0RGK?$TBJH56KJWG("AU'R.I1' M# (JL@$EIY>W\JG[*[?R&:6:"!HN1?1Y8GI$;P'.9F/N+?6HTIYIOP&;WG^P ME>$_.)@^/8V.;/6#:>@>.)Q(\PTDD,FDCC.-\Z,M*WW5T33IMP!R)V76?3EQ MI#>! F17UU86[7+8C)XY2SW#UPUYSRS^^-*X[\^':*$_/0\G\_#Y7,[]>C^W M,*OKGL!=QLT!U/F\,,?F*V)!G(^3YAY>:N ?G::LNSKMO.^/YYU[IR\WJI)[ M"0<)9]@'!#"JJIZU,_ .[ #^83AOMLFP[60X\LV&OP\G+T/XYV#Z;3*2MM_L M:$)Y5K.J%.=<*:A[2TJ<2IQ=WAY!VSV)\1OMMM>3>Z%@E&DR=6H)FFMAJ!_J MK@UU,)3@,-S7*)=XAH_>L#^;P$O#O/$\G#7FO_5G?V-)[5 FV"#1.G-V*=<14.CB1 MNEPQ1;&-<#%@XL4;H=E_9,76OGAP$Q]ZOKF!7,1E MGD\V2C+G5M.:DHH7G6L7HB"?4W(@W!XCRSGSU$T8\L[TP=A\!\MHQ5#Z5*?Z M71R&BG&$4S)Y!:Y?H\U6-]TPX;+[8'I;QX.;<5@1+.1!Q!2Z:UF1H2X/;[R8 MQ"E/M0(0W(1EYQ#P!?XWJ<>WC M0(G0(O:Y.$BQ)?L@;3H&1+@9IO'D4 Y"O%5R^V0 RP-F A?Y!J;)CFE\/3^ZC@W_:H"CHYT.1ZS#7!R^N# HQITHB[EV[NRK"Q3I3>=T MTFFVFQUL#M;&OT9#R7$=J4,RUKFQ!LO @C?&_=QV&?=#SN9&EE%V3^):@[AN MRUGX#+)+Z!]EZ"0X;9P[(@R;?G("?*95V4FO2F+^U;\T)L.%W.4J.!MK4Y:1 M SNWPDE8U5NV!621]7I=B-[J!H2Q95QE6O\WZ?5/EW:5?_FZE R]5"L=UURYYX96@PL/LS!:A#KO+>4PR=72U;2> M A>[?!$17![*$%X7M9&2&2^V\^H!]QTMXI&]#7P4M6\;4%D*)<<(;-(%ULV-J@40@C.,4+*0"_(P5J ML(MC ="4*BA:2DKF=2U+M9=_&3!/9R M]?!+R61__/27G"*<=4P \V,IY4C*[ NEI(Y[22W#!*$)=_E;@U4B?#)C9',.ZUFK]OIM;7F;:_5[DA?_VBFC L]W46Y%5N'&52 M"D3-H?1XRFT> MA22/MA QK%#(!Q.3IIMI'\APBL8GZY9\&5 T:W>KU9.O<62&-!1ZWQK@#/CA+R] MRL?UL3QR]P\/MX&PU#3A\)4+0O8Y.,?IC5>N?2== 87I1I<14)=1!T7N5:[. M!5$RIX3>):$ZL@\EH#I$"XRDS'Y24-(GB:FYD%_+&Q)=AD%=GRF MPA55WSHAJ3C! N)XSG^@I$J9L!PG&?&9Z9H[RT\DA;U\# M;GH/IA6@NRS;!8QI-&56/;VP2'>H\K37IT[&D1^O[9M+Q 'S_E0_+#K4&LV-2U1Q;?2J6J5/D@]8/SZYKQ_70(S A/\2XBC$$'P'S_&\+Y@#>%.XW_V/\S3 M$@H9+91! @]!'<1.2RE6M$*E%$WJP=GHYFDUGM-?*R,?6HXF99!+"B@7O"^-SV2DDBEZ\',10C3*Q<[AT?;O6&;GT# M-O!-P\.+!-.TTM)@H0FK&TNYD'U#CJL H,TX\#).&&P[9>3%]YQAHY=PSY&= M0SE!0.;)1&BIC'#9Q)$C1O&G%O=L[/&KX^%1T;3N^-AS;*!';C9CTP9AF<%L]WOZ_LH(GN]9 MSHO'KFTM1=,U5<$=M.*5F7E\Z)(DY-\7D"KI6H MXD+AL1K^!SFG(H-V6!"WE7N:E/]$;:%X-F;5PC/@D+R>Z0FEG7Y".:JD(/4I MI ZE%#(K ^3-_KAM$K MK=N45 &:02JGN7_HB.+[G"#?=!"5$=IO?V-G5Q,= M;QTB]% 7!KERS<($&YTL<9IJ")EH*2+V45#0;,*B%C>!7K5L!S/(<\BO-7(V M N_ Q!/&\VA/)SSJAN&,P;ZZIOK>)F&&FQC M=85)%LB)68:-/B'NKB4TKCP)_P8VVX%NV_JKZ>6+.-6Z;C*F(U"HZ4*6 6[/ M@T?3-KTU"%- YF[=B<;51T,!^CC9V+/!P!Q+D;?>9_K/)ZB0N*9N[1RF42S_ M86;O([5!\D!6G< >.V*#!Z$3!L M%(6W:WL,C3O9T)B 7 LQ;%)#\>.HV@E<*[L3.+YNE=<$>8O[.YP'>'!^X@UN MIPV33&IK7=D1L>5%3Z9M!X"NH,O [9D>N4BEBMG>O3KI=R^:6L52'\18BQ53 M]X.0T7JWVEW[[J;5:FEWS9ZL-7UP6\$7YB4\H=%V5V[]%Q-1QEMY&08H$] C M8(G^0V1I0F5=\: M"[HX_6J]U.TY0)3V2:L:RY6&4H*Y5[:1[C%P;1.E@(!,>#0_T-_(ZQC?H<9" M9B2:8,Z5+>^PNOR3#KEF _?SF"E$J>=UJ['L"Y&.M=O*RHX([Z:!@28QLB%K MWJ! \EQE\%UJ+&QFLK'VVK-%3LV0VQY(Y(#/45C1HLAP#Z3HI!Y:" MTF6 "9[N&KST] TCV 1A%8,' *=MF)%/.]A:8)<=K[]Q7'^7.0_+) R8> U? M7]@)Y5!9O]8<#R59S]LD_P7672WEZU,G<#%3S+^5\:XV$? M_FMZ/QY]"RO+1@FWIXO?AK/H=[)3:D?$Y_C()1LAQ+1[W5[WKMGNWG:UUJVL M4A)C 4+PMD] ,]PS1"G)!\X0H_D0KC1('ERESL%US.<&Q@)E&^;F@'=&GHH M_!8IQ3B]>4_*P7R ,\"7&4]!$+#)\\1*S)T7U<#+1-\#%=PK ]>TWQYU(ZR#5 _\((/G#]YTK!,&I'M-:&>"45T&*4*IPOO,,,H@N\]CV MRHF814!4XA6O HB1*3G-=5;;*LB2:C-GIU(M269O4WD/Z3F]E)-N^)G(&V7Y1?<89U*.?@6O@7\M9A[E$G-&R06A*)TYE&TOB+"[Y;@)O MEZ_;>PCRDCNS#'$1^"K HJ0(5DWCXA#V11^QO1%>_42U29XA,M)M_Z ]W*B MVE-DP"3K;C6MW9*+GM)RQZE(W+@C]'"4M6E1\0BR?@(^_,5/8+V#)\?VUV0] MG'VX*QP9>7.>>@Z*@A$MT<5/IR0&=Z-=L-+C'6%'PMC>"6T MK"0&2\+NBK0<7G!*EJE6+ &1(R_V=!,OAAP&;]C?H7T60AAOKXF''Q)@= M!N\$!4"I\=ZP9PV3R??S$I#$0OH.*ST%K;H3X,^0,%XMT'>!CI'S22OEY,O' M>D]#I5HI^S$>AUF[7&B.LSY1#=99^IV0MEN2)YK\VNGE)%^*;*'7+%[5/+*( MZ]MVH%LCVW#1OT9V3&7?RWY$+C[0I<"E&"-J>T=RW"1[D,]&6.>>'."5U[%F M:"I).*]+4"9Z-(';3[@P7G>E#J.RW[0;3D;7FH&B-.EE[R72%)1)@)P\IRM( M*/BI6].H%CTM,K)[7PHX&*@GW$4D:"T"#YT=+]!.RG#B'/6J&7C*4!U[CS3% MHD9P,#XJQ>/YX7T_CKN/HO(7R! XT%WW$S($5>@";)'XM^E(_-'D]^%\@0K3 M'(?;1R'Y\-?A%QO&[I.-=_1-R5'X1]QY *]Q;@?_[P]3(@7J8]LGUD@++I*[KOSJ5&RR.]X1V.@D>))Q-F91A6(?4OI% M)#\!?^TL#PQ)_Q0 %&:(B=PO,YQRL& 3[ $80AA!@1M.?H14N,'-'QNH3^Z@ MC.R%R"X)C0*<$!MAW0]QG MW=8-H*/T7G/#!+8!T-1^Q0N+NG/-Q%>.;D[IA3$"'7Z@G O95032#6HFF'S: MU(I2?#1MW39,9)I&]0W">H7X9 "8ULK(L*Q:4X1.BE0 LJ(?%JYN>_#RC2ZS M<^"^FP:\2J) D!1U'@K ]K)_1

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�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�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

  •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end